WorldWideScience

Sample records for clinical labelled compounds

  1. Development of radioisotopically labeled compounds for clinical positron emission tomography

    International Nuclear Information System (INIS)

    It is its quantitative imaging capacity with high spatial resolution that makes positron emission tomography a unique tool for the development of quantitative tracer kinetic studies for the measurement of physiological processes in man. Research success in this area will depend on the ingenuity of biomedical scientists in prioritizing the development of tracers. Choices must be made based on the importance of different physiological measurements, the capacity to synthesize an appropriate radioisotopically labeled compound for this measurement and the ability to determine an adequate kinetic model for its interpretation. Examples are given of these steps in the development of PET tracers at the NIMH. 17 refs.; 1 table

  2. On labelled compounds nomenclature

    International Nuclear Information System (INIS)

    Different approaches of major labelled compounds producers to their nomenclature in technical and commercial documentation are discussed. Some draft options of a standard technical guide document for labelled compounds nomenclature rules are suggested. Such a document after due discussion by the experts will serve to unification of the labelled compounds nomenclature within the frame of the CMEA member-countries co-operation in this field. The suggested options are based on the general recommendations by the International Union of Pure and Applied Chemistry and incorporate some more accurate definitions originating from the labelled compounds production and application experience

  3. Stable isotopes labelled compounds

    International Nuclear Information System (INIS)

    The catalogue on stable isotopes labelled compounds offers deuterium, nitrogen-15, and multiply labelled compounds. It includes: (1) conditions of sale and delivery, (2) the application of stable isotopes, (3) technical information, (4) product specifications, and (5) the complete delivery programme

  4. Nomenclature for labelled compounds

    International Nuclear Information System (INIS)

    This paper report on isotopically labelled compounds. The first indexing system for isotopically labelled organic compounds is generally credited to Boughton and named after him. An extension of his principles for designating compounds containing hydrogen isotopes has been part of the Chemical Abstracts Service index nomenclature system for many years. After close on five years labor the IUPAC sponsored Commission on Nomenclature of Organic Chemistry presented in 1979 their findings on Isotopically Modified Compounds. The system codified in their rules provides for recognition of various types of isotopic modification and is therefore of more general applicability. Concurrently the rules for the nomenclature of isotopically modified inorganic compounds are developed. These are to be seen as supplementing and extending the guidelines laid down in the IUPAC Inorganic Nomenclature Rules already published

  5. Fluorine-18 labelled compounds

    International Nuclear Information System (INIS)

    The work presented in this thesis deals with the problems involved in the adaption of reactor-produced fluorine-18 to the synthesis of 18F-labelled organic fluorine compounds. Several 18F-labelling reagents were prepared and successfully applied. The limitations to the synthetic possibilities of reactor-produced fluoride-18 become manifest in the last part of the thesis. An application to the synthesis of labelled aliphatic fluoro amino acids has appeared to be unsuccessful as yet, although some other synthetic approaches can be indicated. Seven journal articles (for which see the availability note) are used to compose the four chapters and three appendices. The connecting text gives a survey of known 18F-compounds and methods for preparing such compounds. (Auth.)

  6. Stabilization of labelled compounds

    International Nuclear Information System (INIS)

    This invention concerns a composition including a labelled compound, and the vitamin B 12. This vitamin gives a red colour to the solution and stabilize it radiochemically, allowing to transport the solution at ambient temperature and a storage at 4 degrees celsius. (N.C.). 5 refs

  7. Synthesis of labeled compounds

    International Nuclear Information System (INIS)

    Intermediate compounds labeled with 13C included methane, sodium cyanide, methanol, ethanol, and acetonitrile. A new method for synthesizing 15N-labeled 4-ethylsulfonyl-1-naphthalene-sulfonamide was developed. Studies were conducted on pathways to oleic-1-13C acid and a second pathway investigated was based on carbonation of 8-heptadecynylmagnesium bromide with CO2 to prepare sterolic acid. Biosynthetic preparations included glucose-13C from starch isolated from tobacco leaves following photosynthetic incubation with 13CO2 and galactose-13C from galactosylglycerol-13C from kelp. Research on growth of organisms emphasized photosynthetic growth of algae in which all cellular carbon is labeled. Preliminary experiments were performed to optimize the growth of Escherichia coli on sodium acetate-13C

  8. Labelled compounds. (Pt. B)

    International Nuclear Information System (INIS)

    Since the end of World War II there has been a tremendous increase in the number of compounds that have been synthesized with radioactive or stable isotopes. They have found application in many diverse fields, so much so, that hardly a single area in pure and applied science has not benefited. Not surprisingly it has been reflected in appearance of related publications. The early proceedings of the Symposia on Advances in Trace Methodology were soon followed by various Euratom sponsored meetings in which methods of preparing and storing labelled compounds featured prominently. In due course a resurgence of interest in stable isotopes, brought about by their greater availability (also lower cost) and partly by development of new techniques such as gas chromatography - mass spectrometry (gc-ms), led to the publication of proceedings of several successful conferences. More recently conferences dealing with the synthesis and applications of isotopes and isotopically labelled compounds have been established on a regular basis. In addition to the proceedings of conferences and journal publications individuals left their mark by producing definitive texts, usually on specific nuclides. Only the classic two volume publication of Murray and Williams (Organic syntheses with isotopes, New York 1985), now over 30 years old and out of print, attempted to do justice to several nuclides. With the large amount of work that has been undertaken since then it seems unlikely that an updated edition could be produced. The alternative strategy was to ask scientists currently active to review specific areas and this is the approach adopted in the present series of monographs. In this way it is intended to cover the broad advances that have been made in the synthesis and applications of isotopes and isotopically labelled compounds in the physical and biomedical sciences. (author). refs.; figs.; tabs

  9. Synthesizing labeled compounds

    International Nuclear Information System (INIS)

    A metabolic study is presented of the chemical reactions provided by isotopic labeling and NMR spectroscopy. Synthesis of 13C-labeled D-glucose, a 6-carbon sugar, involves adding a labeled nitrile group to the 5-carbon sugar D-arabinose by reaction with labeled hydrogen cyanide. The product of this reaction is then reduced and hydrolyzed to a mixture of the labeled sugars. The two sugars are separated by absorption chromotography. The synthesis of 13C-labeled L-tyrosine, an amino acid, is also presented

  10. Quality control of labelled compounds

    International Nuclear Information System (INIS)

    Some advantages and disadvantages of methods used for quality control of organic labelled compounds (131I, 14C) are shortly discussed. The methods used are electrophoresis, ultraviolet and infrared spectrometry, radiogas and thin-layer chromatography. (author)

  11. Guidelines and recommendations for practices of their clinical use of standards of compounds labeled with positron emitting radionuclides approved as established techniques. 2009 revision

    International Nuclear Information System (INIS)

    The recent advancement and prevalance of clinical application of positron emission tomography (PET) have forced us to review previous manuscript of Standards of compounds labeled with positron emitting radionuclides approved as established techniques for medical use and recommendations on practices of their clinical use'. Subcommittee on Medical Application of Positron Emitting Radionuclides of Medical Science and Pharmaceutical Committee in Japan Radioisotope Association has reviewed standards and recommendations for clinical use. Similar to the previous version of recommendations on practices of clinical use, this version includes 'clinical purpose', 'principle of measurement', 'methods of administration', and 'radiation exposure' of particular PET pharmaceuticals. This version includes 12 PET ligands that have been already approved as 'compounds labeled with positron emitting radionuclides as established techniques for medical use' in the committee (18fluorodeoxyglucose (18FDG), 15O-oxygen, 15O-carbon monoxide, 15O-carbon dioxide, 11C-monoxide, 13N-nitrogen, 13N-ammonia, 15O-water, 11C-L-methionine, 11C-sodium acetate, 11C-N-methylspiperone and 11C-choline), and three newly approved compounds (18F-sodium fluoride, 11C-raclopride, and 11C-flumazenil) which have been required for clinical use in many medical institutes. Each medical institute should have a committee and establish internal system to account for conducting clinical use of radiolabeled compounds. (author)

  12. Clinical applications of cells labelling

    International Nuclear Information System (INIS)

    Blood cells labelled with radionuclides are reviewed and main applications are described. Red blood cell labelling by both random and specific principle. A table with most important clinical uses, 99mTc labelling of RBC are described pre tinning and in vivo reduction of Tc, in vitro labelling and administration of labelled RBC and in vivo modified technique. Labelled leucocytes with several 99mTc-complex radiopharmaceuticals by in vitro technique and specific monoclonal s for white cells(neutrofiles). Labelled platelets for clinical use and research by in vitro technique and in vivo labelling

  13. Radioiodine and its labelled compounds

    International Nuclear Information System (INIS)

    Chemical characteristics and their nuclear characteristics, types of labelled molecules,labelling procedures, direct labelling with various oxidizing agents, indirect labelling with various conjugates attached to protein molecules, purification and quality control. Iodination damage.Safe handling of labelling procedures with iodine radioisotopes.Bibliography

  14. An open-label, randomized clinical trial to assess the immunomodulatory activity of a novel oligosaccharide compound in healthy adults

    Directory of Open Access Journals (Sweden)

    Karriem H. Ali

    2012-07-01

    Full Text Available Background: Rice Bran Arabinoxylan Compound (RBAC is a nutritional supplement produced by enzymatic hydrolysis of hemicellulose B derived from rice bran. Several in vitro studies and clinical reports have shown RBAC to possess promising immunomodulating effects, specifically with respect to natural killer cell and cytokine activity. The concept of a true immunomodulator is an agent possessing a broad range of activity dependent upon the existing state of health and immunity in the individual host. The present study investigated the immunomodulatory effect of RBAC in a healthy adult human population over 60 days by assessing changes in natural killer cell cytotoxicity (NKCC and cytokines and growth factors. Subjects participated in a two-group, randomized intervention, where one group (n=10 consumed 1 gram/day and the other (n=10 consumed 3 gram/day. Safety and tolerability of RBAC were assessed with total bilirubin, total protein, creatinine, and liver function tests.Results: We found that both groups had similar responses for NKCC, cytokines, and growth factors. The NKCC peaked at 1 week, whereas interferon-γ, tumor necrosis factor-α, interleukins-1α, -1β, -8, and -10, and epidermal growth factor peaked at 30 days. All subjects tolerated the supplement without any adverse reactions.Conclusions: Our results showed transient, bi-directional, immune marker effects consistent with true, multifactorial immunomodulation rather than simply immunostimulation or immunosuppression. Given our findings, the immunomodulatory activity of RBAC merits studyFunctional Foods in Health and Disease 2012, 2(7:265-279 in conditions where the immune system is functionally compromised (e.g., otherwise-healthy smokers and HIV/AIDS or cancer patients. RBAC may not only help to destroy tumor cells and viruses directly, but also increase the activity of immune cells, thereby optimizing the immune system, especially NKCC, which can increase the chance and speed of host

  15. Development of labelled compound for neuroreceptor imaging

    Energy Technology Data Exchange (ETDEWEB)

    Cho, J. H.; Oh, C. H.; Lee, K. S.; Lee, S. C. [Korea Institute of Science and Technology, Seoul (Korea)

    2000-03-01

    The purpose of this research and development is to develop the radioisotope labeled compound for serotonin neuroreceptor imaging. This serotonir receptor plays a key role in many neurological disease, such as anxiety and depression. Radio-Labeled compounds (Radio pharmaceuticals) has the advantage of early diagnosis and non-invasiveness. New arylpiplrazine ligand for imaging serotonin receptor 5HT{sub 1A} were synthesized. These ligand has a novel N{sub 2}S{sub 2} moiety of which deprotection process is expected to be much simple and to give high yield. New radiopharmaceuticals which was obtained as a results of this research will be developed as a diagnostic reagent. 5 refs. (Author)

  16. Tritium labeling of organic compounds deposited on porous structures

    Science.gov (United States)

    Ehrenkaufer, Richard L. E.; Wolf, Alfred P.; Hembree, Wylie C.

    1979-01-01

    An improved process for labeling organic compounds with tritium is carried out by depositing the selected compound on the extensive surface of a porous structure such as a membrane filter and exposing the membrane containing the compound to tritium gas activated by the microwave discharge technique. The labeled compound is then recovered from the porous structure.

  17. Synthesis of deuterium-labelled compounds for FOTEK project

    International Nuclear Information System (INIS)

    In the FoTech project there have been utilized labelled compounds of stable isotopes as internal standards. Some of these compounds are commercially available (13C-labelled PCB congeners, 13C-labelled diethylstilbestrol for determination of anabolic steroids). Others, like D9-clenbuterol, D3-clenbuterol, D3-zeramol and D3-dimetridazol have been synthesized. General aspects of deuterium compounds labelling are considered. (EG)

  18. 131I-Lipiodol labelling and its clinical application

    International Nuclear Information System (INIS)

    Lipiodol-131 I is used as a contrast agent in lymphangiography and it also acts as an immunosupress agent for the endolynphatic irradiation in patients who need renal transplant. The labelling of lipiodol with I-131 occurs by isotopic exchange and the separation of the labelled 131 I is carried out through a solvent extraction technique. Quality control tests (radiochemical, biological, microbiological and pyrogenic) were performed, and the result was that the compound is suitable for clinical application. The labelling yield varied from 70 to 85%. Doses of 925 MBq were injected into the dorsal paw of the patient's feet which permitted the visualization of all the lymphatic region. (author)

  19. Radiopharmaceuticals and other compounds labelled with short-lived radionuclides

    CERN Document Server

    Welch, Michael J

    2013-01-01

    Radiopharmaceuticals and Other Compounds Labelled with Short-Lived Radionuclides covers through both review and contributed articles the potential applications and developments in labeling with short-lived radionuclides whose use is restricted to institutions with accelerators. The book discusses the current and potential use of generator-produced radionuclides as well as other short-lived radionuclides, and the problems of quality control of such labeled compounds. The book is useful to nuclear medicine physicians.

  20. Synthesis and applications of isotopically labelled compounds 1994. Proceedings

    International Nuclear Information System (INIS)

    The 5th International Symposium on the Synthesis and Applications of Isotopically Labelled Compounds, 1994, concentrated on the following topics: - the synthesis, analysis and applications of organic compounds labelled with hydrogen and tritium, the production of stable radioactive isotopes such as cobalt 60, germanium 68, holmium 166, dysprosium 166 and tungsten 188; the synthesis of organic compounds labelled with short-lived isotopes such as carbon 11. The uses of isotopes in agriculture, nutrition, pharmaceutical research, pharmacology, medicine and biological pathways was discussed. The final section reviews the regulations governing the safety, handling and disposal of radioisotopes worldwide. (UK)

  1. 99mTc: Labeling Chemistry and Labeled Compounds

    Science.gov (United States)

    Alberto, R.; Abram, U.

    This chapter reviews the radiopharmaceutical chemistry of technetium related to the synthesis of perfusion agents and to the labeling of receptor-binding biomolecules. To understand the limitations of technetium chemistry imposed by future application of the complexes in nuclear medicine, an introductory section analyzes the compulsory requirements to be considered when facing the incentive of introducing a novel radiopharmaceutical into the market. Requirements from chemistry, routine application, and market are discussed. In a subsequent section, commercially available 99mTc-based radiopharmaceuticals are treated. It covers the complexes in use for imaging the most important target organs such as heart, brain, or kidney. The commercially available radiopharmaceuticals fulfill the requirements outlined earlier and are discussed with this background. In a following section, the properties and perspectives of the different generations of radiopharmaceuticals are described in a general way, covering characteristics for perfusion agents and for receptor-specific molecules. Technetium chemistry for the synthesis of perfusion agents and the different labeling approaches for target-specific biomolecules are summarized. The review comprises a general introduction to the common approaches currently in use, employing the N x S4-x , [3+1] and 2-hydrazino-nicotinicacid (HYNIC) method as well as more recent strategies such as the carbonyl and the TcN approach. Direct labeling without the need of a bifunctional chelator is briefly reviewed as well. More particularly, recent developments in the labeling of concrete targeting molecules, the second generation of radiopharmaceuticals, is then discussed and prominent examples with antibodies/peptides, neuroreceptor targeting small molecules, myocardial imaging agents, vitamins, thymidine, and complexes relevant to multidrug resistance are given. In addition, a new approach toward peptide drug development is described. The section

  2. Problems in labeling receptor ligands and related compounds with positron emitting radionuclides

    International Nuclear Information System (INIS)

    In the clinical application of positron-emitting radiopharmaceuticals, there can be a need for tracer preparation several times a day, or in the case of some compounds such as 0-15 labeled water, several times an hour. This type of production schedule means that special emphasis must be placed both on reducing radiation dose to the chemist and on performing rapid quality control of products. The production, reduction of radiation dose, and quality control of oxygen-15 labeled oxygen, carbon monoxide and water, as well as carbon-11 labeled glucose and palmitic acid are used as examples for compounds being produced routinely for PET studies at Washington University

  3. Biokinetics and dosimetry of radioactively labelled organic C-14 compounds

    International Nuclear Information System (INIS)

    The report starts with summarising research work and the resulting scientific information in connection with the dosimetry of C-14 labelled organic compounds. Biokinetic models are developed for compounds such as benzene, phenol, aniline, nitrobenzene, and a selection of pharmaceuticals, in order to show the radioactivity distribution after administration of the C-14 labelled substances. Based on the those models, dose coefficients and excretion rates are derived. The following synoptic view of the available data library leads on to a discussion of various aspects, as eg. the question of whether and how monitoring for detection of incorporation of C-14 administered with labelled organic compounds is possible. None of the questions and aspects arising in connection with this subject can be adequately dealt with in the present document, but concepts and methods are presented which permit an interpretation of radioactivity excretion data measured after incorporation of C-14 labelled organic substances. (orig./CB)

  4. Preparation of labelled compounds for tracer investigations in industry

    International Nuclear Information System (INIS)

    Carrying out tracer investigations in large-scale production plants the labelling of the different materials is characterized by some special aspects. Relatively high activities (108 - 1010 Bq) have to be applied, but in most cases specific activities only amount to 106 - 108 Bq/g. Frequently the syntheses of the labelled compounds required can be performed without complicated purification procedures because often it isn't necessary to separate inactive impurities or by-products or to evaporate the solvents. But on the other hand even if many experiments are carried out with the aid of nonisotopic tracers in any case labelled compounds of certain physical and chemical properties must be available. Due to the fact, that the commercial offer of labelled compounds is limited, the users have to prepare a number of special labelled compounds in their laboratories. Therefore in the report the preparation of corresponding 24Na-, 64Cu-, 77Ge-, 82Br-, /sup 99m/Tc-, /sup 113m/In-, 131I-, 132I-, 140La- and 198Au-labelled inorganic and organic compounds is described. The chemical procedures are simple and quick implying the main principles of radiation protection. (author)

  5. Studies on the preparation of radioactive labelled compounds

    International Nuclear Information System (INIS)

    To deveolp 99mTc instant labelling kits of dimercaptosuccinic acid (DMSA), glucoheptonic acid (GH), and tin colloid, molar ratios of the host compound to the stannous chloride, amount of the stannous chloride and pH were, respectively, controlled. The labelling yields and radiochemical purities were checked by means of a paper chromatography. Animal studies and clinical applications were also carried out. The results indicated that DMSA/SnCl2 2H2O 3/1(mole/mole), SnCl2 2H2O 410ug/ml/vial, pH 2.5, Ca GH/SnCl2 2H2O 53/1(mole/mole), SnCl2 2H2O 350 ug/ml/vial, pH 6.5, NaF 100ug/vial, SnCl2 2H2O 150 ug/ml/vial, pH. 5.6 etc, were optimal conditions for the preparation of DMSA-, GH-, and tin colloid-kits, respectively. (Author)

  6. Generator 113Sn-sup(113m)In. Study of the most important characteristics in the eluate composition for the preparation of clinical labelled compounds

    International Nuclear Information System (INIS)

    The design for the construction of a generator 113Sn-sup(113m)In is described. A systematic assay for the adequate adsorbents has been made, to obtain solutions of high radiochemical purity, as it is required for the radiopharmaceutical preparations. The control of purity is carried on by qualitative and quantitative analysis of the solutions, complemented by radiochemical techniques. The following physico-chemical parameters have been determinated; consecutive equilibrium constants, pH, distribution constants, separation factors and electrophoretic factors. It has been considered the measure of these parameters for the best quality in the preparation of the radiopharmaceutical compounds. (author)

  7. Generator 113Sn- 113mIn. Study of the most important characteristics in the evaluate composition for the preparation of clinical labelled compounds

    International Nuclear Information System (INIS)

    The design for the construction of a generator 113Sn -113mln is described. A systematic assay for de adequate adsorbents has been made, to obtain solutions of high radiochemical purity, as it is required for the radiopharmaceutical preparations. The control of purity is carried on by qualitative and quantitative analysis of the solutions, complemented by radiochemical techniques. The following physico-chemical parameters has been determinate; consecutive equilibrium constants, pH, distribution constants, separation factors and electrophoretic factors. It has been considered the measure of these parameters for the best quality In the preparation of the radiopharmaceutical compounds. (Author) 53 refs

  8. On the nomenclature of isotope-labelled organic compounds

    International Nuclear Information System (INIS)

    After shortly reviewing previously proposed nomenclature systems a compilation is given of the most essential rules out of 35 issued by the IUPAC Commission on Nomenclature of Organic Compounds in 1978 and governing the nomenclature of isotope-labelled organic compounds. Terms defined in detail are assigned to each other. Equivalent English and Russian expressions are given for frequently used terms. Additional rules proposed by a CMEA working group are cited. (author)

  9. Labelled compounds for agrochemical residue studies in developing countries

    International Nuclear Information System (INIS)

    Potential applications of stable and radioactive isotopic tracers for assessing undesirable contaminants in agriculture, fisheries and food are discussed as related to developing countries. Sources and types of residues are considered, and their local implications; also, the availability of suitably labelled compounds, including possible international cooperation to facilitate more centralized and economic preparation, and the distribution of labelled intermediates and compounds for use by local scientists. The provision of training courses and their syllabus are reviewed. Experience in the Joint FAO/IAEA chemical residue and pollution programme has indicated a need for longer-lived radioisotopically labelled pesticides (insecticides, acaricides, fungicides, herbicides, fumigants, etc.) for studying their behaviour. 15N-, 13C- or 2H-labelled fertilizers and fertilizer additives such as nitrification inhibitors will shortly be needed, for studying the behaviour of fertilizer nitrogen residues, and their regulation and conservation, under conditions prevailing in the developing countries. Compounds labelled with stable isotopes are considered particularly valuable under field conditions. The report reviews the present situation and presents specific recommendations to the Directors General of FAO and IAEA

  10. Improved quality control of carbon-14 labelled compounds

    International Nuclear Information System (INIS)

    IUT Ltd is a producer of carbon-14 labelled organic compounds like benzene, methanol, phenol, formaldehyde, Na-acetates and also special ordered compounds. The quality control of these compounds is carried out by means of HPLC and GC-MS due to chemical purity. Molar activity was determined by Liquid Scintillation Counting and HPLC being equipped by a radioactivity detector. Unfortunately the accuracy of the activity determination was arrived only ±4% relatively. This error is too high because of the large dilution factors. In respect of the IUT accreditation as an analytical laboratory in Germany the accuracy had to be improved remarkably. Therefore the GC-MS-determination of molar activities of labelled compounds is used as the 14C-labelled compound. A special evaluation code is used to determine the enrichment values relative to the unlabelled molecules. Taking into account the results of GC-MS the accuracy of molar activity determination is improved to ±2%. The spectra evaluation is demonstrated and some examples are discussed

  11. Measurement of spread of tritium using the tritium labeled compound

    International Nuclear Information System (INIS)

    It is known that a radioisotope disperses in the air from a radioisotope labeled compound in an aqueous solution via the isotopic exchange reaction. In this research, in order to examine the dispersion mechanism of tritium in the air from a tritium labeled compound, the model room which imitated a working room in the controlled area was made, and the radioactivity of the tritium contained in the air of the model room was measured by sampling the air in the model room. It was found that the dispersion rate of tritium in the air increased with the passage time from its purchase. The dispersion rate of tritium from 3H-ATP changed from 0.10% to 0.76% after 17.7 months. Furthermore, the two-dimensional distribution of tritium on the surface of the whole walls in the model room was obtained using an imaging plate technique. (author)

  12. Synthesis of 13C-enriched carbohydrates as chiral synthons for labeled compounds

    International Nuclear Information System (INIS)

    Methods have been developed to synthesize labeled chiral compounds from labeled carbohydrates. During the course of these investigations, we have adapted both chemical and enzymatic methods for the large-scale interconversion of labeled aldoses and ketoses. 6 refs

  13. 131/123 iodine labeled benzamides for the detection of melanomas and metastases. Synthesis, labeling, animal experiences and preliminary clinical studies

    International Nuclear Information System (INIS)

    Radioiodine labeled benzamides are being studied as radiopharmaceuticals for the detection of melanomas and metastases. With this purpose the synthesis and labeling of N-(2-diethylaminoethyl)-3-[131I]-4-methoxybenzamide (IMBA) has been carried out. Tissue distribution of the labeled compound has been studied in C 57 mice, showing a fast renal excretion. The labeled benzamide was also injected in mice with previously induced subcutaneous melanomas and lung metastases using B 16-F0 murine melanoma cells. The tumors show a good uptake of the labeled benzamide. The melanoma/other tissues uptake ratio is suitable for scintigraphic detection. Clinical studies in patients are under way. (author)

  14. Current state and prospects of labelled compounds production in the USSR

    International Nuclear Information System (INIS)

    The results of the production development of organic compounds labelled with radioactive isotopes are presented. Data on the major categories of labelled compounds and isotope production growth dynamics are given as well as some detailes of the CMEA member-countries co-operation in this area. Trends in labelled compounds production for biological and medical purposes are discussed and the similar industries in capitalist countries are analysed

  15. Determination of Radiotracer Stability of Tritium-Labelled Compounds in Biological Studies

    International Nuclear Information System (INIS)

    The recent extensive use of tritium-labelled compounds in biological studies makes it imperative that investigators verify the radiotracer stability of tritiated compounds. Even purification of labelled compounds to constant specific activity does not preclude the possibility of the tritium atom exchanging with hydrogen within a biological system. Radiotracer stability can be demonstrated by various methods once, meticulous radiochemical purification of the labelled material has been effected. In this report three different methods for establishing radiotracer stability of tritiated compounds are described. One approach is to compare the biological half-life of a H3-compound to that of a similar compound labelled with C14. This method is especially applicable to endogenous substances which undergo isotopic dilution when administered to animals. Stability of exogenous compounds can be verified by a second method. Here it is only necessary to demonstrate no diminution in specific activity when the labelled material is re-isolated from biological samples. A third method, less time-consuming than the first, and applicable to both endogenous and exogenous material is the determination of H3 to C14 isotope ratio in a mixture of the same compound labelled with both isotopes. Identical isotope ratios before administration of the double-labelled material and after re-isolation from organs or excreta demonstrate radiotracer stability. This method is particularly applicable where isolation of minute amounts of material necessitates the use of non-radioactive carrier. Data demonstrating the use of these methods for the verification of radiotracer stability will be presented with special reference to labelled cholesterol, morphine and digitoxin as examples for the three respective methods. (author)

  16. Synthesis of deuterium-labelled compounds for FOTEK project; Syntese af deuterium-maerkede forbindelser til FOeTEK projektet

    Energy Technology Data Exchange (ETDEWEB)

    Joergensen, O.; Egsgaard, H.; Larsen, E. [Forskningscenter Risoe, Roskilde (Denmark)

    1996-06-01

    In the FoTech project there have been utilized labelled compounds of stable isotopes as internal standards. Some of these compounds are commercially available ({sup 13}C-labelled PCB congeners, {sup 13}C-labelled diethylstilbestrol for determination of anabolic steroids). Others, like D{sub 9}-clenbuterol, D{sub 3}-clenbuterol, D{sub 3}-zeramol and D{sub 3}-dimetridazol have been synthesized. General aspects of deuterium compounds labelling are considered. (EG).

  17. Indium-111 labelled platelets: experimental and clinical studies

    International Nuclear Information System (INIS)

    The object of the present study became to develop a method of effective and gentle isolation and 111-In labelling of human platelets, as well as to employ these platelets in human clinical studies with the object of elucidating a number of physiological and pathophysiological mechanisms and processes in which platelets take part. 111-In-oxine presents obvious advantages over 51-Cr-sodium chromate; a high labelling efficiency, and more advantageous physical properties (a half life of 68 hours (against the half life of 28 days for 51-Cr) and considerably more effective gamma emission), making external registration by means of a gamma camera possible. Considering the role played by platelets in the development of atherosclerosis and its thromboembolic complications, in the early phases of deep venous thrombosis, and in graft rejection, it is natural that attempts have been made to use 111-In-labelled platelets for scintigraphic and kinetic evaluation of thromboembolic processes. Accumulation of 111-In-labelled platelets at sites of vessel wall injury, on pulmonary emboli (presumably on deep vein thrombi as well), and on catheter material has been demonstrated. Beyond this, the number of publications concerning the use of 111-In-labelled platelets for visualization of atherosclerosis, venous thromboembolism, arterial grafts, intracardiac thrombi, aortic aneurysms, renal allograft rejection, and other situations in which platelet thromboembolism takes place, provides evidence that a tool has finally been found for the study of their nature and response to therapeutic intervention. (eg)

  18. Chains, clusters, inclusion compounds, paramagnetic labels, and organic rings

    CERN Document Server

    Zanello, P

    1994-01-01

    The role of stereochemistry to elucidate reaction patterns and physico-chemical properties in topical subjects ranging from inorganic to organic chemistry are treated in the fifth and final volume of this series. Detailed accounts are given to study: chaining in polyphosphates, electron-transfers in carbonyl clusters, inclusion of organometallic molecules in cyclodextrins, stereochemistry of paramagnetic metal complexes by labeling with nitroxyl radicals, stereocontrol in organic syntheses assisted by inorganic complexes.

  19. Radiation doses from some [3H]-labelled organic compounds following ingestion

    International Nuclear Information System (INIS)

    Published information, especially human data, on the biokinetics of 11 compounds labelled with 3H was used to develop simple, cautious compound-specific models and to calculate both tissue absorbed doses and effective doses using the OLINDA computer code. The compounds were [3H]-cortisol, 3α-Hydroxy-5β-pregnane-11, 20-dione-7-[3H], cyclic 20 trimethylene acetal, [3H]-ifetroban, [3H]-digoxin, 7-[2'-α- methylphenyl-ethylamino[3H

  20. Fate of 14C-labelled compounds in marine environment

    International Nuclear Information System (INIS)

    Model ecosystems have played an important role in predicting environmental behavior of agrochemicals. The microcosms used in these studies generally include soil units containing usual biotic components common for that ecosystem. In present studies, scope of two such ecosystems has been extended to study the fate of 14C-labelled pesticides in marine environment. 14C-labelled pesticides used in these studies were chlorpyrifos, DDT and HCH. Two systems were developed in laboratory simulating marine environment to study the fate of these pesticides. The first system was developed in an all glass aquarium tank with marine sediments, seawater, clams and algae and is referred to as marine ecosystem. The second system was developed to permit the total 14C-mass balance studies. It contained marine sediments under moist (60% water holding capacity) or flooded conditions and it is referred to as continuous flow system. Fate of 14C-DDT was studied in marine ecosystem while degradation of 14C-chlorpyrifos and 14C-HCH was studied in continuous flow system. 14C-DDT did not bioaccumulate in clams while at the end of 60 days 50% of the applied 14C-activity was present in sediment fraction of marine ecosystem. 14C-HCH degradation showed about 22-26% mineralization while 45-55% of the applied activity was recovered as organic volatiles. No significant bound residues were formed. 14C-chorpyrifos underwent considerable degradation in marine environment. TCP was the major degradation product. (author)

  1. Clinical application of antibody monoclonal humanized anti-EGFrnimotuzumab labeled

    International Nuclear Information System (INIS)

    Most malignant tumors are of epithelial origin. These are characterized by overexpression of the receptor of epidermal growth factor (EGFR), which the neoplastic cells escape the regulatory mechanisms are allowed, so its high concentration of membrane is generally associated with a poor prognosis . By binding an antibody specifically to this receptor, preventing binding of EGF latter and activation mechanism tyrosine kinase inhibiting cell mitosis and apoptosis causing tumor cell. For this reason, the EGFr has been considered as an attractive target for anti-tumor therapy. The humanized monoclonal antibody anti-EGFr nimotuzumab was developed by the Center of Molecular Immunology (Havana, Cuba). Numerous clinical trials have been developed in the Department of Clinical Research Center Isotopes (Cuba), in which it has been applied this antibody, both labeled with 99mTc for immuno gammagraphic detection of tumors, as labeled with 188Re for radioimmunotherapy of gliomas high degree of malignancy. The aim of this paper is to show the experience of the Department of Clinical Research of CENTIS in various clinical trials with marking for both immuno gammagraphics detection of tumors, such as for radioimmunotherapy nimotuzumab. (author)

  2. Application of labelled compound produced by reactor to medicament

    International Nuclear Information System (INIS)

    Enriched platinum(mw:194) metals were irradiated in the hydralic conveyer of KUR with a thermalneutron flux of approx. 8.15 x 1013 n · cm-2 · sec-1 for 20 hrs. Two days after irradiation, sample were dissolved in aquaregia, and reduced by hydazin to Pt++. To synthesize 195mPt-labelled CDDP, NH4OH was added to the reaction mixture, and the amination reaction was proceeded under the wild heating condition. The separation and purification of CDDP were carried out using HPLC (Shordex OHpak columm). Present results indicated that the use of HPLC is useful to obtain 195mPt-CDDP with the highest chemical and radiochemical purities. The specific-activity of 195mPt-CDDP was about 100 μCi/mg-CDDP at the present experimental condition. (author)

  3. Chemiluminescent Labeled Organic Reagents and Their Use in Analysis of Organic Compounds

    OpenAIRE

    Hummelen, Jan C.; Wynberg, Hans

    1990-01-01

    Thermochemically induced luminescence is generated in a fluorescent labeled organic compound containing a covalently bonded fluorescent label which is a polycyclic aromatic radical having at least three linearly fused benzene rings and capable of being excited to a fluorescent electronic excited state by energy transfer from an energy donor molecule or radical having an electronic excited state, by a process comprising generating an energy donor radical or molecule by a thermochemical reactio...

  4. Synthesis, labelling and clinical studies of 131 I meta-iodobencylguanidine

    International Nuclear Information System (INIS)

    Radiolabelled meta-iodobencylguanidine (MIBG) is one of the most successful among recent radiopharmaceuticals. It has been shown to have high diagnostic sensitivity and specificity for many tumors of neuroectodermal origin. Synthesis, labelling and clinical studies of 131 I-MIBG are presented. Synthesis of the compound was carried out by condensation of meta-iodobenzylamine with cyanamide and sulphate salt formation. The radiolabelled compound was obtained by isotope exchange in an aqueous system at 150 Centigrade in presence of copper (II) as a catalyst. Clinical tests were carried out administrating the radiotracer to 13 patients (19 images) and comparing with those obtained from 5 patients to whom the study was made again with a commercial product. Results were similar for both products. Furthermore, it was possible to localize three neuroblastomas and one ganglioneuroblastoma. (Author)

  5. Standards of compounds labeled with positron emitting radionuclides approved as established techniques for medical use. 2009 revision

    International Nuclear Information System (INIS)

    For the establishment of positron emission tomography (PET) diagnosis as a routinely used clinical diagnostic tool, the compliances of manufacture regulations under the Good Manufacturing Practice (GMP) principle for PET radiopharmaceuticals are necessary. For this purpose, the Subcommittee on Medical Application of Positron Emitting Radionuclides, Medical Science and Pharmaceutical Committee, in Japan Radioisotope Association has made the Standards for Compounds Labeled with Emitting Radionuclides Approved as Established Techniques for Medical Use'. At present, there are two standards; ones for 15O gases and 18fluorodeoxyglucose (18FDG) (2001 revision), whose studies have been approved by National Health Interview Survey (NHIS), and another for other 10 PET agents (1999 version). Thus, to promote more safe and effective application of compounds labeled with positron emitting radionuclides produced in the hospital, the Subcommittee on Medical Application of Positron Emitting Radionuclides of Medical Science and Pharmaceutical Committee in Japan Radioisotope Association has reviced standards by unifying processes and specifications of 15 compounds including 12 compounds that have been already approved as 'compounds labeled with positron emitting radionuclides as established techniques for medical use' in the committee (18FDG, 15O-oxygen, 15O-carbon monoxide, 15O-carbon dioxide, 11C-monoxide, 13N-nitrogen, 13N-ammonia, 15O-water, 11C-L-methionine, 11C-sodium acetate, 11C-N-methyl-spiperone, and 11C-choline) and three newly compounds approved at 2009 (18F-sodium fluoride, 11C-raclopride, and 11C-flumazenil). This guideline includes the general notices, general rules for preparations, general tests for the quality control, quality of each PET agents, guideline for manufacturing environment and manufacturing process at manufacturing facilities of PET agents. (author)

  6. Production of N-13 labeled compounds with high specific activity

    Energy Technology Data Exchange (ETDEWEB)

    Suzuki, Kazutoshi; Sasaki, Motoji; Yoshida, Yuichiro; Haradahira, Terushi; Inoue, Osamu [National Inst. of Radiological Sciences, Chiba (Japan)

    1997-03-01

    Nitrogen-13 was produced by irradiating ultra pure water saturated with a pure gas (N2, O2, He, H2) with 18 MeV protons. Ion species generated by irradiation were analyzed with radio ion chromatography systems. An automated equipment was developed to synthesize anhydrous (13N)NH3 as a synthetic precursor and (13N)p-nitrophenyl carbamate ((13N)NPC) as a model compound, using the (13N)NH3. The radiochemical yield and specific activity of (13N)NPC was high enough to carry out the receptor study with PET. (author)

  7. Synthesis of Melamine-d6 and the Feasibility of Deuterium Labeled Compounds as Internal Standard

    Directory of Open Access Journals (Sweden)

    GUO Yang-zhen

    2015-11-01

    Full Text Available S-triazine is an important chemical intermediate. Melamine belongs to s-triazine, which has been widely used as an additive in the food industry. To study the stable isotope labeling method of heterocyclic triazine compounds and its application, one step synthesis of melamine-d6 was achieved with a yield of 30% (calculate in ND4OD, which started from ND4OD by the reaction with cyanuric chloride. According to the exchange mechanism of H/D, the feasibility and the necessary conditions were discussed for applying deuterium labeled compounds in isotope dilution mass spectrometry method.

  8. Clinical applications of 111-In-labelled granulocytes

    International Nuclear Information System (INIS)

    The authors studied 542 patients in detail who were referred over the past five years to the Nuclear Medicine Departments of either Stanford University or the VA Medical Center, Palo Alto, CA, for investigation of acute inflammatory disease. The results of the radionuclide imaging procedure (using 111-In-oxinate labelled granulocytes) were correlated to the clinical findings, X-ray studies, surgical procedures or other relevant evidence. The application of the 111-In-oxinate white cell scan in Nuclear Medicine has proved to be highly sensitive, specific and accurate. (orig.)

  9. Direct synthesis and application of 11C and 13N labelled organic compounds by accelerator

    International Nuclear Information System (INIS)

    In the nuclear medicine, the compounds labelled by 11C and 13N, short-lived nuclide, have been used as a diagnostic reagent for PET. We found 80% yield of 11C labelled organic compounds were synthesized by direct irradiation of high energy γ ray to carbon cluster( a kind of fullerene) and other organic reagents. The Electron Linac (Tohoku University) and SF Cyclotron (Tokyo University) were used. By the Electron Linac, the samples were irradiated by Bremsstrahlung generated from platinum plate irradiated with 30 MeV beam using 12C(γ,n)11C. On the SF cyclotron, the mixture between sample and boron was irradiated by 12 MeV proton using 11B(p,n)11C. Many reagents were isolated and refined by a preparative HPLC (high-performance liquid chromatography). Oxine was used as a model compound and experimental results are shown. 54% 11C labeled compounds isolated by sublimation were oxine. This method is very simple and easy. Accordingly, we can use the method to the very complex compound. (S.Y.)

  10. Imaging with FDG labelled leukocytes: is it clinically useful?

    International Nuclear Information System (INIS)

    In vivo and in vitro labeled leukocytes have been shown to be very effective in detecting different infectious and inflammatory conditions. The model of labeled leukocyte imaging is based on the powerful mechanisms of chemotaxis exerted on activated leukocytes by chemo-attractants. The avidity of inflammatory cells for fluorodeoxyglucose (FDG) has led to the concept of labeling leukocytes with [18 F]FDG ex vivo. This concept combines cell-bound radionuclide trafficking from the blood pool compartment to the lesion with the high resolution of positron emission tomography (PET) imaging. The further benefits of having a correlated anatomical map by implementing the acquisition on a hybrid PET/computed tomography (CT) device are obvious. The feasibility and the potential value of leukocyte PET(/CT) imaging in infection have been demonstrated. The available data suggest a high accuracy of the method. Still, leukocyte PET/CT should not be considered as the endpoint of infection imaging, since it only meets a part of the criteria of the ideal infection imaging agent. However, the common clinical need for specific detection of infection with anatomical precision, the availability of the components necessary for performing leukocyte PET/CT, their lack of toxicity or adverse effects and the absence of more superior tracers on the commercial market make it worthwhile to further investigate leukocyte PET/CT imaging in larger prospective series. The advantages of leukocyte PET/CT over the more conventional nuclear medicine and radiological methods makes this imaging tool likely to be useful in certain subsets of infected patients.

  11. Dynamics of growth/mature-related substances in vegetables using specific triple labeled compound

    International Nuclear Information System (INIS)

    To progress physiological studies of vegetables, development of biosynthetic method for production of triple labeled compounds was attempted in this study and such method for vegetables using specifically labeled sugars was examined. As a sugar compound, 6-C14-glucose (14-CG) and 1-H3-glucose (3-HG) were given to culture medium for cells derived from tomato embryonic axis and the changes of these compounds were monitored. Tomato embryonic cells were harvested 20 and 44 hours after the addition of 14-CG or 3-CG into the culture medium the cells. The cells were homogenized and the supernatant after centrifugation was applied onto HPLC. Radio analyzer revealed major two peaks in the chromatography of the sugar fraction from the cells after 20 hours from the addition of 14-CG. One was the peak of glucose, itself and the other was estimated to be that of fructose based on the retention time. Whereas in the elution pattern of the sugar fraction after 44 hours from the addition, a peak of sucrose was found along with the peak of glucose. These results indicate that C14 in 14-CG but not H3 in 3-HG was transferred into fructose after the metabolism in tomato. Moreover, in both elution patterns, there was a peak positioned at the same retention time, indicating that the compound in this peak was produced from either of 14-CG or 3-HG. Therefore, it is thought that H3 and C14 double-labeled compound could be produced from the cell culture added with both labeled compounds; 14-CG and 3-HG. (M.N.)

  12. Measurement of loss rates of organic compounds in snow using in situ experiments and isotopically labelled compounds

    Directory of Open Access Journals (Sweden)

    Erika von Schneidemesser

    2012-07-01

    Full Text Available Organic molecular marker compounds are widely used to identify emissions from anthropogenic and biogenic air pollution sources in atmospheric samples and in deposition. Specific organic compounds have been detected in polar regions, but their fate after deposition to snow is poorly characterized. Within this context, a series of exposure experiments were carried out to observe the post-depositional processing of organic compounds under real-world conditions in snow on the surface of the Greenland Ice Sheet, at the Summit research station. Snow was prepared from water spiked with isotopically labelled organic compounds, representative of typical molecular marker compounds emitted from anthropogenic activities. Reaction rate constants and reaction order were determined based on a decrease in concentration to a stable, non-zero, threshold concentration. Fluoranthene-d10, docosane-d46, hexadecanoic acid-d31, docosanoic acid-d43 and azelaic acid-d14 were estimated to have first order loss rates within surface snow with reaction rate constants of 0.068, 0.040, 0.070, 0.067 and 0.047 h−1, respectively. No loss of heptadecane-d36 was observed. Overall, these results suggest that organic contaminants are archived in polar snow, although significant post-depositional losses of specific organic compounds occur. This has implications for the environmental fate of organic contaminants, as well as for ice-core studies that seek to use organic molecular markers to infer past atmospheric loadings, and source emissions.

  13. Synthesis of labeled compounds using recovered tritium from expired beta light sources

    International Nuclear Information System (INIS)

    In this paper, the technological procedures for extracting tritium from beta light source are highlighted. The recovered tritium was used in the synthesis of organically labeled compounds and in the preparation of tritiated water (HTO) with high specific activity. Technological procedures for treatment of beta light sources consist of: envelope breaking into evacuated enclosure, the radioactive gaseous mixture pumping and its storage on metallic sodium. The mixtures of T2 and 3He were used in the synthesis of tritium labeled steroid hormones, nucleosides analogues and for the preparation of HTO with high radioactivity concentrations. (authors)

  14. Method of labelled neutrons as the way for hidden compounds identification

    International Nuclear Information System (INIS)

    Method of hidden compounds is based on registering of characteristic γ-radiation appealing due to inelastic scattering of the A(n,n'γ)A reaction proceeding at interaction of labelled neutrons flux with energy 14.1 MeV (forming under the d+t→α+n reaction) with nuclei of examined substances (12C, 16O, 14N, ...). In the capacity of labelled neutron source the portable neutron generator with build-in 9-sections silicon α-detector has been applied. Neutron flux integral intensity makes of ≅108/4π n/s. Registration of characteristic γ-radiation is carrying out by detectors on BGO crystals. Application of the labelled neutrons methods provides: high depth sounding and high sensitivity to composition (elementary) content of irradiated object; high identification velocity of suspicious object; and determination it position in space; distant automatic nondestructive test of examined object

  15. Labelling of biorelated compounds and monoclonal antibodies with 188-Re,186-Re and 99mTc

    International Nuclear Information System (INIS)

    Some bio-related compounds were labelled with 188Re and 186Re 188Re was obtained from 188W/188Re generator which was produced by neutron irradiation of enriched 186WO3 target (99.79%) in JRR-2 and 186Re was supplied by Production Div., Department of Radioisotopes, JAERI, Japan. Rhenium labelling involved reduction of perrhenate with SnCl2.2H20 in HCI. Bio-related compounds citrate and gluconate were then labelled with reduced rhenium. The labelling yield of labelled compounds as determined by thin-layer chromatography were greater than 98% and 94% for 188Re-citrate and gluconate, respectively. Monoclonal antibodies (mouse,lgG2A and lgG;Fab'2, human lgG2A; anti-hepatoma and IgG) were also successfully labelled with 188Re, 186Re, and 99mTc by direct method using citrate and glucoheptonate as transchelating agents

  16. Novel ocular antihypertensive compounds in clinical trials

    OpenAIRE

    Chen J; Runyan SA; Robinson MR

    2011-01-01

    June Chen1, Stephen A Runyan1, Michael R Robinson21Department of Biological Sciences, 2Ophthalmology Clinical Research, Allergan, Inc, Irvine, CA, USAIntroduction: Glaucoma is a multifactorial disease characterized by progressive optic nerve injury and visual field defects. Elevated intraocular pressure (IOP) is the most widely recognized risk factor for the onset and progression of open-angle glaucoma, and IOP-lowering medications comprise the primary treatment strategy. IOP elevation in gla...

  17. Report on compounds labelled with nitrogen-13 or carbon-11 used in cancer metabolic studies with quantitative two-dimensional scanning and pet tomography

    International Nuclear Information System (INIS)

    The use of compounds labelled with radionuclides of the elements commonly involved in metabolic processes (oxygen, carbon, nitrogen) is becoming important in the non-invasive study of organ and tumour function. The application of compounds labelled with 13N and 11C to the study of amino-acid metabolism and changes in vasculature following chemotherapy and radiation therapy is described. In particular, 13N-labelled L-glutamate has been found to be useful in visualizing a number of human tumours including osteogenic sarcoma, rhabdomyosarcoma, Ewing's sarcoma, malignant fibrous histiocytoma, pineal gland tumours, primitive neuroectodermal tumours, medulloblastoma and several other solid tumours. In patients with bone tumours, changes in 13N-L-glutamate scans during chemotherapy were found to correlate with changes in other clinical parameters, such as serum alkaline phosphatase, histology and 99Tcsup(m)-bone scans, thus indicating that labelled L-glutamate is potentially useful in evaluating the response of solid tumours to chemotherapy. Scans of patients and volunteers using 13N-L-glutamate and 13N-L-valine indicate that the L-amino acids may be useful in studies of metabolic processes in the liver, myocardium and pancreas. Red blood cells, labelled with 11C-carbon monoxide via inhalation of the radioactive gas, have been used to assess changes in tumour vascularity following radiation therapy. Alpha-aminoisobutyric acid labelled with 11C has been synthesized and its distribution in normal and tumour-bearing dogs has been studied. (author)

  18. The chemistry of positron emitting nucleogenic (hot) atoms with regard to preparation of labelled compounds of practical utility

    International Nuclear Information System (INIS)

    An understanding of the chemistry of nucleogenic (hot) atoms has led to the practical preparation of a wide variety of simple precursors used in the syntheses of more complex labelled compounds used in biological and medical research and application. The hot atom chemistry of carbon-11, nitrogen-13, oxygen-15 and fluorine-18 is presented in the context of the constraints demanded by the need for labelled compounds for animal and human use. (orig.)

  19. Preparing an estrogen - derivative compound labeled with Tc-99m and determination of radiopharmaceutical potential

    International Nuclear Information System (INIS)

    In recent years, estrogen derivative compounds have been used with several purpose which may lead to rapid advances in both diagnosis and therapy of some human cancers. In this study, an estrogen derivative compound (ESTCPTA) that 3,17-β-estradiolyl propinol attached with 1-(4-methylbenzoic acid)-4,8,11- tetraazacyclotetradecane (CPTA) was synthesized at five steps. Synthesized product was purified by recrystallization in ethyl alcohol. Characterizations of purified products were made by NMR and IR spectroscopy. Synthesized compound was labeled with Tc-99m. TLC (Radio Thin Layer Chromatography) and radio-paper electrophoresis were used to determine radiochemical yields. Specific activity was approximately 23.7 GBq/mmol and labeling yield was over 95%. Biodistribution studies were performed on female Albino Wistar rats. Rats were sacrificed by ether narcotization at certain time intervals and the organs were removed. Their activities were counted by a gamma counter. The activity per gram tissue was calculated and time activity curves were generated

  20. Preparation and preclinical evaluation of 211At-labelled compounds for α-particle radiotherapy

    International Nuclear Information System (INIS)

    The interest for α-particle emitters in internal radiotherapy is increasing due to improved conjugation chemistry. Experimental work has concentrated on 211At and 212Bi since these to nuclides have radiochemical and physical properties suitable for medical application. In this report it is demonstrated that biologically active 211At-labelled compounds can be prepared within a relatively short time allowing utilization of this 7.2 h α-particle. It is further shown that 211At-TP-3 treatment of human osteosarcoma in vitro gives promising therapeutic ratios. 76 refs., 5 figs., 3 tabs

  1. Preparation and preclinical evaluation of {sup 211}At-labelled compounds for {alpha}-particle radiotherapy

    Energy Technology Data Exchange (ETDEWEB)

    Larsen, R.H.

    1994-12-31

    The interest for {alpha}-particle emitters in internal radiotherapy is increasing due to improved conjugation chemistry. Experimental work has concentrated on {sup 211}At and {sup 212}Bi since these to nuclides have radiochemical and physical properties suitable for medical application. In this report it is demonstrated that biologically active {sup 211}At-labelled compounds can be prepared within a relatively short time allowing utilization of this 7.2 h {alpha}-particle. It is further shown that {sup 211}At-TP-3 treatment of human osteosarcoma in vitro gives promising therapeutic ratios. 76 refs., 5 figs., 3 tabs.

  2. Off-label prescribing of psychotropic drugs in a Danish child and adolescent psychiatric outpatient clinic

    DEFF Research Database (Denmark)

    Nielsen, Eva Skovslund; Hellfritzsch, Maja; Sørensen, Merete Juul; Rasmussen, Helle; Thomsen, Per Hove; Laursen, Torben

    2015-01-01

    This study aimed to describe the level of off-label treatment with psychotropic drugs at a child and adolescent psychiatric outpatient clinic in Denmark. We performed a cross-sectional study assessing records on patients treated with medicine at two outpatient clinics at the child and adolescent...... prescriptions were off-label, which corresponds to 27.6 %. Attention deficit hyperkinetic disorder (ADHD) drugs were prescribed 450 times (73.2 %) of which 11 prescriptions were off-label (2.4 %). Other psychotropic drugs comprised 165 (26.8 %) prescriptions and of these 159 (96.4 %) were off-label. With 106...... prescriptions, melatonin was the most prescribed of these drugs; all prescriptions were off-label. The main reasons for classifying prescriptions as off-label were age and indication of treatment. This cross-sectional study reveals that medical treatment of children with other psychotropic drugs than ADHD drugs...

  3. MR implant labelling and its use in clinical MRI practice

    International Nuclear Information System (INIS)

    Before a magnetic resonance imaging (MRI) examination, implants in patients must be cleared for MR safety in order to exclude the risk of possible severe injuries and implant malfunction in an MR environment. The general contraindication for measurements of patients with implants still applies; however, in the recent past a way has been found to legally circumvent this contraindication. For this purpose special conditions are required: explicit implant identification and the original manufacturer's labelling are necessary, the required conditions for conditionally MR safe implants must be assured and a risk-benefit analysis with appropriate explanation to the patient has to be performed. This process can be very complex as the implants are often poorly documented and detailed information on the implant MR labelling is also often outdated or not easy to interpret. This article provides information about legal and normative principles of MR measurement of patients with implants. The possible physical interactions with implants will be briefly dealt with as well as possible strategies for better identification and investigation of implants and MR labelling. General approaches for minimizing the risk will be discussed using some examples. The second part deals with the content of MR implant labelling and the current test standards. Furthermore, the additional information from the operating instructions of the MR scanner that are necessary for the interpretation of the MR implant labelling, will be explained. The article concludes with an explanation of the current pattern for MR labelling of implants from the U.S. Food and Drug Administration (FDA) and an exemplary application. (orig.)

  4. Sunscreen compliance with regional clinical practice guidelines and product labeling standards in New Zealand.

    Science.gov (United States)

    Sporer, Matthias E; Mathy, Joanna E; Kenealy, John; Mathy, Jon A

    2016-03-01

    INTRODUCTION For general practitioners, practice nurses and community pharmacists in New Zealand, a core duty is to educate patients about sun protection. We aimed to evaluate compliance of locally available sunscreens with regional clinical practice guidelines and sunscreen labelling standards, to assist clinicians in advising consumers on sunscreen selection. METHODS We audited all sunscreens available at two Auckland stores for three New Zealand sunscreen retailers. We then assessed compliance with accepted regional clinical practice guidelines for sun protection from the New Zealand Guidelines Group. We further assessed compliance with regional Australia/New Zealand consumer standards for sunscreen labelling. RESULTS All sunscreens satisfied clinical guidelines for broad-spectrum protection, and 99% of sunscreens met or exceeded clinical guidelines for minimal Sun Protection Factor. Compliance with regional standardized labelling guidelines is voluntary in New Zealand and 27% of audited sunscreens were not fully compliant with SPF labelling standards. DISCUSSION Sunscreens were generally compliant with clinical guidelines for minimal sun protection. However there was substantial noncompliance with regional recommendations for standardized sunscreen labelling. Primary health care clinicians should be aware that this labelling noncompliance may mislead patients into thinking some sunscreens offer more sun protection than they do. Mandatory compliance with the latest regional labelling standards would simplify sunscreen selection by New Zealand consumers. KEYWORDS Sunscreen; Sun Protection Factor; SPF; Skin Neoplasms; Melanoma; Skin Cancer Prevention. PMID:27477372

  5. Clinical applications of indium-111-acetylacetone-labelled blood cells

    International Nuclear Information System (INIS)

    A method permitting red-cell labelling with 111In-acetylacetone was reported in 1974 for evaluating intestinal blood loss, the liver-spleen ratio and the red-cell volume. White blood cells can be tagged similarly. In white-cell labelling, simultaneous red-cell or platelet tagging is avoided. Several procedures (dextran separation and gradient centrifugations) have been combined, to develop a highly selective cell separation. In osteomyelitis it may not be as advantageous to use 67Ga-citrate, as in inflammatory soft tissue processes. The detection of inflammatory processes with labelled leukocytes could be of great importance for the scintigraphic diagnosis of osteomyelitidies. A group of 97 patients with suspected osteomyelitis have been examined using 111In-acetylacetone-labelled leukocytes (111In-AAL) immediately following positive routine skeletal scintigraphy. Images obtained 24 h post injection usually were the most satisfactory. In the followup group of 70 patients 21 true positives, 43 true negatives, 21 false negatives and 3 false positives were observed. These findings result in a specificity of 92%, sensitivity of 50% and accuracy of 70% with 111In-AAL for osteomyelitis. Preliminary investigations using 111In-acetylacetone-labelled thrombocytes (111In-AAT) were carried out to detect rejection of transplanted kidneys. The platelets were separated by means of additional special density gradient centrifugations but no dextran from 15-20 ml of autologous whole blood. Scans have been obtained 15 min, 2.5 h and 24 h post injection in an initial group of 10 patients. In acute rejection, a high transplant uptake has been detected, whereas patients without acute rejection showed no or only a minimum activity accumulation. Patients with chronic rejection have intermediate uptakes

  6. Pharmacokinetic and metabolic study of the compound GYKI-32 594 labelled with 14C

    International Nuclear Information System (INIS)

    Resorption, blood serum level, tissue distribution and elimination of the 14C-labelled antiserotonin drug 1-methyl-9,10-dihydro-lisergic acid (2'-thiazole-2-il/-amid)bimaleinate were investigated in rats. The compound is resorbed both from the stomach and the small intestine (in two hours 22.5% and 83.8%, resp.). The serum level quickly decreases, Tsub(1/2) being 1.4 - 2.8 hours, depending on the administered dose. Cumulative administration does not increase the serum level. The highest activity was found in the liver and kidneys, but in the brain no radioactivity could be detected. Elimination occurred through the urine (31.7%) and the faeces (23.7%); the enterohepatic circulation was not significant. The compound penetrates into the placenta and appears in the mother's milk. Both in the serum and the urine only a minor part (11-15%) of the radioactivity is represented by the original compound; 4 other metabolites are present. (L.E.)

  7. Purification, labelling and clinical applicability of radioactive asialo-orosomucoid

    International Nuclear Information System (INIS)

    It is shown that purified and modified orosomucoid is rapidly taken up by the liver. For experiments with rats the pharmacon was labelled with 131I. The distribution of the radioactivity was determined in samples of tissues after decapitation of the rats. After this study the method of preparation of the pharmacon was changed in order to meet the requirements for human use, e.g. th neuraminidase (Vibrio Cholerae) was removed. The pharmacon, still 131I-labelled, was tested in a group of patients and controls, however with little success. Therefore a labelling-method was developed which would give better information or even a radiopharmacon which is released via the bile tree. Two methods were developed viz. labelling the pharmacon with sup(99m)Tc and 203Hg. Tissue distribution studies in the rat showed that both radiopharmaceuticals were taken up rapidly by the liver. The release of the radioactivity however was too slow to be of practical use, although autoradiography showed that the radiopharmacon was taken up by the parenchymal cells. In the course of this study 123I became commercially available and was also used. The physical characteristics of this radionuclide are more appropriate for dynamic in vivo studies. A mathematical model was developed which assumes three steps viz. an uptake, a delay-time due to catabolism, and release, and it was used for computer simulation studies. Finally, it was concluded that (1) the liver curve obtained from radioactive asialo-orosomucoid studies does not yield enough information, although a correlation exists between delay-time and release rate constant, (2) the functional images show regional defects in which areas with abnormal uptake and abnormal release are not always superimposable

  8. Dynamics of growth/mature-related substances in vegetables using specific triple labelled compound

    International Nuclear Information System (INIS)

    Dynamics and metabolism of sugars translocated into the fruit region were investigated in tomato using 14C-labelled compounds. The translocation substance in tomato is thought to be sucrose, but the amount of sucrose in its fruit is very small. Therefore, the degradation of sucrose in the fruit and its translocation to the fruit was investigated. The sucrose was digested into hexoses such as glucose, fructose, etc. and the degradation rate was considerably low. In the stage of thickening growth, sucrose was more extensively converted into other substances except for sugars compared with the coloring stage. Then, 14C-labelled fructose was given through its gynophore to investigate the degree of reproduction to sucrose. The fructose level in the fruit reached the platean by 48 hrs after the addition and gradually decreased. The radioactivities were detected in sugars, organic acids and other alcohol soluble substances, etc. These results suggest that the incorporated fructose might be rapidly changed into various substances via complicated metabolism in the fruit. (M.N.)

  9. Clinical imaging with indium 111 oxine-labeled leukocyte scan: review and case report

    International Nuclear Information System (INIS)

    The clinical use and mechanisms of action of technetium 99m pyrophosphate, gallium 67 citrate, and indium 111 oxine have been presented. The diagnosis of osteomyelitis in the lower extremity can often be made on the basis of clinical, laboratory, and conventional radiographic evaluations. In the case report of diabetic osteolysis, initial evaluations revealed osteomyelitis. The use of scanning involving leukocytes labeled with technetium and indium 111 oxine lessened the possibilities of an osseous infection. Studies show the sensitivity, specificity, and accuracy of scans using leukocytes labeled with indium 111 oxine to be superior to those of any other form of nucleotide imaging, but further clinical research is needed.20 references

  10. Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring

    Directory of Open Access Journals (Sweden)

    Fegert Joerg M

    2008-09-01

    Full Text Available Abstract The review presents pediatric adverse drug events from a historical perspective and focuses on selected safety issues associated with off-label use of medications for the psychiatric treatment of youth. Clinical monitoring procedures for major psychotropic drug classes are reviewed. Prior studies suggest that systematic treatment monitoring is warranted so as to both minimize risk of unexpected adverse events and exposures to ineffective treatments. Clinical trials to establish the efficacy and safety of drugs currently being used off-label in the pediatric population are needed. In the meantime, clinicians should consider the existing evidence-base for these drugs and institute close clinical monitoring.

  11. Synthesis, evaluation and application of radioiodine labeled compounds in nuclear medicine

    International Nuclear Information System (INIS)

    This study reviews synthesis, evaluation,diagnostic and therapeutic applications of iodine radiopharmaceutical especially with 13II and 123I in contemporary nuclear medicine. It is well Known that iodine is used in thyroid diagnostic and therapy with sodium iodide and played an important role in diagnostic procedures using single photon emission tomography (SPECT). The study covers the general chemistry of iodine, physical properties, biological role of iodine, general uses of iodine compounds , production and decay schemes of 131I, 125I and 123I in the first chapter. Preparation of radioiodine labeled compounds, quality control of radiopharmaceuticals and safety of radioiodination are dealt with in detail in two chapters. These were followed by chapters dealing in length with the chemistry, preparation, quality control, pharmacokinetics and radiation dosimetry of some iodine radiopharmaceuticals, and then current trends in diagnostic and therapeutic applications of iodine radiopharmaceuticals particularly 131/123I-MIBG and 123I-IMP. We found that the iodine radiopharmaceuticals are considered amongst principal indicators in single photon emission tomography (SPECT), and 131/123I-MIBG and 123I-IMP appear to be appropriate diagnostic and therapeutic agents for variety of diseases.(Author)

  12. 14 C labelled compound Laboratory of Radiochemical Research and Production Department in IFIN-HH. Forty years of experience

    International Nuclear Information System (INIS)

    The first experiments with 14 C in Romania took place in the Institute of Atomic Physics (IFA) in Bucharest. The laboratory for C-14 labelled compounds, with its current structure was conceived by IFA in co-operation with GEC and AERE - England, and designed by IFA and I.P. Carpati. It was built between 1975-1977. The way it was conceived makes it the only laboratory in Romania which can offer various specialized services to interested organizations. The laboratory is able to develop the following types of activity: - primary processing of row materials with 14 C; - chemical syntheses and biosyntheses of labelled organic and inorganic compounds; - production of 14 C tracers; - specific chemical analyses involving 14 C processing. Till now among the most important results the following could be mentioned: over 60 C-14 labelled organic and inorganic compounds; over 20 publications; about 50 certified products and technologies; delivery of C-14 labelled products all over the country, in over 20 research institutes, hospitals and universities; - experiments with tracers for food industry, agriculture and livestock farms; - solutions with C-14 - calibration standards for internal use. Presently the Laboratory is conducting in cooperation with the Institute for Nuclear Research, Pitesti works for recovering of 14 C from gaseous effluents of CANDU-600 Reactor of NNP-Cernavoda. Also, works are done concerning the synthesis with 13 C and 14 C of miscellaneous organic compounds, i.e., 3N-[1-13 C] Capronylphenylthiourea, trans-derma pharmaceutic systems and N -[1 - 13 C,T] pentadecyl pyridinium bromide (both doubly labelled with T and 14 C with high specific activities at known positions); the last two compounds was certified too. The path ways for labelling and analyses are in agreement with the international techniques adopted in this field. (authors)

  13. Clinical relevance of positive patch test reactions to the 26 EU-labelled fragrances

    OpenAIRE

    van Oosten, Eleonoor J; Schuttelaar, Marie-Louise A; Coenraads, Pieter Jan

    2009-01-01

    BACKGROUND: Fragrance mix I (FM I) and fragrance mix II (FM II) in the European baseline series are used as screening tools for fragrance contact allergy. In 2005 the European Union (EU) required labelling of 26 fragrances when present in cosmetic products. INCI nomenclature is obligatory for such labelling. OBJECTIVES: To describe frequencies of contact allergy to these 26 fragrance substances, and to evaluate clinical relevance of these positive reactions. METHODS: Three hundred and twenty ...

  14. Method of obtaining sulphur-labelled compounds by reaction of ''hot'' sulphur-35 atoms with cyclic hydrocarbons

    International Nuclear Information System (INIS)

    The authors discuss methods of obtaining sulphur-labelled compounds, such as aliphatic and cyclic mercaptans and sulphides, by direct synthesis employing recoil atoms from the reaction Cl35 (n, p) S35. Hot S35 atoms were obtained in the middle of the target substance by exposing mixtures of C Cl4 and a cyclic hydrocarbon (cyclopentane, cyelohexane) to neutrons in a reactor. A method is given for irradiating the mixtures and then separating the various sulphur-bearing compounds by specific chemical methods, rectification, and paper and gas-liquid chromatography. The purpose of the exchange is clarified. The relation of the yield of the separated sulphur-labelled products to the composition of the mixture and type of exposure was investigated, and an active-sulphur balance settled. New types of atomic sulphur reactions were established: the CH2-group is replaced and implanted on the C-C link. The cyclic molecule is destroyed in the interaction with the hot sulphur atoms. Hot sulphur atoms can initiate the formation of polymers containing sulphur. The yields of these reactions were established. Up to 98% of the active sulphur is linked in the form of organic sulphur compounds. It was shown that sulphur-labelled thiophene, tetrahydrothiopyrane, cyclopentyl-mercaptan, cyclohexylmercaptan, ethyl-propyl-butyl-mercaptans, dicyclopentyl-sulphide, polymeric mercaptans and sulphides could be synthesized by heat. I t is possible to regulate within broad limits the yield of various labelled compounds by changing the decelerating properties of the medium. (author)

  15. Real time and label free profiling of clinically relevant exosomes.

    Science.gov (United States)

    Sina, Abu Ali Ibn; Vaidyanathan, Ramanathan; Dey, Shuvashis; Carrascosa, Laura G; Shiddiky, Muhammad J A; Trau, Matt

    2016-01-01

    Tumor-derived exosomes possess significant clinical relevance due to their unique composition of genetic and protein material that is representative of the parent tumor. Specific isolation as well as identification of proportions of these clinically relevant exosomes (CREs) from biological samples could help to better understand their clinical significance as cancer biomarkers. Herein, we present a simple approach for quantification of the proportion of CREs within the bulk exosome population isolated from patient serum. This proportion of CREs can potentially inform on the disease stage and enable non-invasive monitoring of inter-individual variations in tumor-receptor expression levels. Our approach utilises a Surface Plasmon Resonance (SPR) platform to quantify the proportion of CREs in a two-step strategy that involves (i) initial isolation of bulk exosome population using tetraspanin biomarkers (i.e., CD9, CD63), and (ii) subsequent detection of CREs within the captured bulk exosomes using tumor-specific markers (e.g., human epidermal growth factor receptor 2 (HER2)). We demonstrate the isolation of bulk exosome population and detection of as low as 10% HER2(+) exosomes from samples containing designated proportions of HER2(+) BT474 and HER2(-) MDA-MB-231 cell derived exosomes. We also demonstrate the successful isolation of exosomes from a small cohort of breast cancer patient samples and identified that approximately 14-35% of their bulk population express HER2. PMID:27464736

  16. Real time and label free profiling of clinically relevant exosomes

    Science.gov (United States)

    Sina, Abu Ali Ibn; Vaidyanathan, Ramanathan; Dey, Shuvashis; Carrascosa, Laura G.; Shiddiky, Muhammad J. A.; Trau, Matt

    2016-01-01

    Tumor-derived exosomes possess significant clinical relevance due to their unique composition of genetic and protein material that is representative of the parent tumor. Specific isolation as well as identification of proportions of these clinically relevant exosomes (CREs) from biological samples could help to better understand their clinical significance as cancer biomarkers. Herein, we present a simple approach for quantification of the proportion of CREs within the bulk exosome population isolated from patient serum. This proportion of CREs can potentially inform on the disease stage and enable non-invasive monitoring of inter-individual variations in tumor-receptor expression levels. Our approach utilises a Surface Plasmon Resonance (SPR) platform to quantify the proportion of CREs in a two-step strategy that involves (i) initial isolation of bulk exosome population using tetraspanin biomarkers (i.e., CD9, CD63), and (ii) subsequent detection of CREs within the captured bulk exosomes using tumor-specific markers (e.g., human epidermal growth factor receptor 2 (HER2)). We demonstrate the isolation of bulk exosome population and detection of as low as 10% HER2(+) exosomes from samples containing designated proportions of HER2(+) BT474 and HER2(−) MDA-MB-231 cell derived exosomes. We also demonstrate the successful isolation of exosomes from a small cohort of breast cancer patient samples and identified that approximately 14–35% of their bulk population express HER2. PMID:27464736

  17. The clinical applications of labelling immunoassay in the cardiovascular disease and its progress

    International Nuclear Information System (INIS)

    The disadvantage of radioimmunoassay are radio contamination and can not automate. In the date, the labelling immunoassay (enzyme immunoassay, fluorescent immunoassay, luminescent immunoassay) will eventually replace radioimmunoassay. The author reviews the clinical application of in the cardiovascular disease by labelling immunoassay thyroid hormone (TH), endothelin (ET), cytokine (CK), collagen, amino-terminal pro-peptide of type III pro-collagen (PIII NP), telopeptide of type I collagen (ICTP), myoglobin (Mb, cytokine isoenzyme cardio-muscle troponin I), growth hormone (GH), c-reactive protein (CRP), tumor necrosis factor-α(TNF-α), carbohydrate antigen-125 (CA-125), neuropeptide Y(NPY) and it's progress

  18. Laboratory animals pulmonary clearance study with chromium 51 labelled polystyrene spherical particles: investigations for clinical application

    International Nuclear Information System (INIS)

    Polystyrene spherical particles labelled with chromium 51, retaining a small amount of chromium acetylacetonate, were administered through different ways to laboratory animals, mice, rats, dogs and monkeys, in order to work out a suitable technique for clinical investigations. The following results were obtained: radioactive labelling may be considered as stable because in vivo chromium elution from the particles does not exceed 0.1% daily. No short-term toxicity has been found for any of the ways of administration due to acetylacetonate or the particles themselves. Long-term pulmonary clearance of inhaled polystyrene particles is close to that of metallic oxides, and no detectable nuisance was observed

  19. Bismuth absorption from 205 Bi-labelled pharmaceutical bismuth compounds used in the treatment of peptic ulcer disease

    International Nuclear Information System (INIS)

    The absorption of bismuth from five 205Bi-labelled pharmaceutically used bismuth compounds was studied in man. From single oral doses of all compounds under investigation only <0.1% bismuth was absorbed and excreted with the urine. A significantly higher absorption was observed from the colloidal bismuth subcitrate and the basic bismuth gallate than from the basic bismuth salicylate, nitrate and aluminate. No retention of bismuth in the whole body was found from the single dose experiment. The biologic fast-term half-lives of absorbed bismuth were calculated to be 0.12 and 1.5 days. 14 refs., 2 figs., 1 tab

  20. Bismuth absorption from sup 205 Bi-labelled pharmaceutical bismuth compounds used in the treatment of peptic ulcer disease

    Energy Technology Data Exchange (ETDEWEB)

    Dresow, B.; Fischer, R.; Gabbe, E.E.; Wendel, J.; Heinrich, H.C. (Eppendorf University Hospital, Hamburg (Germany))

    1992-04-01

    The absorption of bismuth from five {sup 205}Bi-labelled pharmaceutically used bismuth compounds was studied in man. From single oral doses of all compounds under investigation only <0.1% bismuth was absorbed and excreted with the urine. A significantly higher absorption was observed from the colloidal bismuth subcitrate and the basic bismuth gallate than from the basic bismuth salicylate, nitrate and aluminate. No retention of bismuth in the whole body was found from the single dose experiment. The biologic fast-term half-lives of absorbed bismuth were calculated to be 0.12 and 1.5 days. 14 refs., 2 figs., 1 tab.

  1. Studies on the preparation of labelled compounds for γ-scintigraphy use

    International Nuclear Information System (INIS)

    To develop 99mTc instant labelling kit of d,1-HMPAO and 131I labelled IMP for the regional cerebral blood flow scintigraphic use, d,1-HMPAO and IMP were synthesized. The former was prepared from 2,3-butadione monoxim and 2,2-dimethyl-1,3-propanediamine in the presence of cation exchange resin, and then selective reduction of imine bond with sodium borohydride followed by fractional crystallization of diastereometric mixture of HMPAO. The latter was prepared by condensation of p-iodophenylpropanone with isopropylamine, and then reduction of double bond with sodium borohydride. For the preparation of 99mTc labelled HSA, experiments on incorporation of bifunctional chelating agent of DTPA to HSA, establishment of optimal conditions of 99mTc labelling, determination of labelling yield and radiochemical purity, and examination of stability were carried out. (Author)

  2. Clinical application of Tc-99m HMPAO labeled leukocyte imaging in inflammatory disease

    International Nuclear Information System (INIS)

    A radionuclide imaging with Tc-99m HMPAO labeled leukocyte was performed in order to determine its clinical usefulness in inflammatory disease. The mixed leukocyte isolated from 40 ml of whole blood containing 5 ml of acid citrate dextrose A and 7 ml of 6% hydroxyethyl starch was incubated with 370 MBq (10 mCi) of Tc-99m HMPAO at 37degC for 30 minutes. Because the labeling efficiency of Tc-99m HMPAO labeled leukocyte was 60.2±6.3%, the procedure of washing Tc-99m leukocyte with 5 ml of physiological saline was necessary before intravenous injection, in order to remove the unlabeled Tc-99m HMPAO. The recoveries of Tc-99m leukocyte in the blood after intravenous injection were 41.1±6.7% at 5 minutes, 33.4±2.1% at 30 minutes, and 27.2±3.4% at 2 hours after injection. Moreover, the labeled leukocyte was not stained with trypan blue. Therefore, the biological activity of the Tc-99m leukocyte was maintained as that of In-111 oxine labeled leukocyte. In the 39 patients with clinical suspicion of inflammatory disease including 15 patients with acute and chronic infectious disease where both Tc-99m leukocyte and Ga-67 citrate imagings were performed, the sensitivity, specificity and accuracy for infectious disease were 47%, 100%, and 79% with Tc-99m leukocyte, and 67%, 79%, 74% with Ga-67 citrate. These results suggest that Tc-99m HMPAO labeled leukocyte imaging is promising for evaluating inflammatory disease because of much higher specificity, the ready availability of Tc-99m HMPAO, the good image quality, and the lower radiation dose to the patient. (author)

  3. Some chemical synthesis of 14C labelled compounds of pharmaceutical or biological interest

    International Nuclear Information System (INIS)

    The recent discovery of the tuberculostatic properties of the hydrazide of isonicotinic acid (so-called 'Isoniazide', 'Rimifon') has raised considerably its interest, as for metabolic studies which it is more interesting to have it labelled with 14C. We describe in this report the chemical synthesis of 14C carboxyl labelled isoniazide which were done in the pyridine ring to highlight his metabolic function on the Koch's bacillus. (M.B.)

  4. Some chemical synthesis of {sup 14}C labelled compounds of pharmaceutical or biological interest

    Energy Technology Data Exchange (ETDEWEB)

    Pichat, I.; Baret, C.; Audinot, M.; Herbert, M.; Lambin, J. [Commissariat a l' Energie Atomique, Lab. du Fort de Chatillon, Fontenay-aux-Roses (France). Centre d' Etudes Nucleaires

    1955-07-01

    The recent discovery of the tuberculostatic properties of the hydrazide of isonicotinic acid (so-called 'Isoniazide', 'Rimifon') has raised considerably its interest, as for metabolic studies which it is more interesting to have it labelled with {sup 14}C. We describe in this report the chemical synthesis of {sup 14}C carboxyl labelled isoniazide which were done in the pyridine ring to highlight his metabolic function on the Koch's bacillus. (M.B.)

  5. Combining position-specific 13C labeling with compound-specific isotope analysis: first steps towards soil fluxomics

    Science.gov (United States)

    Dippold, Michaela; Kuzyakov, Yakov

    2015-04-01

    Understanding the soil organic matter (SOM) dynamics is one of the most important challenges in soil science. Transformation of low molecular weight organic substances (LMWOS) is a key step in biogeochemical cycles because 1) all high molecular substances pass this stage during their decomposition and 2) only LMWOS will be taken up by microorganisms. Previous studies on LMWOS were focused on determining net fluxes through the LMWOS pool, but they rarely identified transformations. As LMWOS are the preferred C and energy source for microorganisms, the transformations of LMWOS are dominated by biochemical pathways of the soil microorganisms. Thus, understanding fluxes and transformations in soils requires a detailed knowledge on the biochemical pathways and its controlling factors. Tracing C fate in soil by isotopes became on of the most applied and promising biogeochemistry tools. Up to now, studies on LMWOS were nearly exclusively based on uniformly labeled organic substances i.e. all C atoms in the molecules were labeled with 13C or 14C. However, this classical approach did not allow the differentiation between use of intact initial substances in any process, or whether they were transformed to metabolites. The novel tool of position-specific labeling enables to trace molecule atoms separately and thus to determine the cleavage of molecules - a prerequisite for metabolic tracing. Position-specific labeling of LMWOS and quantification of 13CO2 and 13C in bulk soil enabled following the basic metabolic pathways of soil microorganisms. However, only the combination of position-specific 13C labeling with compound-specific isotope analysis of microbial biomarkers and metabolites allowed 1) tracing specific anabolic pathways in diverse microbial communities in soils and 2) identification of specific pathways of individual functional microbial groups. So, these are the prerequisites for soil fluxomics. Our studies combining position-specific labeled glucose with amino

  6. Lyophilized kits of diamino dithiol compounds for labelling with 99m-technetium. Pharmacokinetics studies and distribution compartmental models of the related complexes

    International Nuclear Information System (INIS)

    The present work reflects the clinical interest for labelling diamino dithiol compounds with technetium-99m. Both chosen compounds, L,L-Ethylene dicysteine (L,L-EC) and L,L-Ethylene dicysteine diethyl esther (L,L-ECD) were obtained with relative good yield and characterized by IR and NMR. The study of labelling conditions with technetium-99m showed the influence of the type and mass of reducing agent as well as the pH on the formation of complexes with desired biological characteristics. Radiochemical purity was determined by thin layer chromatography (TLC) and high performance liquid chromatography (HPLC). Lyophilised kits of L,L-EC and L,L-ECD for labelling with 99mTc were obtained, with stability superior to 120 days, when stored under refrigeration, enabling the kits marketing. The ideal formulation of the kits as well as the use of liquid nitrogen in the freezing process, determined the lyophilization success. Distribution biological studies of the 99mTc complexes were performed on mice by invasive method and on bigger animals by scintigraphic evaluation. Biological distribution studies of the complex 99mTc-L,L-EC showed fast blood clearance, with the elimination of about 90% of the administered dose after 60 minutes, almost exclusively by the urinary system. The biological distribution results were adjusted to a three compartmental distribution model, as expected for a radiopharmaceutical designed to renal dynamic studies, with tubular elimination. The complex interaction with renal tubular receptors is related with structural characteristics of the compound, more specifically with the presence and location of polar groups. In comparison with 99mTc-L,L-EC, biological studies of the complex 99mTc -L,L-ECD showed different distribution aspects, despite some structural similarities. The presence of ethyl groups confers to the complex neutrality and lipophilicity. It cross the intact blood brain barrier and is retained in the brain for enough period, permitting

  7. Octreotide labelled with 99Tcm for detecting somatostatin-receptor-positive tumors: preparation, identification and preliminary clinical application

    International Nuclear Information System (INIS)

    Objective: To develop an optimal method to label octreotide with 99Tcm directly and evaluate characteristics of receptor-mediated binding of 99Tcm-octreotide in vitro and its potential as an imaging agent of somatostatin receptor-positive tumors. Methods: Sodium ascorbate and Na2S2O4 were adopted to label octreotide with 99Tcm; cell membrane of Wistar rat brain cortex on which there are numerous somatostatin receptors was used for radioreceptor assay in vitro; radioactivity biodistribution assay and clinical somatostatin receptor imaging were performed. Results: The yield of 99Tcm-octreotide was 78.5%, radiochemical purity was 93.8% after purification. The 99Tcm-octreotide compound remained stable after at least 4 h at room temperature. Wistar rat brain cortex cell membrane receptor-binding showed significant features associated with receptor-mediated binding. Satisfactory 99Tcm-octreotide receptor images were obtained in 3 lung cancer cases. Conclusions: These results suggest that 99Tcm-octreotide is a promising radiopharmaceutical for scintigraphic imaging of tumors rich in somatostatin receptors

  8. Development and evaluation of electro chemical methods for the separation of Tc-99m labelled compounds of medical importance

    International Nuclear Information System (INIS)

    The preparation of sup(99m)Tc radiopharmaceuticals using the electrolytic reduction of sup(99m)Tc pertechnetate was investigated. The effect of current intensity, amount of current, pH and applied voltage on the reduction of the Tc-VII and its incorporation into the radiopharmaceuticals was evaluated. The results indicate that the electrolytic method gives high and reproducible labelling yields and compounds with good radiochemical purity. Procedures for the preparation and control of the following sup(99m)Tc radiopharmaceuticals were standardized by the authors: Tc-tin colloid, Tc-red blood cells, Tc-HSA, Tc-albumin microspheres, Tc-EHDP, Tc-gluconate and Tc-glucoheptonate. A portable electrolytic labelling instrument was designed for use in hospitals

  9. A method for monitoring mineralization of 14C-labeled compounds in aqueous samples

    International Nuclear Information System (INIS)

    Previously reported laboratory methods for measuring the rate of 14CO2 release from an aqueous sample require a series of replicate growth flasks. At chosen times, some of these are sacrificed in order to quantitate the 14CO2 released. The method presented here requires only one culture flask containing 200 ml of sample with labeled substrate, and one control-replacement flask containing 200 ml of sterile sample with labeled substrate. At each sampling time, 1/40th of the liquid and headspace gas is removed from the modified 500 ml Erlenmeyer culture flask for 14CO2 recovery. This method was used to study the mineralization of labeled amino acids, starch, n-hexadecane and anthracene by micro-organisms in river water, and of n-hexadecane and n-hexadecanoic acid by microorganisms in sewage effluent. (author)

  10. Contribution to the study of the biological properties of compounds labeled with radio-chromium 51Cr

    International Nuclear Information System (INIS)

    Among the radioisotopes commonly used in biology and medicine which are controlled Individually in the Radioelement Departement of the Saclay Nuclear Research Centre before being sent to the users, the author has chosen chromium 51 incorporated in inorganic salts or in organic substrates for a study of the biological properties of the compounds. In the first part, he has compared the pathways followed by the radioactive sodium chromate and chromic chloride mixed with blood or given to the whole animal, the object being to determine whether a reduction of hexavalent chromium occurs, both in vitro and in vivo. In the second part, the author has tried to show the validity of using, various substrates labeled with chromium 51, red cells, haemoglobin, plasma proteins and cytochrome c. The results obtained have contributed to underline the interest of using such compounds for biological applications. (author)

  11. Preparation and preclinical evaluation of 211At-labelled compounds for α-particle radiotherapy

    International Nuclear Information System (INIS)

    The present work demonstrate that significant therapeutic gain can be achieved with 211At-labelled MoAbs on single tumour cells and microscopic disease. Β-emitters are less effective on microscopic disease because of radiation dispersion, while longer halflives (e.g., 90Y and 131I) allow favourable therapeutic ratios to be reached in larger tumors. 211At-labelled MoAbs may therefore possibly be used in combination with β-emitting RIC in systemically delivered radioimunnotherapy. Larger tumor nodules are then irradiated effectively due to cross-fire of the longer ranged β-particles while the fraction of tumour cells distributed as single cells and micrometastases may be more effectively radiated with 211At-RIC. 76 refs

  12. Isotopically labelled compounds for hazardous waste site cleanup investigations: Pt. 1

    International Nuclear Information System (INIS)

    The Fries rearrangement of [phenyl-U-14C] propionate forming a mixture of ortho and para hydroxypropiophenones was followed by steam distillation to separate the isomeric products. A Grignard addition to the ortho isomer and elimination of water from the intermediate carbinol, followed by hydrogenation and nitration, yielded [phenyl-U-14C] labelled dinoseb. A Wolff-Kischner reduction of the para isomer furnished [phenyl-U-14C]4-n-propylphenol. (author)

  13. Synthesis of labelled compound of ferulic acid and caffeic acid with tritium

    International Nuclear Information System (INIS)

    Effective components of Chinese traditional herbs consist of many compounds, but some of the compounds usually contain unsaturated carbon-carbon double bonds. The unsaturated organic compounds 3H-Ferulic acid and 3H-Caffeic acid are prepared with their tritiated intermediates made by electric-dischange exposure method, which ensures the compounds contaning double bonds not hydrogenated. The 3H-Ferulic acid is composed of 3H-vanillin and Malonic acid. The 3H-Caffeic acid is composed of 3H-protocatechuyl aldehyde and Malonic acid and the specific activity of the products is 0.2 mCi/mg. The radiochemicaly purity is greater than 90%

  14. Carbon transfer in soil - plant system. Molecular labelling utilization for determining rhizosphere compounds

    International Nuclear Information System (INIS)

    The growing up of the bacteria developing in the rhizosphere of plants is dependent on the compounds exudation by plant roots. Even the bacterial genetics use has permitted to identify diverse functions involved in the process of the rhizosphere colonisation ( mobility, heterotrophic bacteria, growing rate, antibiotics production), there is a big delay in vegetal partners. To decrease this delay we tried to characterize the interactions between a plant model, Arabidopsis thaliana and the rhizosphere bacteria. An experimental device has been conceived for measuring the transfer of carbon issued from the photosynthesis to roots and soil. The exudation by roots has been studied. The analysis of rhizospheric compounds in situ pose some methodological problems, especially, the rhizospheric compounds must be extracted from the soil matrix. we suggest an analysis method of rhizospheric compound and of their dynamics. (F.M.)

  15. Clinical application of 99mTc-HMPAO labeled leucocytes imaging in detecting bone joint infection

    International Nuclear Information System (INIS)

    99mTc-MDP scintigraphy and 99mTc-HMPAO-leucocytes imaging were performed in twenty five patients with clinically suspected bone joint infection. All of the 25 cases were confirmed by surgery, microbiological and histologic examinations. Among them 21 cases were definitively diagnosed as infections, while 3 cases were non-infection. The results of 99mTc-MDP scintigraphy showed that all of 25 cases demonstrated anomalous accumulation of radioactivity in the clinically suspected infections sites, while in 99mTc-HMPAO-leucocytes imaging, concentrated radioactivity in proved infectious sites was observed in 19 cases, non-anomalous radioactivity found in 4 cases of non-infectious sites, but there were 2 cases false negative with long term antibiotics treatment, none of the case was false positive. Thereby a sensitivity of the labelled leucocytes imaging of 90.5%, a specificity of 100%, and a accuracy of about 92% were found. Present research work concluded that 99mTc-HMPAO labelled leucocytes imaging provided a non-invasive, effective, and reliable diagnostic method in detecting patients with clinically suspected bone joint infection and afforded strong evidence for effective therapy

  16. Evaluation of radiolabeling of annexin A5 with technetium-99m: influence of the labeling methods on physico-chemical and biological properties of the compounds

    International Nuclear Information System (INIS)

    Annexin A5 (ANXA5) is an intracellular human protein of 36 kDa with high affinity for membrane-bound phosphatidylserine that is selectively exposed on the surface of cells undergoing apoptosis. Apoptosis is important in normal physiology and innumerous pathologic states. Clinical applications for ANXA5 imaging are being developed in oncology, organ transplantation and cardiovascular diseases. Many strategies to radiolabel the protein have been described, including direct labeling, derivatization through a bifunctional chelating agent (BFC), production of mutated protein or peptide analogs. Several 99mTc-labeling techniques have been reported using different cores, including [Tc=O]+3, [Tc]HYNIC, [Tc≡N]+2 and [Tc(CO3)]+1. In this study, we evaluated the influence of 99mTc cores on biological behavior and physico-chemical properties of radiolabeled annexin. Radiolabeling procedure using [Tc≡N]+2 core was a two-step procedure including the reaction of 99mTcO4 - with SDH in the presence of SnCl2 and PDTA to obtain the intermediate 99mTcN-SDH, and successive addition of ANXA5. The results obtained were not satisfactory, despite the high efficiency in the production of the intermediate. The [Tc=O]+3 core was produced using the ethylene dicysteine (EC) as BFC. TSTU was employed in the derivatization to produce the corresponding hydroxysuccinimide ester. Different ANXA5:EC ratios were studied and all labeling conditions resulted in high radiochemical yield but with differences in lipophilicity, stability, biological distribution and affinity for apoptotic cells. The HYNIC-ANXA5 also produced the labeled protein with high radiochemical yield. The stability of the radiolabeled ANXA5 was evaluated after storing at room temperature, at 2 - 8 degree C and in human serum at 37 degree C. The analysis of these results showed that the 99mTc-EC-ANXA5 (ratio 10-2) was the most stable compound in all the studied conditions. Partition coefficient assay resulted in lower

  17. Radiochemistry, pre-clinical studies and first clinical investigation of 90Y-labeled hydroxyapatite (HA) particles prepared utilizing 90Y produced by (n,γ) route

    International Nuclear Information System (INIS)

    Introduction: The scope of using no carrier added (NCA) 90Y [T1/2 = 64.1 h, Eβ(max) = 2.28 MeV] obtained from 90Sr/90Y generator in radiation synovectomy (RSV) is widely accepted. In the present study, the prospect of using 90Y produced by (n,γ) route in a medium flux research reactor for use in RSV was explored. Methods: Yttrium-90 was produced by thermal neutron irradiation of Y2O3 target at a neutron flux of ~ 1 × 1014 n/cm2.s for 14 d. The influence of various experimental parameters were systematically investigated and optimized to arrive at the most favorable conditions for the formulation of 90Y labeled hydroxyapatite (HA) using HA particles of 1–10 μm size range. An optimized kit formulation strategy was developed for convenient one-step compounding of 90Y-HA, which is easily adaptable at hospital radiopharmacy. The pre-clinical biological evaluation of 90Y-HA particles was studied by carrying out biodistribution and bioluminiscence imaging studies in Wistar rats. The first clinical investigation using the radiolabeled preparation was performed on a patient suffering from chronic arthritis in knee joint by administering 185 MBq 90Y-HA formulated at the hospital radiopharmacy deploying the proposed strategy. Results: Yttrium-90 was produced with a specific activity of 851 ± 111 MBq/mg and radionuclidic purity of 99.95 ± 0.02%. 90Y-labeled HA particles (185 ± 10 MBq doses) were formulated in high radiochemical purity (> 99%) and excellent in vitro stability. The preparation showed promising results in pre-clinical studies carried out in Wistar rats. The preliminary results of the first clinical investigation of 90Y-HA preparation in a patient with rheumatoid arthritis in knee joints demonstrated the effectiveness of the formulation prepared using 90Y produced via (n,γ) route in the management of the disease. Conclusion: The studies revealed that effective utilization of 90Y produced via (n,γ) route in a medium flux research reactor coupled with the

  18. Screening of activators and inhibitors of nuclear protein synthesis using labeled compounds

    International Nuclear Information System (INIS)

    Full text: With the purpose of definition of physiological activity of some known and yet not investigated natural and synthetic compounds (only 40 compounds) their action on protein synthesis ability (PSA) of nucleus of not sharing cells of a brain of rabbits with use of the marked amino acid - C14-lysine has been investigated. As a result of our researches activators of non ribosomal synthesis of protein are revealed: N-(β-chlorethyl)-decahydroquinoline, licorine, lupinine, anabasine hydrochloride, peptides: enkephalin, epitalanine, ACTH 4-7, proteinkinase C, nitrocel, benzolaminopurine - synthetic cytokinin and inhibitors: cocaine, strychnine, aminazine, venom of a cobra snake, indolyl acetic acid, lectin like proteins, extensin like proteins, polyprenol, nitroglycerine. These received results can be used for the decision of the following problems: - Regulation of biosynthesis of the certain kinds of proteins; - Definition of a functional role of studying proteins; - he classification of studying compounds on activity for research of the certain processes in a cellular level

  19. Autoradiographic studies on the penetration of technetium-labelled chelate compounds into the dentin

    International Nuclear Information System (INIS)

    The penetration of /sup 99m/Tc-EDTA and /sup 99m/Tc-DTPA, resp., was investigated in extracted human monoradicular teeth. The distribution of the tracer on the sections corresponded approximately to the gradient of the molecular distribution. The depth of penetration was the same in all groups of teeth. It involved 2/3 of the root dentin and exceeds the softening of the dentin by about 200 μm. The intensity of labelling depended on the number of dentinal tubules. There were no differences between /sup 99m/Tc-EDTA and /sup 99m/Tc-DTPA as to the penetrating power

  20. Preparation, quality control and animal testing of Re-188 labelled compounds

    International Nuclear Information System (INIS)

    Rhenium-188 is an attractive therapeutic radioisotope obtained by elution from tungsten 188/rhenium 188-generator system. We used this eluate to label HEDP and lanreotide to prepare radiopharmaceuticals for experimental use. The results of our studies showed that using methods worked out under the framework of the CRP allowed us to prepare 188Re-HEDP and 188Re-lanreotide with high yield and favourable biodistribution in animals. In animal studies 188Re-HEDP was successfully used for localizing osteosarcoma in dog. (author)

  1. Application of compounds labelled with nitrogen-15 for nutritional studies in children

    International Nuclear Information System (INIS)

    It is proposed to use N-15 labelled amino acids to study protein turnover in nutritionally vulnerable population groups in Ghana, particularly children with Kwashiorkor (protein malnutrition) and measles. The Ministry of Health of Ghana has recently formulated a low cost protein-rich supplement (Weanimix) using local food products. The purpose of the research project is to study protein turnover in normal and malnourished children, and thereby to gain a better understanding of how to identify those children that are really in need of protein supplementation. 2 refs

  2. Determining the isotopic abundance of a labeled compound by mass spectrometry and how correcting for natural abundance distribution using analogous data from the unlabeled compound leads to a systematic error.

    Science.gov (United States)

    Schenk, David J; Lockley, William J S; Elmore, Charles S; Hesk, Dave; Roberts, Drew

    2016-04-01

    When the isotopic abundance or specific activity of a labeled compound is determined by mass spectrometry (MS), it is necessary to correct the raw MS data to eliminate ion intensity contributions, which arise from the presence of heavy isotopes at natural abundance (e.g., a typical carbon compound contains ~1.1% (13) C per carbon atom). The most common approach is to employ a correction in which the mass-to-charge distribution of the corresponding unlabeled compound is used to subtract the natural abundance contributions from the raw mass-to-charge distribution pattern of the labeled compound. Following this correction, the residual intensities should be due to the presence of the newly introduced labeled atoms only. However, this will only be the case when the natural abundance mass isotopomer distribution of the unlabeled compound is the same as that of the labeled species. Although this may be a good approximation, it cannot be accurate in all cases. The implications of this approximation for the determination of isotopic abundance and specific activity have been examined in practice. Isotopically mixed stable-atom labeled valine batches were produced, and both these and [(14) C6 ]carbamazepine were analyzed by MS to determine the extent of the error introduced by the approach. Our studies revealed that significant errors are possible for small highly-labeled compounds, such as valine, under some circumstances. In the case with [(14) C6 ]carbamazepine, the errors introduced were minor but could be significant for (14) C-labeled compounds with particular isotopic distributions. This source of systematic error can be minimized, although not eliminated, by the selection of an appropriate isotopic correction pattern or by the use of a program that varies the natural abundance distribution throughout the correction. PMID:26916110

  3. Clinical Evaluation of 57Co-labelled Bleomycin for Tumor Localization

    International Nuclear Information System (INIS)

    Investigation with 57Co-Bleomycin in patients with the various cancers and in tumor bearing animals are described. In the patients, 57Co-Bleomycin appears to be one of the useful tumor- seeking radiopharmaceuticals, and worth applicable to clinical uses. Labelled yield of 57Co-Bleo was about 97% by thin layer chromatography. The pyrogen free tests were performed to meet U.S.P. critical ranges. In clinical studies with 57Co-Bleo, 4 cases out of 5 patients with lung cancer, 2 cases among 3 thyroid cancer patients, and all 3 hepatoma patients showed positive tumor scans. The patients with stomach cancer, and the esophageal cancer showed false negative scintigraphy. A case with pulmonary tuberculosis showed a positive scan while liver abscess showed a negative picture. The merits of 57Co-Bleomycin scintigraphy seems to be its relatively high affinity to tumors and low radiation hazard in spite of long physical half life.

  4. Sulfur Isotope Exchange between S-35 Labeled Inorganic Sulfur-Compounds in Anoxic Marine-Sediments

    DEFF Research Database (Denmark)

    FOSSING, H.; THODEANDERSEN, S.; JØRGENSEN, BB

    1992-01-01

    of isotope exchange, specific radioactivities of the reduced sulfur pools were poorly defined and could not be used to calculate their rates of formation. Such isotope exchange reactions between the reduced inorganic sulfur compounds will affect the stable isotope distribution and are expected to decrease...

  5. Development of the RI Labelled Compounds by NT Technology for Behavior Detection of the Organic Process Fluid with High Temperature

    International Nuclear Information System (INIS)

    - To prepared metallic nanoparticles with high purity by radiation method (γ-irradiation or electron irradiation) and develop the techniques of particle size control (2-10 nm) and characterization for the various metallic nanoparticles (≥ five types of metallic nanoparticles) prepared. - To prepared the metallic nanoparticles which have various morphologies, e.g. nanoparticle, nanorod, and core-Au-shell-silica structure by radiation method. - To manufacture radioisotopes of the metallic nanoparticles by neutron activation reaction in a research reactor and establish manufacturing technology to develop reliable radiolabelled analytical techniques for the detection and quantification of nanomaterials with efficiency and safety (To applied only Au, silica nanopaticle, and core-Au-shell nanoparticle; specific activity 2-15 mCi/mg Au). - To find the applications of the radiolabeled Au nanoparticles (specific activity 2-15 mCi/mg Au) in industry (To test physical and chemical stability in organic compounds with high temperature). - The manufacturing technology of metallic nanoparticles by radiation (γ-irradiation or electron irradiation) can be employed in the field of semiconductor, bio, and fuel cells. - The radiolabeled Au nanoparticles will be applied in various areas of medicine, engineering, industry, agriculture, and life science since tracer radioisotopes can detect and measure the emitted energy from samples. - The radiolabeled metallic nanoparticles will be promising products for industries since they don't convert to gas state. However, RI labeled organic compounds used as organic compounds with high temperature can be converted to gases and emit radioactive elements

  6. Quantitative chromatography in the analysis of labelled compounds 1. Quantitative paper chromotography of amino acids by A spot comparison technique

    International Nuclear Information System (INIS)

    For the determination of the specific activity of labelled compounds separated by paper sheet chromatography, it was found essential to perfect the quantitative aspect of the paper chromatographic technique. Actually, so far paper chromatography has been used as a separation tool mainly and its use in quantification of the separated materials is by far less studied. In the present work, the quantitative analysis of amino acids by paper sheet chromatography has been carried out by methods, depending on the use of the relative spot area values for correcting the experimental data obtained. The results obtained were good and reproducible. The main advantage of the proposed technique is its extreme simplicity. No complicated equipment of procedures are necessary

  7. Pharmacokinetics of labelled compounds with technetium-99m and samarium-153

    International Nuclear Information System (INIS)

    The purpose of this investigation was to establish the different pharmacokinetics parameters of the main radiopharmaceuticals labeled with technetium-99m and samarium-153. These parameters could be subsequently used as reference to compare other products with the same use. Mathematical models and a computerized pharmacokinetic program were used to this purpose. A biodistribution study in quadruplicate and/or quintuplicate was conducted for each radiopharmaceutical, data was was obtained in injection dose percentages. The biodistribution study involved the injection of a predetermined dose of the radiopharmaceutical into animals (rats or mice), which were subsequently put away at different time intervals, removing the relevant organs. Activity in each organ was read by means of a well-type NaI scintillation counter, data obtained in activity counts was transformed into injection dose percentages. Based on these percentages, the mathematical model was constructed and the pharmacokinetic parameters were obtained using the computerized program Expo 2 v. 1, which is written in C language and works in windows. Analyzing the results obtained, we can conclude that the use of the Expo 2 v. 1 program for a bi compartmental analysis allowed us to obtain reliable pharmacokinetic parameters which describe what happens in the organism when the radiopharmaceutical passes from the central compartment to the peripheral one and vice versa

  8. Relation between clinical mature and immature lymphocyte cells in human peripheral blood and their spatial label free scattering patterns

    Science.gov (United States)

    Zhang, Lu; Zhao, Xin; Zhang, Zhenxi; Zhao, Hong; Chen, Wei; Yuan, Li

    2016-07-01

    A single living cell's light scattering pattern (LSP) in the horizontal plane, which has been denoted as the cell's "2D fingerprint," may provide a powerful label-free detection tool in clinical applications. We have recently studied the LSP in spatial scattering planes, denoted as the cell's "3D fingerprint," for mature and immature lymphocyte cells in human peripheral blood. The effects of membrane size, morphology, and the existence of the nucleus on the spatial LSP are discussed. In order to distinguish clinical label-free mature and immature lymphocytes, the special features of the spatial LSP are studied by statistical method in both the spatial and frequency domains. Spatial LSP provides rich information on the cell's morphology and contents, which can distinguish mature from immature lymphocyte cells and hence ultimately it may be a useful label-free technique for clinical leukemia diagnosis.

  9. Effect of Compound Sulfadiazine Suspension on Growth Performance of Broiler in Clinical Efficacy Trial

    OpenAIRE

    Leilei Wang; Li Zhao; Zhihui Hao; Kefeng Xiao; Fenfang Yang; Zhaopeng Ding

    2014-01-01

    Compound Sulfadiazine suspension is used mainly to prevent and cure E. coli, Salmonella infection of chicken in veterinary clinical application. Effect of compound Sulfadiazine suspension on growth performance of broiler in clinical efficacy trial was studied in the study. One hundred eighty 15-day-old broilers were divided randomly into six groups, blank control group, negative control group, Trisulmixos gavage group, Trisulmixos drinking group, Sufuning gavage group and Sufuning drinking gr...

  10. Clinical utility of labeled cells for detection of allograft rejection and myocardial infarction

    International Nuclear Information System (INIS)

    The choice of a specific radiolabeled blood component for use in detection of allograft rejection depends on several factors including the immunosuppressive agents used, the type of organ allografted, and particularly the length of time the allograft resides in the host and the duration of rejection. To date, only the use of 111In-labeled platelets in renal allograft recipients immunosuppressed with azathioprine and corticosteroids has shown clinical promise in the detection of early allograft rejection. Radiolabeled blood components are unlikely to play a significant role in detection of myocardial infarction. The use of these agents for monitoring therapeutic interventions or as indicators of prognosis in patients with myocardial infarction continues to be investigated

  11. Clinical utility of labeled cells for detection of allograft rejection and myocardial infarction

    Energy Technology Data Exchange (ETDEWEB)

    Fawwaz, R.A.

    1984-07-01

    The choice of a specific radiolabeled blood component for use in detection of allograft rejection depends on several factors including the immunosuppressive agents used, the type of organ allografted, and particularly the length of time the allograft resides in the host and the duration of rejection. To date, only the use of 111In-labeled platelets in renal allograft recipients immunosuppressed with azathioprine and corticosteroids has shown clinical promise in the detection of early allograft rejection. Radiolabeled blood components are unlikely to play a significant role in detection of myocardial infarction. The use of these agents for monitoring therapeutic interventions or as indicators of prognosis in patients with myocardial infarction continues to be investigated.

  12. Applicability of Activated Carbon to Treatment of Waste Containing Iodine-Labeled Compounds

    International Nuclear Information System (INIS)

    The applicability of activated carbon prepared from sawdust (SD) by one-step chemical activation process using H3PO4 (H) to treatment of aqueous waste contaminated with iodine-labeled prolactin (I-PRL) has been investigated. Treatment processes were performed under the varying conditions; contact time, temperature, carbon type, carbon dosage, and different particle size of activated carbon (SDH). Effect of aqueous waste volume has been investigated to calculate the batch factor (V/M) and the distribution coefficient (Kd). The used activated carbon (SDH) was characterized by N2 adsorption, FTIR, density, ph, point of zero charge phpzc, moisture and ash content. Methylene blue (MB) and iodine number was calculated by adsorption from solution. In order to investigate the mechanism of sorption and potential rate controlling steps, pseudo first- and second-order equations, intra particle diffusion equation and the Elovich equation have been used to test experimental data. Kinetic analysis of the four models has been carried out for system variables in order to assess which model provides the best fit predicted data with experimental results. 7 M NaOH can be used for regeneration of spent SDH activated carbon with the efficiency of 99.6% and the regenerated carbon can be reused for five cycles effectively. The prospect of applying the SDH activated carbon prepared from agricultural by-product, sawdust, to treatment of aqueous waste contaminated with I-PRL appears promising and is considered highly applicable because of its high adsorption capacity, available at low cost, easily regenerated and reused

  13. Synthesis and evaluation of fluorine-18 labelled compounds for imaging of bacterial infections with pet

    International Nuclear Information System (INIS)

    Syntheses of no carrier added (n.c.a.) 6-fluoro-1,4-dihydro-1-cyclopropyl-4-oxo-7-[4-[18F]fluoro-phenacyl -1-piperacinyl]-chinolincarboxylic acid ([18F]COPCA) and n.c.a. 4-[18F]fluoro-benzoyl-ubiquicidin 29-41 ([18F]UBI 29-41) are described. [18F]COPCA was synthesised within 120 min with a radiochemical yield of 9-12%. [18F]UBI 29-41 was synthesised within 150 min with a radiochemical yield of 15-20%. Both compounds had a specific activity of more than 35 GBq/μ mol. The biological activity was verified by measuring its binding to Staphylococcus aureus bacteria. Specific binding was found for [18F]UBI 29-41 (12-17%), whereas no specific binding for [18F]COPCA was found

  14. Some preliminary studies of the metabolism of 99Mo-labelled compounds in deer

    International Nuclear Information System (INIS)

    The metabolism of (99Mo) compounds in plasma was followed after intravenous injection of (99Mo) trithiomolybdate and intraruminal infusion of (99Mo) molybdate in one red deer and one sika deer. Clearance of (99Mo) trithiomolybdate was rapid and residual radioactivity was (99Mo) dithiomolybdate. After ruminal infusion of (99Mo) molybdate, the main plasma (99Mo) thiomolybdate detected was also (99Mo) dithiomolybdate. These preliminary studies may provide an explanation of the apparent insensitivity of the deer to high dietary Mo, since dithiomolybdate is less likely to be toxic systemically than trithiomolybdate to tetrathiomolybdate. However, further studies with more animals and over a wider range of conditions would be advisable before definitive conclusions are drawn. (author)

  15. Synthesis and evaluation of fluorine-18 labelled compounds for imaging of bacterial infections with pet

    Energy Technology Data Exchange (ETDEWEB)

    Zijlstra, S. [Institut fuer Molekulare Biophysik, Radiopharmazie und Nuklearmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitaetsklinik der Ruhr-Universitaet, Bochum, Georgstrasse 11, 32545 Bad Oeynhausen (Germany)]. E-mail: szijlstra@hdz-nrw.de; Gunawan, J. [Institut fuer Molekulare Biophysik, Radiopharmazie und Nuklearmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitaetsklinik der Ruhr-Universitaet, Bochum, Georgstrasse 11, 32545 Bad Oeynhausen (Germany); Freytag, C. [Institut fuer Laboratoriums-und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitaetsklinik der Ruhr-Universitaet, Bochum, Georgstrasse 11, 32545 Bad Oeynhausen (Germany); Burchert, W. [Institut fuer Molekulare Biophysik, Radiopharmazie und Nuklearmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitaetsklinik der Ruhr-Universitaet, Bochum, Georgstrasse 11, 32545 Bad Oeynhausen (Germany)

    2006-07-15

    Syntheses of no carrier added (n.c.a.) 6-fluoro-1,4-dihydro-1-cyclopropyl-4-oxo-7-[4-[{sup 18}F]fluoro-phenacyl -1-piperacinyl]-chinolincarboxylic acid ([{sup 18}F]COPCA) and n.c.a. 4-[{sup 18}F]fluoro-benzoyl-ubiquicidin 29-41 ([{sup 18}F]UBI 29-41) are described. [{sup 18}F]COPCA was synthesised within 120 min with a radiochemical yield of 9-12%. [{sup 18}F]UBI 29-41 was synthesised within 150 min with a radiochemical yield of 15-20%. Both compounds had a specific activity of more than 35 GBq/{mu} mol. The biological activity was verified by measuring its binding to Staphylococcus aureus bacteria. Specific binding was found for [{sup 18}F]UBI 29-41 (12-17%), whereas no specific binding for [{sup 18}F]COPCA was found.

  16. PHARMACEUTICAL AND CLINICAL STUDIES ON COMPOUND AYURVEDIC FORMULATION, SARASWATA CHURNA

    OpenAIRE

    Tiwari Radheyshyam; Reddy K.R.C; Gupta Sanjay; Tripathi J.S.

    2011-01-01

    Saraswata Churna is a unique combination of Ayurvedic herbal drugs, containing mainly Medhya Rasayana drugs, like Vacha, Shankhpushpi, Aswagandha, Bramhi, etc. For the first time Saraswata churna is mentioned in Bhavaprakash Unmadadhikar and formula given in the same, selected for present study. The drug is prepared in the Ayurvedic Pharmacy, Institute of Medical Sciences, Banaras Hindu University and was selected for the management of Geriatric Depression. In the clinical study a series of 5...

  17. Clinical value of measurement of regional brain function with inhalation of 15O labeled gas synthesized with automated labeled gas production system

    International Nuclear Information System (INIS)

    In order to examine the clinical value of positron emission tomography (PET), we measured cerebral perfusion and oxygen metabolism using oxygen-15 labeled gas (O2, CO2, CO) produced by small cyclotron and the automated synthesis system (AMGS 01). PET study was carried out using oxygen-15 continuous inhalation technique in 61 cases of various neurological diseases including cerebrovascular disease (39 cases), dementia (6 cases), brain tumor (3 cases) and other neurological diseases (13 cases). In all cases, the labeled gas was produced and delivered in a stable condition. Functional images of regional cerebral blood flow (CBF), oxygen extraction fraction (OEF), cerebral metabolic rate for oxygen (CMRO2), and cerebral blood volume (CBV) were calculated according to the oxygen-15 steady-state model. Visual interpretation of these functional images showed abnormal findings in 74 % (CBF images), 30 % (OEF images), 79 % (CMRO2 images) and 10 % (CBV images) of the total cases. Overall assessment for the clinical usefulness of this method was determined as follows: 28 % as highly useful, 41 % as useful, 31 % as fairly useful. No adverse reaction was observed in this clinical trial. In conclusion, the automated synthesis system provided a stable delivery of oxygen-15 gas, and PET measurement of cerebral blood flow and oxygen metabolism is a valuable technique not only for clinical diagnosis but also for understanding pathophysiology of various neurological diseases. (author)

  18. Multi-purpose synthesis module for preparing [F-18]--labeled compounds

    International Nuclear Information System (INIS)

    -Chemicals, Germany. All other chemicals of and purification columns were were of pharma-grade and procured elsewhere. The modifications were essentially straightforward using readily available spare parts. The adaptation was successful and the module used for preparing the above 18F-PET-tracers whenever required. We have used the module to make over 80 batches of 18F-NaF, 30 batches of 18F-FDG, 18 batches of 18F-FLT, 15 batches of 18F-FMISO and 8 batches of 18F-FHBG. The yields were satisfactory The cleaning run is very satisfactory as no noticeable contamination is seen after it. 18F-NaF was the simplest since no chemical processing was required. With a demand for other [F- I 8]-PET-RPs, there is a need for modules which can handle the required chemistry and purification steps which cannot be carried out in dedicated FDG-synthesis modules. Further, due to space, weight and cost restrictions, it would not be economical to have dedicated modules for every [F-18]-PET-RP. With this in mind, manufacturers are now marketing general purpose fluorination modules that can be used for a number of [F-18] PET-RPs produced by nucleophilic substitution route. The major concern raised by the radio pharmacists is whether there will be contamination of one [F18]-RP with another produced in the same module, compromising radiochemical and radiopharmaceutical purity. We have not found cross-contamination an issue, since the automated cleaning step is very satisfactory. Our experience shows that it is possible, with some ingenuity, to fabricate multi-purpose synthesis modules, which can be used for synthesis of more than one [F-I8]-labeled PET-RPs. (author)

  19. Labeled extra virgin olive oil as food supplement; phenolic compounds in oils from some autochthonous Croatian olives

    Directory of Open Access Journals (Sweden)

    Jakobušić Brala, C.

    2015-12-01

    Full Text Available Within the framework of an incentive to provide labeled extra virgin olive oils as a food supplement in pharmacies, the phenolic profile analysis of extra virgin olive oils obtained from Croatian olive cultivars has been reported. With the aim of increasing the consumption of EVOO-s in northern Croatia, the varieties Bjelica, Buža and Italian Leccino have been studied involving two different agroclimatic locations, over two harvest years differing significantly in the amount of rainfall. The Croatian cultivars Plominka, Žižolera, Oblica and Lastovka, were also examined. Correlation tests and the insight from PCA reveal that the cultivars are highly individualized in character with regard to relationships among phenolic compounds. Some elements of an innovative labeling aimed to better present the authenticity, quality, excellence and uniqueness of the EVOO-s were suggested.En el marco de los incentivos que se han considerado para proporcionar el etiquetado de aceites de oliva virgen extra como suplemento alimenticio en farmacias, se reporta el análisis del perfil fenólico de aceites de oliva vírgenes extra obtenidos a partir de variedades croatas. Para ampliar el consumo de AOVE-s en el norte de Croacia, se han estudiado las variedades Bjelica, Buža y Leccino italiana procedentes de dos lugares agroclimáticos diferentes que difieren significativamente en la cantidad de lluvia y obtenidos en dos cosechas. Tambien fueron examinados los cultivares croatas Plominka, Žižolera, Oblica y Lastovka. Los test de correlación y los resultados de PCA revelan que las variedades están altamente individualizados en su carácter en lo que respecta a las relaciones entre los compuestos fenólicos. Se sugirieron algunos elementos innovadores para un etiquetado dirigido a presentar mejor la autenticidad, la calidad, la excelencia y la singularidad de los AOVE-s.

  20. Ontology-supported processing of clinical text using medical knowledge integration for multi-label classification of diagnosis coding

    CERN Document Server

    Waraporn, Phanu; Clayton, Gareth

    2010-01-01

    This paper discusses the knowledge integration of clinical information extracted from distributed medical ontology in order to ameliorate a machine learning-based multi-label coding assignment system. The proposed approach is implemented using a decision tree based cascade hierarchical technique on the university hospital data for patients with Coronary Heart Disease (CHD). The preliminary results obtained show a satisfactory finding.

  1. Off-label use of recombinant factor VIIa for treatment of haemorrhage: results from randomized clinical trials

    DEFF Research Database (Denmark)

    Johansson, Per Ingemar

    2008-01-01

    Background Recombinant factor VIIa (rFVIIa) is used for haemophilic patients with inhibitors against coagulation factor VIII or IX, but there is also an off-label use of rFVIIa for patients with massive bleeding. The aim of the present study was to review the randomized clinical trials (RCT) for ...

  2. Association between in vivo iododeoxyuridine labeling, MIB-1 expression, malignancy grade and clinical stage in human prostate cancer

    DEFF Research Database (Denmark)

    Borre, M; Høyer, M; Sørensen, Flemming Brandt;

    1998-01-01

    proliferation rates measured by in vivo IdUrd labeling and MIB-1 expression in formalin-fixed paraffin-embedded tumors. Good correlations were also found between S-phase fraction, MIB-1 expression, clinical stage and malignancy grade. These results make larger retrospective studies on archival tissue meaningful....

  3. PHARMACEUTICAL AND CLINICAL STUDIES ON COMPOUND AYURVEDIC FORMULATION, SARASWATA CHURNA

    Directory of Open Access Journals (Sweden)

    Tiwari Radheyshyam

    2011-06-01

    Full Text Available Saraswata Churna is a unique combination of Ayurvedic herbal drugs, containing mainly Medhya Rasayana drugs, like Vacha, Shankhpushpi, Aswagandha, Bramhi, etc. For the first time Saraswata churna is mentioned in Bhavaprakash Unmadadhikar and formula given in the same, selected for present study. The drug is prepared in the Ayurvedic Pharmacy, Institute of Medical Sciences, Banaras Hindu University and was selected for the management of Geriatric Depression. In the clinical study a series of 50 patients of Geriatric Depression were recruited randomly, based on the DSM-IV-TR diagnostic criteria of depression along with their screening for the level of depression using Geriatric Depression Scale (GDS-30. Out of 50, 30 patients were put on Saraswata Churna (Group-A, and 20 patients were on control group, Citalopram (Group-B. The total duration of therapeutic trial was three months. Hamilton Depression Rating Scale (HDRS has been used to evaluate the response of the drugs. Certain basic biochemical and hematological investigations were also measured before and after the trial. The results have been found to be encouraging with significant relief in the patients belonging to ‘group A’ with no side effects.

  4. Development of new and improved labelling procedures for introducing isotopic hydrogen and carbon-11 into organic compounds

    International Nuclear Information System (INIS)

    New and improved methods for introducing radioisotopic hydrogen (tritium) and carbon (positron-emitting short-lived carbon-11, t1/2 = 20.4 min) into organic molecules for application in biological research have been explored. In Chapter 1 the applications of radioactive isotopes in biological and clinical research is surveyed, with particular emphasis on the value of β-emitting tritium and positron-emitting carbon-11. In Chapter 2 we report the use of the non-radioactive hydrogen isotope, deuterium, as a surrogate for tritium in the development of microwave-enhanced labelling procedures, based on catalytic hydrogen transfer to olefins (e.g. styrene, styrene derivatives, cinnamic acid and its derivatives). Hydrogen or deuterium donors (e.g. formate salts) were used alone or in combination with other sources (e.g. D2O). The method was found to give fully hydrogenated products using very short microwave irradiation times (∼ 2 min) and was highly reproducible. Importantly, the method is environmentally clean, as when extended to tritiated formates little or no radioactive waste is produced. In Chapter 3 we explored the labelling of CGP 62349 {3-[1-(R)-[3-(4-methoxybenzyl)phosphinyl-2-(S)-hydroxy-propyl- amino]ethyl]benzoic acid}, a γ-aminobutyric acid type B (GABAB) receptor antagonist, with carbon-11 in order to provide a prospective radioligand for medical imaging with positron emission tomography (PET). Labelling agents, [11C]iodomethane and [11C]methyl triflate, prepared by improved methods, were used in the rapid methylation of desmethyl-CGP 62349. Substantially higher radiochemical yields (78%) of [11C]CGP 62349 were achieved by the new methods compared to that produced in a previously published procedure (9%). In addition, the use of [11C]methyl triflate rather than [11C]iodomethane has the advantage of giving a high radiochemical yield and a lower amount of carrier. In Chapter 4 we report on the use of [11C]carbon monoxide as a labelling agent. This has

  5. In-111-labeled leukocyte brain SPECT imaging. Clinical significance in evaluating acute ischemic stroke

    International Nuclear Information System (INIS)

    Many experimental studies have demonstrated that leukocyte infiltration plays an important role in the progression of ischemic cellular damage or post perfusion brain injury. However, only a few clinical studies have been reported. The purpose of this study is to evaluate the clinical significance of leukocyte accumulation in the ischemic brain tissue. Seventy six patients (49 men, 27 women; mean age: 65.5±13.9 years) with acute ischemic stroke were studied by leukocyte brain SPECT imaging. A diagnosis included cardioembolism (n=46), atherothrombotic infarction (n=24), TIA (n=3) and lacuna (n=3). Immediately after the CBF study using Tc-99m-ECD (600 MBq), indium-111-labeled autologous leukocytes were injected. A brain scan for leukocytes was performed 48 hours later. The leukocyte-SPECT study was made 11.1±7.7 days after the onset of stroke. Regional accumulation of leukocytes in the ischemic tissue was evaluated both by visual assessment and by measuring the hemispheric asymmetry index for leukocyte (AI-leuko), and was evaluated by comparison with variable factors including age, gender, infarction size, hemorrhagic transformation, timing of study after the onset, type of stroke and functional outcome. Of the 61 patients with acute ischemic stroke within 2 weeks of onset, 28 patients showed the accumulation of leukocytes in the central zone of ischemia. Six of 7 patients with repeated studies showed a reduction in leukocyte accumulation with time after the onset. Factors significantly associated with the higher accumulation of leukocyte included cardioembolic stroke, larger size of infarct, presence of hemorrhagic transformation and significant reduction in flow. In the 61 patients within 2 weeks of onset, the functional outcome was significantly correlated with the accumulation of leukocyte (p<0.001). The accumulation of leukocytes was seen more in patients with embolic stroke, larger infarction, and hemorrhagic transformation. The higher accumulation correlated

  6. In-111-labeled leukocyte brain SPECT imaging. Clinical significance in evaluating acute ischemic stroke

    Energy Technology Data Exchange (ETDEWEB)

    Fujinuma, Kunihiko [Kitasato Univ., Sagamihara, Kanagawa (Japan). School of Medicine

    2002-02-01

    Many experimental studies have demonstrated that leukocyte infiltration plays an important role in the progression of ischemic cellular damage or post perfusion brain injury. However, only a few clinical studies have been reported. The purpose of this study is to evaluate the clinical significance of leukocyte accumulation in the ischemic brain tissue. Seventy six patients (49 men, 27 women; mean age: 65.5{+-}13.9 years) with acute ischemic stroke were studied by leukocyte brain SPECT imaging. A diagnosis included cardioembolism (n=46), atherothrombotic infarction (n=24), TIA (n=3) and lacuna (n=3). Immediately after the CBF study using Tc-99m-ECD (600 MBq), indium-111-labeled autologous leukocytes were injected. A brain scan for leukocytes was performed 48 hours later. The leukocyte-SPECT study was made 11.1{+-}7.7 days after the onset of stroke. Regional accumulation of leukocytes in the ischemic tissue was evaluated both by visual assessment and by measuring the hemispheric asymmetry index for leukocyte (AI-leuko), and was evaluated by comparison with variable factors including age, gender, infarction size, hemorrhagic transformation, timing of study after the onset, type of stroke and functional outcome. Of the 61 patients with acute ischemic stroke within 2 weeks of onset, 28 patients showed the accumulation of leukocytes in the central zone of ischemia. Six of 7 patients with repeated studies showed a reduction in leukocyte accumulation with time after the onset. Factors significantly associated with the higher accumulation of leukocyte included cardioembolic stroke, larger size of infarct, presence of hemorrhagic transformation and significant reduction in flow. In the 61 patients within 2 weeks of onset, the functional outcome was significantly correlated with the accumulation of leukocyte (p<0.001). The accumulation of leukocytes was seen more in patients with embolic stroke, larger infarction, and hemorrhagic transformation. The higher accumulation

  7. Reactivity of electrochemically concentrated anhydrous [18F]fluoride for microfluidic radiosynthesis of 18F-labeled compounds

    International Nuclear Information System (INIS)

    In order to demonstrate the usefulness of electrochemically concentrated [18F]fluoride the reactivity of the [K+/K.222] 18F− complex concentrated in an aprotic solvent (ca. 60 μL) was evaluated via nucleophilic 18F-substitution reactions through radiosynthesis of [18F]FDG, [18F]FMISO, [18F]flumazenil and [18F]fluoromethyl bromide. The substitutions were carried out in a microfluidic reaction flow cell and the effects of reaction time, temperature, precursor concentration and reaction solvent on the 18F-substitution yields were investigated. The 18F-fluorination yields for the four 18F-labeled compounds under optimized conditions (98% for protected [18F]FDG, 80% for protected [18F]FMISO, 20% for [18F]flumazenil and 60% for [18F]fluoromethyl bromide) were comparable to or higher than those obtained by conventional means. In this study it is clearly demonstrated that electrochemically concentrated [18F]fluoride enables microfluidic radiosynthesis by effectively reducing synthesis times and especially by increasing radiochemical yields of products labile at high temperatures. - Highlights: ► The high reactivity of electrochemically concentrated [18F]fluoride was shown. ► Microfluidic radiosynthesis with the [18F]fluoride effectively reduced synthesis time. Microfluidic radiosynthesis increased yields of products labile at high temperatures.

  8. Abstracts of the 24th international isotope society (UK group) symposium: synthesis and applications of labelled compounds 2015.

    Science.gov (United States)

    Aigbirhio, F I; Allwein, S; Anwar, A; Atzrodt, J; Audisio, D; Badman, G; Bakale, R; Berthon, F; Bragg, R; Brindle, K M; Bushby, N; Campos, S; Cant, A A; Chan, M Y T; Colbon, P; Cornelissen, B; Czarny, B; Derdau, V; Dive, V; Dunscombe, M; Eggleston, I; Ellis-Sawyer, K; Elmore, C S; Engstrom, P; Ericsson, C; Fairlamb, I J S; Georgin, D; Godfrey, S P; He, L; Hickey, M J; Huscroft, I T; Kerr, W J; Lashford, A; Lenz, E; Lewinton, S; L'Hermite, M M; Lindelöf, Å; Little, G; Lockley, W J S; Loreau, O; Maddocks, S; Marguerit, M; Mirabello, V; Mudd, R J; Nilsson, G N; Owens, P K; Pascu, S I; Patriarche, G; Pimlott, S L; Pinault, M; Plastow, G; Racys, D T; Reif, J; Rossi, J; Ruan, J; Sarpaki, S; Sephton, S M; Simonsson, R; Speed, D J; Sumal, K; Sutherland, A; Taran, F; Thuleau, A; Wang, Y; Waring, M; Watters, W H; Wu, J; Xiao, J

    2016-04-01

    The 24th annual symposium of the International Isotope Society's United Kingdom Group took place at the Møller Centre, Churchill College, Cambridge, UK on Friday 6th November 2015. The meeting was attended by 77 delegates from academia and industry, the life sciences, chemical, radiochemical and scientific instrument suppliers. Delegates were welcomed by Dr Ken Lawrie (GlaxoSmithKline, UK, chair of the IIS UK group). The subsequent scientific programme consisted of oral presentations, short 'flash' presentations in association with particular posters and poster presentations. The scientific areas covered included isotopic synthesis, regulatory issues, applications of labelled compounds in imaging, isotopic separation and novel chemistry with potential implications for isotopic synthesis. Both short-lived and long-lived isotopes were represented, as were stable isotopes. The symposium was divided into a morning session chaired by Dr Rebekka Hueting (University of Oxford, UK) and afternoon sessions chaired by Dr Sofia Pascu (University of Bath, UK) and by Dr Alan Dowling (Syngenta, UK). The UK meeting concluded with remarks from Dr Ken Lawrie (GlaxoSmithKline, UK). PMID:26991121

  9. Effect of Compound Sulfadiazine Suspension on Growth Performance of Broiler in Clinical Efficacy Trial

    Directory of Open Access Journals (Sweden)

    Leilei Wang

    2014-04-01

    Full Text Available Compound Sulfadiazine suspension is used mainly to prevent and cure E. coli, Salmonella infection of chicken in veterinary clinical application. Effect of compound Sulfadiazine suspension on growth performance of broiler in clinical efficacy trial was studied in the study. One hundred eighty 15-day-old broilers were divided randomly into six groups, blank control group, negative control group, Trisulmixos gavage group, Trisulmixos drinking group, Sufuning gavage group and Sufuning drinking group, respectively. There were three repeating treatments in each group and ten broilers in each treatment. Results showed that compound Sulfadiazine suspension can promote the feed conversion rate of broiler when curing E. coli, Salmonella infection of chicken. Both from the perspective of efficacy and from the perspective of growth performance, giving drug by gavage were more effective than giving by drinking. When two products of Compound Sulfadiazine suspension were compared, the indicators of Sufuning were a little better Trisulmixos.

  10. Semantic distribution study of noun-noun compounds in the Japanese CT clinical reports

    OpenAIRE

    Nishimoto, Naoki; Terae, Satoshi; Jiang, Guoqian; Uesugi, Masahito; Terashita, Takayoshi; Tanikawa, Takumi; Endou, Akira; Ogasawara, Katsuhiko; Sakurai, Tasunetaro

    2006-01-01

    The purpose of this study is to investigate the distribution of the semantic relationships between the two atomic medical terms of the noun-noun compounds extracted from the clinical documents in Japanese. Only 29.9% of the compounds had the UMLS semantic relation defined (mainly including “location_of” and “adjacent_to”). The results indicated that the semantic relations defined in the UMLS semantic network are not enough for describing the noun-noun medical compounds extracted from the Japa...

  11. Development of pharmaceuticals with radioactive rhenium for cancer therapy. Production of {sup 186}Re and {sup 188}Re, synthesis of labeled compounds and their biodistributions

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1998-03-01

    Production of the radioactive rhenium isotopes {sup 186}Re and {sup 188}Re, and synthesis of their labeled compounds have been studied together with the biodistributions of the compounds. This work was carried out by the Working Group on Radioactive Rhenium, consisting of researchers of JAERI and some universities, in the Subcommittee for Production and Radiolabeling under the Consultative Committee of Research on Radioisotopes. For {sup 186}Re, production methods by the {sup 185}Re(n,{gamma}){sup 186}Re reaction in a reactor and by the {sup 186}W(p,n){sup 186}Re reaction with an accelerator, which can produce nocarrier-added {sup 186}Re, have been established. For {sup 188}Re, a production method by the double neutron capture reaction of {sup 186}W, which produces a {sup 188}W/{sup 188}Re generator, has been established. For labeling of bisphosphonate, DMSA, DTPA, DADS, aminomethylenephosphonate and some monoclonal antibodies with the radioactive rhenium isotopes, the optimum conditions, including pH, the amounts of reagents and so on, have been determined for each compound. The biodistributions of each of the labeled compounds in mice have been also obtained. (author)

  12. Tracer level radiochemistry to clinical dose preparation of 177Lu-labeled cyclic RGD peptide dimer

    International Nuclear Information System (INIS)

    Aim: Integrin αvβ3 plays a significant role in angiogenesis during tumor growth and metastasis, and is a receptor for the extracellular matrix proteins with the exposed arginine(R)-glycine(G)-aspartic acid(D) tripeptide sequence. The over-expression of integrin αvβ3 during tumor growth and metastasis presents an interesting molecular target for both early detection and treatment of rapidly growing solid tumors. Considering the advantages of 177Lu for targeted radiotherapy and enhanced tumor targeting capability of cyclic RGD peptide dimer, an attempt has been made to optimize the protocol for the preparation of clinical dose of 177Lu labeled DOTA-E[c(RGDfK)]2 (E = Glutamic acid, f = phenyl alanine, K = lysine) as a potential agent for targeted tumor therapy. Methods: 177Lu was produced by thermal neutron bombardment on enriched Lu2O3 (82% in 176Lu) target at a flux of 1 × 1014 n/cm2.s for 21 d. Therapeutic dose of 177Lu-DOTA-E[c(RGDfK)]2 (7.4 GBq) was prepared by adding the aqueous solution of the ligand and 177LuCl3 to 0.1 M NH4OAC buffer containing gentisic acid and incubating the reaction mixture at 90 °C for 30 min. The yield and radiochemical purity of the complex was determined by HPLC technique. Parameters, such as, ligand-to-metal ratio, pH of the reaction mixture, incubation time and temperature were varied using tracer quantity of 177Lu (37 MBq) in order to arrive at the optimized protocol for the preparation of clinical dose. Biological behavior of the radiotracer prepared was studied in C57/BL6 mice bearing melanoma tumors. Results: 177Lu was produced with a specific activity of 950 ± 50 GBq/mg (25.7 ± 1.4 Ci/mg) and radionuclidic purity of 99.98%. A careful optimization of several parameters showed that 177Lu-DOTA-E[c(RGDfK)]2 could be prepared with adequately high radiochemical purity using a ligand-to-metal ratio ∼ 2. Based on these studies therapeutic dose of the agent with 7.4 GBq of 177Lu was formulated in ∼ 63 GBq/μM specific

  13. A neuroradiologist's guide to arterial spin labeling MRI in clinical practice

    International Nuclear Information System (INIS)

    Arterial spin labeling (ASL) is a non-invasive MRI technique to measure cerebral blood flow (CBF). This review provides a practical guide and overview of the clinical applications of ASL of the brain, as well its potential pitfalls. The technical and physiological background is also addressed. At present, main areas of interest are cerebrovascular disease, dementia and neuro-oncology. In cerebrovascular disease, ASL is of particular interest owing to its quantitative nature and its capability to determine cerebral arterial territories. In acute stroke, the source of the collateral blood supply in the penumbra may be visualised. In chronic cerebrovascular disease, the extent and severity of compromised cerebral perfusion can be visualised, which may be used to guide therapeutic or preventative intervention. ASL has potential for the detection and follow-up of arteriovenous malformations. In the workup of dementia patients, ASL is proposed as a diagnostic alternative to PET. It can easily be added to the routinely performed structural MRI examination. In patients with established Alzheimer's disease and frontotemporal dementia, hypoperfusion patterns are seen that are similar to hypometabolism patterns seen with PET. Studies on ASL in brain tumour imaging indicate a high correlation between areas of increased CBF as measured with ASL and increased cerebral blood volume as measured with dynamic susceptibility contrast-enhanced perfusion imaging. Major advantages of ASL for brain tumour imaging are the fact that CBF measurements are not influenced by breakdown of the blood-brain barrier, as well as its quantitative nature, facilitating multicentre and longitudinal studies. (orig.)

  14. A neuroradiologist's guide to arterial spin labeling MRI in clinical practice

    Energy Technology Data Exchange (ETDEWEB)

    Grade, M. [Queen Square, UCL Institute of Neurology, London (United Kingdom); Stanford School of Medicine, Stanford, CA (United States); Hernandez Tamames, J.A. [Rey Juan Carlos University, Medical Image Analysis and Biometry Laboratory, Madrid (Spain); Erasmus MC - University Medical Centre Rotterdam, Department of Radiology, PO Box 2040, Rotterdam (Netherlands); Pizzini, F.B. [Queen Square, UCL Institute of Neurology, London (United Kingdom); Verona University Hospital, Neuroradiology, Department of Diagnostics and Pathology, Verona (Italy); Achten, E. [Ghent University Hospital, Neuroradiology, Department of Radiology, Ghent (Belgium); Golay, X. [Queen Square, UCL Institute of Neurology, London (United Kingdom); Smits, M. [Erasmus MC - University Medical Centre Rotterdam, Department of Radiology, PO Box 2040, Rotterdam (Netherlands)

    2015-12-15

    Arterial spin labeling (ASL) is a non-invasive MRI technique to measure cerebral blood flow (CBF). This review provides a practical guide and overview of the clinical applications of ASL of the brain, as well its potential pitfalls. The technical and physiological background is also addressed. At present, main areas of interest are cerebrovascular disease, dementia and neuro-oncology. In cerebrovascular disease, ASL is of particular interest owing to its quantitative nature and its capability to determine cerebral arterial territories. In acute stroke, the source of the collateral blood supply in the penumbra may be visualised. In chronic cerebrovascular disease, the extent and severity of compromised cerebral perfusion can be visualised, which may be used to guide therapeutic or preventative intervention. ASL has potential for the detection and follow-up of arteriovenous malformations. In the workup of dementia patients, ASL is proposed as a diagnostic alternative to PET. It can easily be added to the routinely performed structural MRI examination. In patients with established Alzheimer's disease and frontotemporal dementia, hypoperfusion patterns are seen that are similar to hypometabolism patterns seen with PET. Studies on ASL in brain tumour imaging indicate a high correlation between areas of increased CBF as measured with ASL and increased cerebral blood volume as measured with dynamic susceptibility contrast-enhanced perfusion imaging. Major advantages of ASL for brain tumour imaging are the fact that CBF measurements are not influenced by breakdown of the blood-brain barrier, as well as its quantitative nature, facilitating multicentre and longitudinal studies. (orig.)

  15. An open label, prospective, clinical study on a polyherbal formulation in osteoarthritis of knee

    Directory of Open Access Journals (Sweden)

    Sanjay U Nipanikar

    2013-01-01

    Full Text Available Background: Currently, though pharmacological, mechanical, and surgical interventions are used, there is no known cure for osteoarthritis (OA. Objectives: The main aim of the study was to assess the efficacy and safety of "TLPL/AY/03/2008," a polyherbal formulation on knee joint pain assessed on visual analogue scale (VAS and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC. Materials and Methods: It was an open label, single center, prospective, clinical study conducted in 36 patients of OA Knee. Two capsules of ′TLPL/AY/03/2008′ were given to all patients twice daily orally after meals for 180 days. Results: Data describing quantitative measures are expressed as mean ± SD. Comparison of variables representing categorical data was performed using Chi-square test. The mean joint pain (as assessed on VAS reduced significantly (59.85%; P < 0.05 and the mean WOMAC combined score, WOMAC pain sub-score, WOMAC stiffness sub-score, and WOMAC difficulty sub-score also reduced significantly at the end of the study. The mean time taken by the patients to walk 50 feet too, was reduced significantly (25.26% at the end of the study. At the end of 4 months of the treatment, no patient needed paracetamol as rescue medicine to control pain. Most of the patients had shown good overall improvement assessed by the physician and by the patients. Majority of the patients showed excellent tolerability to the study drug. No significant change in most of the safety laboratory parameters was observed at the end of the study. Conclusion: The study provides good evidence in support of the efficacy and safety of the ′TLPL/AY/03/2008′ in OA of knee.

  16. Increase of the radiochemical purity of aqueous solutions of compounds labelled with 131I using a ClAg sterile column

    International Nuclear Information System (INIS)

    The use of a C1Ag sterile column that may be easily assembled at any nuclear medical center is proposed. The column is easy to handle and allows to obtain aqueous solutions of compounds labelled with radioactive iodine, with a radiochemical purity greater than 99%, conserving pH values, activity concentration, apyretogenia and sterility, the controls of toxicity and presence of heavy metals being negative. (C.A.K)

  17. Experimental and clinical results of biliary tract scintiscanning with sup(99m)Tc-labelled N-diethyliminodiacetic acid

    International Nuclear Information System (INIS)

    N(2,6-diethyl-acetanilido)-iminodiacetic acid was labelled by means of sup(99m)Tc. Pharmacokinetic studies were performed in various organs of mice. Clinical investigations were accomplished in healthy persons and in patients suffering from different diseases of the biliary tract. The scintigraphy of the biliary tract is most suitable in cases of both partial or total obstruction of the biliary tract and assessment of biliary tract dynamics

  18. Two newly developed methods for the radioactive labeling of tetanus toxins with substances emitting beta-rays and the usefulness of the compounds thus obtained in radioimmunoassays to determine tetanus antibodies

    International Nuclear Information System (INIS)

    Described are two methods to label tetanus toxins using either 14C-formaldehyde or succinimidyl-3H- propionate as radioactive tracers. The question as to whether the labeled compounds thus obtained can be introduced into RIAs for the detection of tetanus antibodies is also discussed. The immunoreactivity of 3H-toxin is not perceptibly changed by the labeling procedure. The compound can be compared to 125I-labeled toxin, although it suffers no adverse effects from long-term due to autoradiolysis. (TRV)

  19. To study the radiolabeling efficiency and clinical utility of 99mTc- HMPAO labeled leukocytes

    International Nuclear Information System (INIS)

    Full text: Accurate diagnosis is essential for the effective management of suspected bone infections. Routine imaging techniques have had limited success exhibiting poor soft tissue sensitivity and specificity. So, to diagnose the infection, 99mTc-HMPAO labeled leukocytes is widely used as standard technique, routinely performed in the evaluation of patients with fever of unknown origin and occult infection. The objective of present study was to evaluate the radiolabeling efficiency of leukocytes and to find out the sensitivity and specificity of 99mTc-MDP 3 phase bone scan compared with 99mTc-HMPAO labeled leukocytes to diagnose various types of infection. Patient with suspected bone infection underwent 99mTc MDP 3-phase bone imaging and 99mTc-HMPAO labeled leukocyte imaging on separate occasions. Leukocytes were obtained from 40-50 ml of venous blood by centrifugation at 2000 rpm. Freshly eluted 99mTc pertechnetate was used to label HMPAO, which in turn was used to tag the leukocytes by adopting the standard technique for labeling leukocytes. In-vitro viability of the cells was demonstrated by Trypan blue dye exclusion method. The labeled cells were resuspended in 2 ml normal saline and administered intravenously to the patient. Images were acquired at 60 min., 4 hrs and 24 hrs post-injection. In our study, the labeling efficiency ranged from 39% to 73% with a mean of 59.1%. 99mTc-MDP 3-phase bone scan showed with higher sensitivity and low specificity and thus may be useful as a screening tool but not for the accurate diagnosis of the infection. With the high labeling efficiency of 99mTc-HMPAO leukocytes, this is the reliable tool for the accurate diagnosis of the infection

  20. Development of a kit for RBC labelling with 99mTc and its clinic evaluation

    International Nuclear Information System (INIS)

    A kit for labelling red blood cells (RBC) with 99mTc based on a Tin Pyrophosphate mixture freeze-dried and a saline solution saturated with nitrogen has been prepared for spleen and placenta scanning, circulatory studies and blood volume determinations. The stannous tin is intended to reduce the 99mTc pertechnetate, obtained either from generators or from solvent extraction, to the appropriate valence state suitable for labelling. The technique is as follows: Add to the heparinized blood sample the Tin-Pyrophosphate mixture dissolved in the saline solution. After five minutes incubation time at room temperature the plasma is discarded by centrifugation. Following the addition of the tracer activity to the separated RBC, the supernatant is discarded after a second centrifugation. Depending on the test to be performed, the RBC are either resuspended in saline solution for blood pool or circulation studies or denaturalized at 49.5 deg C for spleen scanning. The labelling yield (95-88%) and its stability has been checked by in vitro measurements, up to four hours after labelling. The biological distribution and spleen uptake have been determined in rats and rabbits. The developed method proved to be adequate for labelling RBC with good labelling retention. An interesting application is shown in babies with congenital cardiac defects and suspected absence of the spleen, where the scan gave a good image of the existing spleen. (author)

  1. Myocardial uptake of indium-111-labeled antimyosin in acute subendocardial infarction: Clinical, histochemical, and autoradiographic correlation of myocardial necrosis

    International Nuclear Information System (INIS)

    Indium-111-labeled antimyosin has been utilized in the diagnosis and localization of acute transmural myocardial infarction. The present report describes a patient who presented with a massive subendocardial infarction. Two days after the injection of antimyosin, the patient's clinical status markedly deteriorated and he expired. Postmortem examination demonstrated severe three-vessel coronary artery disease with extensive myocyte death in the endocardium. Autoradiography and histochemical staining of the prosected heart demonstrated high correlation for myocardial necrosis and corresponded to clinical evidence for diffuse subendocardial infarction

  2. Myocardial uptake of indium-111-labeled antimyosin in acute subendocardial infarction: Clinical, histochemical, and autoradiographic correlation of myocardial necrosis

    Energy Technology Data Exchange (ETDEWEB)

    Hendel, R.C.; McSherry, B.A.; Leppo, J.A. (Univ. of Massachusetts Medical Center, Worcester (USA))

    1990-11-01

    Indium-111-labeled antimyosin has been utilized in the diagnosis and localization of acute transmural myocardial infarction. The present report describes a patient who presented with a massive subendocardial infarction. Two days after the injection of antimyosin, the patient's clinical status markedly deteriorated and he expired. Postmortem examination demonstrated severe three-vessel coronary artery disease with extensive myocyte death in the endocardium. Autoradiography and histochemical staining of the prosected heart demonstrated high correlation for myocardial necrosis and corresponded to clinical evidence for diffuse subendocardial infarction.

  3. Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model.

    Directory of Open Access Journals (Sweden)

    Mya S Thu

    Full Text Available BACKGROUND: Treatment strategies for the highly invasive brain tumor, glioblastoma multiforme, require that cells which have invaded into the surrounding brain be specifically targeted. The inherent tumor-tropism of neural stem cells (NSCs to primary and invasive tumor foci can be exploited to deliver therapeutics to invasive brain tumor cells in humans. Use of the strategy of converting prodrug to drug via therapeutic transgenes delivered by immortalized therapeutic NSC lines have shown efficacy in animal models. Thus therapeutic NSCs are being proposed for use in human brain tumor clinical trials. In the context of NSC-based therapies, MRI can be used both to non-invasively follow dynamic spatio-temporal patterns of the NSC tumor targeting allowing for the optimization of treatment strategies and to assess efficacy of the therapy. Iron-labeling of cells allows their presence to be visualized and tracked by MRI. Thus we aimed to iron-label therapeutic NSCs without affecting their cellular physiology using a method likely to gain United States Federal Drug Administration (FDA approval. METHODOLOGY: For human use, the characteristics of therapeutic Neural Stem Cells must be clearly defined with any pertubation to the cell including iron labeling requiring reanalysis of cellular physiology. Here, we studied the effect of iron-loading of the therapeutic NSCs, with ferumoxide-protamine sulfate complex (FE-Pro on viability, proliferation, migratory properties and transgene expression, when compared to non-labeled cells. FE-Pro labeled NSCs were imaged by MRI at tumor sites, after intracranial administration into the hemisphere contralateral to the tumor, in an orthotopic human glioma xenograft mouse model. CONCLUSION: FE-Pro labeled NSCs retain their proliferative status, tumor tropism, and maintain stem cell character, while allowing in vivo cellular MRI tracking at 7 Tesla, to monitor their real-time migration and distribution at brain tumor sites

  4. Mn-doped Zinc Sulphide nanocrystals for immunofluorescent labeling of epidermal growth factor receptors on cells and clinical tumor tissues

    Science.gov (United States)

    J, Aswathy; V, Seethalekshmy N.; R, Hiran K.; R, Bindhu M.; K, Manzoor; Nair, Shantikumar V.; Menon, Deepthy

    2014-11-01

    The field of molecular detection and targeted imaging has evolved considerably with the introduction of fluorescent semiconductor nanocrystals. Manganese-doped zinc sulphide nanocrystals (ZnS:Mn NCs), which are widely used in electroluminescent displays, have been explored for the first time for direct immunofluorescent (IF) labeling of clinical tumor tissues. ZnS:Mn NCs developed through a facile wet chemistry route were capped using amino acid cysteine, conjugated to streptavidin and thereafter coupled to biotinylated epidermal growth factor receptor (EGFR) antibody utilizing the streptavidin-biotin linkage. The overall conjugation yielded stable EGFR antibody conjugated ZnS:Mn NCs (EGFR ZnS:Mn NCs) with a hydrodynamic diameter of 65 ± 15 nm, and having an intense orange-red fluorescence emission at 598 nm. Specific labeling of EGF receptors on EGFR+ve A431 cells in a co-culture with EGFR-ve NIH3T3 cells was demonstrated using these nanoprobes. The primary antibody conjugated fluorescent NCs could also clearly delineate EGFR over-expressing cells on clinical tumor tissues processed by formalin fixation as well as cryopreservation with a specificity of 86% and accuracy of 88%, in comparison to immunohistochemistry. Tumor tissues labeled with EGFR ZnS:Mn NCs showed good fluorescence emission when imaged after storage even at 15 months. Thus, ZnS nanobioconjugates with dopant-dependent and stable fluorescence emission show promise as an efficient, target-specific fluorophore that would enable long term IF labeling of any antigen of interest on clinical tissues.

  5. Mn-doped Zinc Sulphide nanocrystals for immunofluorescent labeling of epidermal growth factor receptors on cells and clinical tumor tissues

    International Nuclear Information System (INIS)

    The field of molecular detection and targeted imaging has evolved considerably with the introduction of fluorescent semiconductor nanocrystals. Manganese-doped zinc sulphide nanocrystals (ZnS:Mn NCs), which are widely used in electroluminescent displays, have been explored for the first time for direct immunofluorescent (IF) labeling of clinical tumor tissues. ZnS:Mn NCs developed through a facile wet chemistry route were capped using amino acid cysteine, conjugated to streptavidin and thereafter coupled to biotinylated epidermal growth factor receptor (EGFR) antibody utilizing the streptavidin–biotin linkage. The overall conjugation yielded stable EGFR antibody conjugated ZnS:Mn NCs (EGFR ZnS:Mn NCs) with a hydrodynamic diameter of 65 ± 15 nm, and having an intense orange–red fluorescence emission at 598 nm. Specific labeling of EGF receptors on EGFR+ve A431 cells in a co-culture with EGFR−ve NIH3T3 cells was demonstrated using these nanoprobes. The primary antibody conjugated fluorescent NCs could also clearly delineate EGFR over-expressing cells on clinical tumor tissues processed by formalin fixation as well as cryopreservation with a specificity of 86% and accuracy of 88%, in comparison to immunohistochemistry. Tumor tissues labeled with EGFR ZnS:Mn NCs showed good fluorescence emission when imaged after storage even at 15 months. Thus, ZnS nanobioconjugates with dopant-dependent and stable fluorescence emission show promise as an efficient, target-specific fluorophore that would enable long term IF labeling of any antigen of interest on clinical tissues. (paper)

  6. Gastrointestinal tract radionuclide activity on In-111 labeled leukocyte imaging: clinical significance in patients with fever of unknown origin

    International Nuclear Information System (INIS)

    To determine the frequency and clinical significance of indium-111 labeled leukocyte activity in the gastrointestinal (GI) tract of patients with fever of unknown origin, we reviewed 312 leukocyte studies involving 271 patients. Radionuclide activity was noted in the bowel in 59 cases. Of these, only 27 were due to the infection or inflammatory disease that caused the patient's fever. The 32 false-positive results were due primarily to swallowed leukocytes or bleeding. In two cases, no explanation was found for the activity in the GI tract. We conclude that bowel activity on In-111 labeled leukocyte scans in patients with fever of unknown origin often does not correlate with the true cause of the patient's fever

  7. The clinical utility of indium-111 labelled platelet scintigraphy in the diagnoses of renal transplant rejection

    International Nuclear Information System (INIS)

    It is demonstrated that indium-111 labelled platelet scintigraphy is a highly accurate test for detecting acute untreated renal allograft rejection and it is shown that changes in platelet uptake can precede signs and symptoms of rejection by at least 48 hours. (author). 34 refs.; 2 figs.; 1 tab

  8. Arterial spin labeling perfusion MRI: Inter-vendor reproducibility and clinical applicability

    NARCIS (Netherlands)

    H.J.M.M. Mutsaerts

    2015-01-01

    Arterial spin labeling (ASL) is a perfusion magnetic resonance imaging (MRI) technique that non-invasively measures cerebral blood flow (CBF). The first part of this thesis concerns the inter-vendor reproducibility of ASL. Studies in this thesis show that on a total gray matter (GM) level, long-term

  9. 78 FR 53773 - Select Updates for Non-Clinical Engineering Tests and Recommended Labeling for Intravascular...

    Science.gov (United States)

    2013-08-30

    ... Spring, MD 20993-0002. Send one self-addressed adhesive label to assist that office in processing your... entitled ``Cardiovascular Metallic Implants: Corrosion, Surface Characterization, and Nickel Leaching'' on... corrosion potential; Galvanic corrosion; Surface characterization; and Nickel ion release. This...

  10. Design, synthesis and in vitro biological evaluation of reference compounds of 123I and 99Tcm labeled indole radiotracers for σ2 receptor imaging

    International Nuclear Information System (INIS)

    Novel indole radiotracers for 123I and 99Tcm labeling were designed. The corresponding reference compounds (Indole-I and Indole-MAMA-Re) and the precursor (Indole-MAMA) for 99Tcm labeling were synthesized. Competition binding assays in vitro show that the Ki values of Indole-I for σ1 and σ2 receptors are (0.574±0.355) μmol/L and (0.162±0.030) μmol/L (n=3), respectively. The Ki values of Indole-MAMA-Re for σ1 and σ2 receptors are (3.75±2.22) μmol/L and (7.83±4.87) μmol/L (n=3), respectively. Furthermore, 99Tcm-Indole-MAMA was successfully prepared. The radio-chemical purity (RCP) of 99Tcm-Indole-MAMA after purification was higher than 90% by HPLC analysis. The compounds reported in this paper may be used as lead compounds for further structural modification to develop indole SPECT tumor imaging agents with high affinity and selectivity for σ2 receptors. (authors)

  11. Biogenic volatile organic compounds (BVOCs) emission of Scots pine under drought stress - a 13CO2 labeling study to determine de novo and pool emissions under different treatments

    Science.gov (United States)

    Lüpke, M.

    2015-12-01

    Plants emit biogenic volatile organic compounds (BVOCs) to e.g. communicate and to defend herbivores. Yet BVOCs also impact atmospheric chemistry processes, and lead to e.g. the built up of secondary organic aerosols. Abiotic stresses, such as drought, however highly influence plant physiology and subsequently BVOCs emission rates. In this study, we investigated the effect of drought stress on BVOCs emission rates of Scots pine trees, a de novo and pool emitter, under controlled climate chamber conditions within a dynamic enclosure system consisting of four plant chambers. Isotopic labeling with 13CO2 was used to detect which ratio of emissions of BVOCs derives from actual synthesis and from storage organs under different treatments. Additionally, the synthesis rate of the BVOCs synthesis can be determined. The experiment consisted of two campaigns (July 2015 and August 2015) of two control and two treated trees respectively in four controlled dynamic chambers simultaneously. Each campaign lasted for around 21 days and can be split into five phases: adaptation, control, dry-out, drought- and re-watering phase. The actual drought phase lasted around five days. During the campaigns two samples of BVOCs emissions were sampled per day and night on thermal desorption tubes and analyzed by a gas chromatograph coupled with a mass spectrometer and a flame ionization detector. Additionally, gas exchange of water and CO2, soil moisture, as well as leaf and chamber temperature was monitored continuously. 13CO2 labeling was performed simultaneously in all chambers during the phases control, drought and re-watering for five hours respectively. During the 13CO2 labeling four BVOCs emission samples per chamber were taken to identify the labeling rate on emitted BVOCs. First results show a decrease of BVOCs emissions during the drought phase and a recovery of emission after re-watering, as well as different strength of reduction of single compounds. The degree of labeling with 13

  12. Clinical significance of abdominal scintigraphy using {sup 99m}Tc-HMPAO-labelled leucocytes in patients with seronegative spondyloarthropathies

    Energy Technology Data Exchange (ETDEWEB)

    Alonso Farto, J.C.; Almoguera Arias, I.; Ortega Valle, A.; Perez Vazquez, J.M. [Department of Nuclear Medicine, Univ. Complutense, Madrid (Spain); Lopez Longo, F.J.; Gonzalez Fernandez, C.M.; Monteagudo Saez, I.; Bascones, M.; Carreno Perez, L. [Department of Rheumatology, ' ' Hospital Universitario Gregorio Maranon' ' , Universidad Complutense, Madrid (Spain)

    2000-12-01

    Abdominal scintigraphy shows silent gut inflammation in patients with spondyloarthropathies (Sp) without clinical evidence of gut inflammation. Abdominal scintigraphy images are different than those obtained in patients with ulcerative colitis or Crohn's disease and are not related to the anti-inflammatory drugs administered. The aim of this study was to examine the clinical associations of findings on abdominal scintigraphy in patients with Sp. A total of 204 Sp patients (European Spondylarthropathy Study Group 1991 criteria) and 54 non-Sp controls receiving non-steroidal anti-inflammatory drugs were studied. Abdominal scintigraphy images were obtained at 30 and 120 min after injection of technetium-99m hexamethylpropylene amine oxime ({sup 99m}Tc-HMPAO)-labelled leucocytes. {sup 99m}Tc-HMPAO-labelled leucocyte scans were positive in 104 Sp patients (50.9%) and in six non-Sp controls (2.9%) (P<0.001; OR=8.32; 95% CI=3.23-22.67). Silent gut inflammation was not associated with any of the following: age of onset, duration of evolution, sex, family history of Sp or psoriasis, articular manifestations, extra-articular manifestations, radiological findings or HLA-B27 positivity. Positive abdominal scintigraphy was associated with active disease (P<0.0001; OR=52.7; 95% CI=19-145.6) and an increase in the C-reactive protein (P<0.005; OR=3.4; 95% CI=1.5-7.4). It is concluded that (a) abdominal scintigraphy using {sup 99m}Tc-HMPAO-labelled leucocytes is of value in detecting the silent gut inflammation in Sp patients, and (b) silent gut inflammation is related to the clinical activity, but is not associated with any particular type of illness or with HLA-B27. (orig.)

  13. Review of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compounds

    Directory of Open Access Journals (Sweden)

    Guy-Armel Bounda

    2015-01-01

    Full Text Available Polygonum multiflorum Thunb. (PMT, officially listed in the Chinese Pharmacopoeia, is one of the most popular perennial Chinese traditional medicines known as He shou wu in China and East Asia, and as Fo-ti in North America. Mounting pharmacological studies have stressed out its key benefice for the treatment of various diseases and medical conditions such as liver injury, cancer, diabetes, alopecia, atherosclerosis, and neurodegenerative diseases as well. International databases such as PubMed/Medline, Science citation Index and Google Scholar were searched for clinical studies recently published on P. multiflorum. Various clinical studies published articles were retrieved, providing information relevant to pharmacokinetics-pharmacodynamics analysis, sleep disorders, dyslipidemia treatment, and neurodegenerative diseases. This review is an effort to update the clinical picture of investigations ever carried on PMT and/or its isolated bio-compounds and to enlighten its therapeutic assessment.

  14. /sup 99m/Tc-labeled solid-phase meal: a quantitative clinical measurement of human gastric emptying

    International Nuclear Information System (INIS)

    A solid-phase meal labeled with /sup 99m/Tc-sulfur colloid provides an improved clinical test for the quantitative evaluation of human gastric emptying. We studied 12 healthy male controls and five male patients with known gastric stasis secondary to a vagotomy and drainage procedure. All subjects were fasted for 8 hours before the study, and each consumed an unbuttered biscuit and a poached egg white containing 1 mCi of /sup 99m/Tc-sulfur colloid. For 2 hours, 60-second counts were measured every 10 minutes by a Pho Gamma III scintillation camera. The t1/2 for control subjects was 60 minutes, at which time patients with gastric stasis had retained 98% of the test meal. At 120 minutes, control subjects and patients with gastric stasis had 4.7% and 89%, respectively, of the meal remaining in the stomach. The solid-phase test meal labeled with /sup 99m/Tc-sulfur colloid is easy to perform and can be used clinically to quantitatively measure gastric emptying in humans. This test can discriminate between control subjects and patients with known gastric stasis

  15. The quantitation of biotinylated compounds by a solid-phase assay using a 125I-labelled biotin derivative

    International Nuclear Information System (INIS)

    The biotin analogue biotinylglycyltyrosine has been synthesized and labelled to a specific activity of 2000 Ci/mmol with 125I. This analogue has been used in conjunction with immobilized streptavidin in an assay which detects as little as 1 fmol biotin or biotinylated molecules in solution. The determination of biotinylated insulin in a tissue extract and the quantitation of a transcription assay are given as examples. (Auth.)

  16. Labeled extra virgin olive oil as food supplement; phenolic compounds in oils from some autochthonous Croatian olives

    OpenAIRE

    Jakobušić Brala, C.; Benčić, D.; Šindrak, Z.; Barbarić, M.; Uršić, S.

    2015-01-01

    Within the framework of an incentive to provide labeled extra virgin olive oils as a food supplement in pharmacies, the phenolic profile analysis of extra virgin olive oils obtained from Croatian olive cultivars has been reported. With the aim of increasing the consumption of EVOO-s in northern Croatia, the varieties Bjelica, Buža and Italian Leccino have been studied involving two different agroclimatic locations, over two harvest years differing significantly in the amount of rainfall. The ...

  17. Isotopically labeled sulfur compounds and synthetic selenium and tellurium analogues to study sulfur metabolism in marine bacteria

    Directory of Open Access Journals (Sweden)

    Nelson L. Brock

    2013-05-01

    Full Text Available Members of the marine Roseobacter clade can degrade dimethylsulfoniopropionate (DMSP via competing pathways releasing either methanethiol (MeSH or dimethyl sulfide (DMS. Deuterium-labeled [2H6]DMSP and the synthetic DMSP analogue dimethyltelluriopropionate (DMTeP were used in feeding experiments with the Roseobacter clade members Phaeobacter gallaeciensis DSM 17395 and Ruegeria pomeroyi DSS-3, and their volatile metabolites were analyzed by closed-loop stripping and solid-phase microextraction coupled to GC–MS. Feeding experiments with [2H6]DMSP resulted in the incorporation of a deuterium label into MeSH and DMS. Knockout of relevant genes from the known DMSP demethylation pathway to MeSH showed in both species a residual production of [2H3]MeSH, suggesting that a second demethylation pathway is active. The role of DMSP degradation pathways for MeSH and DMS formation was further investigated by using the synthetic analogue DMTeP as a probe in feeding experiments with the wild-type strain and knockout mutants. Feeding of DMTeP to the R. pomeroyi knockout mutant resulted in a diminished, but not abolished production of demethylation pathway products. These results further corroborated the proposed second demethylation activity in R. pomeroyi. Isotopically labeled [2H3]methionine and 34SO42−, synthesized from elemental 34S8, were tested to identify alternative sulfur sources besides DMSP for the MeSH production in P. gallaeciensis. Methionine proved to be a viable sulfur source for the MeSH volatiles, whereas incorporation of labeling from sulfate was not observed. Moreover, the utilization of selenite and selenate salts by marine alphaproteobacteria for the production of methylated selenium volatiles was explored and resulted in the production of numerous methaneselenol-derived volatiles via reduction and methylation. The pathway of selenate/selenite reduction, however, proved to be strictly separated from sulfate reduction.

  18. Clinical usefulness of dual-label Schilling test for pancreatic exocrine function

    International Nuclear Information System (INIS)

    The usefulness of the pancreatic dual-label Schilling test as an indirect test of pancreatic exocrine function was evaluated. This dual-label Schilling test was based on the difference of absorption for [58Co]cobalamin bound to hog R protein and [57Co]cobalamin bound to intrinsic factor. In this study, the test was performed in 7 normal subjects, 5 patients with pancreatectomy, 12 patients with chronic pancreatitis, 10 patients with suspicion of chronic pancreatitis, and 13 patients without chronic pancreatitis. The normal lower limit (mean -2 SD) of excretion ratio for [58Co]/[57Co] in 24-h urine was 0.68. Of the 26 patients on whom endoscopic retrograde pancreatography was performed, none of the 9 patients with normal pancreatogram, 4 of the 9 patients with mild to moderate pancreatitic changes in pancreatogram, and 7 of the 8 patients with advanced pancreatitic changes in pancreatogram showed a positive value lower than the ratio of 0.68 in this test. In 28 patients examined with the direct test of pancreatic secretory capacity, 2 of the 13 patients with normal function, 6 of the 9 patients with mild dysfunction, and 5 of the 6 patients with definite dysfunction were positive in this test. The results of the pancreatic dual-label Schilling test significantly correlated with those of a direct test of pancreatic secretory capacity and the findings of pancreatitic changes in pancreatogram (p less than 0.01, chi 2 test). The ratio for [58Co]/[57Co] correlated (r = 0.73) with the maximal bicarbonate concentration in duodenal juice of the direct test of pancreatic secretory capacity. The impairment of bicarbonate output by the pancreas may adversely affect the transfer of cobalamin from R protein to intrinsic factor

  19. Re-Evaluation of Clinical Dementia Diagnoses with Pittsburgh Compound B Positron Emission Tomography

    Directory of Open Access Journals (Sweden)

    M. Degerman Gunnarsson

    2013-12-01

    Full Text Available Objectives: There is an overlap regarding Pittsburgh compound B (PIB retention in patients clinically diagnosed as Alzheimer's disease (AD and non-AD dementia. The aim of the present study was to investigate whether there are any differences between PIB-positive and PIB-negative patients in a mixed cohort of patients with neurodegenerative dementia of mild severity regarding neuropsychological test performance and regional cerebral glucose metabolism measured with [18F]fluoro-2-deoxy-D-glucose (FDG positron emission tomography (PET. Methods: Eighteen patients clinically diagnosed as probable AD or frontotemporal dementia were examined with PIB PET, FDG PET and neuropsychological tests and followed for 5-9 years in a clinical setting. Results: The PIB-positive patients (7 out of 18 had slower psychomotor speed and more impaired visual episodic memory than the PIB-negative patients; otherwise performance did not differ between the groups. The initial clinical diagnoses were changed in one third of the patients (6 out of 18 during follow-up. Conclusions: The subtle differences in neuropsychological performance, the overlap of hypometabolic patterns and clinical features between AD and non-AD dementia highlight the need for amyloid biomarkers and a readiness to re-evaluate the initial diagnosis.

  20. Screening small-molecule compound microarrays for protein ligands without fluorescence labeling with a high-throughput scanning microscope

    OpenAIRE

    Fei, Yiyan; Landry, James P.; Sun, Yungshin; Zhu, Xiangdong; Wang, Xiaobing; Luo, Juntao; Wu, Chun-Yi; Lam, Kit S.

    2010-01-01

    We describe a high-throughput scanning optical microscope for detecting small-molecule compound microarrays on functionalized glass slides. It is based on measurements of oblique-incidence reflectivity difference and employs a combination of a y-scan galvometer mirror and an x-scan translation stage with an effective field of view of 2 cm×4 cm. Such a field of view can accommodate a printed small-molecule compound microarray with as many as 10,000 to 20,000 targets. The scanning microscope is...

  1. Clinical impact of ki-67 labeling index in non-small cell lung cancer

    DEFF Research Database (Denmark)

    Jakobsen, Jan Nyrop; Sørensen, Jens Benn

    2013-01-01

    The ki-67 index is a marker of proliferation in malignant tumors. Studies from the period 2000 to 2012 on the prognostic and predictive value of ki-67 labeling index (LI) in non-small cell cancer (NSCLC) are reviewed. Twenty-eight studies reported on the prognostic value of ki-67 index with various...... endpoints. No consensus on the prognostic value of ki-67 LI was found among the published studies neither according to disease stage nor histological subtype. Comparison of studies is hampered by differences in patient populations, methodologies and cut-off values. Five studies explored the predictive value...... of ki-67 to chemotherapy and none revealed significant influence. Ki-67 index seems to be of prognostic influence in NSCLC although largely variable cut-off levels have been used in the various studies and standardization of methodology is required. The relative importance of ki-67 compared to newer...

  2. Macromolecular synthesis in algal cells. A review on the kinetics of incorporation in vivo of radioisotope-labelled compounds

    Energy Technology Data Exchange (ETDEWEB)

    Ishida, M.R.; Kikuchi, T. (Kyoto Univ., Kumatori, Osaka (Japan). Research Reactor Inst.)

    1980-11-01

    The present paper is a review of our experimental results obtained previously on the macromolecular biosyntheses in the cells of blue-green alga Anacystis nidulans as a representative species of prokaryote, and also in those of three species of eukaryotic algae, i.e. Euglena gracilis strain Z, Chlamydomonas reinhardi, and Cyanidium caldarium. In these algal cells, the combined methods consisting of pulse-labelling using /sup 32/P, /sup 3/H- and /sup 14/C-labelled precursors for macromolecules, of their chasing and of the use of inhibitors which block specifically the syntheses of macromolecules such as proteins, RNA and DNA in living cells were very effectively applied for the analyses of the regulatory mechanism in biosyntheses of macromolecules and of the mode of their assembly into the cell structure, especially organelle constituents. Rased on the results obtained thus, the following conclusions are reached: (1) the metabolic pool for syntheses of macromolecules in the cells of prokaryotic blue-green alga is limited to the small extent and such activities couple largely with the photosynthetic mechanism; (2) 70 S ribosomes in the blue-green algal cells are assembled on the surface of thylakoid membranes widely distributed in their cytoplasm; and (3) the cells of eukaryotic unicellular algae used here have biochemical characters specific for already differentiated enzyme system involving in transcription and translation machineries as the same as in higher organisms, but the control mechanism concerning with such macromolecule syntheses are different among each species.

  3. Radiopharmaceutical Chemistry of Targeted Radiopharmaceutics. Synthesis of 211At-Labeled Radiopharmaceuticals at High Activities for Clinical Use

    International Nuclear Information System (INIS)

    Targeted α-particle radiotherapy is an appealing approach to cancer treatment because of the potential for delivering curative doses of radiation to tumor with minimal damage to normal tissue due to a range equivalent to only a few cell diameters. Compared with β-emitters they have significant advantages from a radiobiological perspective. The LET of 211At α-particles is more than 400 times higher than the β-particles emitted by 90Y, in addition the distance between ionizing events is almost the same as that between the two strands of DNA, yielding a high probability of creating non-repairable DNA damage. It gives the ability to kill cancer cells not compromised by hypoxia, dose rate effects or cell cycle position, enhancing their attractiveness for targeted radiotherapy. However, translation of the concept to the clinic has been slow, many obstacles had to be surmounted before clinical studies could be initiated, the first clinical evaluation of a 211At- labeled mAb was made in 2001. This study circumvents many of the challenges to entering clinical studies with 211At. But several problems were encountered in maintaining efficient labeling with escalating radiation dose of alpha-particle likely related to radiolysis. The impact of the radiolysis produced by the α-particle over the labeling chemistry is much higher in comparison with typical β-emitters due to a deposition of energy in the solvent in a highly localized manner two orders of magnitude per unit volume higher than 90Y or 131I. Due to these difficulties a comprehensive basic science study about the radiolytic effects of astatine alpha-particles over the synthesis of 211At-labeled radiopharmaceuticals was carried out. Its main goal was overcoming the problem of the synthesis of 211At-labeled radiopharmaceuticals at the high activities necessaries for therapy and also to extend the shelf life of astatine elutions. Briefly this study held several steps, the first one was to study the role of solvent

  4. Dietary supplement labeling and advertising claims: are clinical studies on the full product required?

    Science.gov (United States)

    Villafranco, John E; Bond, Katie

    2009-01-01

    Whether labeling and advertising claims for multi-ingredient dietary supplements may be based on the testing of individual, key ingredients--rather than the actual product--has caused a good deal of confusion. This confusion stems from the dearth of case law and the open-endedness of Federal Trade Commission (FTC) and Food and Drug Administration (FDA) guidance on this issue. Nevertheless, the relevant regulatory guidance, case law and self-regulatory case law--when assessed together--indicate that the law allows and even protects "key ingredient claims" (i.e., claims based on efficacy testing of key ingredients in the absence of full product testing). This article provides an overview of the relevant substantiation requirements for dietary supplement claims and then reviews FTC's and FDA's guidance on key ingredient claims; relevant case law; use of key ingredient claims in the advertising of other consumer products; and the National Advertising Division of the Better Business Bureau, Inc.'s (NAD's) approach to evaluating key ingredient claims for dietary supplements. This article concludes that key ingredient claims--provided they are presented in a truthful and non-deceptive manner--are permissible, and should be upheld in litigation and cases subject to industry self-regulation. This article further concludes that the NAD's approach to key ingredient claims provides practical guidance for crafting and substantiating dietary supplement key ingredient claims. PMID:19998572

  5. Labeling of receptor ligands with bromine radionuclides. Progress report, March 1, 1981-February 29, 1984

    International Nuclear Information System (INIS)

    We have developed techniques to label several types of organic molecules with radiobromine. We have emphasized techniques to label ligands for the estrogen receptor and have studied two brominated compounds in rat models. One of these compounds has been studied in a limited number of patients and estrogen containing tumors visualized by nuclear medicine imaging. We have recently expanded the size of the work to label receptor ligands with fluorine-18 and have carried out preliminary animal studies which suggest that a clinically useful compound can be prepared. In addition to the receptor studies, we have collaborated in assessing 77Br-labeled compounds as therapeutic agents and in studying 77Br-labeled compounds using perturbed angular correlation techniques

  6. Generator 113{sup S}n-113m{sup I}n. Study of the most important characteristics in the evaluate composition for the preparation of clinical labelled compounds; Generador de 113{sup S}n- 113m{sup I}n. Estudio de las caracteristicas mas relevantes en la composicion del eluido con miras a la obtencion de compuestos marcados de aplicacion clinica

    Energy Technology Data Exchange (ETDEWEB)

    Adan, L.; Rebollo, D. V.

    1978-07-01

    The design for the construction of a generator 113{sup S}n -113m{sup l}n is described. A systematic assay for de adequate adsorbents has been made, to obtain solutions of high radiochemical purity, as it is required for the radiopharmaceutical preparations. The control of purity is carried on by qualitative and quantitative analysis of the solutions, complemented by radiochemical techniques. The following physico-chemical parameters has been determinate; consecutive equilibrium constants, pH, distribution constants, separation factors and electrophoretic factors. It has been considered the measure of these parameters for the best quality In the preparation of the radiopharmaceutical compounds. (Author) 53 refs.

  7. Progesterone and Related Compounds in Hepatocellular Carcinoma: Basic and Clinical Aspects

    Directory of Open Access Journals (Sweden)

    Yao-Tsung Yeh

    2013-01-01

    Full Text Available Primary liver cancer is the fifth most common cancer worldwide and the third most common cause of cancer mortality. Hepatocellular carcinoma (HCC accounts for 85% to 90% of primary liver cancers. Major risk factors for HCC include infection with HBV or HCV, alcoholic liver disease, and most probably nonalcoholic fatty liver disease. In general, men are two to four times more often associated with HCC than women. It can be suggested that sex hormones including progesterone may play some roles in HCC. Rather, very limited information discusses its potential involvement in HCC. This paper thus collects some recent studies of the potential involvement of progesterone and related compounds in HCC from basic and clinical aspects. In addition, two synthetic progestins, megestrol acetate (MA and medroxyprogesterone acetate (MPA, will be discussed thoroughly. It is noted that progesterone can also serve as the precursor for androgens and estrogens produced by the gonadal and adrenal cortical tissues, while men have a higher incidence of HCC than women might be due to the stimulatory effects of androgen and the protective effects of estrogen. Eventually, this paper suggests a new insight on the associations of progesterone and related compounds with HCC development and treatment.

  8. Preliminary open-label clinical evaluation of the soothing and reepithelialization properties of a novel topical formulation for rosacea

    Directory of Open Access Journals (Sweden)

    Sparavigna A

    2014-10-01

    Full Text Available Adele Sparavigna, Beatrice Tenconi, Ileana De Ponti Derming Srl, Monza, Italy Background: Rosacea is a common, incurable skin barrier disorder characterized by relapses and remissions. Purpose: To evaluate the efficacy of Farmaka Rosacea Cream (FRC, a novel topical formulation for rosacea. Methods: This single-center, open-label pilot study comprised a single-dose substudy in 20 healthy subjects and a long-term, repeat-dose substudy in 22 subjects with rosacea. The 2-hour, controlled, single-dose substudy assessed the soothing and reepithelialization properties of FRC after stripping-induced erythema based on the erythema index, transepidermal water loss, skin hydration, and clinical assessments of erythema. In the long-term substudy, subjects applied FRC twice daily for 8 weeks. Clinical assessments included vascular and pigmentary homogeneity and erythema and hemoglobin indices. Subjects completed questionnaires to assess FRC efficacy and cosmetic acceptability. Results: Greater reductions were seen in FRC-treated areas compared with untreated areas for the erythema index (-16% versus -8%; P<0.001 and mean transepidermal water loss (-35.8% versus -10.1%; P<0.001 30 minutes after stripping. Significant improvements over untreated areas were maintained 2 hours after stripping. Skin hydration and clinical erythema assessments also indicated that FRC soothed rosacea symptoms and promoted skin reepithelialization. Erythema and hemoglobin indices were significantly reduced from baseline after 4 and 8 weeks of treatment. Clinically assessed parameters were significantly improved following FRC application. Subjects assessed FRC positively. Conclusion: Improvement of rosacea symptoms was noted with FRC application. The main film-forming ingredients of FRC (trehalose, cholesterol, ceramide, and fatty acids, combined with other soothing and calming ingredients and ultraviolet filters, could explain its efficacy. Keywords: rosacea, erythema, skin

  9. Synthesis and biotransformation of bioactive substances labeles with radionuclides

    International Nuclear Information System (INIS)

    Pharmaceutical characteristics of synthesized compounds were studied and assessment of their possible usage as radiopharmaceuticals was conducted in experiments with mice, rats and rabbits. The following compounds were studied: pyrimidothiazine, krizanol, toberone, sulfadiazine, abdidol. Pharmacokinetic features of these drugs were investigated with help of labelled compounds. Chemical structure of products of biotransformation of some prepartions was studied that was the basis for understanding of mechanism of their action. Investigating results are important for clinical usage of these preparations

  10. First automatic radiosynthesis of 11C labeled Telmisartan using a multipurpose synthesizer for clinical research use

    International Nuclear Information System (INIS)

    Telmisartan, a nonpeptide angiotensin II AT1 receptor antagonist, is an antihypertensive drug. Positron emission tomography (PET) imaging with [11C]Telmisartan is expected to provide information about the whole body pharmacokinetics of telmisartan as well as the transport function of hepatic organic anion-transporting polypeptide (OATP) 1B3. We developed a first automatic preparation system of [11C]Telmisartan to applicable clinical research using a new 11C and 18F multipurpose synthesizer. Two milligrams of precursor (1) in 5 μl of 1 M KOH in 0.5 ml of dimethyl sulfoxide was reacted with [11C]CH3I for 5 min at 120 deg C. The resultant solution was hydrolyzed with 1 M NaOH at 100 deg C for 3 min. The neutralization was carried out with acetic acid, followed by purification with high-performance liquid chromatography. The desired radioactive fraction was collected and solvent was replaced by 10 ml saline containing 0.3 ml of EtOH and 0.5 ml of PEG400, and then passed through a sterile 0.22 μm filter (Millex-GV, Millipore) to a pyrogen-free vial as the final product. The yield of [11C]Telmisartan for clinical research use was 16.8±2.9% end of bombardment (EOB) as decay corrected (n=8, mean ± standard deviation (SD) in 32-36 min. The radiochemical purity of [11C]Telmisartan was >97%, and specific activity was higher than 86.3 MBq/nmol. We succeeded in the first synthesis of [11C]Telmisartan for clinical research use by appropriate quality tests. (author)

  11. Off-label use of maraviroc in HIV-1-infected paediatric patients in clinical practice.

    Science.gov (United States)

    Palladino, Claudia; Gómez, María Luisa Navarro; Soler-Palacín, Pere; González-Tomé, María Isabel; De Ory, Santiago J; Espiau, María; Hoyos, Santiago Pérez; León-Leal, Juan Antonio; Méndez, María; Moreno-Pérez, David; Guasch, Claudia Fortuny; Sierra, Antoni Mur; Guruceta, Itziar Pocheville; Guillén, Santiago Moreno; Briz, Verónica

    2015-10-23

    Maraviroc (MVC) is not approved for HIV-1-infected paediatric patients. This is the first assessment of the use of MVC-based salvage therapy in vertically HIV-1-infected paediatric patients in clinical settings. The results suggest that MVC-based salvage therapy is useful in children and adolescents with extensive resistance profile leading to maintained virological suppression in up to 88% of the patients with CCR5-tropic virus. The likelihood of treatment success might increase when MVC is combined with other active drugs. PMID:26544580

  12. Blood cell labelling

    International Nuclear Information System (INIS)

    The labelling of blood cells in vitro for subsequent in vivo studies was one of the earliest applications of radioactive tracers in clinical medicine and laid the foundations for many important contributions to the advancement of knowledge of human blood cell pathophysiology. The characteristics required for satisfactory clinical studies, the mechanisms of cell labelling, the problems of radiation or chemical damage to the labelled cells and some examples of modern clinical applications are described and discussed. (Author)

  13. Labelling of Vincamine derivatives

    International Nuclear Information System (INIS)

    Tritium labelled Vincamine and ethyl apovincaminate (Cavinton) have been prepared on the bases of known stereospecific synthesis. High specific activity compounds were obtained by the catalytic tritiation of appropriate unsaturated starting compounds. When the structure of the unsaturated starting compounds was changed (even rather for from the reaction centre) instead of the catalytic addition of tritium a specific hydrogen-tritium exchange reaction was found to be the main labelling process

  14. Clinical study with a new radiopharmaceutical (RP-517) for the in vivo labeling of neutrophils with 99mTc

    International Nuclear Information System (INIS)

    RP-517 is a 99mTc labeled antagonist to the LTB4 receptor which, with a single i.v. injection, allows the in vivo labeling of neutrophils for the detection and localization of infectious and/or inflammatory foci. Aim: To determine: 1) the safety and tolerance of the radiopharmaceutical in humans; 2) its pharmacokinetics and dosimetry; 3) its preliminary efficacy for the detection and localization of infectious foci. Materials and Methods: 20 subjects (14M, 6F) received 592 ± 111 MBq (16 ± 3 mCi) of RP-517 intravenously. All subjects were evaluated (medical history, physical exam, vital signs, ECG, blood and urine analysis) before and at several times up to 24 hours post-injection of RP-517. Blood samples were taken to determine pharmacokinetics and blood clearance. Urine and feces were collected to measure excretion. For dosimetry determination, whole body images, one transmission pre-injection and sequential emission images post-injection, were obtained with a dual head gamma camera (ADAC) in 2 patients and 14 volunteers. Sequential focal images were obtained in 4 patients. The presence of infection was determined by culture and/or follow-up. Results: There were no adverse clinical events or clinically significant changes in any of the laboratory analysis parameters, ECG or vital signs. RP-517 clears the blood mainly through the hepatobiliary system. The critical organ is the gall bladder wall, followed by the intestinal wall. A suggested maximum injected dose of about 740MBq of RP-517 would deliver ≤ 50 mGy to the critical organ. There were 6 patients with suspicion of infection: in 2 of them the infection was proven; a third subject had 2 suspected infectious foci, one was proven, the other one was equivocal; at the time of imaging, there was no infections process in the other 3 subjects. RP-517 images showed a clear and persistent uptake in the 3 proven infectious foci, was negative in the equivocal one and in the three patients without infection

  15. Immunoscintigraphic diagnosis of ovarian cancer with Tc-99m labeled MAb ior-c5: First clinical results

    International Nuclear Information System (INIS)

    Purpose: The aim of the present study was to assess the value of radioimmunoscintigraphy using Tc-99m labeled monoclonal antibody ior-c5 labeled with Tc-99m in the detection primary, metastatic and recurrent ovarian cancer. Twenty-two patients, aged between 20 and 67 years were included. There were nine new patients with palpable ovarian mass without any previous treatment nor any past history of ovarian cancer (Group-I). In Group -II there were 13 patients with past history of ovarian tumour. Each patient received 1.85-2.22 GBq Tc-99m -ior-c5 injected intravenously. Radiochemical purity of Tc-99m -ior-c5 was 97±2%. Planar and SPECT images were obtained at 4 hours and 18-24 hours. Final diagnosis was made in all patients on the basis of histopathology. The results of scintigraphic studies were correlated with those of histopathological examinations. Histopathology in all nine patients of Group-I were found to be negative for ovarian cancer. However radioimmunoscintigraphy falsely diagnosed 2 cases from this group as positive. These two cases were an ovarian fibroma and a mature cystic teratoma. Ten out of the 13 patients in Group II (77%) had histologically active malignant disease; immunoscintigraphic images correctly identified all positive lesions (9 locoregional, 3 distant). Tumour-to-background ratio was found to be 2.07±0.41. The sensitivity, specificity and accuracy of immunoscintigraphy with Tc-99m ior-c5 were 100%, 83.3% and 90.9%, respectively. The kappa coefficient of agreement (k) was 0.82±0.12. There were no adverse reactions. It was concluded that radioimmunoscintigraphy with Tc-99m -ior-c5 could be useful in the diagnosis and follow-up of patients with ovarian cancer. However, its clinical role should be more precisely determined in a larger patient population. (author)

  16. New radiopharmaceuticals for adrenal scanning: radioiodine labelled tyramine derivates of heart glycosides and the respective aglycons

    International Nuclear Information System (INIS)

    In order to avoid certain disadvantages of the test substances for adrenal scanning currently being used, new radiopharmaceuticals - hydroxyphenylethylamine derivatives from digitalis glycosides - were synthesized, radioiodine-labelled and tested scintigraphically in animal experiments. The new compounds have been shown to be very appropriate, and it can be expected that they are well suited for clinical purposes especially when labelled by 123Iodine. (orig.)

  17. Cyclotron production of molecules labelled with short-lived radioisotopes β+ emitters (15O, 13N, 11C) and their clinical uses

    International Nuclear Information System (INIS)

    Clinical use of three short-lived radioisotopes: 15O, 13N and 11C is studied on two complementary aspects. A production and purification system is realized; detection instruments in medical use are studied. The production of labelled molecules with the three radiotracers 15O, 13N, 11C from the target bombardment with charged and accelerated particles was studied

  18. Early response assessment in patients with multiple myeloma during anti-angiogenic therapy using arterial spin labelling: first clinical results

    International Nuclear Information System (INIS)

    To determine if arterial-spin-labelling (ASL) MRI can reliably detect early response to anti-angiogenic therapy in patients with multiple myeloma by comparison with clinical/haematological response. Nineteen consecutive patients (10 men; mean age 63.5 ± 9.1 years) were included in the present study. Inclusion criteria were diagnosis of stage III multiple myeloma and clinical indication for therapeutical administration of bortezomib or lenalidomide. We performed MRI on 3.0T MR in the baseline setting, 3 weeks after onset of therapy and after 8 weeks. Clinical responses were determined on the basis of international uniform response criteria in correlation with haematological parameters and medium-term patient outcome. MRI studies were performed after approval by the local institutional review board. Fifteen patients responded to anti-myeloma therapy; 4/19 patients were non-responders to therapy. Mean tumour perfusion assessed by ASL-MRI in a reference lesion was 220.7 ± 132.5 ml min-1 100 g-1 at baseline, and decreased to 125.7 ± 86.3 (134.5 ± 150.9) ml min-1 100 g-1 3 (8) weeks after onset of therapy (P < 0.02). The mean decrease in paraproteinaemia at week 3 (8) was 52.3 ± 47.7% (58.2 ± 58.7%), whereas β2-microglobulinaemia decreased by 20.3 ± 53.1% (23.3 ± 57.0%). Correlation of ASL perfusion with outcome was significant (P = 0.0037). ASL tumour perfusion measurements are a valuable surrogate parameter for early assessment of response to novel anti-angiogenic therapy. (orig.)

  19. Early response assessment in patients with multiple myeloma during anti-angiogenic therapy using arterial spin labelling: first clinical results

    Energy Technology Data Exchange (ETDEWEB)

    Fenchel, Michael [Eberhard-Karls University, Department of Diagnostic and Interventional Radiology, Tuebingen (Germany); Eberhard-Karls University, Department of Diagnostic and Interventional Neuroradiology, Tuebingen (Germany); Konaktchieva, Marina [Eberhard-Karls University, Department of Internal Medicine, Gastroenterology, Tuebingen (Germany); Weisel, Katja; Kraus, Sabina [Eberhard-Karls University, Department of Internal Medicine, Hematology, Tuebingen (Germany); Brodoefel, Harald; Claussen, Claus D.; Horger, Marius [Eberhard-Karls University, Department of Diagnostic and Interventional Radiology, Tuebingen (Germany)

    2010-12-15

    To determine if arterial-spin-labelling (ASL) MRI can reliably detect early response to anti-angiogenic therapy in patients with multiple myeloma by comparison with clinical/haematological response. Nineteen consecutive patients (10 men; mean age 63.5 {+-} 9.1 years) were included in the present study. Inclusion criteria were diagnosis of stage III multiple myeloma and clinical indication for therapeutical administration of bortezomib or lenalidomide. We performed MRI on 3.0T MR in the baseline setting, 3 weeks after onset of therapy and after 8 weeks. Clinical responses were determined on the basis of international uniform response criteria in correlation with haematological parameters and medium-term patient outcome. MRI studies were performed after approval by the local institutional review board. Fifteen patients responded to anti-myeloma therapy; 4/19 patients were non-responders to therapy. Mean tumour perfusion assessed by ASL-MRI in a reference lesion was 220.7 {+-} 132.5 ml min{sup -1} 100 g{sup -1} at baseline, and decreased to 125.7 {+-} 86.3 (134.5 {+-} 150.9) ml min{sup -1} 100 g{sup -1} 3 (8) weeks after onset of therapy (P < 0.02). The mean decrease in paraproteinaemia at week 3 (8) was 52.3 {+-} 47.7% (58.2 {+-} 58.7%), whereas {beta}2-microglobulinaemia decreased by 20.3 {+-} 53.1% (23.3 {+-} 57.0%). Correlation of ASL perfusion with outcome was significant (P = 0.0037). ASL tumour perfusion measurements are a valuable surrogate parameter for early assessment of response to novel anti-angiogenic therapy. (orig.)

  20. Optical elastic scattering for early label-free identification of clinical pathogens

    Science.gov (United States)

    Genuer, Valentin; Gal, Olivier; Méteau, Jérémy; Marcoux, Pierre; Schultz, Emmanuelle; Lacot, Éric; Maurin, Max; Dinten, Jean-Marc

    2016-03-01

    We report here on the ability of elastic light scattering in discriminating Gram+, Gram- and yeasts at an early stage of growth (6h). Our technique is non-invasive, low cost and does require neither skilled operators nor reagents. Therefore it is compatible with automation. It is based on the analysis of the scattering pattern (scatterogram) generated by a bacterial microcolony growing on agar, when placed in the path of a laser beam. Measurements are directly performed on closed Petri dishes. The characteristic features of a given scatterogram are first computed by projecting the pattern onto the Zernike orthogonal basis. Then the obtained data are compared to a database so that machine learning can yield identification result. A 10-fold cross-validation was performed on a database over 8 species (15 strains, 1906 scatterograms), at 6h of incubation. It yielded a 94% correct classification rate between Gram+, Gram- and yeasts. Results can be improved by using a more relevant function basis for projections, such as Fourier-Bessel functions. A fully integrated instrument has been installed at the Grenoble hospital's laboratory of bacteriology and a validation campaign has been started for the early screening of MSSA and MRSA (Staphylococcus aureus, methicillin-resistant S. aureus) carriers. Up to now, all the published studies about elastic scattering were performed in a forward mode, which is restricted to transparent media. However, in clinical diagnostics, most of media are opaque, such as blood-supplemented agar. That is why we propose a novel scheme capable of collecting back-scattered light which provides comparable results.

  1. High-resolution label-free vascular imaging using a commercial, clinically approved dermatological OCT scanner

    Science.gov (United States)

    Byers, R. A.; Tozer, G.; Brown, N. J.; Matcher, S. J.

    2016-02-01

    Background and Aim: Recently developed decorrelative techniques such as speckle-variance optical coherence tomography (svOCT) have demonstrated non-invasive depth-resolved imaging of the microcirculation in-vivo. However, bulk tissue motion (BTM) originating from the subject's breathing or heartbeat remains problematic at low imaging speeds, often resulting in full frame decorrelation and a loss of vascular contrast. The aim of this study was to build upon existing svOCT techniques through utilisation of a commercially available, probe-based VivoSight OCT system running at 20 kHz Axial-scan rate. Methods and results: Custom four-dimensional scanning strategies were developed and utilised in order to maximise the interframe correlation during image acquisition. Volumes of structural OCT data were collected from various anatomical regions and processed using the aforementioned svOCT algorithm to reveal angiographic information. Following data collection, three dimensional image registration and novel filtering algorithms were applied to each volume in order to ensure that BTM artefacts were sufficiently suppressed. This enabled accurate visualisation of the microcirculation within the papillary dermis, to a depth of approximately 2mm. Applications of this technique, including quantitative capillary loop density measurement and visualisation of wound healing are demonstrated and enhanced through widefield mosaicing of the svOCT data. Conclusions: Non-invasive microcirculation imaging using an FDA 510(k) approved OCT scanner such as the VivoSight allows direct clinical utilisation of these techniques, in particular for the pathological analysis of skin diseases. This research was supported by BBSRC Doctoral Training Grant: BB/F016840/1. The authors also gratefully acknowledge the use of equipment funded by MRC grant: MR/L012669/1.

  2. PREPARATION OF ANHYDROUS F-18 FLUORIDE, T. Tewson. Journal of Labelled Compounds and Radiopharmaceuticals S165; 52, Supplement 1 2009

    Energy Technology Data Exchange (ETDEWEB)

    Tewson, T.

    2009-07-01

    The original specific aims of the grant where cut back considerably as the study section reduced both the time and the budget for the project. The objective of the grant was to show that fluorine-18 fluoride could be prepared completely anhydrous and thus substantially more reactive than conventionally dried fluoride using the method of Sun and DiMagno. This method involved using conventionally dried fluoride to prepare an aromatic fluoride in which the aromatic ring is substituted with electron withdrawing groups. The aryl fluoride is then dried and purified and the fluoride is displaced with an anhydrous nucleophile. Using fluorine-19 and macroscopic scale reactions the reactions work well and give anhydrous fluoride salts that are both more reactive and more selective in their reactions than conventionally dried fluoride. The original substrate chosen for the reaction was bromopentacyanobenzene (1). This compound proved to be easy to make but very hard to purify. As an alternative hexabromobenzene, which is commercially available in high purity, was tried. This reacted cleanly with conventionally dried F-18 fluoride in acetonitrile to give [{sup 18}F]-fluoropentabromobenzene (2), which could be dried by passage of the solution over alumina, which also removed any unreacted fluoride. The fluorine-18 fluoride could be liberated from (2) by displacement with an anhydrous nucleophilic tetra-alkylammonium salt but the anion had to be chosen with considerable care. The reaction is potentially reversible especially as, on the no carrier added scale, there is inevitably an excess of hexabromobenzene and so the displacing nucleophile is chosen to deactivate the aromatic compound to further nucleophilic displacement reactions. To this end tetrabutylammonium azide and tetrabutylammonium phenolate have been tried. Both work but the phenolate is probably the better choice. The F-18 fluoride produced by this process is substantially more reactive than conventionally dried

  3. Biogenic volatile organic compound and respiratory CO2 emissions after 13C-labeling: online tracing of C translocation dynamics in poplar plants.

    Directory of Open Access Journals (Sweden)

    Andrea Ghirardo

    Full Text Available BACKGROUND: Globally plants are the primary sink of atmospheric CO(2, but are also the major contributor of a large spectrum of atmospheric reactive hydrocarbons such as terpenes (e.g. isoprene and other biogenic volatile organic compounds (BVOC. The prediction of plant carbon (C uptake and atmospheric oxidation capacity are crucial to define the trajectory and consequences of global environmental changes. To achieve this, the biosynthesis of BVOC and the dynamics of C allocation and translocation in both plants and ecosystems are important. METHODOLOGY: We combined tunable diode laser absorption spectrometry (TDLAS and proton transfer reaction mass spectrometry (PTR-MS for studying isoprene biosynthesis and following C fluxes within grey poplar (Populus x canescens saplings. This was achieved by feeding either (13CO(2 to leaves or (13C-glucose to shoots via xylem uptake. The translocation of (13CO(2 from the source to other plant parts could be traced by (13C-labeled isoprene and respiratory (13CO(2 emission. PRINCIPAL FINDING: In intact plants, assimilated (13CO(2 was rapidly translocated via the phloem to the roots within 1 hour, with an average phloem transport velocity of 20.3±2.5 cm h(-1. (13C label was stored in the roots and partially reallocated to the plants' apical part one day after labeling, particularly in the absence of photosynthesis. The daily C loss as BVOC ranged between 1.6% in mature leaves and 7.0% in young leaves. Non-isoprene BVOC accounted under light conditions for half of the BVOC C loss in young leaves and one-third in mature leaves. The C loss as isoprene originated mainly (76-78% from recently fixed CO(2, to a minor extent from xylem-transported sugars (7-11% and from photosynthetic intermediates with slower turnover rates (8-11%. CONCLUSION: We quantified the plants' C loss as respiratory CO(2 and BVOC emissions, allowing in tandem with metabolic analysis to deepen our understanding of ecosystem C flux.

  4. Preparation of 19 iodocholesterol labelled with 125I

    International Nuclear Information System (INIS)

    A new method of synthesis of 19-iodocholesterol labelled with 125I from commercial cholesterol is described. Its high chemical (96%) and radiochemical (99,9%) purities high yield and short time of preparation permit us to dispose or a more accessible labelled compound, which results appropriate for clinical investigations and in the diagnosis of disturbances of the suprarenal glands. (author). 2 figs., 9 refs

  5. Preparation of 19-iodocholesterol labelled with 125 I

    International Nuclear Information System (INIS)

    In this paper a new method of synthesis of 19-iodo cholesterol labelled with ''125 I, from commercial cholesterol, is described. Its high chemical (96%) and radiochemical (99.9%) purities high yield and short time of preparation permit us to dispose or a more accessible labelled compound, which results appropriates for clinical investigations and in the diagnosis of disturbances of the suprarenal glands. (Author) 9 refs

  6. Clinical evaluation of technetium-99m labeled red blood cell scan in the detection of gastrointestinal hemorrhage

    International Nuclear Information System (INIS)

    A three years' experience at Chigasaki Tokushukai Medical Center with Technetium-99m labeled red blood cell scintiscans (Tc-99m-RBC Scan) performed on 68 cases of suspected lower gastrointestinal (LGI) bleeding was reviewed in retrospect. Of the 36 cases performed within 24 hours from the clinical detection of active LGI hemorrhage on emergency basis, 27 cases were positive (75 % positivity). Of the total 45 positive cases, 21 (47 %) became positive one or more hours post injection, confirming the intermittent nature of the LGI hemorrhage. All studies were completed without untoward effects and confirmed the noninvasive nature of the study, as compared to the other invasive modalities such as endoscopy and angiography. Detection and localization of the site of LGI bleeding directed the precise modality to be chosen subsequently and greatly facilitated in performing the invasive procedure with selectivity further improving its sensitivity. Tc-99m-RBC scan is a completely noninvasive, simple and sensitive procedure, which may be used initially in routine to detect and localize LGI bleeding. (author)

  7. Anti-Cancer Stem-like Cell Compounds in Clinical Development – An Overview and Critical Appraisal

    Science.gov (United States)

    Marcucci, Fabrizio; Rumio, Cristiano; Lefoulon, François

    2016-01-01

    Cancer stem-like cells (CSC) represent a subpopulation of tumor cells with elevated tumor-initiating potential. Upon differentiation, they replenish the bulk of the tumor cell population. Enhanced tumor-forming capacity, resistance to antitumor drugs, and metastasis-forming potential are the hallmark traits of CSCs. Given these properties, it is not surprising that CSCs have become a therapeutic target of prime interest in drug discovery. In fact, over the last few years, an enormous number of articles describing compounds endowed with anti-CSC activities have been published. In the meanwhile, several of these compounds and also approaches that are not based on the use of pharmacologically active compounds (e.g., vaccination, radiotherapy) have progressed into clinical studies. This article gives an overview of these compounds, proposes a tentative classification, and describes their biological properties and their developmental stage. Eventually, we discuss the optimal clinical setting for these compounds, the need for biomarkers allowing patient selection, the redundancy of CSC signaling pathways and the utility of employing combinations of anti-CSC compounds and the therapeutic limitations posed by the plasticity of CSCs.

  8. Clinical evaluation of the effect of a herbal compound made for treatment of discolorations caused by dental fluorosis

    Directory of Open Access Journals (Sweden)

    Mahshid Mohammdi Basir

    2013-08-01

    Full Text Available   Background and Aims: The purpose of this study was research on a new herbal compound (Seidlitzia Rosmarinus made by Traditional Medicine Research Group, University of shahed to find a safer alternative to HCL-Pumice compound technique.   Materials and Methods: In this randomized clinical trial seventy two anterior teeth from 9 patients were divided in to three groups according to fluorosis severity: mild (34 teeth, moderate (14 teeth, and sever (24 teeth. In each patient, half of the teeth were treated with “Shahed” compound and other half treated with HCL-Pumice compound. Before and after treatment, photographs were taken in both groups. HCL-Pumice treatment compound was applied for 30 seconds periods and continued for 10 minutes if necessary. In case of herbal Shahed compound the time was determined by clinical symptoms or when labial contour was dismissed, If the result was not esthetistically acceptabale for the patient, HCL-Pumice compound was applied on teeth. NaF was applied after mouth washing. The photographs of the teeth before and after treatment were reviewed by two experienced observer unaware of the treatment modality. The results were analyzed using willcoxon’s, kruskal-wallis and scheffe test.   Results: There was over 81.3% acceptance between two observers and no significant differences in intraobservers evaluation (P>0.05. Improvement in beauty indexes were observed in all degrees of dental fluorosis by 18% with HCL-Pumice compound application, but “Shahed” herbal compound induced significant reduction in the amount of white spots in mild fluorosis and stain intensity of moderate fluorosis (P<0.05 , while the reduction in the severity of discoloration in group 2, these two techniques were statistically equivalent but in the remainder, HCL-Pumice compound was more significantly effective (P<0.05 .   Conclusion: HCL-Pumice compound reduces the severity of the discoloration of the teeth. Shahed herbal compound

  9. Molecularly imprinted solid phase extraction using stable isotope labeled compounds as template and liquid chromatography-mass spectrometry for trace analysis of bisphenol A in water sample

    International Nuclear Information System (INIS)

    We have developed a molecularly imprinted polymer (MIP) using a stable isotope labeled compound as the template molecule and called it the ''isotope molecularly imprinted polymer'' (IMIP). In this study, bisphenol A (BPA) was used as the model compound. None imprinted polymer (NIP), MIP, dummy molecularly imprinted polymer (DMIP) and IMIP were prepared by the suspension polymerization method using without template, BPA, 4-tert-butylphenol (BP) and bisphenol A-d16 (BPA-d16), respectively. The polymers were subjected to molecularly imprinted solid phase extraction (MI-SPE), and the extracted samples were subjected to liquid chromatography-mass spectrometry (LC-MS). Although the leakage of BPA-d16 from the IMIP was observed and that of BPA was not observed. The selectivity factors of MIP and IMIP for BPA were 4.45 and 4.43, respectively. Therefore, IMIP had the same molecular recognition ability as MIP. When MI-SPE with IMIP was used and followed by LC-MS in the analysis of river water sample, the detection limit of BPA was 1 ppt with high sensitivity. Moreover, the average recovery was higher than 99.8% (R.S.D.: 3.7%) by using bisphenol A-13C12 (BPA-13C12) as the surrogate standard. In addition, the IMIP were employed in MI-SPE of BPA in river water sample by LC-MS. The concentration of BPA in the river water sample was determined to be 32 pg ml-1. We confirmed that it was possible to measure trace amounts of a target analyte by MI-SPE using IMIP

  10. Deuterium labeled cannabinoids

    International Nuclear Information System (INIS)

    Complex reactions involving ring opening, ring closure and rearrangements hamper complete understanding of the fragmentation processes in the mass spectrometric fragmentation patterns of cannabinoids. Specifically labelled compounds are very powerful tools for obtaining more insight into fragmentation mechanisms and ion structures and therefore the synthesis of specifically deuterated cannabinoids was undertaken. For this, it was necessary to investigate the preparation of cannabinoids, appropriately functionalized for specific introduction of deuterium atom labels. The results of mass spectrometry with these labelled cannabinoids are described. (Auth.)

  11. Stable isotope applications in biomolecular structure and mechanisms. A meeting to bring together producers and users of stable-isotope-labeled compounds to assess current and future needs

    Energy Technology Data Exchange (ETDEWEB)

    Trewhella, J.; Cross, T.A.; Unkefer, C.J. [eds.

    1994-12-01

    Knowledge of biomolecular structure is a prerequisite for understanding biomolecular function, and stable isotopes play an increasingly important role in structure determination of biological molecules. The first Conference on Stable Isotope Applications in Biomolecular Structure and Mechanisms was held in Santa Fe, New Mexico, March 27--31, 1994. More than 120 participants from 8 countries and 44 institutions reviewed significant developments, discussed the most promising applications for stable isotopes, and addressed future needs and challenges. Participants focused on applications of stable isotopes for studies of the structure and function of proteins, peptides, RNA, and DNA. Recent advances in NMR techniques neutron scattering, EPR, and vibrational spectroscopy were highlighted in addition to the production and synthesis of labeled compounds. This volume includes invited speaker and poster presentations as well as a set of reports from discussion panels that focused on the needs of the scientific community and the potential roles of private industry, the National Stable Isotope Resource, and the National High Magnetic Field Laboratory in serving those needs. This is the leading abstract. Individual papers are processed separately for the database.

  12. Stable isotope applications in biomolecular structure and mechanisms. A meeting to bring together producers and users of stable-isotope-labeled compounds to assess current and future needs

    International Nuclear Information System (INIS)

    Knowledge of biomolecular structure is a prerequisite for understanding biomolecular function, and stable isotopes play an increasingly important role in structure determination of biological molecules. The first Conference on Stable Isotope Applications in Biomolecular Structure and Mechanisms was held in Santa Fe, New Mexico, March 27--31, 1994. More than 120 participants from 8 countries and 44 institutions reviewed significant developments, discussed the most promising applications for stable isotopes, and addressed future needs and challenges. Participants focused on applications of stable isotopes for studies of the structure and function of proteins, peptides, RNA, and DNA. Recent advances in NMR techniques neutron scattering, EPR, and vibrational spectroscopy were highlighted in addition to the production and synthesis of labeled compounds. This volume includes invited speaker and poster presentations as well as a set of reports from discussion panels that focused on the needs of the scientific community and the potential roles of private industry, the National Stable Isotope Resource, and the National High Magnetic Field Laboratory in serving those needs. This is the leading abstract. Individual papers are processed separately for the database

  13. Identification of Trypanocidal Activity for Known Clinical Compounds Using a New Trypanosoma cruzi Hit-Discovery Screening Cascade

    Science.gov (United States)

    De Rycker, Manu; Thomas, John; Riley, Jennifer; Brough, Stephen J.; Miles, Tim J.; Gray, David W.

    2016-01-01

    Chagas disease is a significant health problem in Latin America and the available treatments have significant issues in terms of toxicity and efficacy. There is thus an urgent need to develop new treatments either via a repurposing strategy or through the development of new chemical entities. A key first step is the identification of compounds with anti-Trypanosoma cruzi activity from compound libraries. Here we describe a hit discovery screening cascade designed to specifically identify hits that have the appropriate anti-parasitic properties to warrant further development. The cascade consists of a primary imaging-based assay followed by newly developed and appropriately scaled secondary assays to predict the cidality and rate-of-kill of the compounds. Finally, we incorporated a cytochrome P450 CYP51 biochemical assay to remove compounds that owe their phenotypic response to inhibition of this enzyme. We report the use of the cascade in profiling two small libraries containing clinically tested compounds and identify Clemastine, Azelastine, Ifenprodil, Ziprasidone and Clofibrate as molecules having appropriate profiles. Analysis of clinical derived pharmacokinetic and toxicity data indicates that none of these are appropriate for repurposing but they may represent suitable start points for further optimisation for the treatment of Chagas disease. PMID:27082760

  14. Identification of Trypanocidal Activity for Known Clinical Compounds Using a New Trypanosoma cruzi Hit-Discovery Screening Cascade.

    Science.gov (United States)

    De Rycker, Manu; Thomas, John; Riley, Jennifer; Brough, Stephen J; Miles, Tim J; Gray, David W

    2016-04-01

    Chagas disease is a significant health problem in Latin America and the available treatments have significant issues in terms of toxicity and efficacy. There is thus an urgent need to develop new treatments either via a repurposing strategy or through the development of new chemical entities. A key first step is the identification of compounds with anti-Trypanosoma cruzi activity from compound libraries. Here we describe a hit discovery screening cascade designed to specifically identify hits that have the appropriate anti-parasitic properties to warrant further development. The cascade consists of a primary imaging-based assay followed by newly developed and appropriately scaled secondary assays to predict the cidality and rate-of-kill of the compounds. Finally, we incorporated a cytochrome P450 CYP51 biochemical assay to remove compounds that owe their phenotypic response to inhibition of this enzyme. We report the use of the cascade in profiling two small libraries containing clinically tested compounds and identify Clemastine, Azelastine, Ifenprodil, Ziprasidone and Clofibrate as molecules having appropriate profiles. Analysis of clinical derived pharmacokinetic and toxicity data indicates that none of these are appropriate for repurposing but they may represent suitable start points for further optimisation for the treatment of Chagas disease. PMID:27082760

  15. Identification of Trypanocidal Activity for Known Clinical Compounds Using a New Trypanosoma cruzi Hit-Discovery Screening Cascade.

    Directory of Open Access Journals (Sweden)

    Manu De Rycker

    2016-04-01

    Full Text Available Chagas disease is a significant health problem in Latin America and the available treatments have significant issues in terms of toxicity and efficacy. There is thus an urgent need to develop new treatments either via a repurposing strategy or through the development of new chemical entities. A key first step is the identification of compounds with anti-Trypanosoma cruzi activity from compound libraries. Here we describe a hit discovery screening cascade designed to specifically identify hits that have the appropriate anti-parasitic properties to warrant further development. The cascade consists of a primary imaging-based assay followed by newly developed and appropriately scaled secondary assays to predict the cidality and rate-of-kill of the compounds. Finally, we incorporated a cytochrome P450 CYP51 biochemical assay to remove compounds that owe their phenotypic response to inhibition of this enzyme. We report the use of the cascade in profiling two small libraries containing clinically tested compounds and identify Clemastine, Azelastine, Ifenprodil, Ziprasidone and Clofibrate as molecules having appropriate profiles. Analysis of clinical derived pharmacokinetic and toxicity data indicates that none of these are appropriate for repurposing but they may represent suitable start points for further optimisation for the treatment of Chagas disease.

  16. In vivo/in vitro labeling of red blood cells with sup(99m)Tc and clinical applications

    International Nuclear Information System (INIS)

    A reliable and stabile in vivo/in vitro labeling technique of red blood cells (RBC) is described. The patients are injected 20% of the content of an unlabeled kit used for bone scintigraphy (TechneScan PYP, Byk-Mallinckrodt). 15 minutes later 3 ml blood are sampled in a heparinized syringe. The blood is incubated together with 30-40 mCi (1-1.5 GBq) sup(99m)Tc for 10 minutes in a water bath at 35-370C. After centrifugation at 500 g a dose of 15-25 mCi (0.6-1 GBq) sup(99m)Tc labeled RBC may be withdrawn in a volume of 1-1.5 ml. Mean labeling efficiency is 88%, without using the first eluat of a Tc-generator the yield is as high as 92%. Due to the small volume, the labeled RBC may be reinjected as bolus and first pass radionuclide angiocardiography can be performed. Using labeled RBC, scintigraphy of the intravasal space is possible up to 20 hours without deterioration in contrast or accumulation of radioactivity in the extravasal space or in other organs. Evaluation of heart function can be performed up to 10 hours. In addition, labeled RBC are useful in detecting unknown gastrointestinal bleeding. (orig.)

  17. Design and Synthesis of 11C-Labelled Compound Libraries for the Molecular Imaging of EGFr, VEGFr-2, AT1 and AT2 Receptors: Transition-Metal Mediated Carbonylations Using [11C]Carbon Monoxide

    International Nuclear Information System (INIS)

    This work deals with radiochemistry and new approaches to develop novel PET tracers labelled with the radionuclide 11C. Two methods for the synthesis of 11C-labelled acrylamides have been explored. First, [1-11C]-acrylic acid was obtained from a palladium(0)-mediated 11C-carboxylation of acetylene with [11C]carbon monoxide; this could be converted to the corresponding acyl chloride and then combined with benzylamine to form N-benzyl[carbonyl-11C]acrylamide. In the second method, the palladium(0)-mediated carbonylation of vinyl halides with [11C]carbon monoxide was explored. This latter method, yielded labelled acrylamides in a single step with retention of configuration at the C=C double bond, and required less amine compared to the acetylene method. The vinyl halide method was used to synthesize a library of 11C-labelled EGFr-inhibitors in 7-61% decay corrected radiochemical yield via a combinatorial approach. The compounds were designed to target either the active or the inactive form of EGFr, following computational docking studies. The rhodium(I)-mediated carbonylative cross-coupling of an azide and an amine was shown to be a very general reaction and was used to synthesize a library of dual VEGFr-2/PDGFrβ inhibitors that were 11C-labelled at the urea position in 38-78% dc rcy. The angiotensin II AT1 receptor antagonist eprosartan was 11C-labelled at one of the carboxyl groups in one step using a palladium(0)-mediated carboxylation. Autoradiography shows specific binding in rat kidney, lung and adrenal cortex, and organ distribution shows a high accumulation in the intestines, kidneys and liver. Specific binding in frozen sections of human adrenal incidentalomas warrants further investigations of this tracer. Three angiotensin II AT2 ligands were 11C-labelled at the amide group in a palladium(0)-mediated aminocarbonylation in 16-36% dc rcy. One of the compounds was evaluated using in vitro using autoradiography, and in vivo using organ distribution and animal

  18. Comparison of the effectiveness and safety of cefpodoxime and ciprofloxacin in acute exacerbation of chronic suppurative otitis media: A randomized, open-labeled, phase IV clinical trial

    Directory of Open Access Journals (Sweden)

    Arijit Ghosh

    2012-01-01

    Full Text Available Objective : To compare the effectiveness and safety of cefpodoxime and ciprofloxacin for the treatment of mild to moderate cases of acute exacerbation of chronic suppurative otitis media (AECSOM. Materials and Methods : Adult patients diagnosed with AECSOM were screened and patients fulfilling the inclusion criteria were randomized to receive either cefpodoxime 200 mg twice daily or ciprofloxacin 500 mg twice daily orally for 7 days. The primary outcome of this randomized, open-labeled, phase IV clinical trial (Registration Number - CTRI/2011/10/002079 was clinical success rate at day 14 visit and the secondary outcome was incidence of adverse events (AEs. Forty-six patients were enrolled: 23 in the cefpodoxime group and 23 in the ciprofloxacin group. Results : The clinical success rates were 95.6% in the cefpodoxime group versus 90.9% in the ciprofloxacin group. These rates are comparable, but no statistically significant difference was observed between the groups. Few mild and self-limiting AEs were observed and the tolerability of both the drugs was also good. Conclusion : The results of this randomized, open-labeled phase IV clinical trial showed that a 7-day course of cefpodoxime is therapeutically comparable to ciprofloxacin in terms of both clinical effectiveness and safety for the treatment of patients with AECSOM.

  19. Plant-Derived Anti-Inflammatory Compounds: Hopes and Disappointments regarding the Translation of Preclinical Knowledge into Clinical Progress

    Directory of Open Access Journals (Sweden)

    Robert Fürst

    2014-01-01

    Full Text Available Many diseases have been described to be associated with inflammatory processes. The currently available anti-inflammatory drug therapy is often not successful or causes intolerable side effects. Thus, new anti-inflammatory substances are still urgently needed. Plants were the first source of remedies in the history of mankind. Since their chemical characterization in the 19th century, herbal bioactive compounds have fueled drug development. Also, nowadays, new plant-derived agents continuously enrich our drug arsenal (e.g., vincristine, galantamine, and artemisinin. The number of new, pharmacologically active herbal ingredients, in particular that of anti-inflammatory compounds, rises continuously. The major obstacle in this field is the translation of preclinical knowledge into evidence-based clinical progress. Human trials of good quality are often missing or, when available, are frequently not suitable to really prove a therapeutical value. This minireview will summarize the current situation of 6 very prominent plant-derived anti-inflammatory compounds: curcumin, colchicine, resveratrol, capsaicin, epigallocatechin-3-gallate (EGCG, and quercetin. We will highlight their clinical potential and/or pinpoint an overestimation. Moreover, we will sum up the planned trials in order to provide insights into the inflammatory disorders that are hypothesized to be beneficially influenced by the compound.

  20. Randomized clinical trial of a phytotherapic compound containing Pimpinella anisum, Foeniculum vulgare, Sambucus nigra, and Cassia augustifolia for chronic constipation

    Directory of Open Access Journals (Sweden)

    Amaral Karine M

    2010-04-01

    Full Text Available Abstract Background A phytotherapic compound containing Pimpinella anisum L., Foeniculum vulgare Miller, Sambucus nigra L., and Cassia augustifolia is largely used in Brazil for the treatment of constipation. However, the laxative efficacy of the compound has never been tested in a randomized clinical trial. The aim of this study was to evaluate the efficacy and safety of the product. Methods This randomized, crossover, placebo-controlled, single-blinded trial included 20 patients presenting with chronic constipation according to the criteria of the American Association of Gastroenterology. The order of treatments was counterbalanced across subjects: half of the subjects received the phytotherapic compound for a 5-day period, whereas the other half received placebo for the same period. Both treatment periods were separated by a 9-day washout period followed by the reverse treatment for another 5-day period. The primary endpoint was colonic transit time (CTT, measured radiologically. Secondary endpoints included number of evacuations per day, perception of bowel function, adverse effects, and quality of life. Results Mean CTT assessed by X ray was 15.7 hours (95%CI 11.1-20.2 in the active treatment period and 42.3 hours (95%CI 33.5-51.1 during the placebo treatment (p Conclusions The findings of this randomized controlled trial allow to conclude that the phytotherapic compound assessed has laxative efficacy and is a safe alternative option for the treatment of constipation. Trial registration ClinicalTrial.gov NCT00872430

  1. Clinical, microbiological and immunological effects of natural compounds-containing mouthrinses in patients with fixed orthodontic appliance therapy

    OpenAIRE

    Chen, Yong; 陳勇

    2013-01-01

    Malocclusion and orthodontic treatment can give rise to bacteria and nonbacterial induced gingival inflammations. Previous studies have shown that some natural compounds-containing mouthrinses (NCCMs) have clinical benefits for maintaining gingival health. The aim of the present study was to investigate the effectiveness of NCCMs in the management of dental plaque and gingivitis among orthodontic patients. The present study consisted of three parts: 1) a systematic review on the effective...

  2. Hurdles for a Broader Use of 211At and for the Synthesis of 211At-Labelled Radiopharmaceuticals at High Activities for Clinical Use

    International Nuclear Information System (INIS)

    One of the key impediments to the use of 211At is the very well known deleterious effect of high radiation fields caused by its alpha particles on the synthesis of 211At-labelled radiopharmaceuticals. This is problematic because radiolysis-mediated effects can produce diminishing efficiency of electrophilic astatination reactions due to increasing deposition of radiation dose with increasing activities and with the passage of the time. Astatine-211 has chemical properties that permit complex labelling strategies and a longer half-life than 213Bi that makes it more suitable when the targeting molecule does not gain immediate access to the tumour cells. The first clinical evaluation was published in 2001 [2] in patients with brain tumour. Although this study circumvents many of the challenges to entering clinical studies with 211At and many obstacles had to be surmounted before clinical studies could be initiated, several problems were encountered in maintaining efficient labelling with escalating radiation dose of α-particle even with fresh 211At elution [3]. Astatine-211 also has an additional hurdle to overcome before to its clinical application in labelled radiopharmaceuticals related with its production and distribution. Among the potential group of promising α- emitter it is the only one produced by cyclotrons, but due to the scarcity of cyclotrons equipped with 25−30 MeV α-particle beams, it will of necessity be utilized in distant locations from the site of production. It presents a major chemical challenge because the diminishing efficiency of electrophilic astatination reactions with the passage of the time is well known, a problem likely related to the radiolysis produced by the high LET (linear energy transfer) meaning that large amounts of energy are deposited in a highly localized manner. This problem has been most comprehensively investigated to understand and evaluate the role of the radiolysis effects of astatine alpha particles in the synthesis

  3. Failure to label red blood cells adequately in daily practice using an in vivo method: methodological and clinical considerations

    International Nuclear Information System (INIS)

    This study was conducted to evaluate the frequency and possible causes of poor red blood cell (RBC) labelling when performing equilibrium gated blood pool (GBP) radionuclide angiography at rest with an in vivo method. The influence of the mode of administration on tagging efficiency was studied. The patients were subclassified into four groups according to the way both molecules involved in the tagging procedure were administered. When poor image quality was found, the labelling efficiency was quantified and the frequency of failed tagging in each group was calculated. A significant association was found between poor labelling and the use of a Teflon catheter or butterfly needle for the injection of the stannous agent. In another 737 patients a strict administration protocol was applied to analyse the frequency of poor tagging and its possible causes. Suboptimal image quality was present in 88 patients. Quantitatively confirmed poor tagging was present in 36 of the 88; the remaining 52 patients showed borderline normal labelling. Drug interference was studied by comparing the medications used by the 36 patients showing poor binding with those used by 44 control patients. A significant relationship was found between the use of heparin or chemotherapy and the tagging. A significant correlation was found between advanced age and poor labelling efficiency. Finally, in 36 patients with poor labelling, a second GBP test was performed. This allowed us to evaluate the accuracy of the obtained ejection fraction value when a suboptimal image set is used, and to assess the feasibility of using the new kit in daily practice. (orig.)

  4. Abdominal scintigraphy using {sup 99m}Tc-HMPAO-labelled leucocytes in patients with seronegative spondylarthropathies without clinical evidence of inflammatory bowel disease

    Energy Technology Data Exchange (ETDEWEB)

    Alonso, J.C. [Department of Nuclear Medicine, Hospital Virgen de Alarcos, Ciudad Real (Spain); Lopez-Longo, F.J. [Department of Rheumatology, Hospital Universitario Gregorio Maranon, Madrid (Spain); Lampreave, J.L. [Department of Nuclear Medicine, Hospital Universitario Gregorio Maranon, Madrid (Spain); Gonzalez, C.M. [Department of Rheumatology, Hospital Universitario Gregorio Maranon, Madrid (Spain); Vegazo, O. [Department of Nuclear Medicine, Hospital Universitario Gregorio Maranon, Madrid (Spain); Carreno, L. [Department of Rheumatology, Hospital Universitario Gregorio Maranon, Madrid (Spain); Almoguera, I. [Department of Nuclear Medicine, Hospital Universitario Gregorio Maranon, Madrid (Spain)

    1996-03-01

    Abdominal scintigraphy with technetium-99m hexamethylpropylene amine oxime ({sup 99m}Tc-HMPAO)-labelled leucocytes is an excellent tool for evaluating disease extent and activity of intestinal lesions in patients with inflammatory bowel disease (IBD). In some cases of seronegative spondylarthropathies (SSp), IBD may remain subclinical. The aim of this study was to evaluate the presence of positive abdominal scintigraphy in patients with SSp and without clinical symptoms or signs of IBD. To this end we studied 32 patients with active SSp (European Spondylarthropathy Study Group 1991 criteria) without clinical evidence of IBD (eight had ankylosing spondylitis, four psoriatic arthritis, three reactive arthritis an 17 undifferentiated SSp) and 11 controls without SSp. All SSp and control patients received similar doses of non-steroidal anti-inflammatory drugs (NSAIDs). Abdominal scintigraphic images were obtained at 30 and 120 min after re-injection of {sup 99m}Tc-HMPAO-labelled leucocytes. The {sup 99m}Tc-HMPAO-labelled leucocyte scan was positive in 17 patients with SSp (53.1%) (six with ankylosing spondylitis, three with psoriatic arthritis, two with reactive arthritis and six with undifferentiated SSp). Fourteen patients scored from 2 to 4 on the intensity of uptake scale. The colon and terminal ileum were predominantly involved. Axial involvement was more frequent in patients with a positive scan than in patients with negative results (P<0.05) (64.7% vs 26.6%; odds ratio: 5). No control patient showed a positive scan. It is concluded that {sup 99m}Tc-HMPAO-labelled leucocyte scan shows increased uptake among patients with SSp without evidence of IBD. These findings provide new evidence linking SSp with intestinal inflammation and suggest that in some cases a bowel-related process could contribute to the development of SSp. Long-term follow-up studies with more patients are necessary to evaluate the diagnostic and therapeutic implications of these results.

  5. Abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondylarthropathies without clinical evidence of inflammatory bowel disease

    International Nuclear Information System (INIS)

    Abdominal scintigraphy with technetium-99m hexamethylpropylene amine oxime (99mTc-HMPAO)-labelled leucocytes is an excellent tool for evaluating disease extent and activity of intestinal lesions in patients with inflammatory bowel disease (IBD). In some cases of seronegative spondylarthropathies (SSp), IBD may remain subclinical. The aim of this study was to evaluate the presence of positive abdominal scintigraphy in patients with SSp and without clinical symptoms or signs of IBD. To this end we studied 32 patients with active SSp (European Spondylarthropathy Study Group 1991 criteria) without clinical evidence of IBD (eight had ankylosing spondylitis, four psoriatic arthritis, three reactive arthritis an 17 undifferentiated SSp) and 11 controls without SSp. All SSp and control patients received similar doses of non-steroidal anti-inflammatory drugs (NSAIDs). Abdominal scintigraphic images were obtained at 30 and 120 min after re-injection of 99mTc-HMPAO-labelled leucocytes. The 99mTc-HMPAO-labelled leucocyte scan was positive in 17 patients with SSp (53.1%) (six with ankylosing spondylitis, three with psoriatic arthritis, two with reactive arthritis and six with undifferentiated SSp). Fourteen patients scored from 2 to 4 on the intensity of uptake scale. The colon and terminal ileum were predominantly involved. Axial involvement was more frequent in patients with a positive scan than in patients with negative results (P99mTc-HMPAO-labelled leucocyte scan shows increased uptake among patients with SSp without evidence of IBD. These findings provide new evidence linking SSp with intestinal inflammation and suggest that in some cases a bowel-related process could contribute to the development of SSp. Long-term follow-up studies with more patients are necessary to evaluate the diagnostic and therapeutic implications of these results. (orig.). With 3 figs., 3 tabs

  6. Clinical studies with oral lipid based formulations of poorly soluble compounds

    DEFF Research Database (Denmark)

    Fatouros, Dimitrios; Karpf, Ditte M; Nielsen, Flemming S;

    2007-01-01

    . Several drug products intended for oral administration have been marketed utilizing lipid and surfactant based formulations. Sandimmune((R)) and Sandimmune Neoral((R)) (cyclosporin A, Novartis), Norvir((R)) (ritonavir), and Fortovase((R)) (saquinavir) have been formulated in self-emulsifying drug delivery...... properties on the in vivo performance of the formulation. Equally important is the effect of concurrent food intake on the bioavailability of poorly soluble compounds. The effect of food on the bioavailability of compounds formulated in lipid and surfactant based formulations is also reviewed....

  7. Food Labels

    Science.gov (United States)

    ... How Can I Help a Friend Who Cuts? Food Labels KidsHealth > For Teens > Food Labels Print A ... have at least 95% organic ingredients. continue Making Food Labels Work for You The first step in ...

  8. SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard

    Directory of Open Access Journals (Sweden)

    Johnson Philip J

    2008-10-01

    Full Text Available Abstract Background Hepcidin is a 25-residue peptide hormone crucial to iron homeostasis. It is essential to measure the concentration of hepcidin in cells, tissues and body fluids to understand its mechanisms and roles in physiology and pathophysiology. With a mass of 2791 Da hepcidin is readily detectable by mass spectrometry and LC-ESI, MALDI and SELDI have been used to estimate systemic hepcidin concentrations by analysing serum or urine. However, peak heights in mass spectra may not always reflect concentrations in samples due to competition during binding steps and variations in ionisation efficiency. Thus the purpose of this study was to develop a robust assay for measuring hepcidin using a stable isotope labelled hepcidin spiking approach in conjunction with SELDI-TOF-MS. Results We synthesised and re-folded hepcidin labelled with 13C/15N phenylalanine at position 9 to generate an internal standard for mass spectrometry experiments. This labelled hepcidin is 10 Daltons heavier than the endogenous peptides and does not overlap with the isotopic envelope of the endogenous hepcidin or other common peaks in human serum or urine mass spectra and can be distinguished in low resolution mass spectrometers. We report the validation of adding labelled hepcidin into serum followed by SELDI analysis to generate an improved assay for hepcidin. Conclusion We demonstrate that without utilising a spiking approach the hepcidin peak height in SELDI spectra gives a good indication of hepcidin concentration. However, a stable isotope labelled hepcidin spiking approach provides a more robust assay, measures the absolute concentration of hepcidin and should facilitate inter-laboratory hepcidin comparisons.

  9. Zingiber officinale (ginger) compounds have tetracycline-resistance modifying effects against clinical extensively drug-resistant Acinetobacter baumannii.

    Science.gov (United States)

    Wang, Hui-Min; Chen, Chung-Yi; Chen, Hsi-An; Huang, Wan-Chun; Lin, Wei-Ru; Chen, Tun-Chieh; Lin, Chun-Yu; Chien, Hsin-Ju; Lu, Po-Liang; Lin, Chiu-Mei; Chen, Yen-Hsu

    2010-12-01

    Extensively drug-resistant Acinetobacter baumannii (XDRAB) is a growing and serious nosocomial infection worldwide, such that developing new agents against it is critical. The antimicrobial activities of the rhizomes from Zingiber officinale, known as ginger, have not been proven in clinical bacterial isolates with extensive drug-resistance. This study aimed to investigate the effects of four known components of ginger, [6]-dehydrogingerdione, [10]-gingerol, [6]-shogaol and [6]-gingerol, against clinical XDRAB. All these compounds showed antibacterial effects against XDRAB. Combined with tetracycline, they showed good resistance modifying effects to modulate tetracycline resistance. Using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging method, these four ginger compounds demonstrated antioxidant properties, which were inhibited by MnO₂, an oxidant without antibacterial effects. After the antioxidant property was blocked, their antimicrobial effects were abolished significantly. These results indicate that ginger compounds have antioxidant effects that partially contribute to their antimicrobial activity and are candidates for use in the treatment of infections with XDRAB. PMID:20564496

  10. Research co-ordination meeting on labelling, quality control and clinical evaluation of monoclonal antibodies for scintigraphy, Kuala Lumpur, Malaysia, 9-13 September 1991

    International Nuclear Information System (INIS)

    The Co-ordinated Research Programme (CRP) on ''Labelling, quality control and clinical evaluation of monoclonal antibodies for scintigraphy'' arose from the deliberations at an IAEA Consultants' Meeting (CM) on ''Radiolabelling techniques of monoclonal antibodies'' held in Vienna on 22-24 August 1988. The following is a brief description of the relevant recommendations arising from said meeting. A more detailed description of the proceedings may be found in the summary report issued on 8 December 1989. This report incorporates the results of the first Research Co-ordination Meeting (RCM) of subject CRP held in Kuala Lumpur, Malaysia on 9-13 September 1991. 9 refs

  11. Simultaneous determination of seven β2-agonists in human and bovine urine by isotope dilution liquid chromatography-tandem mass spectrometry using compound-specific minimally (13)C-labelled analogues.

    Science.gov (United States)

    González-Antuña, Ana; Rodríguez-González, Pablo; Centineo, Giuseppe; García Alonso, J Ignacio

    2014-10-29

    Seven β2-agonist (clenproperol, clenbuterol, salbutamol, bronbuterol, ractopamine, clenpenterol and clencyclohexerol) were determined simultaneously in human and bovine urine by isotope dilution LC-ESI-MS/MS in a triple quadrupole instrument. The method is based on the application of multiple linear regression in combination with compound-specific minimally (13)C-labelled analogues. Additionally, the increase of the bandpass of the first quadrupole during the selected reaction monitoring (SRM) measurement procedure allowed the simultaneous quantification of the seven compounds at sub ngg(-1) levels in a single chromatogram without resorting to a methodological calibration graph. Recovery values at concentration levels between 5.0 and 0.05ngg(-1) ranged from 95 to 110% in fortified bovine urine and from 91 to 108% in human urine, with relative standard deviations lower than 5% except for salbutamol and ractopamine. The proposed methodology was validated by analyzing the certified reference material BCR-503 (lyophilized bovine urine) certified for clenbuterol and salbutamol. The limits of detection (LOD) for a sample volume of 10mL of both human and bovine urine was found to be lower than 0.012ngg(-1) for all compounds, except to salbutamol in bovine urine which was of 0.029ngg(-1). The use of compound-specific isotopically labelled analogues minimally labelled in (13)C minimized the occurrence of isotope effects and corrected for matrix effects during ESI ionization and can be efficiently applied for the quantification of ultra-trace concentrations of β2-agonists in human and bovine urine. PMID:25468499

  12. Clinical Observation in 86 Cases of Acne Vulgaris Treated with Compound Oldenlandis Mixture

    Institute of Scientific and Technical Information of China (English)

    刘瓦林; 沈冬; 宋坪; 许铣

    2003-01-01

    86 cases of acne vulgaris were treated with Fu Fang She She Cao He Ji (复方蛇舌草合剂 CompoundPrepared from Chinese Angelica and Flavescent Sophora Root) as the controls, to observe the therapeuticeffect of the former. The results showed that the cure plus markedly effective rate was 73.26% in thetreatment group, and 47.06% in the control group, with a significant difference in the cure plus markedlyeffective rate between the two groups (P<0.01), and also in the total effective rate between the two groupssignificant (P<0.05). It may be concluded that the Compound Oldenlandis Mixture is a better agent for theillness.

  13. Lyophilized kits of diamino dithiol compounds for labelling with {sup 99m}-technetium. Pharmacokinetics studies and distribution compartmental models of the related complexes; Conjuntos de reativos liofilizados de compostos diaminoditiolicos para marcacao com tecnecio-99m. Estudo farmacocinetico e elaboracao de modelos compartimentalizados dos respectivos complexos

    Energy Technology Data Exchange (ETDEWEB)

    Araujo, Elaine Bortoleti de

    1995-07-01

    The present work reflects the clinical interest for labelling diamino dithiol compounds with technetium-99m. Both chosen compounds, L,L-Ethylene dicysteine (L,L-EC) and L,L-Ethylene dicysteine diethyl esther (L,L-ECD) were obtained with relative good yield and characterized by IR and NMR. The study of labelling conditions with technetium-99m showed the influence of the type and mass of reducing agent as well as the pH on the formation of complexes with desired biological characteristics. Radiochemical purity was determined by thin layer chromatography (TLC) and high performance liquid chromatography (HPLC). Lyophilised kits of L,L-EC and L,L-ECD for labelling with {sup 99m}Tc were obtained, with stability superior to 120 days, when stored under refrigeration, enabling the kits marketing. The ideal formulation of the kits as well as the use of liquid nitrogen in the freezing process, determined the lyophilization success. Distribution biological studies of the {sup 99m}Tc complexes were performed on mice by invasive method and on bigger animals by scintigraphic evaluation. Biological distribution studies of the complex {sup 99m}Tc-L,L-EC showed fast blood clearance, with the elimination of about 90% of the administered dose after 60 minutes, almost exclusively by the urinary system. The biological distribution results were adjusted to a three compartmental distribution model, as expected for a radiopharmaceutical designed to renal dynamic studies, with tubular elimination. The complex interaction with renal tubular receptors is related with structural characteristics of the compound, more specifically with the presence and location of polar groups. In comparison with {sup 99m}Tc-L,L-EC, biological studies of the complex {sup 99m}Tc -L,L-ECD showed different distribution aspects, despite some structural similarities. The presence of ethyl groups confers to the complex neutrality and lipophilicity. It cross the intact blood brain barrier and is retained in the brain

  14. Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

    OpenAIRE

    Gordon, Jessica K.; Martyanov, Viktor; Magro, Cynthia; Wildman, Horatio F.; Wood, Tammara A; Huang, Wei-Ti; Crow, Mary K.; Whitfield, Michael L.; Spiera, Robert F.

    2015-01-01

    Introduction Tyrosine kinase inhibitors (TKI) are medications of interest in the treatment of Systemic Sclerosis (SSc) because of their ability to inhibit pathways involved in fibrosis. In this open-label pilot trial, our objectives were to assess the safety, efficacy, and molecular change associated with treatment of patients with diffuse cutaneous (dc)SSc with the TKI nilotinib (Tasigna™). Methods Ten adult patients with early dcSSc were treated with nilotinib. Primary endpoints were safety...

  15. Preliminary open-label clinical evaluation of the soothing and reepithelialization properties of a novel topical formulation for rosacea

    OpenAIRE

    Sparavigna A; Tenconi B; De Ponti I

    2014-01-01

    Adele Sparavigna, Beatrice Tenconi, Ileana De Ponti Derming Srl, Monza, Italy Background: Rosacea is a common, incurable skin barrier disorder characterized by relapses and remissions. Purpose: To evaluate the efficacy of Farmaka Rosacea Cream (FRC), a novel topical formulation for rosacea. Methods: This single-center, open-label pilot study comprised a single-dose substudy in 20 healthy subjects and a long-term, repeat-dose substudy in 22 subjects with rosacea. The 2-hour, controlled, singl...

  16. 13C- and 15N-labelled non-biogenic compounds used as stable isotope drugs for human liver function tests

    International Nuclear Information System (INIS)

    As a result of liver diseases, the elimination of certain drugs is retarded. After labelling a suitable drug with 13C, the 13CO2 elimination rate serves as a liver function parameter. Current contributions to the 13CO2 breath test method are reviewed and related to the 14CO2 breath test proposals. In spite of several advantages of 13C-labelled agents, some dissatisfaction has remained with the tests, especially at using them with infants. It is the necessity of face masks and the uncertainty to consider endogeneous CO2 contributions diluting the exhaled 13CO2. The problems are avoided if the other molecule site of the drug is labelled which is known to be eliminated via urine. With 15N as a tracer, a suitable urine test using [15N]-methacetin as agent has been proposed and put into practice. (author)

  17. Efficient synthesis of D-branched-chain amino acids and their labeled compounds with stable isotopes using D-amino acid dehydrogenase.

    Science.gov (United States)

    Akita, Hironaga; Suzuki, Hirokazu; Doi, Katsumi; Ohshima, Toshihisa

    2014-02-01

    D-Branched-chain amino acids (D-BCAAs) such as D-leucine, D-isoleucine, and D-valine are known to be peptide antibiotic intermediates and to exhibit a variety of bioactivities. Consequently, much effort is going into achieving simple stereospecific synthesis of D-BCAAs, especially analogs labeled with stable isotopes. Up to now, however, no effective method has been reported. Here, we report the establishment of an efficient system for enantioselective synthesis of D-BCAAs and production of D-BCAAs labeled with stable isotopes. This system is based on two thermostable enzymes: D-amino acid dehydrogenase, catalyzing NADPH-dependent enantioselective amination of 2-oxo acids to produce the corresponding D-amino acids, and glucose dehydrogenase, catalyzing NADPH regeneration from NADP(+) and D-glucose. After incubation with the enzymes for 2 h at 65°C and pH 10.5, 2-oxo-4-methylvaleric acid was converted to D-leucine with an excellent yield (>99 %) and optical purity (>99 %). Using this system, we produced five different D-BCAAs labeled with stable isotopes: D-[1-(13)C,(15)N]leucine, D-[1-(13)C]leucine, D-[(15)N]leucine, D-[(15)N]isoleucine, and D-[(15)N]valine. The structure of each labeled D-amino acid was confirmed using time-of-flight mass spectrometry and nuclear magnetic resonance analysis. These analyses confirmed that the developed system was highly useful for production of D-BCAAs labeled with stable isotopes, making this the first reported enzymatic production of D-BCAAs labeled with stable isotopes. Our findings facilitate tracer studies investigating D-BCAAs and their derivatives. PMID:23661083

  18. Effects of two soil reclamation techniques on the distribution of the organic N compounds in a 15N labelled burnt soil.

    OpenAIRE

    de Castro, A.; González Prieto, S. J.; Carballas, T.

    2007-01-01

    The evolution of the soil organic-N forms and their bio-availability was studied in a 15N labelled and burnt soil (BLS) after two successive reclamation steps under greenhouse conditions: a 3-month growing period of Lolium, without (BLS-L) or with poultry manure addition (4 and 8 Mg ha-1: BLS+PM4-L and BLS+PM8-L), followed by a 12-month growing phase of pine seedlings (BLS-P, BLS+PM4-P and BLS+PM8-P). The results were compared with those obtained for the homologous labelled unb...

  19. Clinical study of the Immunoglobululin Enhancing effect of "Bala compound" on Infants.

    Science.gov (United States)

    Appaji, Rao R; Sharma, R D; Katiyar, G P; Sai, Prasad A J V

    2009-01-01

    Kaumarbhritya a branch of Asthanga Ayurveda deals with neonatal, infant and child health care. Multicentric studies conducted in various developed and developing countries have indicated that Infant Mortality Rate (I.M.R.) is very high in developing countries, and infection has been observed as the major cause. Immune system in neonates is not yet fully functional. Bala compound having the ingredients ofAtibala (Abutilon indicum Linn), Amalaki (Emblica officinalis Linn), Vidanga (Emblica ribes burn), Guduchi (Tinospora cordifolia Welld Miers), Pippali (Piperlongum linn), Yashtimadhu (Glycyrrhiza glabra Linn), Shankhapuspi (Convolvulus pluricaulis Chois ), Vacha (Acorus calamus Linn), Musta (Cyperus rotundus Linn) and Ativisha (Aconitum heterophyllum wall) are Medhya as well as Rasayana drugs mention in Ayurvedic classics. 'Bala compound" was tried in infants in the form of oral drops for a period of six months and result was assessed for serum immuoglobulins IgG, IgM, IgA for three months of interval of two follow ups (i.e., third and six month of infant). There is significant increase of immunoglobulins observed after six months administration of 'Bala compoumd" PMID:22557316

  20. Clinical Research of Compound Zhebei Granules for Increasing the Therapeutic Effect of Chemotherapy in Refractory Acute Leukemia Patients

    Institute of Scientific and Technical Information of China (English)

    LU Dian-rong; LI Dong-yun; CHEN Xin-yi; YE Pei-zhi; TIAN Shao-dan

    2009-01-01

    Objective:To observe the effects of Compound Zhebei Granules (复方浙贝颗粒 CZG) in chemotherapy for refractory acute leukemia.Method:Using a randomized, double-blind and multi-central concurrent control clinical research project, the patients conformed with the diagnostic criteria, according to the drug randomized method, were divided into a CZG group and a control group.The patients of the two groups respectively took the observation drug or a placebo 3 days before chemotherapy, and the therapeutic effects were evaluated after one course of chemotherapy.According to the clinical research project, 137 patients were enrolled, including 71 cases in the CZG group and 66 cases in the control group.Results:The clinical complete remission (CR)rate was 42.3% in the CZG group with a total effective rate of 73.2%, and it was 25.8% in the control group with a total effective rate of 53.0%, showing a statistically significant difference between the two groups (P<0.05).Conclusion:CZG can increase the clinical remission rate for refractory acute leukemia during chemotherapy.

  1. Synthesis of F-18 labeled raloxifene derivative

    International Nuclear Information System (INIS)

    Raloxifene, [6-hydroxy-2-(4-hydroxy-phenyl) benzo [b] thiophen-3-yl]-[4-(2-piperidin-1-yl-ethoxy)phenyl] methanone, a tissue-selective estrogen mixed agonist/antagonist, classified as a selective estrogen receptor modulator (SERM), is currently under clinical evaluation for the prevention and treatment of postmenopausal osteoporosis, breast cancer, uterine dysfunction, and other disorders of the female reproductive system. Based on SAR studies of substituted raloxifenes, we synthesized 3 kinds of fluoroalkylated raloxifene derivatives. These compounds show high relative binding affinities (RBA) to the estrogen receptor in vitro (RBA of estradiol = 100%). The RBA values for compounds 1, 2 and 3 are 89, 60, and 45%, respectively, which are all higher than that of raloxifene itself (34%). Among these compounds, we selected to take the best RBA value one and F-18 labeled. Using 2 kinds of labeling method ; 1) Radiolabeling using [18F]KF was carried out in anhydrous acetonitrile for 10 min at 120 .deg. C. 2) Radiolabeling using [18F]KF was carried out in anhydrous acetonitrile for 15 min at 120 .deg. C in ionic liquid, [bmim][OTf]. Deprotection step added 1N HCl and reacted for 3 min at 120 .deg. C. [18F]Fluoroethyl raloxifene derivative obtained 5-23% decay corrected labeling yield by HPLC system (C18 xterra, 10 i, 34% Acetonitrile/0.1 M formate buffer, flow rate: 4 mL/1 min, collection time : 28-29 min) and total time was around 70 min. Fluoroethyl raloxifene derivative has the best RBA value among the other synthesized derivatives and chose it for radiolabeling. [18F]Fluoroethyl raloxifene derivative prepared 5-23% decay corrected labeling yield. This preparation is on going for labeling optimizing and preparing of in vitro and in vivo test

  2. Synthesis of F-18 labeled raloxifene derivative

    Energy Technology Data Exchange (ETDEWEB)

    Lee, K. C.; Moon, B. S.; Jun, K. S. [KIRAMS, Seoul (Korea, Republic of); Lee, J. H.; Ji, D. Y. [Inha University, Incheon (Korea, Republic of)

    2005-07-01

    Raloxifene, [6-hydroxy-2-(4-hydroxy-phenyl) benzo [b] thiophen-3-yl]-[4-(2-piperidin-1-yl-ethoxy)phenyl] methanone, a tissue-selective estrogen mixed agonist/antagonist, classified as a selective estrogen receptor modulator (SERM), is currently under clinical evaluation for the prevention and treatment of postmenopausal osteoporosis, breast cancer, uterine dysfunction, and other disorders of the female reproductive system. Based on SAR studies of substituted raloxifenes, we synthesized 3 kinds of fluoroalkylated raloxifene derivatives. These compounds show high relative binding affinities (RBA) to the estrogen receptor in vitro (RBA of estradiol = 100%). The RBA values for compounds 1, 2 and 3 are 89, 60, and 45%, respectively, which are all higher than that of raloxifene itself (34%). Among these compounds, we selected to take the best RBA value one and F-18 labeled. Using 2 kinds of labeling method ; 1) Radiolabeling using [{sup 18}F]KF was carried out in anhydrous acetonitrile for 10 min at 120 .deg. C. 2) Radiolabeling using [{sup 18}F]KF was carried out in anhydrous acetonitrile for 15 min at 120 .deg. C in ionic liquid, [bmim][OTf]. Deprotection step added 1N HCl and reacted for 3 min at 120 .deg. C. [{sup 18}F]Fluoroethyl raloxifene derivative obtained 5-23% decay corrected labeling yield by HPLC system (C18 xterra, 10 i, 34% Acetonitrile/0.1 M formate buffer, flow rate: 4 mL/1 min, collection time : 28-29 min) and total time was around 70 min. Fluoroethyl raloxifene derivative has the best RBA value among the other synthesized derivatives and chose it for radiolabeling. [{sup 18}F]Fluoroethyl raloxifene derivative prepared 5-23% decay corrected labeling yield. This preparation is on going for labeling optimizing and preparing of in vitro and in vivo test.

  3. 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives

    International Nuclear Information System (INIS)

    [111In-diethylene triamine penta-acetic acid-d-Phe1]-octreotide (DTPA-octreotide) scintigraphy has gained widespread acceptance as a diagnostic clinical procedure in oncology for imaging somatostatin receptor-positive tumours. However, indium-111 as a radiolabel has several drawbacks, including limited availability, suboptimal gamma energy and high radiation burden to the patient. We have recently reported on the preclinical development of 99mTc-EDDA/HYNIC-TOC, a new octreotide derivative which showed promising results both in vitro and in vivo. We now report our initial clinical experiences with this new radiopharmaceutical in ten oncological patients. The clinical diagnoses were: carcinoid syndrome (n=5), thyroid cancer (n=3), pancreatic cancer (n=1) and pituitary tumour (n=1). The biodistribution and kinetics of 99mTc-EDDA/HYNIC-TOC were compared with those of 111In-DTPA-octreotide in six cases, and with those of 111In-DOTA-TOC in five cases. With the new tracer tumours were imaged within 15 min after injection and showed the highest target/non-target ratios 4 h after injection. Tumour uptake persisted up to 20 h p.i. The rate of blood clearance was similar to that of 111In-DTPA-octreotide but faster than that of 111In-DOTA-TOC, while urinary excretion was lower compared with the 111In derivatives. Semi-quantitative region of interest analysis showed that 99mTc-EDDA/HYNIC-TOC produced higher tumour/organ (target/non-target) ratios than the 111In derivatives, especially in relation to heart and muscle. Significantly more lesions could be detected in 99mTc images. We conclude that 99mTc-EDDA/HYNIC-TOC shows better imaging properties for the identification of somatostatin receptor-positive tumour sites than currently available 111In-labelled octreotide derivatives. (orig.)

  4. Application of Cassette Ultracentrifugation Using Non-labeled Compounds and Liquid Chromatography-Tandem Mass Spectrometry Analysis for High-Throughput Protein Binding Determination.

    Science.gov (United States)

    Kieltyka, Kasia; McAuliffe, Brian; Cianci, Christopher; Drexler, Dieter M; Shou, Wilson; Zhang, Jun

    2016-03-01

    Membrane-based devices typically used for serum protein binding determination are not fully applicable to highly lipophilic compounds because of nonspecific binding to the device membrane. Ultracentrifugation, however, completely eliminates the issue by using a membrane-free approach, although its wide application has been limited. This lack of utilization is mainly attributed to 2 factors: the high cost in acquiring and handling of radiolabeled compounds and low assay throughput owing to the difficulties in process automation. To overcome these challenges, we report a high-throughput workflow by cassette ultracentrifugation of nonradiolabeled compounds followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. Twenty compounds with diverse physicochemical and protein binding properties were selected for the evaluation of the workflow. To streamline the working process, approaches of matrix balancing for all the samples for LC-MS/MS analysis and determining free fraction without analytical calibration curves were adopted. Both the discrete ultracentrifugation of individual compounds and cassette ultracentrifugation of all the test compounds followed by simultaneous LC-MS/MS analysis exhibited a linear correlation with literature values, demonstrating respectively the validity of the ultracentrifugation process and the cassette approach. The cassette ultracentrifugation using nonradiolabeled compounds followed by LC-MS/MS analysis has greatly facilitated its application for high-throughput protein binding screening in drug discovery. PMID:26886323

  5. Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides

    International Nuclear Information System (INIS)

    Medullary thyroid carcinoma (MTC) expresses CCK-2 receptors. 111In-labeled DOTA-DGlu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 (DOTA-MG11), DOTA-DAsp-Tyr-Nle-Gly-Trp-Nle-Asp-Phe-NH2 (DOTA-CCK), and 99mTc-labeled N4-Gly-DGlu-(Glu)5-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 (99mTc-Demogastrin 2) are analogs developed for CCK-2 receptor-targeted scintigraphy. All 3 radiolabeled analogs were selected on the basis of their high CCK-2 receptor affinity and their good in vitro serum stability, with in vitro serum t1/2 values of several hours. Radiolabeling of DOTA-peptides with 111In requires a heating procedure, typically in the range of 80 deg. - 100 deg. C up to 30 min. Following this procedure with DOTA-MG11 resulted in a >98 % incorporation of 111In, however, with a radiochemical purity (RCP) of 111In involved 5 min heating at 80 deg. C and led to an incorporation of 111In of >98 %. In addition, all analogs were radiolabeled in the presence of quenchers to prevent radiolysis and oxidation resulting in a RCP of >90 %. All 3 radiolabeled analogs were i.v. administered to 6 MTC patients: radioactivity cleared rapidly by the kidneys, with no significant differences in the excretion pattern of the 3 radiotracers. All 3 radiolabeled analogs exhibited a low in vivo stability in patients, as revealed during analysis of blood samples, with the respective t1/2 found in the order of minutes. In patient blood, the rank of radiopeptide in vivo stability was: 99mTc-Demogastrin 2 (t1/2 10-15 min)>111In-DOTA-CCK (t1/2∼5-10 min)>111In-DOTA-MG11 (t1/2<5 min)

  6. Wasteful Labeling

    OpenAIRE

    Mahenc, Philippe

    2009-01-01

    The role of labeling is to solve the adverse selection problem caused by unsubstantiated claims from firms. The problem however is likely to remain unsolved if the labeling agency is not trustworthy.The agency can be suspected to divert the fees charged for labeling from their primary purpose of collecting information in order to raise excessive revenue. This paper addresses this issue and shows that labeling may be wasteful if the agency is likely to be untrustworthy. To award firms green la...

  7. Labeled leukocyte imaging: current status and future directions

    International Nuclear Information System (INIS)

    The ability to radiolabel inflammatory cells that migrate to foci of infection was a significant milestone in the evolution of infection imaging. More than 20 years after being approved for clinical use in the United States, labeled leukocyte imaging using cells labeled with 99m Tc exametazime or 111 Inoxine remains the radionuclide procedure of choice for diagnosing most infections in the immunocompetent population. In the central nervous system, labeled leukocyte imaging is useful for differentiating infection from tumor; in the postoperative setting, this test facilitates the differentiation of infection from normal postoperative changes. Labeled leukocyte imaging accurately diagnoses mycotic aneurysms and infected prosthetic vascular grafts. In patients with fever of unknown origin, a negative study excludes, with a high degree of certainty, infection as the source of fever. Labeled leukocyte imaging accurately diagnoses pedal osteomyelitis and is useful for distinguishing infection from the neuropathic joint in this population. Together with bone marrow imaging, the labeled leukocyte study is the imaging procedure of choice for diagnosing prosthetic joint infection. There are limitations to the test. Most of the leukocytes labeled are neutrophils, and the procedure is most useful for detecting neutrophil-mediated inflammatory processes, i.e., bacterial infections. It is less useful for illnesses in which the predominant cellular response is other than neutrophilic, such as most opportunistic infections and spinal osteomyelitis. The in vitro labeling procedure is time consuming and is not routinely available. Results of in vivo leukocyte labeling methods have been variable; none are available in the United States. Labeled leukocyte imaging suffers from inherently poor quality images. Single photon emission compute tomography/computed tomography improves lesion localization, and will undoubtedly improve the accuracy of the test. Efforts to develop methods of

  8. Vitamin D compounds: clinical development as cancer therapy and prevention agents.

    Science.gov (United States)

    Trump, Donald L; Muindi, Josephia; Fakih, Marwan; Yu, Wei-Dong; Johnson, Candace S

    2006-01-01

    While 1,25 dihydroxycholecalciferol (calcitriol) is best recognized for its effects on bone and mineral metabolism, epidemiological data indicate that low vitamin D levels may play a role in the genesis and progression of breast, lung, colorectal and prostate cancer, as well as malignant lymphoma and melanoma. Calcitriol has strong antiproliferative effects in prostate, breast, colorectal, head/neck and lung cancer, as well as lymphoma, leukemia and myeloma model systems. Antiproliferative effects are seen in vitro and in vivo. The mechanisms of these effects are associated with G0/G1 arrest, induction of apoptosis, differentiation and modulation of growth factor-mediated signaling in tumor cells. In addition to the direct effects on tumor cells, recent data strongly support the hypothesis that the stromal effects of vitamin D analogs (e.g., direct effects on tumor vasculature) are also important in the antiproliferative effects. Antitumor effects are seen in a wide variety of tumor types and there are few data to suggest that vitamin D-based approaches are more effective in any one tumor type. Glucocorticoids potentiate the antitumor effect of calcitriol and decrease calcitriol-induced hypercalcemia. In addition, calcitriol potentiates the antitumor effects of many cytotoxic agents. Preclinical data indicate that maximal antitumor effects are seen with pharmacological doses of calcitriol and that such exposure can be safely achieved in animals using a high dose, intermittent schedule of administration. AUC and C(max) calcitriol concentrations of 32 ng.h/ml and 9.2 ng/ml are associated with striking antitumor effects in a murine squamous cell carcinoma model and there is increasing evidence from clinical trials that such exposures can be safely attained in patients. Another approach to maximizing intra-tumoral exposure to vitamin D analogs is to inhibit their catabolism. The data clearly indicate that agents which inhibit the major vitamin D catabolizing enzyme

  9. An Open Label Clinical Trial of a Multi-Ingredient Anti-Aging Moisturizer Designed to Improve the Appearance of Facial Skin.

    Science.gov (United States)

    Herndon, James H; Jiang, Lily; Kononov, Tatiana; Fox, Theresa

    2015-07-01

    An open label clinical trial was conducted to determine the effectiveness of a multi-ingredient anti-aging moisturizer designed to improve the appearance of facial skin. Parameters studied included fine lines and wrinkles, clarity/brightness, visual roughness, tactile roughness, evenness of skin tone (redness), evenness of skin tone (hyperpigmentation) and overall appearance. Thirty-seven female subjects, ages 35-60 years completed the study. Effective ingredients incorporated into the facial anti-aging moisturizer include: Astragalus membranaceus root extract, a peptide blend including palmitoyl tripeptide-38, standardized rosemary leaf extract (ursolic acid), tetrahexyldecyl ascorbate (THD ascorbate) and ubiquinone (coenzyme Q10). Subjects were instructed to apply the moisturizer twice daily, once in the morning and once in the evening. Subjects were evaluated at baseline and after 4, 8, and 12 weeks of product usage. Clinical evaluations were conducted at each visit. A self-assessment questionnaire was conducted at week 4, week 8, and week 12. The self-assessment questionnaire included product efficacy inquiries and product aesthetic inquiries. Digital photography was conducted at baseline, week 8, and week 12. After 8 weeks of twice daily use, clinical evaluation results show that the multi-ingredient anti-aging moisturizer produced a statistically significant improvement in the scores of all clinical grading parameters assessed compared to baseline. A greater statistically significant improvement was seen at 12 weeks. At week 12, there was a statistically significant percentage of favorable results versus unfavorable results in all product efficacy and product aesthetic self-assessment questionnaire results. Digital photography supported the clinical grading and self-assessment questionnaire results. Additionally, the multi-ingredient anti-aging moisturizer is judged to be mild and well tolerated. Several tolerability parameters were assessed at all time

  10. Improving the diagnosis of acute appendicitis in children with atypical clinical findings using the technetium-99m hexamethylpropylene amine oxime-labelled white-blood-cell abdomen scan

    International Nuclear Information System (INIS)

    Heading AbstractBackground. Diagnosing acute appendicitis in children with equivocal signs and symptoms may be difficult. The usual approach is hospital observation and frequent re-examination. However, many surgeons are reluctant to delay surgery because of the risk of perforation and a negative laparotomy.Objective. To assess and compare the value of the technetium-99m hexamethylpropylene amine oxime (99mTc-HMPAO)-labelled white-blood-cell (WBC) abdomen scan in the diagnosis of acute appendicitis in children with atypical clinical presentation.Patients and methods. Fifty children with acute right lower quadrant abdominal pain and possible acute appendicitis, but atypical findings were included. After IV injection of 99mTc-HMPAO-labelled WBCs, serial anterior abdomen scans were obtained using a gamma camera.Results. Thirty-three children underwent surgery, while 17 children were managed conservatively and were followed up for at least 1 month. Four children had false-positive results and one child had a false-negative scan result. The overall sensitivity, specificity, accuracy, positive predictive value and negative predictive value of the scan to diagnose acute appendicitis in children with atypical findings was 96.7, 80.0, 90.0, 87.8 and 94.1%, respectively.Conclusions. The 99mTc-HMPAO WBC abdomen scan is a potential tool for diagnosing acute appendicitis in children with atypical clinical findings. The high sensitivity and negative predictive value allows early discharge from the emergency department to avoid costly observation in hospital and potentially unnecessary surgery in those patients with negative scans. (orig.)

  11. Detection of plasma α-granule membrane protein (GMP-140) using 125I labeled monoclonal antibodies and its clinic applications

    International Nuclear Information System (INIS)

    Radioimmunoassay with two monoclonal antibodies to different epitopes of granule membrane protein (GMP-140) was used to measure the plasma GMP-140 level in patients suffering from acute myocardial infarction (AMI) or cerebral thrombosis and in patients during cardiopulmonary bypass (CPB). Monoclonal antibody (McAb) SZ-51 was used as a solid phase and 125I-labeled McAb S12 as a fluid phase. The assay was so sensitive that it could detect as little as 1 μg/L of purified GMP-140. The intra- and inter-assay coefficients of variation were 4.2% and 7.1% respectively. The concentration of plasma GMP-140 was found to be 10 +- 4.5 μg/L in normal subjects (n = 20). Patients undergoing CPB (n = 10) and patients with AMI (n = 16) or with acute cerebral thrombosis (n = 22) were also studied. The results suggest that plasma GMP-140 can be reliable detected by radioimmunoassay with two McAbs and plasma GMP-140 may provide a useful marker for thrombotic diseases

  12. Tracing in situ amino acid uptake in plants and microbes with15N13C labelled compounds

    DEFF Research Database (Denmark)

    Andresen, Louise Christoffersen; Michelsen, Anders; Jonasson, Sven Evert;

    intact amino acids. Furthermore, tannin addition tended to reduce plant uptake of label. By combining data on 15N recovery after 1 day in shoots and roots (fine and coarse) of the dominant heathland plants: the evergreen dwarf shrub Calluna vulgaris and the graminoid Deschampsia flexuosa, in soil...... microorganisms (chloroform fumigation extraction) and in soil water, we discuss the relative importance of free amino acids and ammonium as plant nutrients and microbial substrates in natural N-limited ecosystems with a high proportion of soil N held in tannin-N complexes. ...

  13. labeling of some organic compounds of expected biological activity with Tc-99m eluted from a chromatographic column packed with zirconium molybdate containing mo-99

    International Nuclear Information System (INIS)

    The growth of nuclear medicine has been due mainly to the availability of 99mTc-radiopharmaceuticals; this single isotope is used in over 80% of all diagnostic procedures. Each year, roughly 25 million procedures are carried out with 99mTc-radio-pharmaceuticals, the universal use of this radioisotope (Technetium-99m, t1/2= 6.02 h) is due to its advantageous properties such as suitable half-life (it is short enough to save the patient from high radiation dose, and long enough to carry out labeling and scintigraphic measurements), γ-ray energy (140 keV; 89.4%) reasonable for SPECT, and very low abundance β- emission. Technetium-99m is readily available in a sterile, pyrogen free, and no-carrier added state from 99Mo/99mTc generators.The selection of iminodiacetic acid (IDA) derivatives to target 99mTc as radioactive element to the hepatobiliary system is based on the reported finding that iminodiacetic acid capable of complexing reduced Tc-99m and easily incorporated into biologically active molecules. 99mTc labeled iminodiacetic acid (IDA) derivatives offer a high degree of specificity for localization in the gallbladder with rapid extraction by the polygonal cells of the liver and very low urinary excretion. Various diseases related to liver function, such as jaundice and biliary obstruction, are diagnosed by the use of 99mTc-labeled IDA derivatives. Chronic and acute cholecystitis can be differentiated with 99mTc-IDA derivatives.In the presented work, 99mTc in an acceptable radionuclidic, radiochemical and chemical purity using an easy and cheap method was produced. The produced 99mTc was suitable to be used in the labeling techniques and in studying of the biological behavior of some synthesized iminodiacetic acid derivatives (1-naphthyl carbamoylmethyl iminodiacetic acid (NIDA), Diphenyl methyl carbamoylmethyl iminodiacetic acid (DMIDA) and Biphenyl-2-yl carbamoylmethyl iminodiacetic acid (BPIDA)). NIDA, DMIDA and BPIDA were synthesized and well characterized

  14. Unlabelled and radioactive labelled derivatives of butylamino propiophenone and their preparation

    International Nuclear Information System (INIS)

    This invention relates to new unlabelled and radioactive labelled derivatives of butylamino propiophenone and their preparation. This invention is primarily directed to a radioimmunoassay for clinical or experimental testing for the presence of and quantitation of bupropion, a pharmacologically active antidepressant compound, in biological fluids

  15. The value of 99mTc-HMPAO labelled white blood cell scintigraphy in acute appendicitis patients with an equivocal clinical presentation

    International Nuclear Information System (INIS)

    Various imaging studies can be performed in the evaluation of patients with a clinical presentation equivocal for acute appendicitis. One of these studies is technetium-99m hexamethylpropylene amine oxime (HMPAO) labelled white blood cell (WBC) scintigraphy. The aim of this study was to evaluate the accuracy and clinical value of 99mTc-HMPAO WBC scintigraphy in the aforementioned group of patients. Forty-one patients who had acute right lower quadrant abdominal pain with a clinical presentation equivocal for acute appendicitis were included in the study. The anterior abdomen and pelvis were imaged up to 4 h after the injection of 125-300 MBq 99mTc-HMPAO WBCs and the results were immediately reported to the surgeon before a decision was taken on whether to perform laparotomy. Diagnostic accuracy was established by the intra-operative findings and the histopathology in operated patients. In non-operated patients, absence of abdominal symptoms 1 month after scintigraphy and/or identification of another cause of abdominal pain was used to rule out acute appendicitis. There were 16 patients with positive scintigraphy and 81% of these patients were positive within 2 h post injection. There were no false-positive or false-negative results. We operated on 17 (41.4%) patients, and only one patient (5.9%) underwent unnecessary laparotomy. We conclude that 99mTc-HMPAO WBC scintigraphy is a rapid, highly accurate method for the exclusion of acute appendicitis and that its use can lower the unnecessarily high laparotomy rate in patients with an equivocal clinical presentation. (orig.)

  16. Nutrition Labeling

    DEFF Research Database (Denmark)

    Grunert, Klaus G

    2013-01-01

    because consumers will avoid products that the label shows to be nutritionally deficient, but also because food producers will try to avoid marketing products that appear, according to the label, as nutritionally problematic, for example, because of a high content of saturated fat or salt. Nutrition......Nutrition labeling refers to the provision of information on a food product’s nutritional content on the package label. It can serve both public health and commercial purposes. From a public health perspective, the aim of nutrition labeling is to provide information that can enable consumers...... to make healthier choices when choosing food products. Nutrition labeling is thus closely linked to the notion of the informed consumer, that chooses products according to their aims, on the basis of the information at their disposal. Because many consumers are assumed to be interested in making healthy...

  17. Clinical application study of bone marrow immunoscintigraphy using 99mTc-labelled anti-granulocyte monoclonal antibody BW250/183

    International Nuclear Information System (INIS)

    Objective: To study: (1) The labelling method of 99mTc-BW250/183 and its organ distribution pattern after injection. (2) The clinical value of bone marrow immunoscintigraphy of evaluation of patients with aplastic anemia. (3) The clinical value of bone marrow immunoscintigraphy of determination of bone metastasis. Methods: (1) Whole body imaging was performed to one volunteer after injection of 555 MBq 99mTc-BW250/183, meanwhile, 2 ml blood samples was taken from a cubital vein. The percentage of radioactivity of different organs and the kinetic data of in-vivo 99mTc-BW250/183 was then calculated. In all the blood samples the peripheral leukocytes were counted by a standard procedure. (2) Bone marrow immunoscintigraphy were performed to 8 patients with aplastic anemia 4 h after injection of 99mTc-BW250/183, 6 of them also underwent bone marrow imaging with 99mTc-SC. (3) Bone marrow immunoscintigraphy and conventional bone scan were performed to 14 patients with suspected bone metastases to detect bone metastases. The results was compared with X-ray, X-CT or MRI. Results: 99mTc-BW250/183 is a safe and ideal bone marrow imaging agent. Bone marrow immunoscintigraphy plays an important role in evaluating patients with aplastic anemia and determining bone metastases

  18. Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: an open-label expanded access study in Korea

    Directory of Open Access Journals (Sweden)

    Ro Jungsil

    2012-07-01

    Full Text Available Abstract Background To evaluate efficacy in patients with brain metastasis (BM on entry into the lapatinib expanded access program (LEAP. Methods LEAP is a worldwide, single-arm, open-label study. HER2-positive, locally-advanced or metastatic breast cancer patients with progression after an anthracycline, taxane, and trastuzumab were eligible. Patients received capecitabine 2000 mg/m2 daily in two divided doses, days 1–14, every 21 days and lapatinib 1250 mg once daily. Results Among 186 patients enrolled in 6 Korean centers, 58 had BM. Progression-free survival (PFS was 18.7 weeks in patients with BM and 19.4 weeks without BM (P = 0.88. In patients with BM, brain response was synchronized with systemic responses (P = 0.0001. Overall survival (OS was 48.9 weeks in patients with BM and 64.6 weeks without BM (P = 0.23. Multivariable analysis found hormone receptor positivity (P = 0.003 and clinical benefit rate (CBR of combined systemic and brain disease (P  Conclusion Lapatinib plus capecitabine is equally effective in patients with or without BM. Trial registration ClinicalTrials.gov (NCT00338247

  19. Nutrition Labeling

    Science.gov (United States)

    Metzger, Lloyd E.

    Nutrition labeling regulations differ in countries around the world. The focus of this chapter is on nutrition labeling regulations in the USA, as specified by the Food and Drug Administration (FDA) and the Food Safety and Inspection Service (FSIS) of the United States Department of Agriculture (USDA). A major reason for analyzing the chemical components of foods in the USA is nutrition labeling regulations. Nutrition label information is not only legally required in many countries, but also is of increasing importance to consumers as they focus more on health and wellness.

  20. Synthesis and pre-clinical evaluation of an (18)F-labeled single-chain antibody fragment for PET imaging of epithelial ovarian cancer.

    Science.gov (United States)

    Sharma, Sai Kiran; Wuest, Melinda; Way, Jenilee D; Bouvet, Vincent R; Wang, Monica; Wuest, Frank R

    2016-01-01

    Anti-CA125 antibodies have been used in immunoassays to quantify levels of shed antigen in the serum of patients who are under surveillance for epithelial ovarian cancer (EOC). However, there is currently no molecular imaging probe in the clinic for the assessment of CA125 expression in vivo. The present study describes the development of an (18)F-labeled single-chain variable fragment (scFv) for PET imaging of CA125 in preclinical EOC models. Anti-CA125 scFv was derived from MAb-B43.13 by recombinant expression of the fragment in E.coli. Fragment scFv-B43.13 was purified via immobilized metal affinity chromatography and characterized for antigen binding via immuno-staining and flow cytometry. Prosthetic group N-succinimidyl 4-[(18)F]fluorobenzoate ([(18)F]SFB) was used for radiolabeling of scFv-B43.13. Preclinical ovarian cancer models were developed based on ovarian cancer cell lines OVCAR3 (CA125-positive) and SKOV3 (CA125-negative) in NIH-III mice. The radiopharmacological profile of (18)F-labeled scFv-B43.13 ([(18)F]FBz-scFv-B43.13) was studied with PET. [(18)F]FBz-scFv-B43.13 was prepared in radiochemical yields of 3.7 ± 1.8% (n = 5) at an effective specific activity of 3.88 ± 0.76 GBq/µmol (n = 5). The radiotracer demonstrated selective uptake in CA125-positive OVCAR3 cells and virtually no uptake in CA125-negative SKOV3 cells. Standardized uptake values (SUV) of radioactivity uptake in OVCAR3 tumors was 0.5 (n = 3) and 0.3 (n = 2) in SKOV3 tumors after 60 min post injection (p.i.). PMID:27508105

  1. Synthesis and pre-clinical evaluation of an 18F-labeled single-chain antibody fragment for PET imaging of epithelial ovarian cancer

    Science.gov (United States)

    Sharma, Sai Kiran; Wuest, Melinda; Way, Jenilee D; Bouvet, Vincent R; Wang, Monica; Wuest, Frank R

    2016-01-01

    Anti-CA125 antibodies have been used in immunoassays to quantify levels of shed antigen in the serum of patients who are under surveillance for epithelial ovarian cancer (EOC). However, there is currently no molecular imaging probe in the clinic for the assessment of CA125 expression in vivo. The present study describes the development of an 18F-labeled single-chain variable fragment (scFv) for PET imaging of CA125 in preclinical EOC models. Anti-CA125 scFv was derived from MAb-B43.13 by recombinant expression of the fragment in E.coli. Fragment scFv-B43.13 was purified via immobilized metal affinity chromatography and characterized for antigen binding via immuno-staining and flow cytometry. Prosthetic group N-succinimidyl 4-[18F]fluorobenzoate ([18F]SFB) was used for radiolabeling of scFv-B43.13. Preclinical ovarian cancer models were developed based on ovarian cancer cell lines OVCAR3 (CA125-positive) and SKOV3 (CA125-negative) in NIH-III mice. The radiopharmacological profile of 18F-labeled scFv-B43.13 ([18F]FBz-scFv-B43.13) was studied with PET. [18F]FBz-scFv-B43.13 was prepared in radiochemical yields of 3.7 ± 1.8% (n = 5) at an effective specific activity of 3.88 ± 0.76 GBq/µmol (n = 5). The radiotracer demonstrated selective uptake in CA125-positive OVCAR3 cells and virtually no uptake in CA125-negative SKOV3 cells. Standardized uptake values (SUV) of radioactivity uptake in OVCAR3 tumors was 0.5 (n = 3) and 0.3 (n = 2) in SKOV3 tumors after 60 min post injection (p.i.). PMID:27508105

  2. Efficacy of Vasa Avaleha and its granules on Tamaka Shwasa (bronchial asthma): Open-label randomized clinical study

    Science.gov (United States)

    Paneliya, Ankit M.; Patgiri, Biswajyoti; Galib, R.; Prajapati, Pradeep Kumar

    2015-01-01

    Introduction: Bronchial asthma is one of the chronic inflammatory disorders of the respiratory tract causing a huge number of deaths annually. Increased industrialization and pollution are the exacerbating factors for this situation. In Ayurveda, this miserable condition is comparable with Tamaka Shwasa. Synthetic drugs provide instant symptomatic relief in cases of bronchial asthma but are known to develop certain adverse drug reactions. Considering this, the current suffering population is looking hopefully towards other systems of medicine such as Ayurveda for better relief. Ayurveda has a number of formulations to treat Tamaka Shwasa and is in practice with proven efficacy. Aims: To evaluate comparative clinical efficacy of Vasa Avaleha (VA) and its granules (GVA) in cases of Tamaka Shwasa. Materials and Methods: A total of 66 patients were registered and randomly grouped into A and B. Patients of Group A were treated with VA, while Group B with GVA at dose of 6 g twice a day with lukewarm water for the duration of 28 days. Follow-up was done after 14 days. The results were assessed in terms of clinical recovery, symptomatic relief, and pulmonary function improvement. Effect of the treatment was assessed based on subjective and objective parameters. Results: Significant improvement was observed in most of the cardinal and associated symptoms. Significant increase in peak expiratory flow rate, considerable decrease in absolute eosinophil count, and increased breath holding time were noticed. Withdrawal of modern emergency drugs, decreased frequency of attacks, improved quality of life were the major observations noticed in both groups. Conclusions: This study highlights the significance of traditional herbal formulations in noncommunicable diseases such as bronchial asthma, which can be used as an effective drug in place or along with modern drugs.

  3. Arterial spin-labeling MR imaging in moyamoya disease compared with clinical assessments and other MR imaging finings

    Energy Technology Data Exchange (ETDEWEB)

    Noguchi, Tomoyuki, E-mail: tnogucci@radiol.med.kyushu-u.ac.jp [Department of Radiology, Faculty of Medicine, Saga University, 5-1-1, Nabeshima, Saga 849-8501 (Japan); Kawashima, Masatou [Department of Neurosurgery, Faculty of Medicine, Saga University, 5-1-1, Nabeshima, Saga 849-8501 (Japan); Nishihara, Masashi; Hirai, Tetsuyoshi [Department of Radiology, Faculty of Medicine, Saga University, 5-1-1, Nabeshima, Saga 849-8501 (Japan); Matsushima, Toshio [Department of Neurosurgery, Faculty of Medicine, Saga University, 5-1-1, Nabeshima, Saga 849-8501 (Japan); Irie, Hiroyuki [Department of Radiology, Faculty of Medicine, Saga University, 5-1-1, Nabeshima, Saga 849-8501 (Japan)

    2013-12-01

    Purpose: Our purpose was to identify the causal factors for the perfusion distribution obtained with ASL-MRI by comparing ASL-MRI with clinical information and other MRI findings in moyamoya disease. Methods: Seventy-one patients with moyamoya disease underwent ASL-MRI and other MRI, including fluid-attenuated inversion recovery imaging (FLAIR) and three-dimensional time-of-flight magnetic resonance angiography (MRA) on 3.0-Tesla MRI system. Cerebral blood flow (CBF) values (ASL values) for the cerebral hemispheres (142 sides) were measured on CBF maps generated by ASL-MRI. Relationships between the ASL values and the following 9 factors were assessed: sex, family history, revascularization surgery, age at MR exam, age at onset, the steno-occlusive severity on MRA (MRA score), degree of basal collaterals, degree of leptomeningeal high signal intensity seen on FLAIR, and size of ischemic or hemorrhagic cerebrovascular accident lesion (CVA score). Results: Patients with a family history had significantly higher ASL values than those without such a history. There were significant negative correlations between ASL values and age at MR exam, MRA score, and CVA score. Conclusions: ASL-MRI may have cause-and-effect or mutual associations with family history, current patient age, size of CVA lesion, and intracranial arterial steno-occlusive severity in Moyamoya disease.

  4. Chiral separation of the clinically important compounds fucose and pipecolic acid using CE: determination of the most effective chiral selector.

    Science.gov (United States)

    Hadjistasi, Christoforos A; Stavrou, Ioannis J; Stefan-Van Staden, Raluca-Ioana; Aboul-Enein, Hassan Y; Kapnissi-Christodoulou, Constantina P

    2013-09-01

    In this study, simple electrophoretic methods were developed for the chiral separation of the clinically important compounds fucose and pipecolic acid. In recent years, these analytes, and particularly their individual enantiomers, have attracted considerable attention due to their role in biological functions and disorders. The detectability and sensitivity of pipecolic acid and fucose were improved by reacting them with fluorenylmethyloxycarbonyl chloride (FMOC-Cl) and 5-amino-2-naphthalene-sulfonic acid (ANSA), respectively. The enantioseparation conditions were optimized by initially investigating the type of the chiral selector. Different chiral selectors, such as polymeric surfactants and cyclodextrins, were used and the most effective ones were determined with regard to resolution and analysis time. A 10-mM β-cyclodextrin was able to separate the enantiomers of ANSA-DL-fucose and the polymeric surfactant poly(sodium N-undecanoyl-LL-leucine-valinate) was able to separate the enantiomers of FMOC-DL-pipecolic acid, with resolution values of 3.45 and 2.78, respectively. Additional parameters, such as the concentration and the pH of the background electrolyte (BGE), the concentration of the chiral selector, and the addition of modifiers were examined in order to optimize the separations. The addition of the chiral ionic liquid D-alanine tert-butyl ester lactate into the BGE was also investigated, for the first time, in order to improve resolution of the enantiomers. PMID:23757267

  5. Preparation of 19-iodo cholesterol labelled with 125 I; Preparacion del 19-yodocolesterol marcado con 125 I

    Energy Technology Data Exchange (ETDEWEB)

    Rodriguez, L.; Rebollo, D. V.; Ruiz, J. M.

    1986-07-01

    In this paper a new method of synthesis of 19-iodo cholesterol labelled with ''125 I, from commercial cholesterol, is described. Its high chemical (96%) and radiochemical (99.9%) purities high yield and short time of preparation permit us to dispose or a more accessible labelled compound, which results appropriates for clinical investigations and in the diagnosis of disturbances of the suprarenal glands. (Author) 9 refs.

  6. Synthesis and evaluation of 18 F-labeled bile acid compound: A potential PET imaging agent for FXR-related diseases

    International Nuclear Information System (INIS)

    The farnesoid-X-receptor (FXR) is a member of the nuclear hormone receptor superfamily. The FXR has critical functions in maintaining bile acid synthesis and homeostasis, liver regeneration and tumorigenesis, intestinal diseases, intestinal tumorigenesis, cholesterol gallstone disease, cholestasis, and atherosclerosis. FXR expression is strongly downregulated in liver fibrosis, hepatocellular adenoma and hepatocellular carcinoma compared to expression levels in adjacent normal tissues. Chenodeoxycholic acid (CDCA) is the most potent physiological ligand for FXR. CDCA was radiolabeled with 18 F based on the efficiency click reaction of 1,3-dipolar cycloaddition of terminal alkynes and organic azides for noninvasively evaluating the relationship between FXR and FXR-related disease. The PET tracer [18 F]8 was produced by ‘click’ labeling and showed a high non-decay corrected radiochemical yield (end of synthesis (EOS) yield = 42 ± 3% (n = 5) from aqueous [18 F]fluoride), high radiochemical purity ( > 99%), and high specific activity (> 320 GBq/μmol). [18 F]8 had a high metabolic stability in vitro and in vivo. PET imaging studies in nude mice indicated a rapid uptake of the tracer into liver tissue with uniform distribution of radioactivity in the liver. Significant accumulation of radioactivity was found in the liver, gallbladder, and intestine, while no obvious uptake was observed in other organs, such as the bladder, heart, and brain. Thus, this PET tracer represents a novel tool for early detection of abnormalities in the liver and staging of neoplasms

  7. Construction of expression vector containing glnA gene and detection of NPT II activity in the transgenic rice calli using 32P-labelled compound

    International Nuclear Information System (INIS)

    The glnA gene encoding glutamine synthetase (GS) was amplified from Azospirillum brasilense Sp7 by PCR technique. the amplified 1.4 kb DNA fragment was cloned at the EcoRV site of Bluescript-SK. Both sequencing and restriction digestion data showed that the 1.4 kb DNA fragment flanked with BamHI site at each end was really the glnA gene of A. brasilense Sp7. The glnA gene was ligated with Bg1 II site of pCo24. As a result, an expression vector pGSC35 with CaMV35S promoter was obtained. Using colony in situ hybridization with α-32P-dATP labelled probes to screen the positive clones, another glnA gene expression vector pAGNB92 with rice actin 1 promoter was constructed after three rounds of ligation and transformation. Protoplasts isolated from rice cell suspension line cv. T986 were transformed with glnA expression vectors pGSC35 and pAGNB92 containing neomycin phosphotransferase II (NPTII) gene by using PEG fusion and electroporation. Transformed microcalli were selected on media containing G418 disulfate salt. NPT II activity was detected in 37% of G418 resistant calli by using dot blot hybridization with γ-32P-ATP and kanamycin as substrate

  8. Risks in production and utilisation of labelled compounds for nuclear medicine. 2. Benefits and risks of utilization of 99mTc generator in nuclear medicine

    International Nuclear Information System (INIS)

    The growth of radioisotope applications in nuclear medicine, imposed the reduction of the radiation effects and so, the reduction of associated risk of these applications. The utilization of radioactive isotopes for investigations in nuclear medicine is conditioned by the chemical behaviour and the means of detection of the emitted radiation on one hand, and by the radiation doses received by the patient, on the other hand. In these conditions, the nuclear medicine uses only the radioisotopes which are short half-time and low radiation energy, but high enough to be detected from the exterior of human body, 99m Tc being the most favourable for utilization in diagnostic purpose. This advantage is increased by the multiple possibilities to obtain different chemical forms with 99m Tc included, which permit the production of a large variety of radiopharmaceutical products, having a specific localization in the human body (organ-targets), thus allowing the diagnosis of numerous diseases. In the work the benefits and risks of the 99m Tc-Generator utilization in the nuclear medicine are shown and the utilization technique in these applications is presented . The 99m Tc-Generator is a compact chromatographic system, with lead shielding, which permits the elution of a sterile, pyrogen-free, injectable sodium pertechnetate solution, from an aluminium chromatographic column which keeps the 99 Mo. The 99m Tc-Generator system ensures the operator protection. The radioactive solution with 99m Tc is obtained in a closed vial, within lead shielding, the irradiation or contamination risks being mostly reduced. The utilization of 99m Tc in scintigraphic exam for diagnostic medicine implies a labelling operation with 99m Tc chemically bounded in forms appropriate to the target-organ and than the intravenously injection in doses dependent on the specific scintigraphic investigation or examination. (authors)

  9. FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis.

    Science.gov (United States)

    Raghu, Ganesh; Scholand, Mary Beth; de Andrade, João; Lancaster, Lisa; Mageto, Yolanda; Goldin, Jonathan; Brown, Kevin K; Flaherty, Kevin R; Wencel, Mark; Wanger, Jack; Neff, Thomas; Valone, Frank; Stauffer, John; Porter, Seth

    2016-05-01

    FG-3019 is a fully human monoclonal antibody that interferes with the action of connective tissue growth factor, a central mediator in the pathogenesis of fibrosis.This open-label phase 2 trial evaluated the safety and efficacy of two doses of FG-3019 administered by intravenous infusion every 3 weeks for 45 weeks in patients with idiopathic pulmonary fibrosis (IPF). Subjects had a diagnosis of IPF within the prior 5 years defined by either usual interstitial pneumonia (UIP) pattern on a recent high-resolution computed tomography (HRCT) scan, or a possible UIP pattern on HRCT scan and a recent surgical lung biopsy showing UIP pattern. Pulmonary function tests were performed every 12 weeks, and changes in the extent of pulmonary fibrosis were measured by quantitative HRCT scans performed at baseline and every 24 weeks.FG-3019 was safe and well-tolerated in IPF patients participating in the study. Changes in fibrosis were correlated with changes in pulmonary function.Further investigation of FG-3019 in IPF with a placebo-controlled clinical trial is warranted and is underway. PMID:26965296

  10. Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial

    Directory of Open Access Journals (Sweden)

    Yu Chih-Chieh

    2012-05-01

    Full Text Available Abstract Background Reducing low-density lipoprotein cholesterol (LDL-C is associated with reduced risk for major coronary events. Despite statin efficacy, a considerable proportion of statin-treated hypercholesterolemic patients fail to reach therapeutic LDL-C targets as defined by guidelines. This study compared the efficacy of ezetimibe added to ongoing statins with doubling the dose of ongoing statin in a population of Taiwanese patients with hypercholesterolemia. Methods This was a randomized, open-label, parallel-group comparison study of ezetimibe 10 mg added to ongoing statin compared with doubling the dose of ongoing statin. Adult Taiwanese hypercholesterolemic patients not at optimal LDL-C levels with previous statin treatment were randomized (N = 83 to ongoing statin + ezetimibe (simvastatin, atorvastatin or pravastatin + ezetimibe at doses of 20/10, 10/10 or 20/10 mg or doubling the dose of ongoing statin (simvastatin 40 mg, atorvastatin 20 mg or pravastatin 40 mg for 8 weeks. Percent change in total cholesterol, LDL-C, high-density lipoprotein cholesterol (HDL-C and triglycerides, and specified safety parameters were assessed at 4 and 8 weeks. Results At 8 weeks, patients treated with statin + ezetimibe experienced significantly greater reductions compared with doubling the statin dose in LDL-C (26.2% vs 17.9%, p = 0.0026 and total cholesterol (20.8% vs 12.2%, p = 0.0003. Percentage of patients achieving treatment goal was greater for statin + ezetimibe (58.6% vs doubling statin (41.2%, but the difference was not statistically significant (p = 0.1675. The safety and tolerability profiles were similar between treatments. Conclusion Ezetimibe added to ongoing statin therapy resulted in significantly greater lipid-lowering compared with doubling the dose of statin in Taiwanese patients with hypercholesterolemia. Studies to assess clinical outcome benefit are ongoing. Trial registration Registered at ClinicalTrials.gov: NCT00652327

  11. Comparison of toxin removal outcomes in online hemodiafiltration and intra-dialytic exercise in high-flux hemodialysis: A prospective randomized open-label clinical study protocol

    Directory of Open Access Journals (Sweden)

    Maheshwari Vaibhav

    2012-11-01

    Full Text Available Abstract Background Maintenance hemodialysis (HD patients universally suffer from excess toxin load. Hemodiafiltration (HDF has shown its potential in better removal of small as well as large sized toxins, but its efficacy is restricted by inter-compartmental clearance. Intra-dialytic exercise on the other hand is also found to be effective for removal of toxins; the augmented removal is apparently obtained by better perfusion of skeletal muscles and decreased inter-compartmental resistance. The aim of this trial is to compare the toxin removal outcome associated with intra-dialytic exercise in HD and with post-dilution HDF. Methods/design The main hypothesis of this study is that intra-dialytic exercise enhances toxin removal by decreasing the inter-compartmental resistance, a major impediment for toxin removal. To compare the HDF and HD with exercise, the toxin rebound for urea, creatinine, phosphate, and β2-microglobulin will be calculated after 2 hours of dialysis. Spent dialysate will also be collected to calculate the removed toxin mass. To quantify the decrease in inter-compartmental resistance, the recently developed regional blood flow model will be employed. The study will be single center, randomized, self-control, open-label prospective clinical research where 15 study subjects will undergo three dialysis protocols (a high flux HD, (b post-dilution HDF, (c high flux HD with exercise. Multiple blood samples during each study session will be collected to estimate the unknown model parameters. Discussion This will be the first study to investigate the exercise induced physiological change(s responsible for enhanced toxin removal, and compare the toxin removal outcome both for small and middle sized toxins in HD with exercise and HDF. Successful completion of this clinical research will give important insights into exercise effect on factors responsible for enhanced toxin removal. The knowledge will give confidence for implementing

  12. The radioactive labeling of monocytes

    International Nuclear Information System (INIS)

    With the aim of studying a possible relationship between circulating monocytes and Sternberg-Reed cells investigations were started on the specific labeling of monocytes. In this thesis the literature on the pertinent data has been reviewed and a series of experiments on the monocyte labeling procedure has been described. The principles of cell labeling with radioactive compounds were discussed. 1. Total separation of the particular cell population to be labeled and subsequent labeling with a non-specific radiopharmaceutical. 2. Specific cell labeling in a mixture of cell types based on a well defined affinity of the cell under study for the radiopharmaceutical used. Next the radionuclides that can be used for cell labeling purposes were discussed with special attention for 111In and its chelates. The principles of radiodosimetry were also discussed shortly. This section was focussed on the radiation dose the labeled cells receive because of the intracellular localized radioactivity. The radiation burden is high in comparison to amounts of radiation known to affect cell viability. A newly developed method for labeling monocytes specifically by phagocytosis of 111In-Fe-colloid without apparent loss of cells was described in detail. (Auth.)

  13. New compounds as potential radio diagnosticians Alzheimer

    International Nuclear Information System (INIS)

    Alzheimer's disease (AD) is the most common cause of dementia in Cuba and all over the World. According to demographic trends it has been called the epidemic of the century. It is characterized by the presence of neuropathological brain deposits: senile plaques, formed by neurofibrillary tangles (NT) and deposits of β-amyloid protein (Aß). Aß plaques could appear even 20 years before the establishment of first clinical symptoms of the disease. The aim of this study was to synthesize new naphthalene derivatives, feasible to be labeled with radionuclides emitters of either gamma radiation or positrons. These labeled compounds should be able to cross blood–brain barrier (BBB) in healthy and AD transgenic animals. As a result of this work, several synthetic precursors were synthesized, which were labeled with iodine-131, carbon-11 and fluorine-18 with a satisfactory radiochemical purity. The corresponding non-radioactive control compounds were also synthesized.In in vitro and in silico studies, obtained compounds showed affinity for the β-amyloid protein. According to SPECT and PET-CT images in healthy laboratory animals, obtained labeled compounds crossed BBB in a bi-directional way without any sign of brain uptake.Furthermore, evaluation of the biodistribution of the [18F] -2- (3-fluoropropyl) -6-methoxynaphthalene ([[18F] Amyloid® was performed in healthy animals.[[18F]Amylovis crossed blood brain barrier. Renal and hepatic pathways were the main excretion routes. On the other hand, in transgenic mice with AD, its uptake and its retention time were higher in comparison with healthy mice. Immunohistochemistry and Congo red staining of control and transgenic mice brain slices were performed to identify β-amyloid plaques.Conclusions: Obtained compounds were able to bi-directionally cross BBB.[[18F]Amylovis® could be a promising PET radiotracer for amyloid plaques visualization. (author)

  14. Labeling of - N-Isopropil - p - I-Anphetamine (IMP-131I) and its biological distribution in rats

    International Nuclear Information System (INIS)

    The described labeling and purification preparation of N-Isopropil-p131I-anphetamine (131I-IMP) represents a fast and efficient method to obtains a compound that fullfills all criterions of purity for its application 'IN VIVO'. The labeling yield was 68-78% and the radiochemical purity performed by paper chromatography and electrophorese was 97-99%. As demostrated in animal experiments, the cerebral affinity offers a possibility to study brain diseases in clinical studies when the product will be labelled with 123I. (author)

  15. Eggshell membrane: A possible new natural therapeutic for joint and connective tissue disorders. Results from two open-label human clinical studies

    Directory of Open Access Journals (Sweden)

    Kevin J Ruff

    2009-05-01

    Full Text Available Kevin J Ruff1, Dale P DeVore2, Michael D Leu3, Mark A Robinson41ESM Technologies, LLC, Carthage, MO, USA; 2Membrell, LLC, Carthage, MO, USA; 3Private Practice, Jenks, OK, USA; 4Robinson Family Health Center, Carthage, MO, USABackground: Natural Eggshell Membrane (NEM® is a novel dietary supplement that contains naturally occurring glycosaminoglycans and proteins essential for maintaining healthy joint and connective tissues. Two single center, open-label human clinical studies were conducted to evaluate the efficacy and safety of NEM® as a treatment for pain and inflexibility associated with joint and connective tissue disorders. Methods: Eleven (single-arm trial and 28 (double-arm trial patients received oral NEM® 500 mg once daily for four weeks. The primary outcome measure was to evaluate the change in general pain associated with the treatment joints/areas (both studies. In the single-arm trial, range of motion (ROM and related ROM-associated pain was also evaluated. The primary treatment response endpoints were at seven and 30 days. Both clinical assessments were performed on the intent-to-treat (ITT population within each study.Results: Single-arm trial: Supplementation with NEM® produced a significant treatment response at seven days for flexibility (27.8% increase; P = 0.038 and at 30 days for general pain (72.5% reduction; P = 0.007, flexibility (43.7% increase; P = 0.006, and ROM-associated pain (75.9% reduction; P = 0.021. Double-arm trial: Supplementation with NEM® produced a significant treatment response for pain at seven days for both treatment arms (X: 18.4% reduction; P = 0.021. Y: 31.3% reduction; P = 0.014. There was no clinically meaningful difference between treatment arms at seven days, so the Y arm crossed over to the X formulation for the remainder of the study. The significant treatment response continued through 30 days for pain (30.2% reduction; P = 0.0001. There were no adverse events reported during either

  16. Lymphatic edema of the lower limbs after orthopedic surgery: results of a randomized, open-label clinical trial with a new extended-release preparation.

    Science.gov (United States)

    Lessiani, G; Iodice, P; Nicolucci, E; Gentili, M

    2015-01-01

    The lymphedema is a high interstitial protein concentration edema, caused by impaired lymphatic transport capacity. It can be primary or secondary. The secondary form may be caused by a lesion of the lymphatic vessels and/or lymph nodes during diagnostic or therapeutic procedures such as surgical interventions. Often, in clinical practice, there is lymphedema after orthopedic surgery, even in minor orthopedic surgery. Lymphedema, typically presents symptoms of swelling, pain, inflammation, and itching, and it can generate, over the years, acute disability in the affected limbs. The standard therapy is mainly represented by medical treatment, such as manual lymphatic drainage and compression with bandages and stockings. In literature it is documented that lymphedema is responsive to alpha and the gamma benzopyrones. The aim of this study was to determine the effectiveness of delayed extended-release formulation of a compound containing apha-benzo-pyrone (Coumarin), benzo-gamma-pyrone (Troxuretina) and oligomeric proanthocyanidins from Vitis vinifera (OPC), in addition to compression therapy, in the reduction of lymphatic edema after prosthetic hip and knee surgery. In the group treated, after 30 days, a reduction was observed of the edema of 4.8% in the ankle area (p less than 0.008) and 2.7% in the calf area (p less than 0.013). The control group showed no significant reduction. The treated group showed a marked reduction of all the secondary symptoms considered in the study, although variations were not significant. The results show that the compound used was effective in reducing edema after major orthopedic surgery, and consequently in alleviating some related symptoms, such as pain, itching, and burning. As an edema has extensive inflammatory components in patients with reduced mobility, the final data seems interesting, however, further investigations and a better follow-up are required. PMID:26753640

  17. Concentration of labelled polyphosphates in soft tissue lesions. Application to the study of cerebral and myocardial infarction

    International Nuclear Information System (INIS)

    The biological behavior and tissue localization of phosphorus compounds used in Nuclear Medicine are reviewed. The mechanism of skeletal localization is emphasized. Labeled pyrophosphate compounds have proved extremely useful for skeletal imaging, however the mechanism of increased accumulation of these agents has been observed also in soft tissues. They localize in the acutely infarcted myocardium and in brain lesions. Clinical results obtained with sup(99m)Tc stannous pyrophosphate in brain and myocardium imaging are reported

  18. Work Productivity and Healthcare Resource Utilization Outcomes for Patients on Etanercept for Moderate-to-Severe Plaque Psoriasis: Results from a 1-Year, Multicentre, Open-Label, Single-Arm Study in a Clinical Setting

    OpenAIRE

    Ronald Vender; Charles Lynde; Vincent Ho; Dina Chau; Melanie Poulin-Costello

    2012-01-01

    Background:Background: Data investigating the effect of etanercept on work productivity and healthcare resource utilization in Canadian patients in a clinical setting is limited. Abstract: Objective:Objective: The aim of the study was to describe work productivity and healthcare resource utilization in patients with psoriasis prescribed etanercept. Abstract: Methods:Methods: A 12-month, phase IV, non-randomized, multicentre, open-label, single-arm prospective trial of patients with moderate-t...

  19. An open-label randomized clinical trial of prophylactic paracetamol coadministered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated poliovirus, and Haemophilus influenzae type b vaccine

    OpenAIRE

    Rose, Markus A.; Jürgens, Christine; Schmoele-Thoma, Beate; Gruber, William C.; Baker, Sherryl; Zielen, Stefan

    2013-01-01

    BACKGROUND: In two clinical trials, low-grade fever was observed more frequently after coadministration than after separate administration of two recommended routine pediatric vaccines. Since fever is an important issue with vaccine tolerability, we performed this open-label study on the efficacy and safety of prophylactic use of paracetamol (acetaminophen, Benuron(R)) in children administered routine 7-valent pneumococcal conjugate vaccine (PCV-7) coadministered with hexavalent vaccine (diph...

  20. Contribution to the study of the biological properties of compounds labeled with radio-chromium {sup 51}Cr; Contribution a l'etude des proprietes biologiques des composes marques au radiochrome {sup 51}Cr

    Energy Technology Data Exchange (ETDEWEB)

    Ingrand, J. [Commissariat a l' Energie Atomique, Saclay (France). Centre d' Etudes Nucleaires

    1964-07-15

    Among the radioisotopes commonly used in biology and medicine which are controlled Individually in the Radioelement Departement of the Saclay Nuclear Research Centre before being sent to the users, the author has chosen chromium 51 incorporated in inorganic salts or in organic substrates for a study of the biological properties of the compounds. In the first part, he has compared the pathways followed by the radioactive sodium chromate and chromic chloride mixed with blood or given to the whole animal, the object being to determine whether a reduction of hexavalent chromium occurs, both in vitro and in vivo. In the second part, the author has tried to show the validity of using, various substrates labeled with chromium 51, red cells, haemoglobin, plasma proteins and cytochrome c. The results obtained have contributed to underline the interest of using such compounds for biological applications. (author) [French] Parmi les radioisotopes d'utilisation courants en biologie et en medecine qui sont l'objet d'un controle particulier dans le Departement des Radioelements du Centre d'Etudes Nucleaires de Saclay avant leur diffusion aux utilisateurs, l'auteur a choisi le chrome 51 incorpore a des sels mineraux ou a des substrats organiques, afin d'en etudier les proprietes biologiques. Dans la premiere partie, il a compare le sort du chromate de sodium et du chlorure chromique radioactifs melanges a du sang ou administres a l'animal entier en s'efforcant de mettre en evidence une reduction du chrome hexavalent aussi bien in vitro qu'in vivo. Dans la deuxieme partie, il a cherche a etablir la validite de l'emploi de differents substrats marques au chrome 51, l'hematie, l'hemoglobine, les proteines plasmatiques et le cytochrome c. Les resultats obtenus ont permis de souligner le reel interet des applications biologiques des composes marques par le radioisotope. (auteur)

  1. Evaluation of radiolabeling of annexin A5 with technetium-99m: influence of the labeling methods on physico-chemical and biological properties of the compounds; Avaliacao da radiomarcacao da anexina A5 com tecnecio-99m: influencia do metodo de marcacao nas propriedades fisico-quimicas e biologicas do composto

    Energy Technology Data Exchange (ETDEWEB)

    Santos, Josefina da Silva

    2009-07-01

    Annexin A5 (ANXA5) is an intracellular human protein of 36 kDa with high affinity for membrane-bound phosphatidylserine that is selectively exposed on the surface of cells undergoing apoptosis. Apoptosis is important in normal physiology and innumerous pathologic states. Clinical applications for ANXA5 imaging are being developed in oncology, organ transplantation and cardiovascular diseases. Many strategies to radiolabel the protein have been described, including direct labeling, derivatization through a bifunctional chelating agent (BFC), production of mutated protein or peptide analogs. Several {sup 99}mTc-labeling techniques have been reported using different cores, including [Tc=O]{sup +3}, [Tc]HYNIC, [Tc{identical_to}N]+2 and [Tc(CO{sub 3})]{sup +1}. In this study, we evaluated the influence of {sup 99}mTc cores on biological behavior and physico-chemical properties of radiolabeled annexin. Radiolabeling procedure using [Tc{identical_to}N]{sup +2} core was a two-step procedure including the reaction of {sup 99}mTcO4 - with SDH in the presence of SnCl{sub 2} and PDTA to obtain the intermediate {sup 99}mTcN-SDH, and successive addition of ANXA5. The results obtained were not satisfactory, despite the high efficiency in the production of the intermediate. The [Tc=O]{sup +3} core was produced using the ethylene dicysteine (EC) as BFC. TSTU was employed in the derivatization to produce the corresponding hydroxysuccinimide ester. Different ANXA5:EC ratios were studied and all labeling conditions resulted in high radiochemical yield but with differences in lipophilicity, stability, biological distribution and affinity for apoptotic cells. The HYNIC-ANXA5 also produced the labeled protein with high radiochemical yield. The stability of the radiolabeled ANXA5 was evaluated after storing at room temperature, at 2 - 8 degree C and in human serum at 37 degree C. The analysis of these results showed that the {sup 99}mTc-EC-ANXA5 (ratio 10-2) was the most stable compound

  2. Labelling of human platelets with 111indium-oxine and 99m-Tc-oxine. Comparison of in vitro and clinical use for monitoring of kidney transplants

    International Nuclear Information System (INIS)

    One of the earliest signs of acute kidney transplant rejection are thrombotic depositions in the glomerulae vessels of the transplant. After injection of radioactive labelled platelets, the cell deposition can be visualized using a gamma camera. The authors have investigated cell labelling with 111indium-oxine and with 99m-Tc-oxine (half life 6 hours) and have studied the usefulness of these methods for the detection of transplant rejection. (Auth.)

  3. Measurement of renal glomerular filtration rate using labelled substances with compartmental analysis

    International Nuclear Information System (INIS)

    Using a model for the two-compartmental open system and experiments on animals (rabbits and dogs) as well as on human healthy volunteers, an attempt was made to study the advantages and limitations of different radionuclide methods for glomerular filtration rate determination. Labelled compounds used in different combinations were: 3H-inulin, sup(113m)In-EDTA, 131I-iothalamate, sup(99m)Tc-DTPA and 14C-creatinine. The results of the study lead to some working hypotheses concerning the value of creatinine and other labelled substances in the measurement of glomerular filtration rate in clinical practice. The advantages and disadvantages of individual methods summarized in the final report are generally in agreement with the present views of many research workers. Also the hypothesis can be justified that the different labelled compounds which have been studied might be handled independently by the membranes involved but at the long run produce similar homeostatic balance

  4. Applications of stable isotopes of 2H, 13C and 15N to clinical problems

    International Nuclear Information System (INIS)

    The function of the Argonne Program is to provide synthetic, analytical instrumental capability in a core facility for the clinical investigator who needs to use 2H, 13C, or 15N labelled compounds for metabolic or clinical research on pregnant women, newborn infants, young children, or for mass screening. To carry out such application development, there were six stages which were recurrent steps in every application. Five fundamental strategies should be adopted to establish the use of stable isotopes in clinical work. The instrument required for measurements was a combined gas chromatograph-mass spectrometer, and its use was schematically illustrated. Some of the successful experiences with compounds labelled by stable isotopes, such as deuterium labelled chenodeoxycholic acid, and respective 13C and 15N-labelled glycine were described. Deutrium labelled bile acid enabled easy and safe determination of the size of the bile acid pool and the replacement rate, providing clearer diagnoses for cholestatic liver disease and gallstones. 13C and 15N labelled compounds were used in clinical studies, of children with genetic disorders of amino acid metabolism, i.e., non ketotic hyperflycinemia, B12-responsive methyl malonic acidemia, and Lesch-Nyhan syndrome. 15N-labelled glycine was also studied in a child with Lesch-Nyhan syndrome. (Mukohata, S.)

  5. Radiopharmaceutical potential of I-131 labelled diazepam

    International Nuclear Information System (INIS)

    In this study, diazepam is a derivative of the 1.4 benzodiazepine family that the most widely used drug as anticonvulsant agent has been labeled with I-131, as a new radiopharmaceutical and its radiopharmaceutical potential has been determined. Labeling of diazepam has been performed by iodogen method and optimum labeling conditions have been determined. Optimum reaction conditions are 1 mg for iodogen amount; 1-5 mg for diazepam amount, 15-20 minutes for reaction time and room temperature for reaction temperature. Specific activity of labeled compound was 0,15 Ci/mmol level. N-octanol/water ratio was found 1.9 for 131IDZ (131I labeled diazepam). In vivo experiments have been carried out to determine radiopharmaceutical potentials of labeled compound. Biodistribution studies on rats showed that 131IDZ have accumulated in kidneys, liver, lungs and brain tissues. Scintigraphic results taken with gamma camera on rabbits agree with biodistribution results of rats. (author)

  6. Labelling, quality control and clinical evaluation of monoclonal antibodies for scintigraphy. Final report of a co-ordinated research programme 1991-1996

    International Nuclear Information System (INIS)

    Realizing the potential of labelled monoclonal antibodies for in vivo diagnosis and therapy and the interest in many developing Member States for acquiring expertise in this field the IAEA initiated a co-ordinated research programme in 1991 focusing on 99Tcm labelling of antibodies, their quality control and scintigraphic evaluation. Twelve laboratories from Asia, Latin America, Europe and North America participated in this programme which was concluded in 1996. During this programme the participants investigated the 99Tcm labelling of a murine anti-CEA antibody using the method of chelating 99Tcm with the free sulfhydryl groups generated by reaction with reducing agents such as mercapto ethanol. During the later part of the programme this method was also extended to 99Tcm labelling of hIgG. All the participating laboratories could gain valuable experience in 99Tcm antibody labelling techniques and formulation of kits. Many of them have been use in patients by collaborating nuclear medicine specialists with satisfactory results. This report is a compilation of the detailed results obtained by the participating laboratories and includes a summary and assessment of the achievement of the CRP

  7. Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study.

    Science.gov (United States)

    Leuzy, Antoine; Chiotis, Konstantinos; Hasselbalch, Steen G; Rinne, Juha O; de Mendonça, Alexandre; Otto, Markus; Lleó, Alberto; Castelo-Branco, Miguel; Santana, Isabel; Johansson, Jarkko; Anderl-Straub, Sarah; von Arnim, Christine A F; Beer, Ambros; Blesa, Rafael; Fortea, Juan; Herukka, Sanna-Kaisa; Portelius, Erik; Pannee, Josef; Zetterberg, Henrik; Blennow, Kaj; Nordberg, Agneta

    2016-09-01

    The aim of this study was to assess the agreement between data on cerebral amyloidosis, derived using Pittsburgh compound B positron emission tomography and (i) multi-laboratory INNOTEST enzyme linked immunosorbent assay derived cerebrospinal fluid concentrations of amyloid-β42; (ii) centrally measured cerebrospinal fluid amyloid-β42 using a Meso Scale Discovery enzyme linked immunosorbent assay; and (iii) cerebrospinal fluid amyloid-β42 centrally measured using an antibody-independent mass spectrometry-based reference method. Moreover, we examined the hypothesis that discordance between amyloid biomarker measurements may be due to interindividual differences in total amyloid-β production, by using the ratio of amyloid-β42 to amyloid-β40 Our study population consisted of 243 subjects from seven centres belonging to the Biomarkers for Alzheimer's and Parkinson's Disease Initiative, and included subjects with normal cognition and patients with mild cognitive impairment, Alzheimer's disease dementia, frontotemporal dementia, and vascular dementia. All had Pittsburgh compound B positron emission tomography data, cerebrospinal fluid INNOTEST amyloid-β42 values, and cerebrospinal fluid samples available for reanalysis. Cerebrospinal fluid samples were reanalysed (amyloid-β42 and amyloid-β40) using Meso Scale Discovery electrochemiluminescence enzyme linked immunosorbent assay technology, and a novel, antibody-independent, mass spectrometry reference method. Pittsburgh compound B standardized uptake value ratio results were scaled using the Centiloid method. Concordance between Meso Scale Discovery/mass spectrometry reference measurement procedure findings and Pittsburgh compound B was high in subjects with mild cognitive impairment and Alzheimer's disease, while more variable results were observed for cognitively normal and non-Alzheimer's disease groups. Agreement between Pittsburgh compound B classification and Meso Scale Discovery/mass spectrometry reference

  8. Food labels

    DEFF Research Database (Denmark)

    Selsøe Sørensen, Henrik; Clement, Jesper; Gabrielsen, Gorm

    2012-01-01

    The food industry develops tasty and healthy food but fails to deliver the message to all consumers. The consumers’ background knowledge is essential for how they find and decode relevant elements in the cocktail of signs which fight for attention on food labels. In this exploratory study, we find...... evidence for dividing consumers into two profiles: one relying on general food knowledge and another using knowledge related to signpost labels. In a combined eyetracking and questionnaire survey we analyse the influence of background knowledge and identify different patterns of visual attention for the...... two consumer profiles. This underlines the complexity in choosing and designing the ‘right’ elements for a food package that consumers actually look at and are able to make rational use of. In spite of any regulation of food information provided by authorities, consumers will still be confronted with...

  9. Environmental Labeling

    OpenAIRE

    Andrea Podhorsky

    2009-01-01

    This paper studies how information disclosed by voluntary environmental labels creates incentives for firms to invest in environmentally-friendly production technologies. I develop a model with differentiated products and imperfectly-informed consumers. Consumers care about the environmental characteristics of goods (for example, how they were produced), but cannot directly observe these product characteristics. Firms differ in their abilities to develop "clean" technologies, but have no ince...

  10. Labelled compounds as radiopharmaceuticals for radiosynoviorthesis

    Czech Academy of Sciences Publication Activity Database

    Melichar, František; Kropáček, Martin; Šrank, Jiří; Beran, Miloš; Mirzajevová, Marcela; Zimová, Jana; Eigner-Henke, Kateřina; Forsterová, Michaela

    2009-01-01

    Roč. 280, č. 2 (2009), s. 353-358. ISSN 0236-5731. [2nd International Nuclear Chemistry Congress (2nd-INCC). Cancun, 13.04.2008-17.04.2008] R&D Projects: GA MŠk OE08018; GA MPO 2A-1TP1/055; GA MŠk 2B06165 Institutional research plan: CEZ:AV0Z10480505 Keywords : RHEUMATOID- ARTHRITIS * RADIATION SYNOVECTOMY * FOLLOW-UP Subject RIV: FR - Pharmacology ; Medidal Chemistry Impact factor: 0.631, year: 2009

  11. Tritium labeling for bio-med research

    International Nuclear Information System (INIS)

    A very large fraction of what we know about biochemical pathways in the living cell has resulted from the use of radioactively-labeled tracer compounds; the use of tritium-labeled compounds has been particularly important. As research in biochemistry and biology has progressed the need has arisen to label compounds of higher specific activity and of increasing molecular complexity - for example, oligo-nucleotides, polypeptides, hormones, enzymes. Our laboratory has gradually developed special facilities for handling tritium at the kilocurie level. These facilities have already proven extremely valuable in producing labeled compounds that are not available from commercial sources. The principal ways employed for compound labeling are: (1) microwave discharge labeling, (2) catalytic tritio-hydrogenation, (3) catalytic exchange with T2O, and (4) replacement of halogen atoms by T. Studies have also been carried out on tritiation by the replacement of halogen atoms with T atoms. These results indicate that carrier-free tritium-labeled products, including biomacromolecules, can be produced in this way

  12. Single step signal group-imidazole labeling of organic phosphate groups under aqueous conditions

    International Nuclear Information System (INIS)

    Compounds and methods for single step, covalent labeling of the phosphate group of an organic substance under aqueous conditions are described. The labeling compound includes any kind of detectable signal group covalently bound to an imidazole moiety, which can be imidazole or a substituted imidazole. A preferred labeling compound has the formula shown in the accompanying diagram. 4 figs

  13. Single step signal group-imidazole labeling of organic phosphate groups under aqueous conditions

    Science.gov (United States)

    Giese, Roger W.; Wang, Poguang

    1996-01-01

    Compounds and methods for single step, covalent labeling of the phosphate group of an organic substance under aqueous conditions are described. The labeling compound includes any kind of detectable signal group covalently bound to an imidazole moiety, which can be imidazole or a substituted imidazole. A preferred labeling compound has the formula ##STR1##

  14. A Clinical study of Matra Vasti and an ayurvedic indigenous compound drug in the management of Sandhigatavata (Osteoarthritis).

    Science.gov (United States)

    Shah, Mayuri R; Mehta, Charmi S; Shukla, V D; Dave, Alankruta R; Bhatt, N N

    2010-04-01

    Sandhigatavata is described under vatavyadhi in all ayurvedic classical texts. Osteoarthritis is the most common articular disorder which begins asymptomatically in the second and third decades and is extremely common by age 70. Here Matra Vasti (therapeutic enema) was given with Bala taila as Vasti is the best treatment for vatavyadhies. It has vatashamaka and rasayana properties. Indigenous compound drug containing Guggulu, Shallaki, Yastimadhu, Pippali, Guduchi, Nirgundi, Kupilu and Godanti was given in one group along with Matra Vasti. In this study, 33 patients of Sandhigatavata completed the treatment. Patients were randomly divided into two groups. Sixteen patients in Group-A (sarvanga Abhyanga-swedana + matravasti) and 17 patients in Group-B (sarvanga Abhyanga-swedana+ matravasti + indigenous compound drug). The results of the study indicate that the patients of both the groups obtained highly significant relief in almost all the signs and symptoms of Sandhigatavata. PMID:22131712

  15. Characterisation of selenium compounds in rye seedling biomass using {sup 75}Se-labelling/SDS-PAGE separation/{gamma}-scintillation counting, and HPLC-ICP-MS analysis of a range of enzymatic digests

    Energy Technology Data Exchange (ETDEWEB)

    Bryszewska, Malgorzata A. [Technical University of Lodz (Poland). Institute of General Food Chemistry; Ambroziak, Wojciech [Technical University of Lodz (Poland). Institute of Fermentation Technology and Microbiology; Rudzinski, Juliusz [Technical University of Lodz (Poland). Institute of Applied Radiation Chemistry; Lewis, D. John [Central Science Laboratory, York (United Kingdom)

    2005-07-01

    In the present study, selenium-enriched plant biomass was investigated to evaluate the ability of rye seedlings to take up, and assimilate, inorganic selenium. Two different analytical approaches were used. Electrophoretic separation (SDS-PAGE) of proteins extracted from {sup 75}Se-labelled biomass was used to investigate the biotransformation of selenite into organic forms of the element. Ion-pair chromatography coupled with ICP-MS detection was chosen for the analysis of selenium species, enzymatically extracted from the plant biomass. The results of three enzymatic hydrolysis procedures and three sequential enzymatic extractions procedures are compared. The most effective single extraction was proteolysis (using protease type XIV), giving an overall extraction efficiency of 48%. However, for combinations of enzymes, the most effective was cellulase (Trichoderma viride) followed by sequential extraction of the solid pellet using protease type XIV, giving an extraction efficiency of 70%. The complementary data from the electrophoretic fractionation of proteins, and the HPLC separation of Se-species in the proteolytic digests, reveal the existence of large number of selenium-containing compounds in the rye seedling plant biomass. The results showed the complete biotransformation of inorganic selenium into organic forms during germination of the rye seedlings. HPLC-ICP-MS analysis of extracts from the plant biomass did not show the presence of selenate or selenite. At the time of this study, the lack of suitable organic-MS facilities meant that it was not possible to characterise them fully. However, the data does show that a combination of different enzymes, rather than just the commonly-used protease, should be considered when developing an extraction strategy for selenium in different food types to those already reported in the literature. (orig.)

  16. Characterisation of selenium compounds in rye seedling biomass using 75Se-labelling/SDS-PAGE separation/γ-scintillation counting, and HPLC-ICP-MS analysis of a range of enzymatic digests

    International Nuclear Information System (INIS)

    In the present study, selenium-enriched plant biomass was investigated to evaluate the ability of rye seedlings to take up, and assimilate, inorganic selenium. Two different analytical approaches were used. Electrophoretic separation (SDS-PAGE) of proteins extracted from 75Se-labelled biomass was used to investigate the biotransformation of selenite into organic forms of the element. Ion-pair chromatography coupled with ICP-MS detection was chosen for the analysis of selenium species, enzymatically extracted from the plant biomass. The results of three enzymatic hydrolysis procedures and three sequential enzymatic extractions procedures are compared. The most effective single extraction was proteolysis (using protease type XIV), giving an overall extraction efficiency of 48%. However, for combinations of enzymes, the most effective was cellulase (Trichoderma viride) followed by sequential extraction of the solid pellet using protease type XIV, giving an extraction efficiency of 70%. The complementary data from the electrophoretic fractionation of proteins, and the HPLC separation of Se-species in the proteolytic digests, reveal the existence of large number of selenium-containing compounds in the rye seedling plant biomass. The results showed the complete biotransformation of inorganic selenium into organic forms during germination of the rye seedlings. HPLC-ICP-MS analysis of extracts from the plant biomass did not show the presence of selenate or selenite. At the time of this study, the lack of suitable organic-MS facilities meant that it was not possible to characterise them fully. However, the data does show that a combination of different enzymes, rather than just the commonly-used protease, should be considered when developing an extraction strategy for selenium in different food types to those already reported in the literature. (orig.)

  17. Compound heterozygosity with a novel S222N GALT mutation leads to atypical galactosemia with loss of GALT activity in erythrocytes but little evidence of clinical disease

    Directory of Open Access Journals (Sweden)

    Benjamin Cocanougher

    2015-03-01

    Full Text Available Galactosemia is an inborn error of galactose metabolism caused by mutations in the GALT gene. Though early detection and galactose restriction prevent severe liver disease, affected individuals have persistently elevated biomarkers and often neuro-developmental symptoms. We present a teenage compound heterozygote for a known pathogenic mutation (H132Q and a novel variant of unknown significance (S222N, with nearly absent erythrocyte GALT enzyme activity but normal biomarkers and only mild anxiety despite diet non-adherence. This case is similar to a previously reported S135L mutation. In this report we investigate the novel S222N variant and critically evaluate a clinically puzzling case.

  18. Evaluation of copper-labeled Cu(II) bis(thiosemicarbazone) complexes as blood flow tracers for positron emission tomography

    Energy Technology Data Exchange (ETDEWEB)

    Bott, A.J.

    1990-01-01

    Positron emmision tomography (PET) is an imaging technique not widely available for clinical diagnosis due to the costs of producing positron-emitting radiolabels. The development of radiotracers labeled with generator-produced positron emitters would facilitate the use of PET by eliminating the need for an in-house cyclotron. Copper-62 is a generator-produced positron emitter potentially useful for labeling PET radiopharmaceuticals. Copper-62 labeled Cu(II) pyruvaldehyde bis(N[sup 4]-methylthiosemicarbazone), Cu(PTSM), is a proposed PET perfusion tracer of the brain, heart, and kidneys. After IV injection in animals, copper-labeled Cu(PTSM) affords high initial uptake followed by prolonged retention of radiocopper in these organs. This retention is thought to be a result of reductive decomposition of the copper-labeled copper(II) complex by intracellular glutathione, GSH. To validate copper-62 labeled Cu(PTSM) as a myocardial and renal perfusion tracer, the regional radiocopper level afforded by intravenous copper-67 labeled Cu(PTSM) was compared to the absolute blood flow measured with labeled microspheres in normal dog kidneys and surgically infarcted myocardia. In the heart and randomly sectioned kidneys, an excellent correlation resulted. In kidneys dissected to separate anatomical regions, radiocopper levels increased montonically with increasing blood flows for individual dogs, but a linear correlation was observed when data from 12 animals was combined. Should the distribution of Cu(PTSM) vary with naturally occuring GSH fluctuations, the clinical utility of this radiotracer would be limited. Therefore, to validate further copper-62 labeled Cu(PTSM), the biodistribution of copper-67 labeled (PTSM) was determined in GSH-depleted rats. Relatively large GSH reductions in the experimental animals caused only slight changes in the distribution of Cu(PTSM). Another 23 copper-67 labeled compounds were tested.

  19. Evaluation of copper-labeled Cu(II) bis(thiosemicarbazone) complexes as blood flow tracers for positron emission tomography

    International Nuclear Information System (INIS)

    Positron emmision tomography (PET) is an imaging technique not widely available for clinical diagnosis due to the costs of producing positron-emitting radiolabels. The development of radiotracers labeled with generator-produced positron emitters would facilitate the use of PET by eliminating the need for an in-house cyclotron. Copper-62 is a generator-produced positron emitter potentially useful for labeling PET radiopharmaceuticals. Copper-62 labeled Cu(II) pyruvaldehyde bis(N4-methylthiosemicarbazone), Cu(PTSM), is a proposed PET perfusion tracer of the brain, heart, and kidneys. After IV injection in animals, copper-labeled Cu(PTSM) affords high initial uptake followed by prolonged retention of radiocopper in these organs. This retention is thought to be a result of reductive decomposition of the copper-labeled copper(II) complex by intracellular glutathione, GSH. To validate copper-62 labeled Cu(PTSM) as a myocardial and renal perfusion tracer, the regional radiocopper level afforded by intravenous copper-67 labeled Cu(PTSM) was compared to the absolute blood flow measured with labeled microspheres in normal dog kidneys and surgically infarcted myocardia. In the heart and randomly sectioned kidneys, an excellent correlation resulted. In kidneys dissected to separate anatomical regions, radiocopper levels increased montonically with increasing blood flows for individual dogs, but a linear correlation was observed when data from 12 animals was combined. Should the distribution of Cu(PTSM) vary with naturally occuring GSH fluctuations, the clinical utility of this radiotracer would be limited. Therefore, to validate further copper-62 labeled Cu(PTSM), the biodistribution of copper-67 labeled (PTSM) was determined in GSH-depleted rats. Relatively large GSH reductions in the experimental animals caused only slight changes in the distribution of Cu(PTSM). Another 23 copper-67 labeled compounds were tested

  20. Study of tritium labeling of complex mixture of polychlorinated biphenyls

    International Nuclear Information System (INIS)

    The method for tritium labeling of technical mixture (commercial mark - SOVOL, USSR) of polychlorinated biphenyls (PCBs) was developed. The influence of procedure of labeling by thermally activated tritium on the nativity of polychlorinated biphenyls (PCBs) was studied. The method of labeling by thermally activated tritium has some factors, which are able to destroy organic compounds - photodegradation, thermo-degradation and degradation caused by reaction of substitution of organic compounds hydrogen atoms by activated tritium atoms. To develop a method of labeling of every organic compound by thermally activated tritium it is necessary to determine and optimize the conditions of labeling. In our case procedure of labeling is complicated because of technical mixture of PCBs consist from more than 20 isomers, chlorinated with different degree. We studied the dependence of appearance of products of degradation PCBs from duration of labeling procedure. It was found that some part of PCBs and product of its degradation were evaporated under vacuum and were collected on the glass flask cooled by liquid nitrogen. It was found that correlation between labeled of PCBs and products of degradation did not changed with increasing time of labeling, and radiochemical yield of tritium labeled of PCBs was stable - about 15-20 %. The optimum regime of labeling was selected. It was found that purification of labeled PCBs by TLC on silica gel with hexane allows obtaining tritium-labeled PCBs purified from by-products. Thus, TLC purification seems inexpensive, fast and suitable for purification of tritium-labeled PCBs

  1. Utilization of a novel electrochemical {sup 90}Sr/{sup 90}Y generator for the preparation of {sup 90}Y-labeled RGD peptide dimer in clinically relevant dose

    Energy Technology Data Exchange (ETDEWEB)

    Chakraborty, Sudipta; Chakravarty, Rubel; Pillai, Maroor Raghavan Ambikalmajan; Dash, Ashutosh [Bhabha Atomic Research Centre, Mumbai (India). Radiopharmaceuticals Div.; Sarma, Haladhar Dev [Bhabha Atomic Research Centre, Mumbai (India). Radiation Biology and Health Sciences Div.

    2014-09-01

    The work reported in this paper provides a systematic study towards the development of an optimized strategy for preparation of a clinically relevant dose of {sup 90}Y-labeled dimeric RGD peptide derivative, DOTA-E[c(RGDfK)]{sub 2} [DOTA-(RGD){sub 2}] for in vivo targeted therapy utilizing {sup 90}Y obtained from a novel electrochemical {sup 90}Sr/{sup 90}Y generator. The performance of the generator was evaluated to ensure its suitability for providing {sup 90}Y in adequate quantity and purity required for formulation of clinically relevant dose for PRRT. {sup 90}Y-DOTA-(RGD){sub 2} was synthesized in high yield (86.2 ± 2.5%) and radiochemical purity (98.4 ± 0.5%) using clinically relevant dose (∝ 3.8 GBq) of {sup 90}Y. In vitro stability studies revealed that the radiolabeled conjugate retained its radiochemical purity in normal saline and human serum. Preliminary biodistribution studies carried out in C57/BL6 mice bearing melanoma tumors showed that the preparation exhibited significant tumor uptake (5.30 ± 0.78% of injected activity at 30 min post-injection) with good tumor to background ratio. The optimized radiolabeling protocol seems to be an attractive strategy which is largely viewed as a springboard to realize scope of developing {sup 90}Y labeled cyclic RGD peptides for targeted therapy of tumors over-expressing integrin-α{sub ν}β{sub 3} receptors. (orig.)

  2. Clinical, legal and ethical implications of the intra-ocular (off-label) use of bevacizumab (avastin)--a South African perspective.

    Science.gov (United States)

    Jansen, Rita-Marié; Gouws, Chris

    2009-06-01

    Choroidal neovascularisation is a potentially visually devastating element of various forms of eye pathology. Recent research has focused on neurovascular age-related macular degeneration (AMD) as a cause. AMD can be classified as being exudative (wet) or atrophic (dry). Wet AMD is characterised by a pathological process in which new blood vessels develop in the choroids, causing leakage of fluid and haemorrhage under the retina and leading to localised serous detachment and loss of central vision. Vascular endothelial growth factor (VEGF) stimulates growth of neovascular membranes. Treatments have until recently yielded disappointing results. Ophthalmologists are using intra-ocular injections of bevacizumab (Avastin), an anti-VEGF, to treat AMD. Avastin appears to be safe and effective in the short term, but its intra-ocular administration is entirely off-label. Avastin is registered for treating metastatic colorectal and breast cancer. The off-label use of medication is an important part of mainstream, legitimate medical practice worldwide. Lawyers representing plaintiffs injured by drugs increasingly encounter off-label use claims. From a legal/ethical point of view the off-label use of medication represents a delicate balance between the statutory regulation of medication and a physician's prerogative to prescribe medication that in his or her medical opinion will be beneficial to the patient. The main reason for the controversy created by the off-label use of Avastin is that there are anti-VEGF drugs on the market that have formal approval for the treatment of AMD (and other eye conditions). Lucentis, for example, is extremely expensive, with treatment cost approximately 50 times that of Avastin. Many patients suffering from AMD and macular oedema cannot afford the registered product. The off-label use of Avastin has passed the innovative or experimental stages, as ophthalmologists have used it regularly and openly for a long time, with good success. Such use

  3. Studies on Ancylostomiasis: II.Clinical Symptomatology, Effects of Drugs, especially of Iron Compounds, with Relation to the Severity of Artificial Infection

    Energy Technology Data Exchange (ETDEWEB)

    Lee, Mun Ho; Kim, Dong Jip; Lee, Jang Kyu; Seo, Byong Sul [Seoul National University College of Medicine, Seoul (Korea, Republic of)

    1967-09-15

    This study was aimed; firstly to observe various clinical symptomatology with relation to the number of Ancylostoma duodenale larvae orally given to the human beings, secondly to evaluate the effects of some drugs like steroid hormones, antihistaminics and antitussives, and, thirdly to study the influences of some iron compounds in prevention and treatment of anemia of such origin. Ten healthy volunteers free from the previous history of hookworm infection were divided into 4 groups, to whom various numbers of actively moving filariform Ancylostoma duodenale larvae were orally given; 500 to 4 cases, 250 to 3 cases and 100 to 3 cases. Following were the results: 1. Clinical symptomatology. 1) The most frequently encountered symptoms and signs were general malaise, cough and hoarseness. The tracheal itching and pain, low back pain, arthralgia, sputum and salivation, acid belching, loss of appetite, abdominal pain and vomiting were also noted. 2) If the larger number of the larvae was given, the clinical symptomatology was more severe. 3) Prednisolone medication caused some improvement of such symptomatology, while the antihistaminics and antitussives like codeine or ephedrine were ineffective. 4) In volunteers whose nutritional conditions were rather poor appeared to show more severe symptomatology. 2. Effects of iron compounds. 1) The oral administration of ferrous fumarate induced a slight increase of serum iron levels in the initial stage of the infection, then a decrease from 15-20 days later and a recovery after 2 months. 2) The intravenous administration of saccharated ferric oxide induced a steady upkeep of the serum iron levels. 3) The hemoglobin contents also showed the upkeeps after either the oral or intravenous administration of the iron compounds. 4) The iron compounds, therefore, are considered to have the preventive as well as the therapeutic effects on hookworm anemia, which may strongly suggest that hookworm anemia is essentially the iron deficiency

  4. Short-lived positron emitter labeled radiotracers - present status

    International Nuclear Information System (INIS)

    The preparation of labelled compounds is important for the application of positron emission transaxial tomography (PETT) in biomedical sciences. This paper describes problems and progress in the synthesis of short-lived positron emitter (11C, 18F, 13N) labelled tracers for PETT. Synthesis of labelled sugars, amino acids, and neurotransmitter receptors (pimozide and spiroperidol tagged with 11C) is discussed in particular

  5. Improved kinetic stability of DTPA-dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives

    International Nuclear Information System (INIS)

    higher background activity in the whole body and those organs known to accumulate the respective free radiometal (e.g. 88Y-DTPA-Leu1-minigastrin had bone uptake of 22%ID/g as compared to only 1.2%ID/g with its dGlu1 analogue). In humans, fast tumour and stomach uptake was observed for both 111In-labelled compounds, but DTPA-dGlu1-minigastrin lacked the liver, spleen and bone marrow uptake observed with its Leu1 analogue. In conclusion, anionic amino acid derivatives of DTPA may display improved metabolic stability as compared with monofunctional DTPA conjugates. DTPA-dGlu1-minigastrin is preferred to ''monofunctional'' DTPA-Leu1-minigastrin for diagnostic application with 111In for the in vivo detection of CCK-B receptor-expressing tissues. (o

  6. Improved kinetic stability of DTPA-dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives

    Energy Technology Data Exchange (ETDEWEB)

    Behe, Martin; Gotthardt, Martin; Behr, Thomas M. [Department of Nuclear Medicine, Philipps-University of Marburg, Baldingerstrasse, 35043, Marburg (Germany); Becker, Wolfgang; Angerstein, Christa [Department of Nuclear Medicine, Georg-August-University of Goettingen, Goettingen (Germany)

    2003-08-01

    as a fast renal clearance pattern. However, DTPA-Leu{sup 1}-minigastrin showed higher background activity in the whole body and those organs known to accumulate the respective free radiometal (e.g. {sup 88}Y-DTPA-Leu{sup 1}-minigastrin had bone uptake of 22%ID/g as compared to only 1.2%ID/g with its dGlu{sup 1} analogue). In humans, fast tumour and stomach uptake was observed for both {sup 111}In-labelled compounds, but DTPA-dGlu{sup 1}-minigastrin lacked the liver, spleen and bone marrow uptake observed with its Leu{sup 1} analogue. In conclusion, anionic amino acid derivatives of DTPA may display improved metabolic stability as compared with monofunctional DTPA conjugates. DTPA-dGlu{sup 1}-minigastrin is preferred to ''monofunctional'' DTPA-Leu{sup 1}-minigastrin for diagnostic application with {sup 111}In for the in vivo detection of CCK-B receptor-expressing tissues. (orig.)

  7. In vivo labeling of amyloid with BF-108.

    Science.gov (United States)

    Suemoto, Takahiro; Okamura, Nobuyuki; Shiomitsu, Tsuyoshi; Suzuki, Masako; Shimadzu, Hiroshi; Akatsu, Hiroyasu; Yamamoto, Takayuki; Kudo, Yukitsuka; Sawada, Tohru

    2004-01-01

    Detection of aggregated amyloid-beta (Abeta) with a non-invasive imaging modality such as positron emission tomography (PET) was suggested to be ideal for the diagnosis of Alzheimer's disease (AD) prior to the onset of clinical symptoms. We have been searching for imaging probe candidates with a high affinity for aggregated Abeta in vitro and in vivo and high lipophilicity, a characteristic that allows for the permeation of the blood-brain barrier (BBB). As analyzed by Thioflavin T (ThT) assay and octanol/water partition coefficient test (PC), 3-diethylamino-6-(2-fluoroethyl)ethylaminoacridine (BF-108) were found to have high affinity for Abeta aggregates in vitro and high lipophilicity. Intravenously administrated BF-108 labeled Abeta aggregates injected into the amygdala as observed under a fluorescence microscope, showing this compound's permeability of BBB and an ability to label Abeta in vivo. BF-108 also labeled neuritic senile plaques (SPs), neurofibrillary tangles, and amyloid-laden vessels in temporal and hippocampal sections from AD patients. Following intravenous administration of BF-108 to an APP23 transgenic (TG) mouse, in vivo labeling of endogenous plaques was seen in brain sections by fluorescence microscopy. These properties suggest the potential utility of BF-108 for in vivo imaging of AD pathology. PMID:14687882

  8. 1-HEXYL N-CYANOACRYLATE COMPOUND (NEUCRYLATE™ AN, A NEW TREATMENT FOR BERRY ANEURYSM. III: INITIAL CLINICAL RESULTS

    Directory of Open Access Journals (Sweden)

    Hossein Ghanaati

    2012-05-01

    Full Text Available Background/Objective:As part of an institutionally approved research protocol, patients with cerebral berry aneurysm were enrolled in a clinical trial designed to evaluate the safety of the new moldable liquid embolic agent Neucrylate AN.Materials and Methods:Twelve patients with aneurysms judged to be suboptimal for treatment by standard endovascular or surgical approaches were treated with Neucrylate AN. The agent was injected during temporary balloon occlusion at the neck of the aneurysm. The immediate angiographic percentage of aneurysm occlusion and periprocedural adverse events were assessed for each patient. Six-month follow-up angiographic studies were obtained for nine of the 12 patients.Results:Ten of the 12 aneurysms treated (83% were large to giant (>1.0 cm in diameter, nine (75% were wide-necked (dome/neck ratio <2.0 and three (25% were dissecting aneurysms. There were four (33% periprocedural neurological events. Immediate aneurysm occlusion of >90% was obtained in nine of the 12 cases (75%. There were five recurrences (55.5% at 6 months.Conclusion: This preliminary clinical series shows that it is feasible to achieve a high percentage of immediate aneurysm occlusion with limited patient morbidity and mortality in the setting of morphologically challenging aneurysms. These preliminary data support larger trials assessing the safety and efficacy of this agent.      

  9. MR implant labelling and its use in clinical MRI practice; MR-Implantatkennzeichnungen und ihre Anwendung in der klinischen MRT-Praxis

    Energy Technology Data Exchange (ETDEWEB)

    Muehlenweg, M. [Krankenhaus Martha-Maria Halle-Doelau, Institut fuer Radiologie, Halle (Saale) (Germany); Schaefers, G. [MR:comp GmbH, Gelsenkirchen (Germany)

    2015-08-15

    Before a magnetic resonance imaging (MRI) examination, implants in patients must be cleared for MR safety in order to exclude the risk of possible severe injuries and implant malfunction in an MR environment. The general contraindication for measurements of patients with implants still applies; however, in the recent past a way has been found to legally circumvent this contraindication. For this purpose special conditions are required: explicit implant identification and the original manufacturer's labelling are necessary, the required conditions for conditionally MR safe implants must be assured and a risk-benefit analysis with appropriate explanation to the patient has to be performed. This process can be very complex as the implants are often poorly documented and detailed information on the implant MR labelling is also often outdated or not easy to interpret. This article provides information about legal and normative principles of MR measurement of patients with implants. The possible physical interactions with implants will be briefly dealt with as well as possible strategies for better identification and investigation of implants and MR labelling. General approaches for minimizing the risk will be discussed using some examples. The second part deals with the content of MR implant labelling and the current test standards. Furthermore, the additional information from the operating instructions of the MR scanner that are necessary for the interpretation of the MR implant labelling, will be explained. The article concludes with an explanation of the current pattern for MR labelling of implants from the U.S. Food and Drug Administration (FDA) and an exemplary application. (orig.) [German] Implantate in Patienten muessen vor einer MR-Untersuchung auf MR-Sicherheit abgeklaert werden, um moegliche z. T. schwere Verletzungen und Implantatfehlfunktionen in einer MR-Umgebung weitestgehend auszuschliessen. Es gilt unveraendert die generelle Kontraindikation von

  10. Synthesis of a new NIR fluorescent Nd complex labeling agent.

    OpenAIRE

    Aita, Kazuki; Temma, Takashi; Shimizu, Yoichi; Kuge, Yuji; Seki, Koh-ichi; Saji, Hideo

    2010-01-01

    Fluorescent analysis has been widely used in biological, chemical and analytical research. A useful fluorescent labeling agent should include NIR emission, a large Stoke's shift, and good labeling ability without interfering with the pharmacological profile of the labeled compound. Thus, we planned to develop an M-AMF-DOTA(Nd) derivative composed of an NIR fluorescent moiety and a maleimide conjugating moiety as a new NIR fluorescent labeling agent which fulfills these requirements. M-AMF-DOT...

  11. Transplantation of autologous ex vivo expanded human conjunctival epithelial cells for treatment of pterygia: A prospective open-label single arm multicentric clinical trial

    Directory of Open Access Journals (Sweden)

    Viraf Sam Vasania

    2014-01-01

    Conclusion: We have, for the 1 st time, standardized a protocol for preparing autologous hCjEC grafts that can be safely transported to multiple centers across the country for transplantation. The clinical outcome was satisfactory for treating pterygia.

  12. Compound odontoma

    Directory of Open Access Journals (Sweden)

    José Marcelo Vargas Pinto

    2008-01-01

    Full Text Available Odontomas are the most common types of odontogenic tumors, as they are considered more as a developmental anomaly (hamartoma than as a true neoplasia. The aim of the present study is to describe a clinical case of compound odontoma, analyzing its most commonsigns, its region of location, the decade of life and patient’s gender, disorders that may occur as well as the treatment proposed. In order to attain this objective, the method was description of the present clinical case and bibliographic revision, arriving at the result that the treatment for this type of lesion invariably is surgical removal (enucleation and curettage and the prognosis is excellent. The surgical result was followed up in the post-operative period by radiographic exam, and it was possible to conclude that there was complete cicatrization and tissue repair.

  13. Radioactive labelling of alkaloids with morphine skeleton

    International Nuclear Information System (INIS)

    Results achieved by the sup(14)C, sup(125)I and sup(3)H labelling of alkaloids with morphine skeleton for kinetic, receptor, metabolims and pharmacological investigations are summarized and evaluated. The methods for the preparation of sup(3)H labelled dihydromorphine, dihydroethylmorphine, dihydrocodeine, naloxone and naloxazone are described. The compounds have higher specific molar activity than those referred to in literature which makes them suitable for a number of investigations. (author)

  14. Economical Synthesis of 13C-Labeled Opiates, Cocaine Derivatives and Selected Urinary Metabolites by Derivatization of the Natural Products

    OpenAIRE

    Morten Karlsen; Huiling Liu; Jon Eigill Johansen; Bård Helge Hoff

    2015-01-01

    The illegal use of opiates and cocaine is a challenge world-wide, but some derivatives are also valuable pharmaceuticals. Reference samples of the active ingredients and their metabolites are needed both for controlling administration in the clinic and to detect drugs of abuse. Especially, 13C-labeled compounds are useful for identification and quantification purposes by mass spectroscopic techniques, potentially increasing accuracy by minimizing ion alteration/suppression effects. Thus, the ...

  15. Issues in Data Labelling

    NARCIS (Netherlands)

    Cowie, Roddy; Cox, Cate; Martin, Jeam-Claude; Batliner, Anton; Heylen, Dirk; Karpouzis, Kostas; Cowie, Roddy; Pelachaud, Catherine; Petta, Paolo

    2011-01-01

    Labelling emotion databases is not a purely technical matter. It is bound up with theoretical issues. Different issues affect labelling of emotional content, labelling of the signs that convey emotion, and labelling of the relevant context. Linked to these are representational issues, involving time

  16. Chemical study on the labeling of EDTB with 153Sm

    International Nuclear Information System (INIS)

    Objective: According to conjugation characteristic of N, N, N', N'-tetrakis (2-benzymidazolylmethyl)-1, 2-ethanediamine (EDTB) with lipiodol selectively retained within hepatic tumors, in this paper, the labeling of EDTB with therapeutic nuclide 153Sm was first systematically studied by different labeling pathways, to further develop new labeled compounds with 153Sm for the treatment of hepatocellular carcinoma. Methods: A radio-paper chromatography (RPC) was used to determine the purity of the labeled compound with the mixture of pyridine: ethanol: water (1:2:4, V/V) as developer. Using independence variable method, the effect of labeling conditions, such as reaction time, temperature and concentration of EDTB on labeling yield were investigated, and the in vitro stability of 153Sm-EDTB was also demonstrated by RPC. Results: the RPC analysis indicated that Rf value of free 153Sm or 153Sm-EDTB was 0.0-0.1 and 0.6-0.7, respectively. Using acetic acid as reaction medium, in an open nitrogen-pouring labeling system, heated in boiling water bath for not less than 30 min, the labeling yield of 153Sm-EDTB was more than 97% and could remain in 24 hours after preparing the labeled compound at room temperature. Conclusion: The optimum labeling method and conditions were achieved. The in vitro stability of 153Sm-EDTB was good; thereby this provided possibility for further preparation and biological research of potential therapeutic radiopharmaceutical labeled lipiodol with 153Sm via EDTB for liver cancer

  17. Tritium labelling of two new analgesic drugs

    International Nuclear Information System (INIS)

    The labelling with tritium of two arylpropionic esters was studied. The synthesis between 3H-Ibuprofen and the two unlabelled alcoholic moieties (Cl-Alkanol and CF3-Alkanol) was performed. Assuming that we got ready the acidic moiety, 3H-Ibuprofen, in our Laboratory, we attempted to label with tritium the alcoholic moiety and then go on to its esterification. Prior to labelling, thermic stability of 2-(4-(3-chlorophenyl)-1-piperazinyl) ethanol (Cl-Alkanol) was studied. As result of this study we had to change the labelling method, so that the Cl-Alkanol was unstable at 700C. Purification was accomplished through thin layer chromatography (TLC) and high performance liquid chromatography (HPLC). Concentration, purity and specific activities of the two labelled compounds were determined by ultraviolet, HPLC and liquid scintillation techniques. (author)

  18. Clinic-like animal model for causal-pathogenetical investigations of hypoxic-ischemic brain injuries (Combined application of radioactively labelled microspheres and PET)

    International Nuclear Information System (INIS)

    The complex nature of the pathogenesis in hypoxic-ischemic brain injuries, requires the combined determination of the dynamics of main factors in these disturbing processes. The application of suitable methods for registration of such pathogenetic processes is shown in an adequate animal model for simulating the early hypoxic-ischemic brain injuries. That the radioactive labelled microsphere technique is suitable to comprehend quantitatively the dynamics of the intracerebral redistribution of the circulating blood due to hypoxia/hyercapnia by simultaneous-multiple measuring of the regional cerebral blood flow. Therefore, at the first time an inadequate hypoxia-induced blood flow increase was shown in large parts of the forebrain in intrauterine growth retarded newborn piglets. For estimation of the regional cerebral glucose utilization in newborn piglets, the 18F-FDG PET is introduced. The measurements were carried out on a stationary high-density avalanche chamber (HIDAC) camera and yielded the fundamental application of this camera model for PET investigations also in the newborn brain due to the very good spatial resolution. (author)

  19. Lu-177-Labeled Zirconia Particles for Radiation Synovectomy.

    Science.gov (United States)

    Polyak, Andras; Nagy, Lívia Naszályi; Drotár, Eszter; Dabasi, Gabriella; Jóba, Róbert P; Pöstényi, Zita; Mikolajczak, Renata; Bóta, Attila; Balogh, Lajos

    2015-12-01

    The present article describes the preparation of β-emitter lutetium-177-labeled zirconia colloid and its preliminary physicochemical and biological evaluation of suitability for local radionuclide therapy. The new (177)Lu-labeled therapeutic radiopharmaceutical candidate was based on the synthesis mode of a previously described zirconia nanoparticle system. The size and shape of the developed radiopharmaceutical compound were observed through a scanning electron microscope and dynamic light scattering methods. The radiocolloid had a 1.7 μm mean diameter and showed high in vitro radiochemical and colloid size stability at room temperature and during the blood sera stability test. After the in vitro characterizations, the product was investigated in the course of the treatment of a spontaneously diseased dog veterinary patient's hock joint completed with single-photon emission computed tomography (SPECT) imaging follow-up measurements and a dual-isotope SPECT imaging tests with conventional (99m)Tc-methanediphosphonic acid bone scintigraphy. In the treated dog, no clinical side-effects or signs of histopathological changes of the joints were recorded during the treatment. SPECT follow-up studies clearly and conspicuously showed the localization of the (177)Lu-labeled colloid in the hock joint as well as detectable but negligible leakages of the radiocolloid in the nearest lymph node. On the basis of biological follow-up tests, the orthopedic team assumed that the (177)Lu-labeled zirconia colloid-based local radionuclide therapy resulted in a significant and long-term improvement in clinical signs of the patient without any remarkable side-effects. PMID:26683134

  20. Effect of THIP and SL 76002, two clinically experimented GABA-mimetic compounds, on anterior pituitary GABA receptors and prolactin secretion in the rat

    International Nuclear Information System (INIS)

    In the present study, the ability of three direct GABA agonists, muscimol, THIP and SL 76002 to displace 3H-GABA binding from anterior pituitary and medio-basal hypothalamus membranes was evaluated. Further, the effect of both THIP and SL 76002 on baseline prolactin levels or after stimulation of hormone release with haloperidol has been also studied. Either muscimol, THIP or SL 76002 have shown to posses 7-, 7- and 3-fold higher affinity, respectively, for the central nervous system than for the anterior pituitary 3H-GABA binding sites. Moreover, THIP and SL 76002 have demonstrated to be respectively, 25- and 1000- fold less potent than muscimol in inhibiting 3H- GABA binding at the level of the anterior pituitary and about 25- and 2700-fold less potent at the level of the medio-basal hypothalamus. Under basal conditions, either THIP or SL 76002 were ineffective to reduce prolactin release. However, after stimulation of prolactin secretion through blockade of the dopaminergic neurotransmission with haloperidol (0.1 mg/kg), both THIP (10 mg/kg) and SL 76002 (200 mg/kg) significantly counteracted the neuroleptic-induced prolactin rise with a potency which is in line with their ability to inhibit 3H-GABA binding in the anterior pituitary. The present results indicate that both compounds inhibit prolactin release under specific experimental situations probably through a GABAergic mechanism. In view of the endocrine effects of these GABA-mimetic compounds, the possibility arises for an application of these type of drugs in clinical neuroendocrinology. 35 references, 3 figures, 2 tables

  1. Preparation of 11C labelled tamoxifen

    Institute of Scientific and Technical Information of China (English)

    1999-01-01

    The syntheses and HPLC analysis of N-desmethyltamoxifen and carbon-11labelled tamoxifen are described. In order to obtain the N-desmethyltamoxifen,tamoxifencitrate was first converted to tamoxifen free base.N-desmethyltamoxifen wasprepared by reacting tamoxifen free base with 1-chloroethyl-chloroformate(ACE.Cl).For 11C labeling, N-desmethyltamoxifen was heated with 11Cmethyl iodide for 10min at 130℃,and the 11Clabelled compound was purifiedby HPLC on a μBonapak TM C18 column.Injectable 11C-tamoxifen was obtained within 50~60min from EOB (end-of-bombardment) with a labeling yield of 60%~70%.

  2. Off-label Paediatric Drug Use for Juvenile Depression and the Clinical Trial Regulations 2004: The Impact of Available Protective Mechanisms

    OpenAIRE

    Glover-THomas, N.

    2008-01-01

    Across Europe, around one in four adults experience a mental health problem in any one year. It is estimated that 2 – 6% of children and adolescents suffer from depression and suicide is now the third leading cause of death in 10-19 year olds. Despite traditional Freudian teachings that children rarely suffer from clinically diagnosed depression, treatment figures for juvenile depression have soared in recent years. For adults, the current treatment trend, as advocated by the National Insti...

  3. Sudarshan Kriya yoga improves quality of life in healthy people living with HIV (PLHIV: results from an open label randomized clinical trial

    Directory of Open Access Journals (Sweden)

    N Mawar

    2015-01-01

    Full Text Available Background & objectives: Improving quality of life (QOL of healthy people living with HIV (PLHIV is critical needing home-based, long-term strategy. Sudarshan Kriya yoga (SKY intervention is acknowledged for its positive impact on health. It is hypothesised that SKY would improve PLHIV′s QOL, justifying an evaluation. Methods: In this open label randomized controlled pilot trial, 61 adult PLHIV with CD4 count more than 400 cells/µl and Karnofsky scale score above 70 were enrolled. Those with cardiac disease, jaundice, tuberculosis, or on antiretroviral therapy/yoga intervention were excluded. All were given standard care, randomized to SKY intervention (31: I-SKY and only standard of care in control (30: O-SOC arms. The I-SKY participants were trained for six days to prepare for daily practice of SKY at home for 30 min. A validated 31-item WHOQOL-HIVBREF questionnaire was used to document effect in both arms from baseline to three visits at 4 wk interval. Results: Baseline QOL scores, hypertension and CD4 count were similar in both arms. An overall 6 per cent improvement of QOL scores was observed in I-SKY group as compared to O-SOC group, after controlling for baseline variables like age, gender, education and occupation ( p0 =0.016; 12 per cent for physical ( p0 =0.004, 11 per cent psychological ( p0 =0.023 and 9 per cent level of independence ( p0 =0.001 domains. Improvement in I-SKY observed at post-training and in the SKY adherence group showed increase in these two domains. Conclusions: A significant improvement in QOL scores was observed for the three health related QOL domains in SKY intervention arm. This low cost strategy improved physical and psychological state of PLHIV calling for upscaling with effective monitoring for sustainability of quality of life.

  4. Synthesis of 14C-labelled hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX), 2,4,6-trinitrotoluene (TNT), nitrocellulose (NC) and glycidyl azide polymer (GAP) for use in assessing the biodegradation potential of these energetic compounds

    International Nuclear Information System (INIS)

    Within the framework of an R and D project on bioremediation of soils contaminated with energetic compounds, the biodegradation of energetic products such as hexogen (RDX), trinitrotoluene (TNT), nitrocellulose (NC) and glycidyl azide polymer (GAP) is under study. Microcosm assays must be performed with radioactive carbon-14 labelled products in order to follow the biodegradation process. 14C-RDX was prepared by nitration of hexamethylenetetramine (HMTA) according to the Hale process. 14C-ring and methyl labelled TNTs synthesized according to the Dorey and Carper procedure. 14C-cellulose was synthesized from 14C-glucose by Acetobacter xylinum. Nitration of the 14C-cellulose yielded 14C-nitrocellulose. 14C-glycidyl azide polymer was obtained by polymerization and azidation of 14C-epichlorohydrin (ECH) which was synthesized from 14C-glycerol. Hydrochlorination of 14C-glycerol and epoxidation of the resulting 14C-1,3-dichloro 2-propanol yielded 14C-ECH. The syntheses of these 14C-labelled explosives are described in this paper. (Author)

  5. Isotopically labelled vitamin D derivatives and processes for preparing same

    International Nuclear Information System (INIS)

    This invention relates to 26,27-isotopically labelled vitamin D3 compounds, including radiolabelled vitamin D3 compounds of high specific activity, methods for their preparation, and intermediates obtained in their synthesis. The method involves reacting an ester of a 26,27-dinor-vitamin D-25-carboxylic acid with an isotopically labelled methyl Grignard reagent or methyl lithium reagent to obtain a 26,27-isotopically labelled compound in which at least some of the H atoms and/or C atoms are heavy isotopes. (author)

  6. LabeledIn: cataloging labeled indications for human drugs.

    Science.gov (United States)

    Khare, Ritu; Li, Jiao; Lu, Zhiyong

    2014-12-01

    Drug-disease treatment relationships, i.e., which drug(s) are indicated to treat which disease(s), are among the most frequently sought information in PubMed®. Such information is useful for feeding the Google Knowledge Graph, designing computational methods to predict novel drug indications, and validating clinical information in EMRs. Given the importance and utility of this information, there have been several efforts to create repositories of drugs and their indications. However, existing resources are incomplete. Furthermore, they neither label indications in a structured way nor differentiate them by drug-specific properties such as dosage form, and thus do not support computer processing or semantic interoperability. More recently, several studies have proposed automatic methods to extract structured indications from drug descriptions; however, their performance is limited by natural language challenges in disease named entity recognition and indication selection. In response, we report LabeledIn: a human-reviewed, machine-readable and source-linked catalog of labeled indications for human drugs. More specifically, we describe our semi-automatic approach to derive LabeledIn from drug descriptions through human annotations with aids from automatic methods. As the data source, we use the drug labels (or package inserts) submitted to the FDA by drug manufacturers and made available in DailyMed. Our machine-assisted human annotation workflow comprises: (i) a grouping method to remove redundancy and identify representative drug labels to be used for human annotation, (ii) an automatic method to recognize and normalize mentions of diseases in drug labels as candidate indications, and (iii) a two-round annotation workflow for human experts to judge the pre-computed candidates and deliver the final gold standard. In this study, we focused on 250 highly accessed drugs in PubMed Health, a newly developed public web resource for consumers and clinicians on prevention

  7. Succesful labelling schemes

    DEFF Research Database (Denmark)

    Juhl, Hans Jørn; Stacey, Julia

    2001-01-01

    It is usual practice to evaluate the success of a labelling scheme by looking at the awareness percentage, but in many cases this is not sufficient. The awareness percentage gives no indication of which of the consumer segments that are aware of and use labelling schemes and which do not. In the...... spring of 2001 MAPP carried out an extensive consumer study with special emphasis on the Nordic environmentally friendly label 'the swan'. The purpose was to find out how much consumers actually know and use various labelling schemes. 869 households were contacted and asked to fill in a questionnaire....... 664 households returned a completed questionnaire. There were five answering categories for each label in the questionnaire: * have not seen the label before. * I have seen the label before but I do not know the precise contents of the labelling scheme. * I have seen the label before, I do not know...

  8. A New F-18 Labeled PET Agent For Imaging Alzheimer's Plaques

    International Nuclear Information System (INIS)

    Amyloid plaques and neurofibrillary tangles are hallmarks of Alzheimer's disease (AD). Advances in development of imaging agents have focused on targeting amyloid plaques. Notable success has been the development of C-11 labeled PIB (Pittsburgh Compound) and a number of studies have demonstrated the utility of this agent. However, the short half life of C-11 (t1/2: 20 min), is a limitation, thus has prompted the development of F-18 labeled agents. Most of these agents are derivatives of amyloid binding dyes; Congo red and Thioflavin. Some of these agents are in clinical trials with encouraging results. We have been exploring new class of agents based on 8-hydroxy quinoline, a weak metal chelator, targeting elevated levels of metals in plaques. Iodine-123 labeled clioquinol showed affinity for amyloid plaques however, it had limited brain uptake and was not successful in imaging in intact animals and humans. We have been successful in synthesizing F-18 labeled 8-hydroxy quinoline. Small animal PET/CT imaging studies with this agent showed high (7-10% ID/g), rapid brain uptake and fast washout of the agent from normal mice brains and delayed washout from transgenic Alzheimer's mice. These promising results encouraged us in further evaluation of this class of compounds for imaging AD plaques.

  9. Adaptation of Campylobacter jejuni to biocides used in the food industry affects biofilm structure, adhesion strength, and cross-resistance to clinical antimicrobial compounds.

    Science.gov (United States)

    Techaruvichit, Punnida; Takahashi, Hajime; Kuda, Takashi; Miya, Satoko; Keeratipibul, Suwimon; Kimura, Bon

    2016-08-01

    The emergence of biocide-adapted Campylobacter jejuni strains that developed into biofilms and their potential to develop clinical resistance to antimicrobial compounds was studied. C. jejuni was grown in sub-lethal concentrations of five biocides used in the food industry. C. jejuni exhibited adaptation to these biocides with increased minimum inhibitory concentrations. The 3-D structures of the biofilms produced by the biocide-adapted cells were investigated by atomic force microscopy (AFM). The results revealed marked variability in biofilm architecture, including ice-crystal-like structures. Adaptation to the biocides enhanced biofilm formation, with significant increases in biovolume, surface coverage, roughness, and the surface adhesion force of the biofilms. Adaptation to commercial biocides induced resistance to kanamycin and streptomycin. This study suggests that the inappropriate use of biocides may lead to cells being exposed to them at sub-lethal concentrations, which can result in adaptation of the pathogens to the biocides and a subsequent risk to public health. PMID:27353218

  10. Donepezil Combined with Natural Hirudin Improves the Clinical Symptoms of Patients with Mild-to-Moderate Alzheimer's Disease: A 20-Week Open-Label Pilot Study

    Directory of Open Access Journals (Sweden)

    De-qiang Li, Yu-ping Zhou, Han Yang

    2012-01-01

    Full Text Available Aim: To evaluate the efficacy and safety of donepezil plus natural hirudin in patients with mild-to-moderate Alzheimer's Disease. Methods: In the 20-week, randomized, open-label and controlled study, 84 patients received either donepezil (5 mg/day for the first 4 weeks and 10 mg/day thereafter or donepezil plus natural hirudin (3 g/day treatment. Efficacy was reflected by the change of the total scores of Alzheimer's Disease Assessment Scale cognitive subscale (ADAS-Cog, Activities of Daily Life (ADL and Neuropsychiatric Inventory (NPI. Results: The patients with the donepezil plus natural hirudin treatment showed more significant improvement in the daily activities and the decline of the cognition than those with donepezil treatment. Significant difference was present in the groups since the 8th week. No group difference was found in the NPI change. However, within the hirudin treatment group, more powerful efficacy including NPI assessment was found in the patients with vascular risk factors (VRF as comparing to with those without VRF. The combination of donepezil and natural hirudin was well tolerated. The dropout rate was greater in the donepezil and natural hirudin (50% treatment group than in the donepezil (39% treatment group. Similar result was found in the incidence of adverse events (23.8% vs 19.0%, but there was no statistical difference between the two groups. Adverse events were the most common reason for the dropout. Although hemorrhage and hypersensitiveness were more common in donepezil plus Maixuekang treatment (11.9% and 7.1% group than in donepezil treatment (2.4% and 2.4% group, no significant difference was present between the two groups. Economic problem was another important reason for the patients' withdrawal. Conclusions: Compared with the donepezil treatment in the patients with mild-to-moderate AD, our results suggest that donepezil combined with natural hirudin may improve the treatment effects in the ADL, BPSD and

  11. Simultaneous extraction from clinical biopsies of high-molecular-weight DNA and RNA: comparative characterization by biotinylated and 32P-labeled probes on Southern and Northern blots

    International Nuclear Information System (INIS)

    A method for efficient simultaneous extraction of high-molecular-weight DNA and RNA from solid mammalian tissues including clinical biopsies is described. It is based on the disruption and subsequent melting of deep frozen tissue in the presence of frozen phenol and nucleic acid extraction buffer; this allows for simultaneous disruption of tissue and inactivation of nucleases. The yield is about 0.7-5.8 mg of DNA and 0.5-8.1 mg of total RNA/g of tissue depending upon the tissue type; this is higher than the yield of other methods tested. Analysis of total RNA by denaturing gel electrophoresis, and of DNA and poly(A)+ RNA by Southern and Northern blot hybridization using 32P and biotinylated probes, indicated that c-Ha-ras gene and its transcripts were undegraded. Biotinylated and 32P probes had approximately the same sensitivity in detecting nucleic acids on Southern and Northern blots. This extraction procedure is simple and, when used with biotinylated probes, is rapid, inexpensive, and nonhazardous. The methodology can be modified for use with other clinical samples and cells grown in culture

  12. Simultaneous segmentation and statistical label fusion

    Science.gov (United States)

    Asman, Andrew J.; Landman, Bennett A.

    2012-02-01

    Labeling or segmentation of structures of interest in medical imaging plays an essential role in both clinical and scientific understanding. Two of the common techniques to obtain these labels are through either fully automated segmentation or through multi-atlas based segmentation and label fusion. Fully automated techniques often result in highly accurate segmentations but lack the robustness to be viable in many cases. On the other hand, label fusion techniques are often extremely robust, but lack the accuracy of automated algorithms for specific classes of problems. Herein, we propose to perform simultaneous automated segmentation and statistical label fusion through the reformulation of a generative model to include a linkage structure that explicitly estimates the complex global relationships between labels and intensities. These relationships are inferred from the atlas labels and intensities and applied to the target using a non-parametric approach. The novelty of this approach lies in the combination of previously exclusive techniques and attempts to combine the accuracy benefits of automated segmentation with the robustness of a multi-atlas based approach. The accuracy benefits of this simultaneous approach are assessed using a multi-label multi-atlas whole-brain segmentation experiment and the segmentation of the highly variable thyroid on computed tomography images. The results demonstrate that this technique has major benefits for certain types of problems and has the potential to provide a paradigm shift in which the lines between statistical label fusion and automated segmentation are dramatically blurred.

  13. Clinical result of intra-arterial lymphocyte injection therapy for treatment of lymphedema and the evaluation of the efficacy of the therapy. Quantitative analysis by an injection of {sup 111}In-labeled lymphocytes and by MR imaging

    Energy Technology Data Exchange (ETDEWEB)

    Yoshizumi, Masanori; Kitagawa, Tetsuya; Hori, Takaki; Katoh, Itsuo; Harada, Masashi; Matsumoto, Takahiro; Nishitani, Hiromu [Tokushima Univ. (Japan). School of Medicine

    1995-11-01

    We have employed the intra-arterial lymphocytes injection therapy for treatment of lymphedema of the limbs with various causes. In the present study, we observed the clinical outcome of our therapy in 38 patients with lymphedema of the limbs. Results showed that the therapy was effective in 26 of 38 patients (68% of the total). Moreover, a marked efficacy was obtained in 13 of 38 patients (34% of the total). In the latest 5 patients, to evaluate the efficacy of our therapy, we examined the distribution of the {sup 111}In-oxine labeled lymphocytes injected into the proximal artery of the affected limb. The radioactivities of the affected limbs were apparently higher than that of the healthy limbs in effective cases. Moreover, MR imaging showed that the reduction of STIR ratio and T{sub 2} ratio well correlate with the results of clinical course. Thus, the efficacy of the lymphocyte injection therapy is able to be evaluated by radiolabeled lymphocytes and MR imaging. (author).

  14. Human plasma concentrations of tolbutamide and acetaminophen extrapolated from in vivo animal pharmacokinetics using in vitro human hepatic clearances and simple physiologically based pharmacokinetic modeling for radio-labeled microdose clinical studies

    International Nuclear Information System (INIS)

    The aim of the current study was to extrapolate the pharmacokinetics of drug substances orally administered in humans from rat pharmacokinetic data using tolbutamide and acetaminophen as model compounds. Adjusted animal biomonitoring equivalents from rat studies based on reported plasma concentrations were scaled to human biomonitoring equivalents using known species allometric scaling factors. In this extrapolation, in vitro metabolic clearance data were obtained using liver preparations. Rates of tolbutamide elimination were roughly similar in rat and human liver microsome experiments, but acetaminophen elimination by rat liver microsomes and cytosolic preparations showed a tendency to be faster than those in humans. Using a simple physiologically based pharmacokinetic (PBPK) model, estimated human plasma concentrations of tolbutamide and acetaminophen were consistent with reported concentrations. Tolbutamide cleared in a roughly similar manner in humans and rats, but medical-dose levels of acetaminophen cleared (dependent on liver metabolism) more slowly from plasma in humans than it did in rats. The data presented here illustrate how pharmacokinetic data in combination with a simple PBPK model can be used to assist evaluations of the pharmacological/toxicological potential of new drug substances and for estimating human radiation exposures from radio-labeled drugs when planning human studies. (author)

  15. Mental Labels and Tattoos

    Science.gov (United States)

    Hyatt, I. Ralph

    1977-01-01

    Discusses the ease with which mental labels become imprinted in our system, six basic axioms for maintaining negative mental tattoos, and psychological processes for eliminating mental tattoos and labels. (RK)

  16. Pesticide Product Label System

    Data.gov (United States)

    U.S. Environmental Protection Agency — The Pesticide Product Label System (PPLS) provides a collection of pesticide product labels (Adobe PDF format) that have been approved by EPA under Section 3 of the...

  17. Preparation of Radiopharmaceuticals Labeled with Metal Radionuclides

    Energy Technology Data Exchange (ETDEWEB)

    Welch, M.J.

    2012-02-16

    The overall goal of this project was to develop methods for the production of metal-based radionuclides, to develop metal-based radiopharmaceuticals and in a limited number of cases, to translate these agents to the clinical situation. Initial work concentrated on the application of the radionuclides of Cu, Cu-60, Cu-61 and Cu-64, as well as application of Ga-68 radiopharmaceuticals. Initially Cu-64 was produced at the Missouri University Research Reactor and experiments carried out at Washington University. A limited number of studies were carried out utilizing Cu-62, a generator produced radionuclide produced by Mallinckrodt Inc. (now Covidien). In these studies, copper-62-labeled pyruvaldehyde Bis(N{sup 4}-methylthiosemicarbazonato)-copper(II) was studied as an agent for cerebral myocardial perfusion. A remote system for the production of this radiopharmaceutical was developed and a limited number of patient studies carried out with this agent. Various other copper radiopharmaceuticals were investigated, these included copper labeled blood imaging agents as well as Cu-64 labeled antibodies. Cu-64 labeled antibodies targeting colon cancer were translated to the human situation. Cu-64 was also used to label peptides (Cu-64 octriatide) and this is one of the first applications of a peptide radiolabeled with a positron emitting metal radionuclide. Investigations were then pursued on the preparation of the copper radionuclides on a small biomedical cyclotron. A system for the production of high specific activity Cu-64 was developed and initially the Cu-64 was utilized to study the hypoxic imaging agent Cu-64 ATSM. Utilizing the same target system, other positron emitting metal radionuclides were produced, these were Y-86 and Ga-66. Radiopharmaceuticals were labeled utilizing both of these radionuclides. Many studies were carried out in animal models on the uptake of Cu-ATSM in hypoxic tissue. The hypothesis is that Cu-ATSM retention in vivo is dependent upon the

  18. On Online Labeling with Polynomially Many Labels

    DEFF Research Database (Denmark)

    Babka, Martin; Bulánek, Jan; Cunat, Vladimír; Koucky, Michal; Saks, Michael

    2012-01-01

    In the online labeling problem with parameters n and m we are presented with a sequence of nkeys from a totally ordered universe U and must assign each arriving key a label from the label set {1,2,…,m} so that the order of labels (strictly) respects the ordering on U. As new keys arrive it may be...... necessary to change the labels of some items; such changes may be done at any time at unit cost for each change. The goal is to minimize the total cost. An alternative formulation of this problem is the file maintenance problem, in which the items, instead of being labeled, are maintained in sorted order in...... are known that use O(n logn) relabelings. A matching lower bound was claimed in [7]. That proof involved two distinct steps: a lower bound for a problem they call prefix bucketing and a reduction from prefix bucketing to online labeling. The reduction seems to be incorrect, leaving a (seemingly...

  19. Experimental and clinical studies on regional lymph drainage of the skin using sup(99m)Tc-labelled antimony trisulphide colloid

    International Nuclear Information System (INIS)

    124 male and female patients aged 18 to 83 were examined pre-operatively with the newly developed and standardized lymphoscintigraphic method for establishing the regional lymph drainage pattern of a circumscribed skin tumour. Each patient received peritumoral interstitial injections of 1.5-2.0 mCi of sup(99m)Tc-Sb2S3 colloid, both intracutaneously and subcutaneously. Lymphoscintigrams were made by means of a gamma camera 3 to 6 h p.i. and the regional lymph node group(s) of the primary tumour was (were) identified. No principal difference in regional lymph drainage pattern between malignant melanomas and benign pigmented naevi was objectivized. Based on the regional lymph drainage pattern identified by lymphoscintigraphy, it was possible to purposefully perform preventive lymph adenectomy on 42 high-risk melanomas and, while doing so, to detect histologically 31% of clinically obscure lymph node metastases. The lymphoscintigraphic method, however, turned out to be inappropriate for scintigraphic verification of metastases, espec. micrometastases, already existing in the regional lymph node group established. Results showed that lymphoscintigraphy, in the form practised, constitutes an appropriate reproduceable method for non-invasive identification of the regional lymph node group(s) with malignant skin melanoma. The method is indicated in cases of primary tumour localization on the skin of the trunk, proximal upper arm, shoulder, neck/throat and head. (orig./MG)

  20. The tritium labelling of ibuprofen by heterogeneous catalytic exchange

    International Nuclear Information System (INIS)

    The tritium labelling of 2-(4-isobutylphenyl) propionic acid (ibuprofen) was performed. The method employed was heterogeneous catalytic exchange between ibuprofen and tritiated water. Prior to labelling, thermic stability of ibuprofen was studied. Purification was accomplished through thin layer chromatography (TLC) and high performance liquid chromatography (HPLC). Concentration, purity and specific activity of the labelled compound were determined by ultraviolet, HPLC and liquid scintillation techniques. (author)

  1. Labelling and biological evaluation of therapeutic radiopharmaceuticals

    International Nuclear Information System (INIS)

    The paper describes research aimed at developing radiolabelled agents using 'bone seeking' molecules and peptides as the target specific moieties. For the study of bone seeking molecules, hydroxyethylene diphosphonate (HEDP) and dimercaptosuccinic acid (DMSA) (V) were labelled with 188Re. For peptide radiolabelling, 99mTc and 111In were used as the diagnostic radioisotopes, and 90Y was used as the therapeutic radioisotope. The labelling yielded agents with high radiochemical purity. The labelled compounds - 188Re- HEDP, 188Re-DMSA(V), 111In-DOTATOC, 99mTc-HYNIC-TATE, 90Y-DOTATOC and 90Y-DOTATATE - were evaluated in mice, rats and healthy beagle dogs. All compounds were also tested in dogs with spontaneous tumours as pathological models. Biodistribution studies showed that the molecules accumulated in their respective target cells. Spontaneous tumours in dogs offered a unique opportunity to investigate the diagnostic utility and therapeutic behaviour of the radiopharmaceuticals. (author)

  2. Clinical Study of Drug-resistant Pulmonary Tuberculosis Treated by Combination of Anti-Tuberculosis Chemicals and Compound Astragalus Capsule(复方黄芪胶囊)

    Institute of Scientific and Technical Information of China (English)

    姜艳; 李新; 于志勇; 尹红义; 韩玉庆

    2004-01-01

    Objective: To observe and evaluate the therapeutic effect of anti-tuberculosis (anti-TB) chemicals and Compound Astragalus Capsule (CAC) in combinedly treating drug resistant pulmonary tuberculosis (DR-TB). Methods: Ninety-two patients with DR-TB were equally randomized into the treated group (treated with combination therapy) and the control group (treated with anti-TB chemicals alone). The therapeutic course for both groups was 18 months. Therapeutic effects between the two groups were compared at the end of the therapeutic course. Sputum bacterial negative rate, focal absorption effective rate, cavity closing rate, 10-day symptom improving rate, the incidence of adverse reaction and 2-year bacteriological recurrence rate between the two groups were compared. Results: In the treated group, the sputum bacterial negative conversion rate was 84. 8%, focal absorption effective rate 91.3 %, cavity closing rate 58. 7 % and 10-day symptom improving rate 54.4%, while in the control group, the corresponding rates were 65.2%,73.9 %, 37. 0% and 26.1%, respectively. Comparison between the groups showed significant difference in all the parameters ( P<0.05, P<0.05, P<0.05 and P<0.01 ). The incidence of adverse reaction and 2year bacteriological recurrence rate in the treated group were 23.9 % and 2.6 % respectively, while those in the control group 50.0% and 16.7%, which were higher than the former group with significant difference ( P<0.01 and P<0.05, respectively). Conclusion: The therapeutic effect of combined treatment with antiTB and CAC is superior to that of treatment with anti-TB chemicals alone, and the Chinese herbal medicine showed an adverse reaction alleviating effect, which provides a new therapy for DR-TB, and therefore, it is worth spreading in clinical practice.

  3. Clearance of technetium-99m-labeled DTPA in hyperthyroidism without clinical evidence of lung disease, and relation to pulmonary function

    International Nuclear Information System (INIS)

    The mechanisms of dyspnea and exercise intolerance have not been fully elucidated. We aimed to investigate the clearance rate of technetium-99m diethyltriaminepentaaceticacid (Tc-99m DTPA) from lungs in hyperthyroid patients without clinical evidence of lung disease and to explore the interactions between their Tc-99m DTPA radioaerosol lung scintigraphy, spirometric measurements, and the levels of thyroid hormones. We studied 19 hyperthyroid patients and 16 sex- and age-matched controls. Thyroid hormone levels were assessed. Spirometric lung function tests, diffusing capacity of the lung for carbon monoxide (DLCO) and the clearance rate of Tc-99m DTPA were performed in all participants. Ratio of DLCO value to the alveolar ventilation (DLCO/VA) and the means of half-time (T1/2) of Tc-99m DTPA clearance rate, which were used to evaluate alveolar-capillary membrane permeability, were calculated. There were no statistical differences between spirometric parameters (vital capacity (VC), force vital capacity (FVC), one second forced expiratory volume (FEV1)/FVC, mean forced expiratory flow during the middle of FVC (FEF 25-75)) of the two groups (p>0.05). Although the mean FEV1 level was significantly lower in the hyperthyroid patients than the control subjects (p1 was only less than 80 percent of the predicted value. No significant difference in the means of DLCO, DLCO/VA or T1/2 values of Tc-99m DTPA clearance was observed between the two groups (p>0.05). In hyperthyroid patients, there was a positive relation between DLCO/VA, DLCO/VA% and T1/2 values of Tc-99m DTPA clearance (p1/2 values of Tc-99m DTPA clearance in hyperthyroid group (p>0.05). We conclude that increased thyroid hormones have no effect on permeability of alveolar-capillary membrane in hyperthyroid patients. (author)

  4. Ivabradine: A Review of Labeled and Off-Label Uses.

    Science.gov (United States)

    Oliphant, Carrie S; Owens, Ryan E; Bolorunduro, Oluwaseyi B; Jha, Sunil K

    2016-10-01

    Ivabradine is a unique medication recently approved in the USA for the treatment of select heart failure patients. It was first approved for use in several countries around the world over a decade ago as an anti-anginal agent, with subsequent approval for use in heart failure patients. Since ivabradine has selective activity blocking the I f currents in the sinus node, it can reduce heart rate without appreciable effects on blood pressure. Given this heart-rate-specific effect, it has been investigated in many off-label indications as an alternative to traditional heart-rate-reducing medications such as beta blockers and calcium channel blockers. We conducted searches of PubMed and Google Scholar for ivabradine, heart failure, HFrEF, HFpEF, angina, coronary artery disease, inappropriate sinus tachycardia, postural orthostatic hypotension, coronary computed tomography angiography and atrial fibrillation. We reviewed and included studies, case reports, and case series published between 1980 and June 2016 if they provided information relevant to the practicing clinician. In many cases, larger clinical trials are needed to solidify the benefit of ivabradine, although studies indicate benefit in most therapeutic areas explored to date. The purpose of this paper is to review the current labeled and off-label uses of ivabradine, with a focus on clinical trial data. PMID:27405864

  5. Radiochemical synthesis of 14C-labelled pesticides

    International Nuclear Information System (INIS)

    Radioisotopic derivatives of pesticides labelled with either 14C or tritium are indispensable experimental tools for toxicology or metabolism studies required for registration of new compounds. The radiochemical synthetic pathways leading to the preparation of 14C-labelled pesticides of high specific activity, good chemical/radiochemical yield, and high radiochemical purity are presented for three groups of pesticides; triazines, aryl-haloids, and organometallic compounds. (N.T.). 10 refs., 1 tab

  6. The solid-state synthesis of tritium labelled heterocyclic bases

    Energy Technology Data Exchange (ETDEWEB)

    Sidorov, G.V.; Myasoedov, N.F. (AN SSSR, Moscow (Russian Federation). Inst. Molekulyarnoj Genetiki)

    1994-04-01

    The results of a study of the solid-state catalytic hydrogenation and the synthesis of tritium labelled native heterocyclic bases are presented. The effect of different palladium catalysts and reaction conditions on yield and molar radioactivity of final compounds was investigated. For some compounds, data on the intramolecular distribution of tritium were obtained by using the isotope exchange reaction and tritium NMR. Tritium labelled purine and pyrimidine bases (25-180 Ci/mmol.) were synthesized. (Author).

  7. The efficacy of oral isotretinoin versus cyproterone compound in female patients with acne and the triad of cutaneous hyperandrogenism: A randomized clinical trial

    Directory of Open Access Journals (Sweden)

    Gita Faghihi

    2014-01-01

    Conclusion: This study indicates that cyproterone compound is not superior to isotretinoin in the treatment of nodulocystic acne in patient with SAHA syndrome or triad of cutaneous hyperandrogenism. Indeed, other studies are needed to evaluate the effect of cyproterone compound (regardless of androgen level and isotretinoin in subjects with only nodulocystic acne.

  8. Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis.

    Science.gov (United States)

    Damy, Thibaud; Judge, Daniel P; Kristen, Arnt V; Berthet, Karine; Li, Huihua; Aarts, Janske

    2015-03-01

    A phase 2, open-label study in 21 patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis showed that tafamidis (20 mg daily for 12 months) stabilized these transthyretin variants. We assessed cardiac amyloid infiltration and cardiac abnormalities in this same study population. At baseline, median age was 64.3 years, 11 patients were in NYHA class II, 13 had conduction abnormalities, 14 N-terminal pro-hormone brain natriuretic peptide concentrations >300 pg/ml, and 17 interventricular septal thickness >12 mm. Mean (SD) left ventricular ejection fraction was 60.3% (9.96). Patients with normal heart rate variability increased from 4/19 at baseline to 8/19 at month 12 (p < 0.05). Cardiac biomarkers remained stable. Although four patients had increases in interventricular septal thickness ≥ 2 mm, the remainder had stable septal wall thickness. There were no clinically relevant changes in mean echocardiographic/electrocardiographic variables and no safety concerns. PMID:25743445

  9. Minicyclotron-based technology for the production of positron-emitting labelled radiopharmaceuticals

    International Nuclear Information System (INIS)

    The use of short-lived positron emitters such as carbon 11, fluorine 18, nitrogen 13, and oxygen 15, together with positron-emission tomography (PET) for probing the dynamics of physiological and biochemical processes in the normal and diseased states in man is presently an active area of research. One of the pivotal elements for the continued growth and success of PET is the routine delivery of the desired positron emitting labelled compounds. To date, the cyclotron remains the accelerator of choice for production of medically useful radionuclides. The development of the technology to bring the use of cyclotrons to a clinical setting is discussed

  10. Compuestos nitrogenados de interés en nutrición clínica Nitrogenous compounds of interest in clinical nutricion

    Directory of Open Access Journals (Sweden)

    L. Fontana Gallego

    2006-05-01

    , choline, and polyamines are conditionally essential compounds. In addition, dietary nucleotides are considered semi-essential since some rapidly growing tissues such as the gut, bone marrow, and lymphocytes, preferentially use preformed purine and pyrimidine bases for nucleic acid synthesis. This review discusses the study of conditionally essential nitrogenous nutrients of interest in clinical nutrition. Among them we highlight arginine, involved in endothelial, immune, gastrointestinal, and renal functions, in reproduction, neonatal development, wound healing, and tumorigenesis; glutamine, necessary for maintaining bowel integrity, and with beneficial effects on catabolic states such as sepsis, infection, trauma, and cancer; and nucleotides, implicated in cell growth and differentiation, and with various effects on lipid metabolism, intestinal microbiota, and immune system.

  11. Synthesis, Radiolabelling and In Vitro Characterization of the Gallium-68-, Yttrium-90- and Lutetium-177-Labelled PSMA Ligand, CHX-A''-DTPA-DUPA-Pep

    OpenAIRE

    Benjamin Baur; Christoph Solbach; Elena Andreolli; Gordon Winter; Hans-Jürgen Machulla; Sven N. Reske

    2014-01-01

    Since prostate-specific membrane antigen (PSMA) has been identified as a diagnostic target for prostate cancer, many urea-based small PSMA-targeting molecules were developed. First, the clinical application of these Ga-68 labelled compounds in positron emission tomography (PET) showed their diagnostic potential. Besides, the therapy of prostate cancer is a demanding field, and the use of radiometals with PSMA bearing ligands is a valid approach. In this work, we describe the synthesis of a ne...

  12. Picolylamine-methylphosphonic acid esters as tridentate ligands for the labeling of alcohols with the fac-[M(CO)3]+ core (M=99mTc, Re): synthesis and biodistribution of model compounds and of a 99mTc-labeled cobinamide

    International Nuclear Information System (INIS)

    [(Methyl-pyridin-2-ylmethyl-amino)-methyl]-phosphonic acid is a new bifunctional chelator for the fac-[99mTc(CO3)]+ core which can be linked to biomolecules via formation of phosphonic acid esters. Its synthesis and the coupling to model alcohols and to a bioactive molecule (cobinamide) are described. The rhenium complexes [Re(CO)3L] of the esters have been prepared and characterized, one of them by X-ray crystallography. The model esters could be labeled with [99mTc(OH2)3(CO)3]+ under mild conditions and relatively low ligand concentration with >97% yield and only one isomer formed. The 99mTc-labeled cobinamide analog was a mixture of four isomers. It bound strongly to transcobalamin I (TC I, haptocorrin) but only slightly to transcobalamin II (TC II) and intrinsic factor (IF), reflecting the binding abilities of cobinamide. Biodistribution studies in mice with B16 melanoma exhibited fast clearance with no specific tissue binding

  13. Feasibility of labeled α-acetamido-aminoisobutyric acid as new tracer compound for kinetic labeling of neutral amino acid transport: Preparation of α-(N-[1-11C]acetyl)- and α-(N-[1-14C]acetyl)-aminoisobutyric acid

    International Nuclear Information System (INIS)

    The nonphysiological, nonracemic, branched-chain α-acetamido-aminoisobutyric acid was labeled with the carbon isotope 11C with the intention to use it in conjunction with positron emission tomography (PET) to measure the kinetics of amino acid transport in vivo. It was produced by the reaction of the novel 11C-precursor N-[1-11C]acetylpyridinium chloride with α-aminoisobutyric acid. Typically, 2 GBq of α-(N-[1-11C]acetyl)-aminoisobutyric acid were isolated with a specific activity of 12 to 20 GBq · μmol-1 at the time of application, and with a radiochemical purity of >98%. The chemical identity of α-(N-[1-11C]acetyl)-aminoisobutyric acid was confirmed by comparison with α-(N-[1-14C]acetyl)-aminoisobutyric acid that was independently prepared by a standard acetylation procedure of α-aminoisobutyric acid using [1-14C]acetic anhydride. In vivo, both labeled substrates were not metabolized. In cell-culture experiments, 84% of the substrate entered the cells by the sodium-dependent amino acid transport system A, whereas 16% was taken up by the sodium-independent system. The uptake of the radiotracer was measured 20 min and 40 min postinjection in tumor-bearing male Copenhagen rats for assessment of its in vivo biodistribution

  14. Development of lyophilized kit of Tin-Glucoheptonate for in vitro labeling of leucocytes with 99mTc

    International Nuclear Information System (INIS)

    The study and localization of inflammatory and infection process in Nuclear Medicine represents a relevant tool in diagnostic procedures. In same cases, the diagnostic is easy and based on anamnesis and clinical observation; in other cases, the patients are asymptomatic or present non specific symptoms that difficult the diagnostic. The early diagnostic of inflammatory or infectious process allow the early introduction of therapy and prevents complications. Farther, the differentiation between inflammation and infection is of extreme importance as well as the localization of the focus. The use of labeled leucocytes, studied and applied in much pathologies, is the method of choice for the visualization of inflammation and infection. The scintigraphy using labeled leucocytes was introduced at 1976 by McAffe and Thakur and since of this is used in the diagnostic of different pathologies related to leucocyte infiltration like intestinal inflammatory disease, bone or prosthetic-vascular infections. The in vitro labeling of leucocytes with 111In was performed using oxime or tropolone as ligand and with 99mTc using hexamethylpropylene amine oxime (HMPAO) as ligand, resulting in a lipophilic complex. The 99mTc-HMPAG complex was preferably employed in many indications and countries do to the ideal physical properties of 99mTc that results in low dose to the patient. However, the labeling employing the HMPAO complex results in some disadvantages like the low stability of the complex, and some requirements related to the 99mTc elution (like the time pos elution), beyond the high cost of the compound that is imported. The aim of this work was the development of a tin-glucoheptonate lyophilized kit for in vitro leucocytes labeling with 99mTc using the pre-stannization method. The optimization of the labeling technique was developed using leucocytes isolated from total blood and employing different volumes of the tinglucoheptonate reagent and different incubation times at 37 deg

  15. Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazole.

    NARCIS (Netherlands)

    Afeltra, J.; Vitale, R.G.; Mouton, J.W.; Verweij, P.E.

    2004-01-01

    To develop new approaches for the treatment of invasive infections caused by Aspergillus fumigatus, the in vitro interactions between itraconazole (ITZ) and seven different nonantimicrobial membrane-active compounds--amiodarone (AMD), amiloride, lidocaine, lansoprazole (LAN), nifedipine (NIF), verap

  16. 15N-labelled pyrazines of triterpenic acids

    International Nuclear Information System (INIS)

    Triterpenoid pyrazines from our research group were found selectively cytotoxic on several cancer cell lines with IC50 in low micromolar range. This sparked our interest in preparing their labeled analogs for metabolic studies. In this work, we prepared a set of non-labeled pyrazines from seven triterpenoid skeletal types along with their 15N labelled analogs. In this work, we present the synthesis and characterization of the target 15N labelled pyrazines. Currently, these compounds are being studied in complex metabolic studies. (author)

  17. Labelling Fashion Markets

    OpenAIRE

    Aspers, P.

    2008-01-01

    The present article discusses how an ethical and environmental labelling system can be implemented in fashion garment markets. Consumers act in markets that provide them with more information than their limited cognitive capacity allows them to handle. Ethical and environmental labelling in markets characterized by change, such as the fashion garment market, makes decision-making even more complicated. The ethical and environmental labelling system proposed here is designed to alleviate firms...

  18. The utility of stable isotope labeled (SIL) analogues in the bioanalysis of endogenous compounds by LC-MS applied to the study of bile acids in a metabolomics assay.

    Science.gov (United States)

    Zheng, Joanna J; Shields, Eric E; Snow, Kimberly J; Nelson, David M; Olah, Timothy V; Reily, Michael D; Robertson, Donald G; Shipkova, Petia A; Stryker, Steven A; Xin, Baomin; Drexler, Dieter M

    2016-06-15

    The growing field of biomarker bioanalysis by liquid chromatography mass spectrometry (LC-MS) is challenged with the selection of suitable matrices to construct relevant and valid calibration curves resulting in not only precise but also accurate data. Because surrogate matrices are often employed with the associated concerns about the accuracy of the obtained data, here we present an assay using surrogate analytes in naive biological matrices. This approach is illustrated with the analysis of endogenous bile acids (e-BAs) in serum and plasma using stable isotope-labeled (SIL) analogues as calibration standards to address the matrix concerns. Several deuterated BAs (d-BAs) were used as standards representing respectively grouped e-BAs with structural similarity allowing for the simultaneous bioanalysis of 16 e-BA. The utility of this LC-MS assay employing d-BAs is demonstrated with the analysis of samples resultant of a controlled metabolomics study where a cohort of rats was fed/fasted to investigate the change of e-BAs dependent on food consumption and fasting time. PMID:27033006

  19. Solid support for [11C]cyanide labelling of radiopharmaceuticals

    International Nuclear Information System (INIS)

    [11C]HCN plays a major role in synthesis of 11C-labelled organic radiopharmaceuticals because of its on-line availability as a primary precursor of Carbon-11. [11C]HCN is usually trapped in 0.5-1.0 ml of 0.1 M NaOH or KOH solution for the synthesis of organic labelled compounds. Though [11C]HCN in 0.1 M base can be utilized for labelling base resistant organic compounds, substrates with esters, amide like functional groups cannot be labelled using this method due to the instability of these groups in basic medium. The authors report a novel approach for trapping no-carrier-added [11C]HCN on a silica gel support and its incorporation into model compounds

  20. Chloramine-T as labelling agent for oleic acid and olive oil

    International Nuclear Information System (INIS)

    Olive oil and its main constituent, oleic acid, have been labelled with 125I using chloramine-T (CAT) as an oxidizing agent. The maximum yields of labelling in different organic solvents were found to vary between 10 to 50% for oleic acid. The values for olive oil were 70% of those of oleic acid. The labelled compounds were stable in organic solvents except acetone where they start to decompose after 20 minutes of starting the experiments. The low yields could be attributed partly to a possible labelling of CAT or to the reaction of CAT with labelled compounds or their precursors. (author)

  1. Laboratory of radioisotopes of IOCB ASCR - recent results of labeling by 3-H and 125-I

    Czech Academy of Sciences Publication Activity Database

    Elbert, Tomáš; Veselá, Iva

    Bad Soden : International Isotope Society, 2008. -. [Workshop the Synthesis and Applications of Isotopes and Isotopically Labelled Compounds /15./. 12.06.2008-13.06.2008, Bad Soden] Institutional research plan: CEZ:AV0Z40550506 Keywords : labelled compounds * tritium * 125-iodine Subject RIV: CC - Organic Chemistry

  2. Labeling and Delinquency.

    Science.gov (United States)

    Adams, Mike S.; Robertson, Craig T.; Gray-Ray, Phyllis; Ray, Melvin C.

    2003-01-01

    Index comprised of six contrasting descriptive adjectives was used to measure incarcerated youths' perceived negative labeling from the perspective of parents, teachers, and peers. Results provided partial support for hypothesis that juveniles who choose a greater number of negative labels will report more frequent delinquent involvement. Labeling…

  3. Label Fusion Strategy Selection

    Directory of Open Access Journals (Sweden)

    Nicolas Robitaille

    2012-01-01

    Full Text Available Label fusion is used in medical image segmentation to combine several different labels of the same entity into a single discrete label, potentially more accurate, with respect to the exact, sought segmentation, than the best input element. Using simulated data, we compared three existing label fusion techniques—STAPLE, Voting, and Shape-Based Averaging (SBA—and observed that none could be considered superior depending on the dissimilarity between the input elements. We thus developed an empirical, hybrid technique called SVS, which selects the most appropriate technique to apply based on this dissimilarity. We evaluated the label fusion strategies on two- and three-dimensional simulated data and showed that SVS is superior to any of the three existing methods examined. On real data, we used SVS to perform fusions of 10 segmentations of the hippocampus and amygdala in 78 subjects from the ICBM dataset. SVS selected SBA in almost all cases, which was the most appropriate method overall.

  4. OR Specimen Labeling.

    Science.gov (United States)

    Zervakis Brent, Mary Ann

    2016-02-01

    Mislabeled surgical specimens jeopardize patient safety and quality care. The purpose of this project was to determine whether labeling surgical specimens with two patient identifiers would result in an 80% reduction in specimen labeling errors within six months and a 100% reduction in errors within 12 months. Our failure mode effects analysis found that the lack of two patient identifiers per label was the most unsafe step in our specimen handling process. We piloted and implemented a new process in the OR using the Plan-Do-Check-Act conceptual framework. The audit process included collecting data and making direct observations to determine the sustainability of the process change; however, the leadership team halted the direct observation audit after four months. The total number of surgical specimen labeling errors was reduced by only 60% within six months and 62% within 12 months; therefore, the goal of the project was not met. However, OR specimen labeling errors were reduced. PMID:26849982

  5. Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice: a randomized, open-label, parallel-group, multi-center study: the DISCOVERY-Beta study

    Directory of Open Access Journals (Sweden)

    Toivo Laks

    2008-09-01

    Full Text Available Toivo Laks1, Ester Keba2, Mariann Leiner3, Eero Merilind4, Mall Petersen5, Sirje Reinmets6, Sille Väli7, Terje Sööt8, Karin Otter81Clinic of Internal Medicine, North-Estonia Regional Hospital, Tallinn, Estonia; 2Clinic of Internal Medicine, Viljandi County Hospital, Viljandi, Estonia; 3Mustamäe Family Doctors Centre, Tallinn, Estonia; 4Nõmme Family Doctors Centre, Tallinn, Estonia; 5Saku Health Centre, Saku, Estonia; 6Kristiine Family Doctors, Tallinn, Estonia; 7Family Doctor Sille Väli, Kuressaare, Estonia; 8AstraZeneca, Tallinn, EstoniaAbstract: The aim of this multi-center, open-label, randomized, parallel-group trial was to compare the efficacy of rosuvastatin with that of simvastatin in achieving the 1998 European Atherosclerosis Society (EAS lipid treatment goals. 504 patients (≥18 years with primary hypercholesterolemia and a 10-year cardiovascular (CV risk >20% or history of coronary heart disease (CHD or other established atherosclerotic disease were randomized in a 2:1 ratio to receive rosuvastatin 10 mg or simvastatin 20 mg once daily for 12 weeks. A significantly higher proportion of patients achieved 1998 EAS low-density lipoprotein cholesterol (LDL-C goal after 12 weeks of treatment with rosuvastatin 10 mg compared to simvastatin 20 mg (64 vs 51.5%, p < 0.01. Similarly, significantly more patients achieved the 1998 EAS total cholesterol (TC goal and the 2003 EAS LDL-C and TC goals (p < 0.001 with rosuvastatin 10 mg compared with simvastatin 20 mg. The incidence of adverse events and the proportion of patients who discontinued study treatment were similar between treatment groups. In conclusion, in the DISCOVERY-Beta Study in patients with primary hypercholesterolemia greater proportion of patients in the rosuvastatin 10 mg group achieved the EAS LDL-C treatment goal compared with the simvastatin 20 mg group. Drug tolerability was similar across both treatment groups.Keywords: hypercholesterolemia, low-density lipoprotein

  6. State of the science of blood cell labeling

    International Nuclear Information System (INIS)

    Blood cell labeling can be considered a science in as far as it is based on precise knowledge and can be readily reproduced. This benchmark criterion is applied to all current cell labeling modalities and their relative merits and deficiencies are discussed. Mechanisms are given where they are known as well as labeling yields, label stability, and cell functionality. The focus is on the methodology and its suitability to the clinical setting rather than on clinical applications per se. Clinical results are cited only as proof of efficacy of the various methods. The emphasis is on technetium as the cell label, although comparisons are made between technetium and indium, and all blood cells are covered. 52 refs., 6 figs., 7 tabs

  7. Antibiotic residues (bacterial inhibitory substances) in the milk of cows treated under label and extra-label conditions

    OpenAIRE

    McEwen, Scott A.; Black, William D.; Meek, Alan H.

    1992-01-01

    The objectives of this study were to describe the depletion pattern of antibiotic residues (microbial inhibitory substances) from the milk of cows treated under field conditions of clinical disease and antibiotic administration, including both label and extra-label use, and to determine if the type of extra-label use, the route of administration, and the drug used were factors associated with prolonged shedding of residues in milk.

  8. Chiral dimethylamine flutamide derivatives-modeling, synthesis, androgen receptor affinities and carbon-11 labeling

    International Nuclear Information System (INIS)

    Most prostate cancers are androgen dependent upon initial diagnosis. On the other hand, some very aggressive forms of prostate cancer were shown to have lost the expression of the androgen receptor (AR). Although the AR is routinely targeted in endocrine treatment, the clinical outcome remains suboptimal. Therefore, it is crucial to demonstrate the presence and activity of the AR in each case of prostate cancer, before and after treatment. While noninvasive positron emission tomography (PET) has the potential to determine AR expression of tumor cells in vivo, fully optimized PET imaging agents are not yet available. Based on molecular modeling, three novel derivatives of hydroxyflutamide (Compounds 1-3) were designed and synthesized. They contain an electron-rich group (dimethylamine) located on the methyl moiety, which may confer a better stability to the molecule in vivo. Compounds 1-3 have AR binding that is similar or higher than that of the currently used commercial drugs. An automated carbon-11 radiolabeling route was developed, and the compounds were successfully labeled with a 10-15% decay-corrected radiochemical yield, 99% radiochemical purity and a specific activity of 4Ci/μmol end of bombardment (n=15). These labeled biomarkers may facilitate the future quantitative molecular imaging of AR-positive prostate cancer using PET and may also allow for image-guided treatment of prostate cancer

  9. Nutrition Facts: Reading the Label

    Science.gov (United States)

    ... My Go4Life Get Free Stuff Be a Partner Nutrition Facts: Reading the Label Reading labels can help ... of information on their labels or packaging about nutrition and food safety. Product dates . You might see ...

  10. Use of 15N Label in Organic Synthesis and Spectroscopy. Part I: Preparation of 15N-Labeled tert-Butylamine

    Science.gov (United States)

    Talaty, Erach R.; Boese, Christopher A.; Adewale, Sanni M.; Ismail, Mohammed S.; Provenzano, Frank A.; Utz, Melissa J.

    2002-02-01

    The preparation of 15N-labeled tert-butylamine involves the conversion of the correspondingly labeled potassium cyanide into the 15N-labeled tert-butylformamide via the Ritter reaction in 85% yield, followed by hydrolysis with either aqueous sodium hydroxide or hydrochloric acid. The NMR spectra of the compounds provide a valuable opportunity for discussing several important topics in NMR spectroscopy, such as cis-trans isomerism due to restricted rotation and 15N coupling. Comparison of the IR spectra of the labeled and unlabeled compounds permits a forum for discussing the theory of vibrational frequencies.

  11. Radioactive labelled orgotein

    International Nuclear Information System (INIS)

    The preparation and use of radioactively labelled orgotein, i.e. water-soluble protein congeners in pure, injectable form, is described. This radiopharmaceutical is useful in scintigraphy, especially for visualization of the kidneys where the orgotein is rapidly concentrated. Details of the processes for labelling bovine orgotein with sup(99m)Tc, 60Co, 125I or 131I are specified. The pharmaceutical preparation of the labelled orgotein for intravenous and parenteral administration is also described. Examples using either sup(99m)TC or 125I-orgotein in scintiscanning dogs' kidneys are given. (UK)

  12. Biokinetics of radioactive compounds

    International Nuclear Information System (INIS)

    Biokinetics of radioactive compounds in the human organism represent the central notion in this work, consisting of a theoretical and an experimental part. The first chapter contains definitions and explanations on the importance of the biokinetics of radioactive compounds in clinical therapy and pharmaceuticals research as well as for assessing radiation exposure and radiation hazards. Chapter 2 describes the bases of the biokinetics of radioactive compounds in the medical and non-medical sector, and biokinetics. Chapter 3 deals with obtaining biokinetics data for radioactive compounds from investigations in animals and man, evaluation of measurements, transferring data obtained by animal experiments to man, and with the variability of biokinetics data. In Chapter 4 the results of comprehensive studies in literature on the biokinetics of radioactive compounds are summarized. They relate to three areas: professional and environmental incorporation of radioactive compounds, use of radioactive pharmaceuticals in therapy and research, and incorporation of radioactive compounds by embryo and fetus in consequence of the uptake of radioactive compounds by the mother. Chapter 5 gives an assessment of radiation hazards from radioactive compounds in connection with occupational radiation exposure and nuclear diagnostics in vivo, and a comparison with other risks. For that purpose the concept of effective dose equivalent is applied in connection with suitable risk coefficients to professional and nuclear-medical radiation exposure. Chapter 6 is dedicated to measurement of the biokinetics of radioactive compounds in man using conventional devices. The object of Chapter 7 is measurement of the biokinetics of radioactive pharmaceuticals in man by means of single photon emission computed tomography. (orig./MG)

  13. The efficacy of oral isotretinoin versus cyproterone compound in female patients with acne and the triad of cutaneous hyperandrogenism: A randomized clinical trial

    OpenAIRE

    Gita Faghihi; Kioumars Jamshidi; Nabet Tajmirriahi; Bahareh Abtahi-Naeini; Mohamadali Nilforoshzadeh; Mohamadreza Radan; Sayed Mohsen Hosseini

    2014-01-01

    Background: SAHA (Seborrhea, Acne, Hirsutism and Androgenetic Alopecia) syndrome is a dermatologic disorder, with variant response to treatment. Triad of cutaneous hyperandrogenism included nodulocystic or severe acne, female pattern hair loss and hirsutism. Aim: The aim of this study is to compare the effectiveness of isotretinoin and cyproterone compound in the treatment of nodulocystic acne, in patients with SAHA syndrome or triad of cutaneous hyperandrogenism. Materials and Method...

  14. Compound heterozygosity with a novel S222N GALT mutation leads to atypical galactosemia with loss of GALT activity in erythrocytes but little evidence of clinical disease

    OpenAIRE

    Benjamin Cocanougher; Umut Aypar; Amber McDonald; Linda Hasadsri; Bennett, Michael J; Edward Highsmith, W.; Kristin D'Aco

    2015-01-01

    Galactosemia is an inborn error of galactose metabolism caused by mutations in the GALT gene. Though early detection and galactose restriction prevent severe liver disease, affected individuals have persistently elevated biomarkers and often neuro-developmental symptoms. We present a teenage compound heterozygote for a known pathogenic mutation (H132Q) and a novel variant of unknown significance (S222N), with nearly absent erythrocyte GALT enzyme activity but normal biomarkers and only mild a...

  15. FDA Online Label Repository

    Data.gov (United States)

    U.S. Department of Health & Human Services — The drug labels and other drug-specific information on this Web site represent the most recent drug listing information companies have submitted to the Food and...

  16. Like your labels?

    Science.gov (United States)

    Field, Michele

    2010-01-01

    The descriptive “conventions” used on food labels are always evolving. Today, however, the changes are so complicated (partly driven by legislation requiring disclosures about environmental impacts, health issues, and geographical provenance) that these labels more often baffle buyers than enlighten them. In a light-handed manner, the article points to how sometimes reading label language can be like deciphering runes—and how if we are familiar with the technical terms, we can find a literal meaning, but still not see the implications. The article could be ten times longer because food labels vary according to cultures—but all food-exporting cultures now take advantage of our short attention-span when faced with these texts. The question is whether less is more—and if so, in this contest for our attention, what “contestant” is voted off. PMID:21539053

  17. Stability of rhenium-188 labeled antibody

    International Nuclear Information System (INIS)

    For clinical application of beta-emitter labeled antibody, high specific activity is important. Carrier-free Re-188 from W-188/Re-188 generator is an ideal radionuclide for this purpose. However, low stability of Re-188 labeled antibody, especially in high specific activity, due to radiolytic decomposition by high energy (2.1 MeV) beta ray was problem. We studied the stability of Re-188 labeled antibody, and stabilizing effect of several nontoxic radical-quenching agents. Pre-reduced monoclonal antibody (CEA79.4) was labeled with Re-188 by incubating with generator-eluted Re-188-perrhenate in the presence of stannous tartrate for 2 hr at room temperature. Radiochemical purity of each preparation was determined by chromatography (ITLC-SG/acetone, ITLC-SG/Umezawa, Whatman No.1/saline). Human serum albumin was added to the labeled antibodies(2%). Stability of Re-188-CEA79.4 was investigated in the presence of vitamin C, ethanol, or Tween 80 as radical-quenching agents. Specific activities of 4.29∼5.11 MBq/μg were obtained. Labeling efficiencies were 88±4%(n=12). Very low stability after removal of stannous tartrate from the preparation was observed. If stored after purging with N2, all the preparations were stable for 10 hr. However, if contacted with air, stability decreased. Perrhenate and Re-188-tartrate was major impurity in declined preparation (12∼47 and 9∼38% each, after 10 hr). Colloid-formation was not a significant problem in all cases. Addition of vitamin C stabilized the labeled antibodies either under N2 or under air by reducing the formation of perrhenate. High specific activity Re-188 labeled antibody is unstable, especially, in the presence of oxygen. Addition of vitamin C increased the stability

  18. Certified Rule Labeling

    OpenAIRE

    Nagele, Julian; Zankl, Harald

    2015-01-01

    The rule labeling heuristic aims to establish confluence of (left-)linear term rewrite systems via decreasing diagrams. We present a formalization of a confluence criterion based on the interplay of relative termination and the rule labeling in the theorem prover Isabelle. Moreover, we report on the integration of this result into the certifier CeTA, facilitating the checking of confluence certificates based on decreasing diagrams for the first time. The power of the method is illustrated by ...

  19. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: A randomized, open label, active-controlled, multicentric, phase IV clinical trial

    Directory of Open Access Journals (Sweden)

    Siva Prasad

    2012-01-01

    Full Text Available Background: Acne vulgaris is a very common skin disease with a significant detrimental effect on the quality of life of the patients. Aims: To assess the comparative efficacy and safety of a nano-emulsion gel formulation of adapalene and clindamycin combination with its conventional formulation in the treatment of acne vulgaris of the face. It was a prospective, randomized, open label, active-controlled, multicentric, clinical trial. Methods: Eligible patients suffering from acne vulgaris of the face were randomized to receive once-daily treatment with a nano-emulsion gel or conventional gel formulation of adapalene 0.1% and clindamycin (as phosphate 1% combination for 12 weeks. Total, inflammatory and noninflammatory lesion counts, with grading of acne severity were carried out on a monthly basis. Safety assessments were done to determine the comparative local and systemic tolerability. Two-tailed significance testing was carried out with appropriate statistical tests, and P-values < 0.05 were considered as significant. Results: 209/212 patients enrolled in the study were eligible for efficacy and safety assessments in both nano-emulsion gel (118/119 patients and conventional gel (91/93 patients groups. Significantly better reductions in total (79.7% vs. 62.7%, inflammatory (88.7% vs. 71.4% and noninflammatory (74.9% vs. 58.4% lesions were reported with the nano-emulsion gel as compared to the conventional gel (P < 0.001 for all. Mean acne severity score also reduced significantly more with the nano-emulsion formulation (1.9 ± 0.9 vs. 1.4 ± 1.0; P < 0.001 than the comparator. Significantly lower incidence and lesser intensity of adverse events like local irritation (4.2% vs. 19.8%; P < 0.05 and erythema (0.8% vs. 9.9%; P < 0.05 were recorded with the nano-emulsion gel. Conclusions: The nano-emulsion gel formulation of adapalene and clindamycin combination appears to be more efficacious and better tolerated than the conventional formulation

  20. Labelling of electricity

    International Nuclear Information System (INIS)

    This comprehensive report for the Swiss Federal Office of Energy (SFOE) presents a possible course of action to be taken to provide a means of declaring the sources of electrical power, as is foreseen in the draft of new Swiss electricity market legislation. The report presents the basic ideas behind the idea and defines the terms used such as labelling, certificates and declarations. Also, the legal situation in the European Union and in Switzerland is examined and a quantitative overview of electricity production and consumption is presented. Suggestions for a labelling scheme are made and some of the problems to be expected are looked at. The report also presents a series of examples of labelling schemes already implemented in other countries, such as Austria, Great Britain, Sweden and Germany. Tradable certificates and tracking systems are discussed as are initial quality labels like the Swiss 'Naturemade' label for green power. A concrete recommendation for the declaration and labelling of electricity in Switzerland is presented and various factors to be considered such as import/export, pumped storage, distribution losses, small-scale producers as well as the time-scales for introduction are discussed

  1. Targeted Radiolabeled Compounds in Glioma Therapy.

    Science.gov (United States)

    Cordier, Dominik; Krolicki, Leszek; Morgenstern, Alfred; Merlo, Adrian

    2016-05-01

    Malignant gliomas of World Health Organization (WHO) grades II-IV represent the largest entity within the group of intrinsic brain tumors and are graded according to their pathophysiological features with survival times between more than 10 years (WHO II) and only several months (WHO IV). Gliomas arise from astrocytic or oligodendrocytic precursor cells and exhibit an infiltrative growth pattern lacking a clearly identifiable tumor border. The development of effective treatment strategies of the invasive tumor cell front represents the main challenge in glioma therapy. The therapeutic standard consists of surgical resection and, depending on the extent of resection and WHO grade, adjuvant external beam radiotherapy or systemic chemotherapy. Within the last decades, there has been no major improvement of the prognosis of patients with glioma. The consistent overexpression of neurokinin type 1 receptors in gliomas WHO grades II-IV has been used to develop a therapeutic substance P-based targeting system. A substance P-analogue conjugated to the DOTA or DOTAGA chelator has been labeled with different alpha-particle or beta-particle emitting radionuclides for targeted glioma therapy. The radiopharmaceutical has been locally injected into the tumors or the resection cavity. In several clinical studies, the methodology has been examined in adjuvant and neoadjuvant clinical settings. Although no large controlled series have so far been generated, the results of radiolabeled substance P-based targeted glioma therapy compare favorably with standard therapy. Recently, labeling with the alpha particle emitting Bi-213 has been found to be promising due to the high linear energy transfer and the very short tissue range of 0.08mm. Further development needs to focus on the improvement of the stability of the compound and the application by dedicated catheter systems to improve the intratumoral distribution of the radiopharmaceutical within the prognostically critical infiltrative

  2. Accelerated stem cell labeling with ferucarbotran and protamine

    OpenAIRE

    Golovko, Daniel M.; Henning, Tobias; Bauer, Jan S.; Settles, Marcus; Frenzel, Thomas; Mayerhofer, Artur; Rummeny, Ernst J.; Daldrup-Link, Heike E.

    2009-01-01

    Objective To develop and characterize a clinically applicable, fast and efficient method for stem cell labeling with ferucarbotran and protamine for depiction with clinical MRI. Methods The hydrodynamic diameter, zeta potential and relaxivities of ferucarbotran and varying concentrations of protamine were measured. Once the optimized ratio was found, human mesenchymal stem cells (MSCs) were labeled at varying incubation times (1–24 h). Viability was assessed via Trypan blue exclusion testing....

  3. Comparative studies of antibody anti-CD20 labeled with 188Re

    International Nuclear Information System (INIS)

    Tc(I)-RTXred was faster than 188Re(I)-RTXred, that on the other hand showed better stability in human plasma and no transquelation in the cysteine or histidine challenge studies. Both compounds showed good binding affinity and a biodistribution in mice bearing tumor compatible with the normal mAb distribution and a reasonable tumor uptake proving the efficiency of the labeling and the potential clinical use. (author)

  4. Preparation of radiopharmaceuticals labeled with metal radionuclides

    International Nuclear Information System (INIS)

    We recently developed a useful zinc-62/copper-62 generator and are presently evaluating copper-62 radiopharmaceuticals for clinical studies. While developing these copper-62 radiopharmaceuticals, in collaboration with the University of Missouri Research Reactor, Columbia we have also explored copper-64 radiopharmaceuticals. The PET images we obtained with copper-64 tracers were of such high quality that we have developed and evaluated copper-64 labeled antibodies for PET imaging. The major research activities described herein include: the development and assessment of gallium-68 radiopharmaceuticals; the development and evaluation of a new zinc-62/copper-62 generator and the assessment of copper-62 radiopharmaceuticals; mechanistic studies on proteins labeled with metal radionuclides

  5. Preparation of radiopharmaceuticals labeled with metal radionuclides

    Energy Technology Data Exchange (ETDEWEB)

    Welch, M.J.

    1992-06-01

    We recently developed a useful zinc-62/copper-62 generator and are presently evaluating copper-62 radiopharmaceuticals for clinical studies. While developing these copper-62 radiopharmaceuticals, in collaboration with the University of Missouri Research Reactor, Columbia we have also explored copper-64 radiopharmaceuticals. The PET images we obtained with copper-64 tracers were of such high quality that we have developed and evaluated copper-64 labeled antibodies for PET imaging. The major research activities described herein include: the development and assessment of gallium-68 radiopharmaceuticals; the development and evaluation of a new zinc-62/copper-62 generator and the assessment of copper-62 radiopharmaceuticals; mechanistic studies on proteins labeled with metal radionuclides.

  6. Streaming Label Learning for Modeling Labels on the Fly

    OpenAIRE

    You, Shan; Xu, Chang; Wang, Yunhe; Xu, Chao; Tao, Dacheng

    2016-01-01

    It is challenging to handle a large volume of labels in multi-label learning. However, existing approaches explicitly or implicitly assume that all the labels in the learning process are given, which could be easily violated in changing environments. In this paper, we define and study streaming label learning (SLL), i.e., labels are arrived on the fly, to model newly arrived labels with the help of the knowledge learned from past labels. The core of SLL is to explore and exploit the relations...

  7. Technetium compounds

    International Nuclear Information System (INIS)

    Radiopharmaceutical, chemical and pharmacological investigations on the development and application of carrier-free sup(99m)Tc radiopharmaceuticals are comprehensively reported. The radiopharmaceutical section deals with the elaboration of labelling methods. The influence of different factors on the kit production and the sup(99m)Tc radiopharmaceutical preparation is discussed. The relationship between the chemical structure and the biodistribution is in the centre of the radiopharmalogical section. (author)

  8. Phase I clinical trial of the humanized anti-EGF-r antibody H-R3 labeled with 99mTc in patients with tumor of epithelial origin

    International Nuclear Information System (INIS)

    Aim: The aim of this study was to evaluate the biodistribution, internal radiation dosimetry, human anti-mouse antibody (HAMA) response and toxicity of the 99mTc labeled humanized H-R3 MAb using two dose levels. A preliminary analysis of the diagnostic efficacy was also performed. Material and methods: Twenty-five patients with suspicion of epithelial tumors were included on this study. They were divided in two groups. Group I (G-I): Ten patients received intravenous injection of 30mCi-3mg of 99mTc-H-R3; Group II (G-II): 15 patients received 60mCi-6mg of 99mTc-H-R3. Sequential Whole-Body, SPECT and planar images were acquired at different time intervals using a Sophy Camera DS7. Multiple blood and urine samples were collected up to 24 hours after injection. Hematological parameters and adverse effects were evaluated and classified using the WHO classification and HAMA response was also determined. Biodistribution was computed from the scintigraphic images using the Bio Dose software. The absorbed dose for 24 target organs and the equivalent and effective dose (EED, ED) were estimated using the Medical Internal Radiation Dosimetry (MIRD) Committee methodology. Data processing and statistic analyses were performed using the SPSS and microcal Origin v4.0 software packages. Results: Hepatic uptake showed the higher values: 50,7±6,4%ID (Teff = 2,9 hours) and 45.1±6, 25ID (Teff = 3.9 hours) in group I and II, respectively. Maximum uptakes in spleen and heart, for both group, were detected in the first image data-sets (1,6%ID and 2,5%ID respectively) and kidneys reaches the maximum value (1,9%ID) at 3 hours post-injection. The urinary bladder and large intestine had also a significant uptake due to the clearance pattern of this product. The mean urinary excretion was 22.2±7.6% up to 24 hours post-injection. The higher tumor uptake was estimated as 0.026%DI/g in a brain lesion. Liver received the higher absorbed doses (4,90E-02 mGy/MBq in G-I and 4,66E-02 mGy/MBq in G

  9. Eco-labelling, competition and environment: Endogenization of labelling criteria

    OpenAIRE

    Ben Youssef, Adel; Lahmandi-Ayed, Rim

    2008-01-01

    This paper suggests a modelling of the labelling procedure consistent with empirical observations, that allows the endogenous calculation of labelling criteria. The authority in charge of the labelling program chooses the level of labelling criteria so as to maximise the social surplus, anticipating competition between firms in environmental qualities and prices. While accounting simply for the informational role of labels, this model allows to understand observed behavior such as firms' igno...

  10. On online labeling with polynomially many labels

    Czech Academy of Sciences Publication Activity Database

    Babka, M.; Bulánek, Jan; Čunát, V.; Koucký, Michal; Saks, M.

    Berlin : Springer, 2012 - (Epstein, L.; Ferragina, P.), s. 121-132 ISBN 978-3-642-33089-6. - (Lecture Notes in Computer Science. 7501). [20th Annual European Symposium on Algorithms (ESA 2012). Ljubljana (SI), 10.09.2012-12.09.2012] R&D Projects: GA ČR GAP202/10/0854; GA AV ČR IAA100190902 Institutional support: RVO:67985840 Keywords : online labeling * file maintenance problem * lower bounds Subject RIV: BA - General Mathematics http://link.springer.com/chapter/10.1007/978-3-642-33090-2_12

  11. European consumers and nutrition labelling

    DEFF Research Database (Denmark)

    Wills, Josephine M.; Grunert, Klaus G.; Celemín, Laura Fernández;

    2009-01-01

    Nutrition labelling of food in Europe is not compulsory, unless a nutrition or health claim is made for the product. The European Commission is proposing mandatory nutrition labelling, even front of pack labelling with nutrition information. Yet, how widespread is nutrition labelling in the EU...

  12. Genetic algorithms for map labeling

    NARCIS (Netherlands)

    Dijk, Steven Ferdinand van

    2002-01-01

    Map labeling is the cartographic problem of placing the names of features (for example cities or rivers) on the map. A good labeling has no intersections between labels. Even basic versions of the problem are NP-hard. In addition, realistic map-labeling problems deal with many cartographic constr

  13. Off-Label Drug Use

    Science.gov (United States)

    ... Your Local Offices Close + - Text Size Off-label Drug Use What is off-label drug use? In the United States new drugs are ... unapproved use of a drug. Is off-label drug use legal? The off-label use of FDA- ...

  14. Development of methods of labeling pentavalent DMSA with 99mTc and 188Re

    International Nuclear Information System (INIS)

    Technetium-99 m is the most useful radionuclide in diagnostic imaging procedures in Nuclear Medicine, more than 80 percent of radiopharmaceuticals are 99mTc-labeled compounds. 99mTc-DMSA(V) has been used for imaging of soft tissue, head and neck tumors. It shows a particularly high specificity for medullary thyroid carcinoma and bone metastases in a variety of cancers. Biodistribution studies of 188Re-DMSA(V) have shown that its general pharmacokinetic properties are similar to that of 99mTc-DMSA(V), so this agent could be used for targeted radiotherapy of these tumors. The aim of this work is the development of methods of labeling DMSA(V) with 99mTc and 188Re. 99mTc-DMSA(V) can be prepared by two methods. One of them is the indirect one, through the use of a commercial kit of DMSA (III), by adjusting the pH from 2.5 to ∼ 8.5 with NaHCO3. This method was evaluated and optimized presenting high labeling yields. The other method is the direct one, through the preparation of a lyophilised kit ready for labeling with 99mTc, being the method of interest of this work, due to the easy of its clinical use. The most adequate formulation of the kit was: 1.71 mg of DMSA, 0.53 mg of SnCl2.2H2O and 0.83 mg of ascorbic acid (pH 9). Labeling yields higher than 95% were achieved labeling this kit with 1 to 2 m L of 99mTc with activities up to 4736 MBq (128 mCi). The kit was stable up to 6 months and biodistribution studies confirmed the quality of the DMSA (V) labeled with 99mTc using this kit. The reduction potential of Re is lower than the one for Tc, so the labeling conditions of 188Re-DMSA(V) are different from the ones used for 99mTc- DMSA(V). 188Re-DMSA(V) is prepared in acid solution, that makes it possible to use the DMSA (III) commercial kit developed for labeling with 99mTc, prepared in pH 2.5, for labeling with 188Re. Labeling yields higher than 95% were achieved with this methodology, with a rection time of 30 minutes at 100 deg C using no more than 1 m L of 188ReO4

  15. Radio labeling with preassigned frequencies.

    OpenAIRE

    2004-01-01

    A radio labeling of a graph G is an assignment of pairwise distinct, positive integer labels to the vertices of G such that labels of adjacent vertices differ by at least $2$. The radio labeling problem (RL) consists in determining a radio labeling that minimizes the maximum label that is used (the so-called span of the labeling). RL is a well-studied problem, mainly motivated by frequency assignment problems in which transmitters are not allowed to operate on the same frequency channel. We c...

  16. Radioactive labelling of peptidic hormones

    International Nuclear Information System (INIS)

    The labelling of peptidic hormones requires stability, specificity and sensitivity of the label. Introduction of a radioactive atome is one way to satisfy these criteria. Several processes have been described to prepare radioactive TRF: synthesis of the peptide with labelled aminoacids or introduction of the label into the hormone. In that approach, tritium can be substituted in the imidazole ring, via precursors activating the proper carbon. Monoiodo TRF leads essentially to tritium labelling of the 5 positions whereas monoazo TRF allows the preparation of 3H TRF labelled in the 2 positions. Di-substituted TRF leads to labelling into the 2 and 5 carbons. Labelled analogs of TRF can be prepared with labelled iodine; further developments of peptide labelling, will be presented. In particular, the homolytic scission of the C-iodine, bond by photochemical activation. The nascent carbon radical can be stabilized by a tritiated scavenger. This approach eliminates the use of heavy metal catalysts

  17. Bioactive Labels for Fresh Fruits and Vegetables

    Directory of Open Access Journals (Sweden)

    Nasui Liana

    2013-11-01

    Full Text Available Pesticide residues and microbial load on the surface of fresh fruits and vegetables becomes a major concern due to the safety and quality of these products for consumer.In order to minimize these risk factors (pesticide residues and microbial load, were achieved labels for fruits and vegetables that are consumed with shell which disintegrates under the influence of water jet and thus reduce the amount of these contaminants. Were elaborated labels based on polymer (chitosan at a concentration of 2%, which incorporate bioactive compounds from green tea with potential decontaminant of the peel of this products. Green tea extract was obtained by infusing 1 g of dried green tea in 100 ml water at 80° C for 10 minutes. The extract was filtered and then mixed with 2 g chitosan acidified with 0.7% glacial acetic acid and dilute to the mark with distilled water. Were identified bioactive compounds from green tea, using UV-VIS and HPLC. Then were elaborated the labels. These tags were used on pepper, tomato, apple and  nectarine. Were quantified the microbial load and the pesticide residues on their surface unwashed, washed only with water and were monitored the influence of labels on these factors. Identified pesticides were mefenoxan and thiamethoxam, which were quantified by HPLC. In what it concerns the influence, were founded the absence of germs at pepper and a significant decrease at the other. In terms of  the potential of reducing pesticide, the experimental results have indicated that the label can prove its effectiveness.  

  18. Bioactive Labels for Fresh Fruits and Vegetables

    Directory of Open Access Journals (Sweden)

    Liana Nasui

    2013-11-01

    Full Text Available Pesticide residues and microbial load on the surface of fresh fruits and vegetables becomes a major concern due to the safety and quality of these products for consumer.In order to minimize these risk factors (pesticide residues and microbial load, were achieved labels for fruits and vegetables that are consumed with shell which disintegrates under the influence of water jet and thus reduce the amount of these contaminants. Were elaborated labels based on polymer (chitosan at a concentration of 2%, which incorporate bioactive compounds from green tea with potential decontaminant of the peel of this products. Green tea extract was obtained by infusing 1 g of dried green tea in 100 ml water at 80° C for 10 minutes. The extract was filtered and then mixed with 2 g chitosan acidified with 0.7% glacial acetic acid and dilute to the mark with distilled water. Were identified bioactive compounds from green tea, using UV-VIS and HPLC. Then were elaborated the labels. These tags were used on pepper, tomato, apple and  nectarine. Were quantified the microbial load and the pesticide residues on their surface unwashed, washed only with water and were monitored the influence of labels on these factors. Identified pesticides were mefenoxan and thiamethoxam, which were quantified by HPLC. In what it concerns the influence, were founded the absence of germs at pepper and a significant decrease at the other. In terms of  the potential of reducing pesticide, the experimental results have indicated that the label can prove its effectiveness.

  19. Preparation of labelled zt-1 with tritium and deuterium

    International Nuclear Information System (INIS)

    zt-1 is a potential drug for treatment of Alzheimer's disease. For the study of this drug, isotope labeled compounds should be prepared. After reduction of 5-chloro-o-vanillin with sodium boron deuteride and tritide, and condensation, zt-1 labeled with tritium and deuterium are prepared. UV absorption spectrum and Rf of tritium labeled zt-1 are the same as authentic sample. The radiochemical purity of 3H-zt-1 is more than 95%, and the specific radioactivity is 401.3 GBq/g

  20. Synthesis of carbon-11 labelled calcium channel antagonists

    International Nuclear Information System (INIS)

    A useful synthetic approach to carbon-11 labelled 1,4-dihydropyridines is described. Carbon-11 labelled calcium channel antagonists 11C-Nifedipine, 11C-Nisoldipine, 11C-nitrendipine and 11C-CF3-Nifedipine were synthesized by a modified Hantzsch method using protected carboxy functions. Deprotection of the carboxylic acids by alkaline hydrolysis followed by conversion into the corresponding potassium salts and subsequent methylation with 11CH3I produced the labelled compounds in very good chemical and radiochemical yields (94%). (author)

  1. 复方甘草酸苷治疗酒精性肝炎临床疗效观察%Compound glycyrrhizin for alcoholic hepatitis:observation of clinical efficacy

    Institute of Scientific and Technical Information of China (English)

    董晓艳

    2008-01-01

    目的 观察复方甘草酸苷治疗酒精性肝炎的临床疗效.方法 对照组30例,戒酒,运动,调整饮食.治疗组35例,在对照组基础上加用复方甘草酸苷片.4周为1个疗程,共3个疗程.治疗前后分别测定肝功能及肝脏B型超声波检查.结果 治疗组临床症状明显减轻,血清ALT、AST、GGT水平降低,治疗组明显优于对照组(P<0.05).肝脏B超显示脂肪肝影像明显改善或消失.结论 复方甘草酸苷治疗酒精性肝炎可以明显改善患者的临床症状和肝功能.%Objective To observe the therapeutic effect of compound glycyrrhizin on alcoholic hepatitis.Methods A total of 65 patients with alcoholic hepatitis were assigned to group A(30 cases) treated with abstinence of alcohol,physical exercise and adjusted diet, and group B(35 cases) treated with compound glycyrrhizin together with the treatment given to group A. Before and after receiving three 4-week treatment periods, all the patients had their liver function tested and received examination of ultrasonic weave type B. Results Group B had significantly alleviated clinical symptoms, and ACT,A ST, GGT in blood serum are significantly lower than group A(P<0.05).Examination of ultrasonic wave type B on the liver shows significant amelioration and disappearance of symptoms of fatty liver. Conclusion Compound glycyrrhizin can significantly ameliorate the clinical symptoms and improve the liver function of the patients.

  2. The tritium labelling of organic molecules by heterogeneous catalytic exchange

    International Nuclear Information System (INIS)

    The influence of the temperature at 65 degree centigree and 120 degree centigree on the labelling of three organic molecules with tritium was studied. The compounds were: benzoic acid, de phenyl glyoxal and 2,3-tetramethylene-4-pantothenyl-7-oxo diacetin.The method employed was the heterogeneous catalytic exchange between tritiated water and the organic compound. The purification was made by thin-layer chromatography and the concentration, purity and specific activity of the products were determined by counting and ultraviolet techniques. The thermal stability and the radiolytic effects on labelled benzoic acid were also considered. (Author) 9 refs

  3. Semantic Role Labeling

    CERN Document Server

    Palmer, Martha; Xue, Nianwen

    2011-01-01

    This book is aimed at providing an overview of several aspects of semantic role labeling. Chapter 1 begins with linguistic background on the definition of semantic roles and the controversies surrounding them. Chapter 2 describes how the theories have led to structured lexicons such as FrameNet, VerbNet and the PropBank Frame Files that in turn provide the basis for large scale semantic annotation of corpora. This data has facilitated the development of automatic semantic role labeling systems based on supervised machine learning techniques. Chapter 3 presents the general principles of applyin

  4. Multipurpose Compound

    Science.gov (United States)

    1983-01-01

    Specially formulated derivatives of an unusual basic compound known as Alcide may be the answer to effective treatment and prevention of the disease bovine mastitis, a bacterial inflammation of a cow's mammary gland that results in loss of milk production and in extreme cases, death. Manufactured by Alcide Corporation the Alcide compound has killed all tested bacteria, virus and fungi, shortly after contact, with minimal toxic effects on humans or animals. Alcide Corporation credits the existence of the mastitis treatment/prevention products to assistance provided the company by NERAC, Inc.

  5. Indium-111-labeled platelets: Applications in human platelet imaging and survival studies

    International Nuclear Information System (INIS)

    Clinical indications for the use of platelets labeled with indium-111 are not well established at this time, and the procedure should be considered an investigational tool. The procedure is used to study platelet kinetics, platelet distribution, and organ uptake. Although the /sup 51/Cr technique is still the reference procedure, the indium label has advantages that make it a more useful tool for clinical studies. Like the /sup 51/Cr method, /sup 111/In-oxine is a random label, that is, a mixed population (with respect to age) of circulating platelets is labeled in vitro and reinjected. Other random labels such as /sup 14/C-serotonin and diisopropylfluorophosphate (DFP) labeled with /sup 32/P or /sup 3/H have been used in research applications but are not well suited as clinical test procedures. Efforts to use cohort labeling with /sup 32/P, /sup 35/S, and /sup 75/Se-methionine have not resulted in a generally accepted procedure

  6. The use of redox polymers in labelling procedures of proteins and peptides with 99mTc. I. Properties of redox polymers and technique of labelling

    International Nuclear Information System (INIS)

    Background: Using a polymer-analogue reaction, redox polymers with a dextran matrix to anchor the end a(b)-alanine-N,N'-diacetate group converted into the Sn2+ cycle have been developed for the labelling of proteins, peptides, and labile compounds with 99mTc. The reaction kinetics and the labelling efficiency of 99mTc depend primarily on the degree of dextran matrix cross-linking and the qualitative nature of the redox polymer end groups. METHODS: Preparation for labelling takes place directly in basic protein and peptide solutions without adjusting pH or adding other adjuvants. Prior to the final modification into kit form, the redox polymers are removed by ultrafiltration. RESULTS: The results of labelling of model compounds (aspartic acid, cysteine) with 99mTc at various solution pH values clearly show that, at pH values over 6.0, it will be primarily the free end SH groups that will serve as binding sites for the proteins and peptides. To label proteins and peptides, we selected a redox polymer with G-25 cross-linking, which allows the achievement of a radiochemical purity over 95% and high stability of the labelled compounds. CONCLUSION: The method of radiolabelling compounds with 99mTc based on redox polymers was developed mainly to overcome the problems faced when using other conventional methods in the labelling of sensitive compounds. (author)

  7. The impact of antimicrobial allergy labels on antimicrobial usage in cancer patients

    OpenAIRE

    Trubiano, Jason A; Leung, Vivian K.; Chu, Man Y.; Leon J. Worth; Slavin, Monica A.; Thursky, Karin A

    2015-01-01

    Background Antibiotic allergy labels are associated with sub-optimal prescribing patterns and poorer clinical outcomes in non-cancer populations, but the effect of labelling on antimicrobial usage in patients with cancer is unknown. Findings A retrospective review of hospitalized patients admitted to the Peter MacCallum Cancer Centre (2010-2012) identified 23 % of cancer patients (n = 198) with an antimicrobial allergy label (AA). Comparison of those with an antimicrobial allergy label to tho...

  8. Irradiation of blood, blood compounds and cell culture in equipment of radiotherapy of clinical usage. Study about volume and ideal dose

    International Nuclear Information System (INIS)

    The irradiation of blood bags with the objective of minimizing the graft-versus-host disease in the proceedings of blood transfusion has been consolidated as an indispensable step in the advances of hematopoietic system diseases therapeutics. This practice performed in the great oncological treatment centers requires appropriate equipment (cell irradiators), that due to the high coast, is inaccessible to the majority of the services. The main objective of this work is the show the technique developed by the Radiological Physics Service of the Hospital A. C. Camargo Radiation Department, using the teletherapy equipment of clinical usage available at the Institution. The literature shows that a total dose of 2000 to 3500 c Gy must be administered to all target volume to get an ideal dose/volume relation that proportionates better therapeutic results, neutralizing the cells which are causative of post transfusion reactions of rejection, without prejudicing the other cells that are necessary to the maintenance and preservation of the transplanted person's hematopoietic system functions. With the technic developed for optimization of the irradiation. it is possible to conclude that the utilization of radiotherapy equipment of clinical usage for blood irradiation, substituting cells irradiators, is a good option, permitting safe transfusion of products irradiated with adequate dose. (author)

  9. Frustrated Lewis pairs-assisted reduction of carbonyl compounds

    Czech Academy of Sciences Publication Activity Database

    Marek, Aleš; Pedersen, M. H. F.

    2015-01-01

    Roč. 71, č. 6 (2015), s. 917-921. ISSN 0040-4020 Institutional support: RVO:61388963 Keywords : frustrated Lewis pairs * hydrogen activation * benzyl alcohol * tritium labeling * labeled compounds Subject RIV: CC - Organic Chemistry Impact factor: 2.641, year: 2014

  10. Microfluidic Radiometal Labeling Systems for Biomolecules

    Energy Technology Data Exchange (ETDEWEB)

    Reichert, D E; Kenis, P J. A.

    2011-12-29

    In a typical labeling procedure with radiometals, such as Cu-64 and Ga-68; a very large (~ 100-fold) excess of the non-radioactive reactant (precursor) is used to promote rapid and efficient incorporation of the radioisotope into the PET imaging agent. In order to achieve high specific activities, careful control of reaction conditions and extensive chromatographic purifications are required in order to separate the labeled compounds from the cold precursors. Here we propose a microfluidic approach to overcome these problems, and achieve high specific activities in a more convenient, semi-automated fashion and faster time frame. Microfluidic reactors, consisting of a network of micron-sized channels (typical dimensions in the range 10 - 300¼m), filters, separation columns, electrodes and reaction loops/chambers etched onto a solid substrate, are now emerging as an extremely useful technology for the intensification and miniaturization of chemical processes. The ability to manipulate, process and analyze reagent concentrations and reaction interfaces in both space and time within the channel network of a microreactor provides the fine level of reaction control that is desirable in PET radiochemistry practice. These factors can bring radiometal labeling, specifically the preparation of radio-labeled biomolecules such as antibodies, much closer to their theoretical maximum specific activities.

  11. 臭氧联合复方曲安奈德局部注射治疗肩周炎临床观察%Clinical Observation of Ozone Combined with Compound Triamcinolone Acetonide in the Treatment of Scapulohumeral Periararthritis

    Institute of Scientific and Technical Information of China (English)

    朱红; 李安学; 王新; 蔡云亮; 李文兵

    2011-01-01

    Objective: To evaluate the clinical effect of ozone and compound triamcinolone acetonide injection in the treatment of scapulohumeral periarthritis. Method: 80 patients diagnosed with scapulohumeral periarthritis were randomly divided into two groups. Experimental group patients were injected ozone and compound Iriamcinolone acetonide into trigger points or shoulder joints while control group patients were only injected compound triamcinolone acelonide. The clinical effects were assessed according to the improvement of visual analog scales (VAS) and the function of shoulder joints after treatment. Result: The VAS of experimental group patients was lower than that of control group patients in 1,4 and 12 weeks (P <0. 05). Compared with that of control group, the shoulders function of experimental group was improved in 12 weeks (P <0. 05). Conclusion: The method of ozone and compound triamcinolone acetonide injected into trigger points and shoulder joints is effective for the treatment of scapulohumeral periarthritis. It can not only relief the pain,but also improve the function of shoulders.%目的:观察臭氧联合复方曲安奈德局部注射治疗肩周炎的疗效.方法:80例肩周炎患者随机分为观察组和对照组各40例,观察组臭氧联合复方曲安奈德局部行肩周痛点阻滞或肩关节腔内注射,对照组仅复方曲安奈德行肩周痛点阻滞或肩关节腔内注射.比较治疗前和治疗1、4、12周时两组患者的疼痛视觉模拟评分(VAS),12周时评价肩关节功能.结果:治疗1、4、12周时,观察组患者的VAS评分均低于对照组(P<0.05).12周时观察组患者肩关节功能改善的总有效率高于对照组(P<0.05).结论:臭氧联合复方曲安奈德局部注射治疗肩周炎,镇痛效果满意,肩关节功能恢复良好.

  12. Fluorinated Compounds Labelled with F-18 as Radiopharmaceuticals

    Czech Academy of Sciences Publication Activity Database

    Procházka, Libor; Kropáček, Martin; Mirzajevová, Marcela; Zimová, Jana; Forsterová, Michaela; Švecová, Helena; Melichar, František; Bělohlávek, O.

    2009-01-01

    Roč. 103, č. 12 (2009), s. 1017-1021. ISSN 0009-2770 R&D Projects: GA MPO 2A-1TP1/055 Institutional research plan: CEZ:AV0Z10480505 Keywords : POSITRON-EMISSION-TOMOGRAPHY * TUMOR HYPOXIA * PET Subject RIV: FR - Pharmacology ; Medidal Chemistry Impact factor: 0.717, year: 2009

  13. Synthesis of high specific activity tritium labelled compounds

    International Nuclear Information System (INIS)

    Tritiated methyl iodide of high specific activity is synthetized by Fischer-Tropsch reaction of tritium with carbon monoxide, tritiated methanol obtained is reacted with hydriodic acid. It is used for the synthesis of S-adenosyl L-methionine 3H-methyl and of diazepam 3H-methyl derivatives. Synthesis of 3-PPP3H: (hydroxy-3 phenyl)-3N-n propyl [3H-2.3] piperidine [3H-2.3] with a specific activity of 4.25 T Bq/mM (115 Ci/mM) and of baclofene 3H with a specific activity of 0.925 TBq (25 Ci/mM) are also described

  14. Sediment Transport Study in Haeundae Beach using Radioisotope Labelled Compound

    International Nuclear Information System (INIS)

    Haeundae beach is one of the most famous resorts in Korea and plays an important role as a special tourism district. However, the length and width of the beach are being reduced continuously, which would have bad influence on the regional economy and be the financial burden to the local authority considering that a large amount of budget is spent in the beach nourishment annually. Hence, it is necessary to understand the dynamic behavior of sediments in the coast for the systematic preservation plan of coastal environment. Lately a monitoring system using radioactive isotope as tracers is considered as a novel technique in understanding the dynamic transport of sediments. The objective of this study is to investigate the possible variations in sedimentary distribution and quantify the characteristics of sediments using radiotracer

  15. Radiolanthanide labeled compounds as radiopharmaceuticals for radio-synoviorthesis

    Czech Academy of Sciences Publication Activity Database

    Melichar, František; Kropáček, Martin; Šrank, Jiří; Mirzajevová, Marcela; Beran, Miloš; Zimová, Jana; Eigner-Henke, Kateřina; Forsterová, Michaela; Kraft, O.

    2007-01-01

    Roč. 6, č. 1 (2007), s. 45-45. ISSN 1450-1147 R&D Projects: GA AV ČR 1QS100480501 Institutional research pla n: CEZ:AV0Z10480505 Keywords : radiosynoviorthesis * holmium-166 Subject RIV: FR - Pharmacology ; Medidal Chemistry

  16. Clinical Study on Treatment of Mid-Late Stage Gastric Carcinoma by Compound Xiansu Capsule (仙酥胶囊) Combined with Chemotherapy

    Institute of Scientific and Technical Information of China (English)

    2001-01-01

    Objective: To assess the effect and mechanism of compound Xiansu capsule (仙酥胶囊, XSC) combined with chemotherapy in treating gastric carcinoma of mid-late stage. Methods: Sixty-one patients of the test group were treated by XSC combined with chemotherapy and 30 patients of the control group treated with chemotherapy alone. The effect of treatment and cell mediated immunity of patients were observed. Results: The effective rate of the test group and the control group was 32.8% and 13.3% respectively (P<0.05), the toxic reaction occurrence caused by chemotherapy was less in the former than that in the latter group (P<0.01). The CD8 level of patients in the test group decreased, and CD4/CD8 level was raised obviously, which suggested that XSC had immuno-regulating effect on T-cell. Conclusion: XSC could enhance the efficacy and reduce the toxic and side-effect of chemotherapy. To regulate the cell mediated immunity of patients is possibly its mechanism.

  17. Radioactively labelled porphyrin derivatives

    International Nuclear Information System (INIS)

    Radioactive labelling of guanidine bearing tetraphenylporphyrin and Dy-texaphyrin with 166Ho and 90Y is described. UV-VIS absorption spectrometry was used to describe porphyrin and texaphyrin, including their behaviour over a wide pH range. This technique also provided preliminary information about the complexation of holmium and yttrium with porphyrin and texaphyrin. The labelling yield of the macrocyclic molecules depends on the pH of the reaction mixture, metal-to-ligand ratio and time of incubation. The optimum reaction conditions for the formation of radioactive complexes of porphyrin and texaphyrin were determined by thin layer chromatography combined with beta activity measurement. The ability of porphyrin derivatives to bind anions was also examined. Our experiments were focused on perrhenate ion (ReO4-) because radiopharmaceuticals labeled with 186Re and 188Re play an important role in the therapy of many tumorous diseases. The possibility of using the ReO4- anion directly for labeling without reduction to a lower oxidation state can simplify considerably the preparation of the radiotherapeutic pharmaceuticals. Neither UV-Vis spectrometry nor TLC gave evidence of any incorporation of the ReO4- anion into the porphyrin ring

  18. Labeling of herbicide femesafen

    International Nuclear Information System (INIS)

    5-[2-chroo-4-(trifluoromethyl ) phenoxy]-N-(methyl sulphonyl )-2-niorobenzamide [femesafen] was labeled by six steps. Radio-chemical yield was 19.15%. TLC analysis of the final product showed that the radiochemical purity is not less than 99%. (authors)

  19. Waisda?: video labeling game

    NARCIS (Netherlands)

    Hildebrand, M.; Brinkerink, M.; Gligorov, R.; Steenbergen, M. van; Huijkman, J.; Oomen, J.

    2013-01-01

    The Waisda? video labeling game is a crowsourcing tool to collect user-generated metadata for video clips. It follows the paradigm of games-with-a-purpose, where two or more users play against each other by entering tags that describe the content of the video. Players score points by entering the sa

  20. Understanding Food Labels

    Science.gov (United States)

    ... girls Eating healthy at restaurants Special food issues Vegetarian eating Eating for strong bones Quiz: Food Facts Links to more information girlshealth glossary girlshealth.gov home http://www.girlshealth.gov/ Home Nutrition Healthy eating for girls Understanding food labels Understanding ...

  1. Syntheses of C-13 and C-14-labeled versions of the investigational proteasome inhibitor MLN9708.

    Science.gov (United States)

    Plesescu, Mihaela; Elliott, Eric L; Li, Yuexian; Prakash, Shimoga R

    2013-01-01

    MLN9708 (ixazomib citrate) is an investigational, orally bioavailable proteasome inhibitor that is under development by Millennium in clinical studies in both hematologic and nonhematologic malignancies. The stable isotope-labeled MLN9708 was required for bio-analytical studies. [(13) C9 ]-MLN9708 (11) was synthesized in seven steps from the uniformly labeled [(13) C6 ]-1,4-dichlorobenzene (3) and [1-(13) C]-acetyl chloride. Because of the presence of two chlorine atoms and a boron atom, compound 6 was further reacted with [(13) C2 ]-glycine to provide an internal standard that is well separated from the parent compound during mass spectrometric analysis. The radiolabeled version was prepared to support metabolite profiling and whole body autoradiography studies in experimental animals. [(14) C]-MLN9708 (19) was synthesized in six steps from commercially available [(14) C]-barium carbonate. The key intermediate, [carboxyl-(14) C]-2,5-dichlorobenzoic acid (14), was prepared by selective lithiation of 1-bromo-2,5-dichlorobenzene (12) followed by carbonation with [(14) C]-barium carbonate. In preparation for a one-time human absorption, distribution, metabolism and excretion (ADME) study, the stability of [(14) C]-MLN9708 and its precursors were also evaluated. PMID:24285522

  2. Genetic algorithms for map labeling

    OpenAIRE

    Dijk, Steven Ferdinand van

    2002-01-01

    Map labeling is the cartographic problem of placing the names of features (for example cities or rivers) on the map. A good labeling has no intersections between labels. Even basic versions of the problem are NP-hard. In addition, realistic map-labeling problems deal with many cartographic constraints, which pose more demands on how the labels should be placed in relation to their surroundings. For example, a label is preferably placed above and to the right of a city. These two aspects (comb...

  3. Pharmacodynamics of benziadarone labelled with 131-I

    International Nuclear Information System (INIS)

    Regarding the importance of benziodarone (Retrangor) - 2-ethyl-3-(3',5'-diiodo-4'-hidrovibenzoyl)benzofuran - in medical practice in respect of its vasodilator and uricosuric action, a working plan was developed intending to study the biological distribution of the drug rats Wistar and, using the plasmatic curve, to find out the existence of other compartments besides the intravascular one. With these data, the rhythms of benziodarone exchange were established, simulating its distribution in the organism. It was possible to develop this working project because the benziodarone structure could be labelled with iodine-131, using an isotopic exchange reaction, having chloramine T as an oxidant agent. The labelled compound was employed as radioactive tracer, and its specific activities varied from 18 uCi/mg to 20 uCi/mg

  4. Comparison of 90Y/177Lu labeled DOTA-Bz-RGD tetramer and DOTA-RGD tetramer

    International Nuclear Information System (INIS)

    90Y/177Lu labeled DOTA-Bz-RGD tetramer and DOTA-RGD tetramer were prepared, and the effect of Bz-DOTA and DOTA on labeling conditions and in vitro stability of radiolabeled compounds was compared. The labeling conditions, including reaction pH, reaction temperature and reaction time, were investigated. ITLC and HPLC show that the labeling yields of four radiolabeled compounds are more than 95% under optimal conditions (pH=6.0, reacting at 100 degree C for 15-20 min); the four radiolabeled compounds show pretty good stability in saline and fetal bovine serum. Although introducing of Bz has no effect on labeling conditions and in vitro stability of radiolabeled compounds, it brings a little change on molecule polarity. HPLC analysis and lg P values reveal that introducing of Bz increases the lipophilicity of radiolabeled compounds. (authors)

  5. Compound odontoma

    Directory of Open Access Journals (Sweden)

    Monica Yadav

    2012-01-01

    Full Text Available Odontomas have been extensively reported in the dental literature, and the term refers to tumors of odontogenic origin. Though the exact etiology is still unknown, the postulated causes include: local trauma, infection, inheritance and genetic mutation. The majority of the lesions are asymptomatic; however, may be accompanied with pain and swelling as secondary complaints in some cases. Here, we report a case of a compound odontome in a 14 year old patient.

  6. Magnesium compounds

    Science.gov (United States)

    Kramer, D.A.

    2006-01-01

    In 2005, seawater and natural brines accounted for 51% of US magnesium compounds production. World magnesia production was estimated to be 14.5 Mt. Most of the production came from China, North Korea, Russia and Turkey. Although no specific production figures are available, Japan and the United States are estimated to account for almost one-half of the world's capacity from seawater and brines.

  7. Labelling of some amino acids with radioiodine

    International Nuclear Information System (INIS)

    Some radioiodine labelled compounds which have application in nuclear medicine have been prepared. Two common techniques were employed. A comparative study on the radioiodination of the amino acids, L - tyrosine, L - a - methyl tyrosine and L-tyrosine methyl ester has been carried out by the electrophilic radioiodination technique. The blood flow reagent, antipyrine, also has been prepared by this technique using chloramine - T, iodogen and H2 O2 as oxidizing agents to generate electrophilic iodine. Radio chromatograms revealed side product impurities at long reaction times and high oxidizing agent concentrations. Comparison between the different oxidizing agents was done. Optimization of the radioiodination conditions, such as Ph of the medium, reaction time, oxidizing agent and substrate concentrations and carrier KI concentration was performed resulting in high radiochemical yields of 97% L - 3 -(131) iodotyrosine, 95% L -3-(131) iodo-a-methyl tyrosine, 88% L-3-(131) iodotyrosine methyl ester and 96% 4-(131) iodoantipyrine within short reaction times at room temperature when chloramine - T was used as oxidizing agent. Purification by high pressure liquid chromatography resulted in high radiochemically pure products suitable for medical application. Radioiodinated 3- iodotyrosine and 4- iodophenyl alanine have been prepared by the isotopic exchange technique using cuprous chloride as catalyst for the exchange reaction. The effect of solvents and the different parameters affecting the labelling yield were investigated to optimize the conditions for labelling of these compounds. Kinetic study indicated a second order reaction with an activation energy of 9.6 and 12.20 Kcal/mole for 3- iodotyrosine and 4-iodophenyl alanine respectively. Reducing agents were added to the Cu CI catalyzed reactions to improve the yield and decrease side products formation. Applying the results obtained to the radioiodination of the phenyl fatty acid 15(p-iodophenyl) pentadecanoic acid

  8. Spin labels. Applications in biology

    International Nuclear Information System (INIS)

    The main applications of spin labels in the study of biomembranes, enzymes, nucleic acids, in pharmacology, spin immunoassay are reviewed along with the fundamentals of the spin label method. 137 references. (author)

  9. Use the Nutrition Facts Label

    Science.gov (United States)

    ... Features Spokespeople News Archive eNewsletters Calendar Use the Nutrition Facts Label You can help your family eat ... to some of their favorite foods. Use the Nutrition Facts label found on food packages to make ...

  10. Labeling lake water with tritium

    Science.gov (United States)

    Frederick, B.J.

    1963-01-01

    A method of packaging tritiated water in a manner that facilitates safe handling in environmental labeling operations, and procedures followed in labeling a large body of water with a small volume of tritiated water are described. ?? 1963.

  11. Synthesis of 131I labeled diiodothyronine (131I-T2)

    International Nuclear Information System (INIS)

    Objective: To synthesise 131I-T2 as the basis for future synthesis of 131I-T2S with sulfation. Methods: Firstly 3-T1 was radiolabeled with 131I with chloramine-T(Ch-T) labeling method. Then gel column chromatography and paper chromatography were used for separation and purification. Measurement of the labeling efficiency, radiochemical purity,stability of labeled compound, and identification of the product of immune activity were carried out. Results: The radiolabeling yield of the labeled compound produced with the modified Ch-T method was about 65.1%±4.5% (n=5) and the radiochemical purity was about 96.5%±1.1% (n=5). After 10d storage at -20 degree C, the radiochemical purity of the product still remained above 90%. Conclusion: High rate of labeling efficiency and good stability could be obtained with Ch-T labeling method. (authors)

  12. Clinical Observation of Shujing Decoction Combined with Compound Anisodine in Treatment of Blepharospasm%舒经汤合复方樟柳碱治疗眼睑痉挛临床疗效观察

    Institute of Scientific and Technical Information of China (English)

    杨春煦

    2015-01-01

    目的:观察舒经汤合复方樟柳碱治疗眼睑痉挛的临床疗效。方法62例眼睑痉挛患者随机分为两组,对照组采用复方樟柳碱治疗,治疗组采用舒经汤结合复方樟柳碱治疗,比较两组患者的治疗效果、复发情况、不良反应等。结果治疗组总有效率明显高于对照组(P<0.05);治疗组复发率明显低于对照组(P<0.05)。结论舒经汤结合复方樟柳碱治疗眼睑痉挛效果显著,不良反应少。%s:Objective To observe the clinical efficacy of Shujing decoction combined with compound anisodine in treatment of blepharo-spasm.Methods 62casesofblepharospasmwererandomlydivideintotwogroups,thecontrolgroupreceivedcompoundanisodine,thetreat-ment group was given Shujing decoction and compound anisodinethe,the treatment effect, recurrence and adverse reactions of two groups were compared.Results The total effective rate of treatment group were significantly higher than control group (P<0.05);the recurrence rate of treatment group was significantly lower than the control group (P<0.05).Conclusion Shujing decoction combined with compound anisod-ine in treatment of blepharospasm has significantly effect and less adverse reaction.

  13. Odontoma compuesto: Diagnóstico radiográfico y tratamiento quirúrgico de un caso clínico Compound odontoma: Radiographic diagnosis and surgical management of a clinical case

    Directory of Open Access Journals (Sweden)

    J. Vázquez Diego

    2008-10-01

    Full Text Available Se presenta un caso clínico de odontoma compuesto asociado a un diente supernumerario y un canino retenido superior derecho. El paciente de 16 años de edad es de sexo masculino. Se realizan diversos estudios radiográficos para su diagnóstico, que consisten en técnica panorámica y técnicas intraorales. Posteriormente se realizó la intervención quirúrgica para extirpar la lesión y las estructuras dentarias asociadas a ella. El estudio histopatológico confirmó el diagnóstico presuntivo. Basado en lo expuesto se analiza al odontoma compuesto según localización, sexo y edad habiendo realizado una revisión del tema según diversos autores.A clinical case of a compound odontoma associated with a supernumerary tooth and an upper right impacted canine in a 16-year-old male, is reported. To perform the diagnosis, several radiographic studies were made, mainly consisting of panoramic and intraoral techniques. Then, a surgical procedure was carried out to remove both the lesion and the surrounding tooth structures. The histo-pathological examination confirmed our presumptive diagnosis. Therefore, based on these findings, the compound odontoma is analyzed according to its location, sex and age of patients as well, after reviewing other authors´ opinions in the current literature.

  14. Preparation of Radiopharmaceuticals Labeled with Metal Radionuclides. Final Report

    International Nuclear Information System (INIS)

    The overall goal of this project was to develop methods for the production of metal-based radionuclides, to develop metal-based radiopharmaceuticals and in a limited number of cases, to translate these agents to the clinical situation. Initial work concentrated on the application of the radionuclides of Cu, Cu-60, Cu-61 and Cu-64, as well as application of Ga-68 radiopharmaceuticals. Initially Cu-64 was produced at the Missouri University Research Reactor and experiments carried out at Washington University. A limited number of studies were carried out utilizing Cu-62, a generator produced radionuclide produced by Mallinckrodt Inc. (now Covidien). In these studies, copper-62-labeled pyruvaldehyde Bis(N4-methylthiosemicarbazonato)-copper(II) was studied as an agent for cerebral myocardial perfusion. A remote system for the production of this radiopharmaceutical was developed and a limited number of patient studies carried out with this agent. Various other copper radiopharmaceuticals were investigated, these included copper labeled blood imaging agents as well as Cu-64 labeled antibodies. Cu-64 labeled antibodies targeting colon cancer were translated to the human situation. Cu-64 was also used to label peptides (Cu-64 octriatide) and this is one of the first applications of a peptide radiolabeled with a positron emitting metal radionuclide. Investigations were then pursued on the preparation of the copper radionuclides on a small biomedical cyclotron. A system for the production of high specific activity Cu-64 was developed and initially the Cu-64 was utilized to study the hypoxic imaging agent Cu-64 ATSM. Utilizing the same target system, other positron emitting metal radionuclides were produced, these were Y-86 and Ga-66. Radiopharmaceuticals were labeled utilizing both of these radionuclides. Many studies were carried out in animal models on the uptake of Cu-ATSM in hypoxic tissue. The hypothesis is that Cu-ATSM retention in vivo is dependent upon the oxygen

  15. Food Labels Tell the Story!

    Science.gov (United States)

    ... My World From the Label to the Table! Food Labels Tell the Story! What is in food? Food provides your body with all of the ... your food choices. Nutrition Facts—the Labels on Food Products Beginning in 1994, the US government began ...

  16. 复方羊毛脂尿素乳膏的制备及稳定性考察和临床应用%Preparation of compound lanolin urea cream and investigation of its stability and clinical application

    Institute of Scientific and Technical Information of China (English)

    李成; 巫小娟; 蔡柳清; 路伟; 曾繁涛; 吴远婷

    2014-01-01

    目的:制备水包油型非离子复方羊毛脂尿素乳膏,考察其稳定性,并验证其治疗皮肤皲裂的临床效果。方法以羊毛脂和尿素为主药,以非离子型乳化剂司盘-60和吐温-60为配对乳化剂,以单硬脂酸甘油酯为稳定剂,采用反相快速加入法制备O/W型乳剂;通过离心试验、耐寒耐热试验、留样观察、pH值、乳滴粒径等考察其稳定性;并以尿素乳膏作对照,观察临床疗效。结果制备的乳膏细腻、均匀、稳定,易于涂布及洗除;稳定性试验均符合规定;临床疗效优于尿素乳膏。结论按本处方及制备工艺所得乳膏质量合格、性质稳定,所建立的质控方法可靠,临床疗效好。%Objective To prepare a nonionic compound lanolin urea cream of the oil in water type and inves-tigate its stability, and to verify its clinical efficacy for the treatment of chapped skin. Methods The O/W compound lanolin urea cream was prepared by fast-adding reversed phase preparation method with urea and lanolin as principal components, non-ionic emulsifier span-60 and tween-60 as paired emulsifier, and glycerol monostearate as stabilizer. The stability of cream was evaluated by centrifugation test, cold and heat resistant test, sample observation test under room temperature, pH, droplet size. The clinical efficacy of cream was verified with urea cream as a reference prepara-tion. Results The prepared cream was stable, uniform in color, homogeneous, exquisite and easy to spread and wash out. The results of stability test were in accordance with the regulations of SFDA. The clinical efficacy of the prepared cream was better than that of urea cream. Conclusion The formulation and preparation technology of compound lan-olin urea cream is optimal and feasible. The prepared cream has a good stability and controllable quality. The cream has excellent clinical efficacy and is worthy of wide use in clinical practice.

  17. Isotopically labelled benzodiazepines

    International Nuclear Information System (INIS)

    This paper reports on the benzodiazepines which are a class of therapeutic agents. Improvements in the analytical methodology in the areas of biochemistry and pharmacology were significant, particularly in the application of chromatographic and spectroscopic techniques. In addition, the discovery and subsequent development of tritium and carbon-14 as an analytical tool in the biological sciences were essentially post-world war II phenomena. Thus, as these new chemical entities were found to be biologically active, they could be prepared in labeled form for metabolic study, biological half-life determination (pharmacokinetics), tissue distribution study, etc. This use of tracer methodology has been liberally applied to the benzodiazepines and also more recently to the study of receptor-ligand interactions, in which tritium, carbon-11 or fluorine-18 isotopes have been used. The history of benzodiazepines as medicinal agents is indeed an interesting one; an integral part of that history is their use in just about every conceivable labeled form

  18. Labelling of 123I-Mibg

    International Nuclear Information System (INIS)

    Iodine-123 is a well-known radioisotope in nuclear medicine. The efficiency of I-Mibg (Metaiodobenzyl Guanidine) in the diagnosis of neuroblastoma, pheocromocyoma. I-123 is produced by cyclotron through the reaction; 124Xe(P, 2 n) 123Cs(5.9h)→123Xe(2.08 h)→123I. 124Xe(P,2 n) 123Xe(2.08 h)→123I. The procedure is as follows: A 30μl Cu solution (20 mmol), 500 μl tin sulfate solution add in a vial containing 1 mg Mibg and mix it in a ultrasound bath, after mixing, the septum-closed vial is heated. A heating time of 30 min and a temperature of 100 deg C were found to be adequate. Under this condition side products is minimum, and quantitative labeling yield is more than 90%. After labeling, the solution is made isotonic and brought on a P H of 5.5.-6.5 by addition of 3m l of H2O and ascorbic acid. The preparation is sterilized for injection into the patient by filtration through the sterile 0.22μm filter. An HPLC quality control procedure which can be performed in less than 10 min has also been developed to verify the chemical purity of compound. In conclusion, the quantitative labeling yield, up to 370 MBq/mg (10 mCi/mg), the high radiochemical purity, reproducibility, simplicity and speed, of the labeling procedure described above, made it suitable for kit form preparation of I-labeled Mibg

  19. Imaging of Enzymes in the Steroid Biosynthetic Pathway : Synthesis of 18F-Labelled Tracers

    OpenAIRE

    ERLANDSSON Maria

    2009-01-01

    This thesis deals with the synthesis and development of 18F-labelled alkyl etomidate and vorozole analogues, and their use as positron emission tomography (PET) tracers for the imaging of the steroid enzymes 11β-hydroxylase and aromatase. Two synthetic 18F-labelling approaches to the etomidate and vorozole analogues were developed, and the analogues were evaluated in some biological assays. The two-step labelling method was used to synthesise many compounds for biological evaluation. In the f...

  20. Labelling, Deviance and Media

    OpenAIRE

    Greer, C.

    2014-01-01

    Labelling theory is a perspective that emerged as a distinctive approach to criminology during the 1960s, and was a major seedbed of the radical and critical perspectives that became prominent in the 1970s. It represented the highpoint of an epistemological shift within the social sciences away from positivism – which had dominated criminological enquiry since the late-1800s – and toward an altogether more relativistic stance on the categories and concepts of crime and control. It inspired a ...

  1. Eco-labelling

    OpenAIRE

    Kuna-Marszałek, Anetta

    2016-01-01

    Considering environmental protection requirements in business operations may, in the long run, determine if a lasting comparative advantage can be achieved. That is why our textbook, rich in case studies, identifies not only the threats a business may pose to the environment but stresses the ways of reducing its negative impact. It discusses, among other things, the concept of corporate social responsibility, environmental management systems, methods and the importance of eco-labelling goods ...

  2. Myocardial arterial spin labeling

    OpenAIRE

    Kober, Frank; Jao, Terrence; Troalen, Thomas; Nayak, Krishna S.

    2016-01-01

    Arterial spin labeling (ASL) is a cardiovascular magnetic resonance (CMR) technique for mapping regional myocardial blood flow. It does not require any contrast agents, is compatible with stress testing, and can be performed repeatedly or even continuously. ASL-CMR has been performed with great success in small-animals, but sensitivity to date has been poor in large animals and humans and remains an active area of research. This review paper summarizes the development of ASL-CMR techniques, c...

  3. Simple, rapid method for the preparation of isotopically labeled formaldehyde

    Science.gov (United States)

    Hooker, Jacob Matthew; Schonberger, Matthias; Schieferstein, Hanno; Fowler, Joanna S.

    2011-10-04

    Isotopically labeled formaldehyde (*C.sup..sctn.H.sub.2O) is prepared from labeled methyl iodide (*C.sup..sctn.H.sub.3I) by reaction with an oxygen nucleophile having a pendant leaving group. The mild and efficient reaction conditions result in good yields of *C.sup..sctn.H.sub.2O with little or no *C isotopic dilution. The simple, efficient production of .sup.11CH.sub.2O is described. The use of the .sup.11CH.sub.2O for the formation of positron emission tomography tracer compounds is described. The reaction can be incorporated into automated equipment available to radiochemistry laboratories. The isotopically labeled formaldehyde can be used in a variety of reactions to provide radiotracer compounds for imaging studies as well as for scintillation counting and autoradiography.

  4. 复方石韦片治疗尿路感染的临床观察%Clinical observation of compound Shiwei tablets in the treatment of urinary tract infections

    Institute of Scientific and Technical Information of China (English)

    罗恒

    2015-01-01

    目的:观察复方石韦片治疗尿路感染的临床效果。方法:收治尿路感染患者82例,随机分为治疗组和对照组,对照组采用三金片治疗,治疗组采用复方石韦片治疗,对比两组患者的治疗效果和中医证候评分结果。结果:治疗后治疗组上尿路感染患者和下尿路感染患者的中医证候评分结果分别是(7.00±5.13)分和(3.95±2.92)分,和对照组上尿路感染患者和下尿路感染患者的中医证候评分结果对比差异存在统计学意义(P<0.05)。结论:尿路感染患者采用复方石韦片治疗后,明显改善了患者的中医证候积分情况。%Objective:To observe the clinical effect of compound Shiwei tablets in the treatment of urinary tract infections. Methods:82 patients with urinary tract infections were selected.They were randomly divided into the treatment group and the control group.The control group was treated with Sanjin tablets treatment,and the treatment group with compound Shiwei tablets in the treatment.Curative effect and traditional Chinese medicine syndrome score results were compared.Results:After treatment, upper urinary tract infection and lower urinary tract infections in patients with traditional Chinese medicine symptoms score results were(7.00±5.13)points and(3.95±2.92)points,and comparing the control group of upper urinary tract infection patients and lower urinary tract infection in patients with traditional Chinese medicine syndrome score results,there was a significant difference (P<0.05).Results:The clinical effect of compound Shiwei tablets in the treatment of urinary tract infections is outstanding.

  5. Clinical Observation of Compound Tripterygium Particles in Treatment of Chronic Aplastic Anemia%复方雷公藤颗粒治疗慢性再生障碍性贫血临床观察

    Institute of Scientific and Technical Information of China (English)

    邢海燕; 胡灿红

    2012-01-01

    目的:观察复方雷公藤颗粒联合安雄、环孢菌素A治疗慢性再生障碍性贫血的临床疗效.方法:采用复方雷公藤颗粒联合安雄、环孢菌素A治疗慢性再障22例,同时与18例单用安雄、环孢菌素A治疗慢性再生障碍性贫血比较.结果:治疗组总有效率为81.8%,对照组为50.0%,两组比较有显著性差异(P<0.05).治疗组的白细胞、血红蛋白、血小板计数明显高于对照组(P<0.05).结论:复方雷公藤颗粒联合安雄、环孢菌素A治疗慢性再障能起到协同增效作用,加速症状的改善,提高疗效.%Objective: To observe the clinical effect of compound tripterygium particles combined with testosterone undecanoate and cyclosporin A in treatment of chronic aplastic anemia. Methods : In experiment group, there were 22 patients with aplastic anemia treated by compound tripterygium particles combined with testosterone undecanoate and cyrlosporin A. In control group, there were 18 patients treated by estosterone undecanoate and cyclosporin A. Then the clinical effect was compared between the two groups. Results: The total efficiency of experiment group was 81.8%, compared with 50.0% of the control group. The difference was significant ( P<0.05 ). White blood cell, hemoglobin and platelet count of experiment group were significantly higher than those of control group ( P<0.05 ) . Conclusion : Compound tripterygium particles combined with testosterone undecanoate and cyclosporin A can play synergistic effect, accelerate the improvement of symptoms , and improve the curative effect in treatment of chronic aplastic anemia.

  6. The Clinical Curative Effect of Traditional Chinese Medicine Enema Combined with Compound Carraghenates Suppositories Treating Proctitis%中药灌肠联合复方角菜酸酯栓治疗直肠炎的临床疗效

    Institute of Scientific and Technical Information of China (English)

    赵益增; 魏艳芬

    2015-01-01

    目的:探讨中药灌肠联合复方角菜酸酯栓治疗直肠炎的临床疗效。方法选取2010年7月至2014年3月我院收治的直肠炎患者182例,随机分为试验组和对照组,各91例。对照组患者单纯使用复方角菜酸酯栓外用治疗,试验组患者给予中药灌肠联合复方角菜酸酯栓治疗,比较两组患者治疗3个疗程后的临床效果。结果试验组患者的治疗总有效率为92.3%,明显高于对照组的74.7%,差异有统计学意义(P<0.05)。结论中药灌肠联合复方角菜酸酯栓对直肠炎进行治疗,疗效确切,且安全有效、疗效持久、复发率低。%Objective To explore the clinical curative effect of traditional Chinese medicine enema combined with Titanoreine suppository in the treatment of proctitis.Methods 182 patients in our hospital in 2010 July to select proctitis to 2014 March were cases were randomly divided into experimental group and control group,each of 91 cases.Control group patients were treated with compound titanore topical treatment,the test group were treated with carraghenates suppository in the treatment of Chinese medicine enema combined with compound,compared two groups of patients with clinical treatment effect after 3 courses of treatment.Results Treatment of patients in experi- mental group the total effective rate was 92.3%,significantly higher than 74.7% in the control group,the difference has statistical significance(P<0.05).Conclusion Traditional Chinese medicine enema on proctitis treated,combined with compound titanore curative effect,safe and effective,lasting effect,low recurrence rate.

  7. The chemistry of 99mTc-labeled radiopharmaceuticals

    International Nuclear Information System (INIS)

    The subject of the chemistry of 99mTc-radiopharmaceuticals consists of a collection of bits and pieces of information without a unifying theme. Since the initial impetus to the field of organ imaging was provided by radiochemists, nuclear chemists, and clinician-investigators, using easily prepared 99mTc-compounds from available off-the-shelf ligands, complete chemical characterization was not carried for the 99mTc-radiopharmaceuticals and their metabolites. The influx of coordination, organic, and analytic chemists and their systematic studies clarified some of the structures of these tracers, and promoted the general synthetic methods of a variety of ligands and the corresponding 99mTc-chelates as well as understanding of the nature of their metabolites. Although major developments for organ-imaging radiopharmaceuticals had been made, future studies will result in the simplified methodology of protein-labeling, fine-tuning of the currently available radiopharmaceuticals for higher organ-extraction, and replacement of expensive 123I-labeled tracers with the corresponding 99mTc-tracers. In general, the Tc-complexes are thermodynamically less stable and kinetically more labile than the corresponding Re-complexes. The well established chemistry of Re-compounds, the similarity of Tc-chemistry to that of Re compounds, and structure-activity relationships of a few classes of 99mTc-labeled compounds, may promote the development of new generation of 99mTc-labeled radiopharmaceuticals.69 references

  8. Food and Drug Labeling and the Adult Reader.

    Science.gov (United States)

    McKenna, Michael C.; Aker, Richard

    1978-01-01

    Full disclosure of ingredients on food, drugs, and cosmetic labels is really non-disclosure where the chemical formulation has no common name or where one generic name covers a variety of formations. The Food and Drug Administration offers suggestions for adult education programs in consumer awareness, understanding compound nomenclature, and…

  9. Synthesis of deuterium labelled cocaine and pseudococaine

    International Nuclear Information System (INIS)

    Cocaine and pseudococaine were mass-labelled with deuterium at various positions on the tropane ring. The synthetic procedures followed were adaptations of those previously published for the unlabelled compounds. The isotopic purity was greater than 95% for 2-[2H]-, 4,4-[2H2]-, and 1,5,6,6,7,7-[2H6]-cocaine and 3-[2H]-, 4,4-[2H2]-, and 1,5,6,6,7,7-[2H6]-pseudococaine, while that of 3-[2H]-cocaine exceeded 90%. (author)

  10. Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients with non-Val30Met and non-Val122Ile Hereditary Transthyretin Amyloidosis

    OpenAIRE

    Damy, Thibaud; Judge, Daniel P; Kristen, Arnt V.; Berthet, Karine; Li, Huihua; Aarts, Janske

    2015-01-01

    A phase 2, open-label study in 21 patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis showed that tafamidis (20 mg daily for 12 months) stabilized these transthyretin variants. We assessed cardiac amyloid infiltration and cardiac abnormalities in this same study population. At baseline, median age was 64.3 years, 11 patients were in NYHA class II, 13 had conduction abnormalities, 14 N-terminal pro-hormone brain natriuretic peptide concentrations >300 pg/ml, and 1...

  11. Self-esteem in adolescent patients with attention-deficit/hyperactivity disorder during open-label atomoxetine treatment: psychometric evaluation of the Rosenberg Self-Esteem Scale and clinical findings

    OpenAIRE

    Dittmann, Ralf W.; Wehmeier, Peter M; Schacht, Alexander; Lehmann, Martin; Lehmkuhl, Gerd

    2009-01-01

    To report on (1) psychometric properties of the Rosenberg Self-Esteem Scale (SES) studied in adolescents with ADHD, (2) correlations of SES with ADHD scale scores, and (3) change in patient-reported self-esteem with atomoxetine treatment. ADHD patients (12–17 years), treated in an open-label study for 24 weeks. Secondary analyses on ADHD symptoms (assessed with ADHD-RS, CGI, GIPD scales) and self-esteem (SES) were performed. One hundred and fifty-nine patients were treated. A dichotomous stru...

  12. Tritium labeling of peptides using synthetic incorporated diiodinated tyrosine amino acid residues as precursor

    Czech Academy of Sciences Publication Activity Database

    Marek, Aleš; Baun, M.; Bruun, S. W.; Pedersen, M. H. F.

    Heidelberg : -, 2012. s. 57-57. [International Symposium on the Synthesis and Applications of Isotopes and Isotopically Labelled Compounds /11./. 09.09.2012-13.09.2012, Heidelberg] Institutional research plan: CEZ:AV0Z40550506 Keywords : tritium * labeled peptides Subject RIV: CC - Organic Chemistry

  13. In vivo tracing of superparamagnetic iron oxide-labeled

    OpenAIRE

    CHENG Jing-liang; YANG Yun-jun; Li, Hua-Li; Wang, Juan; WANG Mei-hao; Zhang, Yong

    2010-01-01

    In recent years, a great progress has beenmade in the management of central nervous system disease such asbrain trauma by transplantationof bonemarrow stromal cells.1 Fluorescence microscopy of host brain sections can trace and show the proliferation, migration and differentiation of bone marrow mesenchymal stem cells (BMSCs) labeled with green fluorescent protein. However, in clinic we need a noninvasive approach. In vivo monitoring of magnetically labeled stem cells by routine MRI ...

  14. Nomenclature and spelling rules of chemistry in Hungary Pt. 1 Nomenclature of elements and inorganic compounds

    International Nuclear Information System (INIS)

    The part of the updated edition of 'Nomenclature and spelling rules of chemistry in Hungary' (Budapest, 1972), referring to the isotopically modified inorganic compounds is presented. The rules are based on the proposals of IUPAC (1981). Spelling rules concerning the isotopically substituted, isotopically labelled, specifically labelled, selectively and non-selectively labelled compounds, and the positional and numbering rules of nuclides are treated. (Sz.J.)

  15. Labeling monocytes for imaging chronic inflammation

    International Nuclear Information System (INIS)

    With growing interest in cell-based scintigraphic diagnosis or therapy monitoring, there is an increasing demand for non-invasive observation and quantification of cell trafficking in the preclinical and clinical setting. Monocytes are members of the human mononuclear phagocyte system originating from a myeloid precursor in the bone. Labeled monocytes are being used for investigation of pathogenesis like atherosclerosis and for monitoring of therapeutic intervention in inflammatory diseases like rheumatoid arthritis. Labeling mononuclear cells at high specific activity without affecting their biological functions allows (delayed) non-invasive imaging with g or PET cameras. Monocytes labeled before their final differentiation into macrophages or dendritic cells may reveal centers of inflammation in a patient and, thereby, contribute to scintigraphic diagnosis. Macrophages or dendritic cells may be in vitro cultured and by means of genetic transformation specified towards specific targets prior to re-injection, an approach with therapeutic potency. This review addresses issues on autologous monocytes, particularly their properties and labeling for non-invasive in vivo radionuclide imaging of chronic inflammation.

  16. A synthetic approach to carbon-14 labeled anti-bacterial naphthyridine and quinolone carboxylic acids

    Energy Technology Data Exchange (ETDEWEB)

    Ekhato, I.V.; Huang, C.C. (Parke, Davis and Co., Ann Arbor, MI (United States))

    1993-09-01

    Labeled versions of (S)-clinafloxacin (1) and two napththyridine carboxylic acid anti-bacterial compounds 2 and 3 which are currently in development were synthesized. Preparations started from hitherto unknown bromo compounds 22 and 10, from which the corresponding [sup 14]C-labeled aromatic carboxylic acids 23 and 12 were generated by metal-halogen exchange followed by carboxylation reaction. Details of these preparations are given. (author).

  17. Labeling Lanreotide with 125I and 188Re

    International Nuclear Information System (INIS)

    Lanreotide is a new somatostatin analogue. It can bind to human somatostatin receptor (hSSTR) subtype 2 through 5 with high affinity and to hSSTR subtype I with low affinity. We investigate labeling condition, quality control and stability in vitro of 125I-Lanreotide and 188Re-lanreotide respectively. (A) Lanreotide is labeled with 125I using Chloramine T. The effect of reaction condition (such as reaction time, pH value, Lanreotide amount, quantity of Chloramine T and reaction volume) on labeling yield is investigated in detail. (B) The labeling yield and radiochemical purity (RP) is measured with paper chromatography (PC) and Sep-Pak C18 Cartridge. (C) The stability of 125I-Lanreotide in vitro is investigated by labeling compound incubating for 48 hours at 37 deg C in the 0.9% sodium chloride solution and RP is tested by PC at specific time intervals. (D) Lanreotide is labeled directly with 188Re via the mixture of citrate and tartate using stannous chloride as reduced agent. The influence of reaction conditions such as pH, temperature, amount of stannous chloride, amount of Lanreotide and reaction time on labeling yield is investigated in detail. At the time, the stability in vitro quality control and animal test are evaluated

  18. Intermetallic Compounds

    Science.gov (United States)

    Takagiwa, Y.; Matsuura, Y.; Kimura, K.

    2014-06-01

    We have focused on the binary narrow-bandgap intermetallic compounds FeGa3 and RuGa3 as thermoelectric materials. Their crystal structure is FeGa3-type (tetragonal, P42/ mnm) with 16 atoms per unit cell. Despite their simple crystal structure, their room temperature thermal conductivity is in the range 4-5-W-m-1-K-1. Both compounds have narrow-bandgaps of approximately 0.3-eV near the Fermi level. Because their Seebeck coefficients are quite large negative values in the range 350-thermoelectric materials both by adjusting the carrier concentration and by reducing the thermal conductivity. Here, we report the effects of doping on the thermoelectric properties of FeGa3 and RuGa3 as n and p-type materials. The dimensionless figure of merit, ZT, was significantly improved by substitution of Sn for Ga in FeGa3 (electron-doping) and by substitution of Zn for Ga in RuGa3 (hole-doping), mainly as a result of optimization of the electronic part, S 2 σ.

  19. Linerless label device and method

    KAUST Repository

    Binladen, Abdulkari

    2016-01-14

    This apparatus and method for applying a linerless label to an end user product includes a device with a printer for printing on a face surface of a linerless label, and a release coat applicator for applying a release coat to the face surface of the label; another device including an unwinder unit (103) to unwind a roll of printed linerless label; a belt (108); a glue applicator (102) for applying glue to the belt; a nip roller (106) for contacting and applying pressure to the face surface of the linerless label such that the glue on the belt transfers to the back surface of the linerless label; at least one slitting knife 105) positioned downstream the belt and a rewinder unit (104) positioned downstream the slitting knife; and a third device which die cuts and applies the linerless label to an end user object.

  20. Label-Guided Graph Exploration with Adjustable Ratio of Labels

    CERN Document Server

    Zhang, Meng; Tang, Jijun

    2012-01-01

    The graph exploration problem is to visit all the nodes of a connected graph by a mobile entity, e.g., a robot. The robot has no a priori knowledge of the topology of the graph or of its size. Cohen et al. \\cite{Ilcinkas08} introduced label guided graph exploration which allows the system designer to add short labels to the graph nodes in a preprocessing stage; these labels can guide the robot in the exploration of the graph. In this paper, we address the problem of adjustable 1-bit label guided graph exploration. We focus on the labeling schemes that not only enable a robot to explore the graph but also allow the system designer to adjust the ratio of the number of different labels. This flexibility is necessary when maintaining different labels may have different costs or when the ratio is pre-specified. We present 1-bit labeling (two colors, namely black and white) schemes for this problem along with a labeling algorithm for generating the required labels. Given an $n$-node graph and a rational number $\\rh...

  1. The isotopic fractionation of organic compounds

    International Nuclear Information System (INIS)

    Isotopic fractionation of organic compounds is the observation of their chromatographic separation caused solely by differing isotopic content. The phenomenon has been observed for over 35 years by investigators in various disciplines working with labeled compounds on GC, TLC, and HPLC. Over 100 reports of such separations for organic compounds labeled with 2H, 3H, 13C, and 14C are scattered throughout the literature, and it has been over twenty years since the topic was adequately reviewed. This paper will highlight the existing literature and examples from the author's own laboratory as well as emphasize the thoroughness and caution that one must exercise before invoking this explanation for anomalous chromatographic behavior of organic isotopomers

  2. Waisda?: video labeling game

    OpenAIRE

    Hildebrand, Michiel; Brinkerink, M.; Gligorov, R.; Steenbergen, Van; Huijkman, J.; Oomen, J.

    2013-01-01

    The Waisda? video labeling game is a crowsourcing tool to collect user-generated metadata for video clips. It follows the paradigm of games-with-a-purpose, where two or more users play against each other by entering tags that describe the content of the video. Players score points by entering the same tags as one of the other players. As a result each video that is played in the game is annotated with tags that are anchored to a time point in the video. Waisda? has been deployed in two projec...

  3. From Label to Practice

    DEFF Research Database (Denmark)

    Byrkjeflot, Haldor; Strandgaard, Jesper; Svejenova, Silviya

    2013-01-01

    This article examines the process of creation of new Nordic cuisine (NNC) as a culinary innovation, focusing on the main stages, actors, and mechanisms that shaped the new label and its practices and facilitated its diffusion in the region and internationally. Fast-paced diffusion was possible...... because NNC was conceived as an identity movement, triggered by active involvement of entrepreneurial leaders from the culinary profession, high-profile political supporters, legitimating scientists, disseminating media, and interpreting audiences. It was facilitated by three mechanisms: First, the use of...

  4. Labeled bile acids

    International Nuclear Information System (INIS)

    A general short procedure for the introduction of 13C to the side chain of bile acids is described. Suitable (Z)-pregn-17(20)-enes are key intermediates, while the isotope is introduced by an ene reaction with [1,2,3-13C3]-methyl propiolate. For the labeling with tritium, the unlabeled product of the ene synthesis, a Δsup(5,16,22)-triene was saturated selectively at 16,17 and 22,23 with tritium gas. (author)

  5. A Food Labeling

    Science.gov (United States)

    ... " ﻗﺎﻧﻮن اﻟﺒﻄﺎﻗﺎت واﻟﺘﻮﻋﻴﺔ اﻟﻐﺬاﺋﻴﺔ " [ Nutrition Labeling and Education Act ... ﻟﻠﻌﺼﻴﺮ اﻟﻤﻜﻮن ﺑﺈﺿﺎﻓﺔ اﻟﻤﺎء إﻟﻰ ﺧﻼﺻﺔ ﻣﺮآﺰة : ﻳﺠﺮى اﻟﺤﺴﺎب ﻣﻦ ﺟﺪول Brix ﻓﻲ 21 CFR 101.30(h)(1) ...

  6. Towards Multi Label Text Classification through Label Propagation

    Directory of Open Access Journals (Sweden)

    Shweta C. Dharmadhikari

    2012-06-01

    Full Text Available Classifying text data has been an active area of research for a long time. Text document is multifaceted object and often inherently ambiguous by nature. Multi-label learning deals with such ambiguous object. Classification of such ambiguous text objects often makes task of classifier difficult while assigning relevant classes to input document. Traditional single label and multi class text classification paradigms cannot efficiently classify such multifaceted text corpus. Through our paper we are proposing a novel label propagation approach based on semi supervised learning for Multi Label Text Classification. Our proposed approach models the relationship between class labels and also effectively represents input text documents. We are using semi supervised learning technique for effective utilization of labeled and unlabeled data for classification. Our proposed approach promises better classification accuracy and handling of complexity and elaborated on the basis of standard datasets such as Enron, Slashdot and Bibtex.

  7. Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice: a randomized, open-label, parallel-group, multi-center study: the DISCOVERY-Beta study

    OpenAIRE

    Laks, Toivo

    2008-01-01

    Toivo Laks1, Ester Keba2, Mariann Leiner3, Eero Merilind4, Mall Petersen5, Sirje Reinmets6, Sille Väli7, Terje Sööt8, Karin Otter81Clinic of Internal Medicine, North-Estonia Regional Hospital, Tallinn, Estonia; 2Clinic of Internal Medicine, Viljandi County Hospital, Viljandi, Estonia; 3Mustamäe Family Doctors Centre, Tallinn, Estonia; 4Nõmme Family Doctors Centre, Tallinn, Estonia; 5Saku Health Centre, Saku, Estonia; 6Kristiine Family Doctors, Ta...

  8. CNN: Single-label to Multi-label

    OpenAIRE

    Wei, Yunchao; Xia, Wei; Huang, Junshi; Ni, Bingbing; Dong, Jian; Zhao, Yao; Yan, Shuicheng

    2014-01-01

    Convolutional Neural Network (CNN) has demonstrated promising performance in single-label image classification tasks. However, how CNN best copes with multi-label images still remains an open problem, mainly due to the complex underlying object layouts and insufficient multi-label training images. In this work, we propose a flexible deep CNN infrastructure, called Hypotheses-CNN-Pooling (HCP), where an arbitrary number of object segment hypotheses are taken as the inputs, then a shared CNN is...

  9. Short-term effect of strontium- and zinc-containing toothpastes and mouthrinses on volatile sulphur compounds in morning breath: a randomized, double-blind, cross-over clinical study.

    Science.gov (United States)

    Soares, Léo G; Jonski, Grazyna; Tinoco, Eduardo M B; Young, Alix

    2015-04-01

    Zinc (Zn) reduces the formation of volatile sulphur compounds (VSCs) associated with oral malodour. Although strontium (Sr) is included in some products for reducing dental hypersensitivity, it may also have anti-halitosis properties. This randomized, double-blind, cross-over clinical study compared the anti-VSC effect of brushing with commercial toothpastes and rinses containing Zn and Sr. The volunteers (n = 30) either brushed/rinsed with/without tongue brushing using Zn-containing toothpaste/rinse, Sr-containing toothpaste/rinse, or placebo (control). Volatile sulphur compounds [hydrogen sulphide (H2 S) and methyl mercaptan (CH3 SH)] were measured, in morning breath, using gas chromatography. The anti-VSC effects of the test toothpastes and test rinses were significantly better than the anti-VSC effects of the respective controls. Toothbrushing with test toothpastes gave median reductions, compared with the control, of 70% for H2 S and 55-57% for CH3 SH. Rinsing with the Sr- and Zn-containing solutions had the same anti-VSC effect as toothbrushing and tooth- and tongue brushing with the Sr- and Zn-containing toothpastes. Zinc-containing rinse resulted in a significantly higher median salivary level of Zn compared with brushing with Zn-containing toothpaste, although this effect did not correlate with the anti-VSC effect. It can be concluded that the Sr- and Zn-containing toothpastes and the Zn- and Sr-containing rinses, when used in the evening, are equally effective in reducing morning-breath VSCs the following day. PMID:25689513

  10. Label and Label-Free Detection Techniques for Protein Microarrays

    Directory of Open Access Journals (Sweden)

    Amir Syahir

    2015-04-01

    Full Text Available Protein microarray technology has gone through numerous innovative developments in recent decades. In this review, we focus on the development of protein detection methods embedded in the technology. Early microarrays utilized useful chromophores and versatile biochemical techniques dominated by high-throughput illumination. Recently, the realization of label-free techniques has been greatly advanced by the combination of knowledge in material sciences, computational design and nanofabrication. These rapidly advancing techniques aim to provide data without the intervention of label molecules. Here, we present a brief overview of this remarkable innovation from the perspectives of label and label-free techniques in transducing nano‑biological events.

  11. First realisation of a labelling kit of N.T.P. 15-5 ligand by {sup 99m}Tc in view of a clinical application in cartilage functional imaging; Premiere realisation d'une trousse de marquage du ligand NTP 15-5 par le 99mTc en vue d'une application clinique en imagerie fonctionnelle du cartilage

    Energy Technology Data Exchange (ETDEWEB)

    Miot-Noirault, E.; Cachin, F.; Vidal, A.; Auzeloux, P.; Chezal, J.M.; Gaumet, V.; Askienazy, S. [Inserm, EA4231, UMR 990, 63 - Clermont-Ferrand (France); Guenu, S. [UFR de pharmacie, laboratoire de chimie analytique, 63 - Clermont-Ferrand (France); Askienazy, S. [Laboratoires Cyclopharma, 63 - Saint-Beauzire (France)

    2010-07-01

    We are working on a SPECT tracer for functional imaging of articular cartilage, the {sup 99m}Tc-NTP 15-5. This molecule has its application in degenerative diseases of cartilage (arthrosis, arthritis and chondrosarcoma). Excellent reports of cartilage versus tissues fixing ratios are obtained in different animal models as well as human anatomical parts. For clinical application, we present the development of a labelling kit by the technetium of the ligand NTP 15-5. (N.C.)

  12. Development of lyophilized kit of Tin-Glucoheptonate for in vitro labeling of leucocytes with {sup 99m}Tc; Desenvolvimento de reagente liofilizado de glucoheptonato-estanho para marcacao de leucocitos com Tecnecio-99m in vitro

    Energy Technology Data Exchange (ETDEWEB)

    Nascimento, Rosemeire Fagundes

    2007-07-01

    The study and localization of inflammatory and infection process in Nuclear Medicine represents a relevant tool in diagnostic procedures. In same cases, the diagnostic is easy and based on anamnesis and clinical observation; in other cases, the patients are asymptomatic or present non specific symptoms that difficult the diagnostic. The early diagnostic of inflammatory or infectious process allow the early introduction of therapy and prevents complications. Farther, the differentiation between inflammation and infection is of extreme importance as well as the localization of the focus. The use of labeled leucocytes, studied and applied in much pathologies, is the method of choice for the visualization of inflammation and infection. The scintigraphy using labeled leucocytes was introduced at 1976 by McAffe and Thakur and since of this is used in the diagnostic of different pathologies related to leucocyte infiltration like intestinal inflammatory disease, bone or prosthetic-vascular infections. The in vitro labeling of leucocytes with {sup 111}In was performed using oxime or tropolone as ligand and with {sup 99m}Tc using hexamethylpropylene amine oxime (HMPAO) as ligand, resulting in a lipophilic complex. The {sup 99m}Tc-HMPAG complex was preferably employed in many indications and countries do to the ideal physical properties of {sup 99m}Tc that results in low dose to the patient. However, the labeling employing the HMPAO complex results in some disadvantages like the low stability of the complex, and some requirements related to the {sup 99m}Tc elution (like the time pos elution), beyond the high cost of the compound that is imported. The aim of this work was the development of a tin-glucoheptonate lyophilized kit for in vitro leucocytes labeling with {sup 99m}Tc using the pre-stannization method. The optimization of the labeling technique was developed using leucocytes isolated from total blood and employing different volumes of the tinglucoheptonate reagent and

  13. Modeling the effects of labeling

    DEFF Research Database (Denmark)

    Juhl, Hans Jørn; Fjord, Thomas Ahle; Poulsen, Carsten Stig

    A new approach to evaluate the consequences of labeling is presented and applied to test the potential effect of a label on fresh fish. Labeling effects on quality perceptions and overall quality are studied. The empirical study is based on an experimental design and nearly 500 respondents partic...... participated in an in home test. The results indicate that catch time alone is not enough to work as an efficient predictor of actual perceived quality.......A new approach to evaluate the consequences of labeling is presented and applied to test the potential effect of a label on fresh fish. Labeling effects on quality perceptions and overall quality are studied. The empirical study is based on an experimental design and nearly 500 respondents...

  14. Edge colouring by total labellings

    DEFF Research Database (Denmark)

    Brandt, Stephan; Rautenbach, D.; Stiebitz, M.;

    2010-01-01

    We introduce the concept of an edge-colouring total k-labelling. This is a labelling of the vertices and the edges of a graph G with labels 1, 2, ..., k such that the weights of the edges define a proper edge colouring of G. Here the weight of an edge is the sum of its label and the labels of its...... two endvertices. We define χ (G) to be the smallest integer k for which G has an edge-colouring total k-labelling. This parameter has natural upper and lower bounds in terms of the maximum degree Δ of G : ⌈ (Δ + 1) / 2 ⌉ ≤ χ (G) ≤ Δ + 1. We improve the upper bound by 1 for every graph and prove χ (G...

  15. Study on preparation of labelled leptin antigen with indirect iodination

    International Nuclear Information System (INIS)

    Objective: To develop method of RIA of leptin for clinical use with 125I-leptin prepared with indirect iodination. Methods: BH reagent was iodinated by ch-T, then conjugated with leptin in ice bath. Results: The specific radioactivity of 125I-leptin obtained was 1.43 MBq/μg, the total labelling rate of 125I was 37.8%, and the technical specifications of leptin RIA could meet the requirement for clinical use. Conclusion: 125I-leptin with higher total labelling rate and specific radioactivity was prepared, lessening the possible harm of direct iodination and other chemicals to the leptin antigen. (authors)

  16. Aggregating Labels in Crowdsourcing Data

    OpenAIRE

    Priisalu, Maria; Grey, Francois; Segal, Ben

    2015-01-01

    Project Specification Crowdsourcing is gaining popularity in academia with the launch of crowdsourcing platforms such as Crowdcrafting [Lombraña, 2015] and GeoTagX [UNOSAT, 2015]. There have been a number of proposed algorithms for the aggregation of true labels and a confusion matrix from crowdsourced labels for ordinal, nominal and binary labels. The work here consists of an implementation of the Dawid Skene [Dawid 1979] adaptation of the Expectation Maximization algorithm [D...

  17. Classification and Labelling for Biocides

    OpenAIRE

    Rubbiani, Maristella

    2015-01-01

    CLP and biocides The EU Regulation (EC) No 1272/2008 on Classification, Labelling and Packaging of Substances and Mixtures, the CLP-Regulation, entered into force on 20th January, 2009. Since 1st December, 2010 the classification, labelling and packaging of substances has to comply with this Regulation. For mixtures, the rules of this Regulation are mandatory from 1st June, 2015; this means that until this date classification, labelling and packaging could either be carried out according to D...

  18. Co-Labeling for Multi-View Weakly Labeled Learning.

    Science.gov (United States)

    Xu, Xinxing; Li, Wen; Xu, Dong; Tsang, Ivor W

    2016-06-01

    It is often expensive and time consuming to collect labeled training samples in many real-world applications. To reduce human effort on annotating training samples, many machine learning techniques (e.g., semi-supervised learning (SSL), multi-instance learning (MIL), etc.) have been studied to exploit weakly labeled training samples. Meanwhile, when the training data is represented with multiple types of features, many multi-view learning methods have shown that classifiers trained on different views can help each other to better utilize the unlabeled training samples for the SSL task. In this paper, we study a new learning problem called multi-view weakly labeled learning, in which we aim to develop a unified approach to learn robust classifiers by effectively utilizing different types of weakly labeled multi-view data from a broad range of tasks including SSL, MIL and relative outlier detection (ROD). We propose an effective approach called co-labeling to solve the multi-view weakly labeled learning problem. Specifically, we model the learning problem on each view as a weakly labeled learning problem, which aims to learn an optimal classifier from a set of pseudo-label vectors generated by using the classifiers trained from other views. Unlike traditional co-training approaches using a single pseudo-label vector for training each classifier, our co-labeling approach explores different strategies to utilize the predictions from different views, biases and iterations for generating the pseudo-label vectors, making our approach more robust for real-world applications. Moreover, to further improve the weakly labeled learning on each view, we also exploit the inherent group structure in the pseudo-label vectors generated from different strategies, which leads to a new multi-layer multiple kernel learning problem. Promising results for text-based image retrieval on the NUS-WIDE dataset as well as news classification and text categorization on several real-world multi

  19. Synthesis and Preliminary Biological Evaluations of Fluorescent or 149Promethium Labeled Trastuzumab-Polyethylenimine

    Directory of Open Access Journals (Sweden)

    Jonathan Fitzsimmons

    2015-12-01

    Full Text Available Background: Radioimmunotherapy utilize a targeting antibody coupled to a therapeutic isotope to target and treat a tumor or disease. In this study we examine the synthesis and cell binding of a polymer scaffold containing a radiotherapeutic isotope and a targeting antibody. Methods: The multistep synthesis of a fluorescent or 149Promethium-labeled Trastuzumab-polyethyleneimine (PEI, Trastuzumab, or PEI is described. In vitro uptake, internalization and/or the binding affinity to the Her2/neu expressing human breast adenocarcinoma SKBr3 cells was investigated with the labeled compounds. Results: Fluorescent-labeled Trastuzumab-PEI was internalized more into cells at 2 and 18 h than fluorescent-labeled Trastuzumab or PEI. The fluorescent-labeled Trastuzumab was concentrated on the cell surface at 2 and 18 h and the labeled PEI had minimal uptake. DOTA-PEI was prepared and contained an average of 16 chelates per PEI; the compound was radio-labeled with 149Promethium and conjugated to Trastuzumab. The purified 149Pm-DOTA-PEI-Trastuzumab had a radiochemical purity of 96.7% and a specific activity of 0.118 TBq/g. The compound demonstrated a dissociation constant for the Her2/neu receptor of 20.30 ± 6.91 nM. Conclusion: The results indicate the DOTA-PEI-Trastuzumab compound has potential as a targeted therapeutic carrier, and future in vivo studies should be performed.

  20. In vivo stability and inertness of various direct labelled and chelate-tagged protein

    International Nuclear Information System (INIS)

    There were looking for methods giving precise information about composition and activity distribution of protein components, both in the initial samples and serum samples after intravenous administration. It was tested the applicability of electroimmunoassay, polyacrilamide gel electrophoresis and high performance liquid chromatography for the assessment of in vivo stability and labelled proteins. The model compound was human serum albumin (HSA) labelled with 99mTc and 125I, respectively. Bifunctional chelate labelling was done with desferrioxamine, in this case protein was labelled with 67Ga. Biodistribution of the labelled compounds and their elimination from the blood were studied in rabbits. Experience with various labelling proteins, especially with Tc-Sn-HSA system indicate that in vivo stability of this compounds are generally low. Following intravenous injection of proteins labelled with metal isotopes, due to dilution and to the presence of considerable amount of compatitive protein in the serum, part of the label is being detached from the carrier protein. Distribution of the detached metal is different from the original distribution of the protein. This problem arises also with radiopharmaceuticals based on monoclonal antibodies. (M.E.L.)

  1. Labelled molecules, modern research implements

    International Nuclear Information System (INIS)

    Details of the synthesis of carbon 14- and tritium-labelled molecules are examined. Although the methods used are those of classical organic chemistry the preparation of carbon 14-labelled molecules differs in some respects, most noticeably in the use of 14CO2 which requires very special handling techniques. For the tritium labelling of organic molecules the methods are somewhat different, very often involving exchange reactions. The following are described in turn: the so-called Wilzbach exchange method; exchange by catalysis in solution; catalytic hydrogenation with tritium; reductions with borotritides. Some applications of labelled molecules in organic chemistry, biochemistry and pharmacology are listed

  2. Labeling and biodistribution of Re-188-DTPA (diethylenetriminepentaaceticacid)

    International Nuclear Information System (INIS)

    Re-188 is useful candidate for therapeutic radionuclide because it has a physical half life of 17 hours, contains beta emissions suitable for therapy(maximum energy 2.12MeV) and emits a gamma ray that is suitable for quantitative diagnostic scanning (155keV). To use Re-188 as a radionuclide compound of angioplasty balloon radiotherapy, we investigated the labelling method and biodistribution of Re-188-DTPA. We postulated that labeled Re-188-DTPA is preferable because it would be excreted via urinary system more easily than other compounds. To label Re-188 with DTPA, 1ml of 222MBq(6mCi) of Re-188 was added to DTPA solution (DTPA 20mg, SnCl2·2H2O 10mg, pH 3.5) and boiled at 100 .deg. C for 120min in water bath. pH was adjusted to 5 with 2.3% sodium acetate. Labeling efficiency was measured using TLC-SG(acetone, saline). We evaluated biodistribution of Re-188-DTPA in sacrificed mice at 10 and 60 minutes after injection. We acquired images of kidneys, and drew time-activity curves in normal dogs and rats and calculated Tmax and T1/2 in rats. The labelling efficiency was 95.7% on average. Labelling of Re-188-DTPA was stable(90% after 5 hours) in vitro at room temperature. According to time-activity curves of dogs and rats, it took 15 to 20 minutes, after injection for Re-188-DTPA to be washed out though kidneys. In conclusion, Re-188-DTPA was successfully labeled, Re-188-DTPA was stable in vitro and was excreted early via kidneys in animals. We could recommend Re-188-DTPA as radionuclide of potential use in angioplasty balloon radiotherapy

  3. 11C-labeling of indolealkylamine alkaloids and the comparative study of their tissue distributions

    International Nuclear Information System (INIS)

    Five indolealkylamines (N,N-dimethyltryptamine, N-methyltryptamine, bufotenine, O-methylbufotenine, N,N,N-trimethyltryptamine iodide) were labeled with 11C by use of 11CH3I. The labeled compounds were synthesized with a radiochemical yield of 2-50% (based on trapped 11CH3I) in 20-35 min with radiochemical purities of more than 92%. The tissue distributions of these labeled compounds were investigated in rats. In all cases, the accumulations in the liver, lung and small intestine were high. [11C]DMT and [11C]OMB also accumulated to a large extent in the brain, where their accumulation was retained. Brain uptake of three other radiopharmaceuticals was low. [11C]DMT is the radiopharmaceutical of choice for the study of the serotonin action mechanism in the brain, because it has the highest radiochemical yield and the highest brain uptake of these 11C-labeled compounds. (author)

  4. 76 FR 75809 - Prior Label Approval System: Generic Label Approval

    Science.gov (United States)

    2011-12-05

    ... the type of packaging material on which the label is printed; n. Brand name changes, provided that... poultry products will take effect January 1, 2012 (75 FR 82148, Dec. 29, 2010). These mandatory features..., location, and indication of final color. To obtain sketch label approval, domestic meat and...

  5. Laser labeling, a safe technology to label produce

    Science.gov (United States)

    Laser labeling of fruits and vegetables is an alternative means to label produce. Low energy CO2 laser beams etch the surface showing the contrasting underlying layer. These etched surfaces can promote water loss and potentially allow for entry of decay organisms. The long-term effects of laser labe...

  6. Clinical Observation of Bronchial Asthma at Chronic Persistent Stage Treated with Compound Chinese Herbal Formulas%中药复方治疗支气管哮喘慢性持续期患者临床观察

    Institute of Scientific and Technical Information of China (English)

    隋艾凤; 徐艳玲; 邓虎

    2015-01-01

    treatment group were better than those in the control group(P<0. 05). Conclusion Com-pound Chinese herbal formulas improves the clinical efficacy on bronchial asthma at chronic persistent stage ( mixture syndrome of deficiency and excess),relieve patients'symptoms and physical signs and benefit lung function,superior to the simple administration of western medicine. This therapy fully implies the advantages of integrated Chinese and western medicine in the treatment of the disease and deserves to be promoted in clinical practice.

  7. Clinical Observation of Compound Carraghenates Suppositories in the Treatment of Wounds after Anal Fissure Operation%复方角菜酸酯栓对肛裂术后创面愈合的临床观察

    Institute of Scientific and Technical Information of China (English)

    毛建波; 郑伯安; 黄银伟

    2015-01-01

    Objective:To investigate the clinical efficacy and safety of compound carraghenates suppositories in the treatment of wounds after anal fissure operation. Methods:Eighty-eight cases of patients with anal fistula post-operation wounds were diagnosed from June 2011 to June 2014 and randomly divided into the observation group (n=44) and the control group (n=44). The control group was treated with the conventional treatment and the observation group was treated with external compound carraghenates suppositories additionally. The efficacy, average healing time, growing time of granulation tissue and removal time of necrotic tissue, pain disappear-ance time and wound edema disappearance time after the operation and the area of wound surface in the two groups were observed and compared. Results:After the 14-day treatment, the time of wound healing, granulation growth and cure in the observation group was shorter than that in the control group (P<0. 05). In the observation group, the total effective rate (93. 18%) was higher than that in the control group (77. 27%, P<0. 05). After the 7-day and 14-day treatment, the pain score and wound edema score in the observa-tion group were significantly lower than those in the control group (P<0. 05), and the wound area was significantly smaller than that in the control group (P<0. 05). Conclusion:The clinical efficacy of external compound carraghenates suppositories in the treatment of wounds after anal fissure operation is significant, safe and reliable.%目的:探讨复方角菜酸酯栓对肛裂术后创面愈合的临床效果及安全性. 方法:2011年6月~2014年6月肛裂术后患者88例随机分为观察组(n=44)和对照组(n=44). 对照组给予常规处理,观察组在对照组基础上加用复方角菜酸酯栓,疗程均为14d. 比较两组创面平均愈合时间、肉芽生长时间及祛腐时间、疗效、术后疼痛程度评分及术后创面水肿评分、术后创面面积. 结果:观察组治疗14 d后创

  8. Economical synthesis of 13C-labeled opiates, cocaine derivatives and selected urinary metabolites by derivatization of the natural products.

    Science.gov (United States)

    Karlsen, Morten; Liu, Huiling; Johansen, Jon Eigill; Hoff, Bård Helge

    2015-01-01

    The illegal use of opiates and cocaine is a challenge world-wide, but some derivatives are also valuable pharmaceuticals. Reference samples of the active ingredients and their metabolites are needed both for controlling administration in the clinic and to detect drugs of abuse. Especially, (13)C-labeled compounds are useful for identification and quantification purposes by mass spectroscopic techniques, potentially increasing accuracy by minimizing ion alteration/suppression effects. Thus, the synthesis of [acetyl-(13)C4]heroin, [acetyl-(13)C4-methyl-(13)C]heroin, [acetyl-(13)C2-methyl-(13)C]6-acetylmorphine, [N-methyl-(13)C-O-metyl-(13)C]codeine and phenyl-(13)C6-labeled derivatives of cocaine, benzoylecgonine, norcocaine and cocaethylene was undertaken to provide such reference materials. The synthetic work has focused on identifying (13)C atom-efficient routes towards these derivatives. Therefore, the (13)C-labeled opiates and cocaine derivatives were made from the corresponding natural products. PMID:25816077

  9. Economical Synthesis of 13C-Labeled Opiates, Cocaine Derivatives and Selected Urinary Metabolites by Derivatization of the Natural Products

    Directory of Open Access Journals (Sweden)

    Morten Karlsen

    2015-03-01

    Full Text Available The illegal use of opiates and cocaine is a challenge world-wide, but some derivatives are also valuable pharmaceuticals. Reference samples of the active ingredients and their metabolites are needed both for controlling administration in the clinic and to detect drugs of abuse. Especially, 13C-labeled compounds are useful for identification and quantification purposes by mass spectroscopic techniques, potentially increasing accuracy by minimizing ion alteration/suppression effects. Thus, the synthesis of [acetyl-13C4]heroin, [acetyl-13C4-methyl-13C]heroin, [acetyl-13C2-methyl-13C]6-acetylmorphine, [N-methyl-13C-O-metyl-13C]codeine and phenyl-13C6-labeled derivatives of cocaine, benzoylecgonine, norcocaine and cocaethylene was undertaken to provide such reference materials. The synthetic work has focused on identifying 13C atom-efficient routes towards these derivatives. Therefore, the 13C-labeled opiates and cocaine derivatives were made from the corresponding natural products.

  10. N-13 labeled amino acids: biodistribution, metabolism and dosimetric considerations

    International Nuclear Information System (INIS)

    With the growing interest in metabolic imaging and with the increasing number of cyclotron/PET facilities, more studies are being performed in animal and humans using short-lived positron-emitting radionuclides. Amino acids labeled either with N-13 or C-11 are one group of compounds being used to study in vivo regional organ (i.e., brain and heart) or tumor metabolism. Of the studies previously reported using C-11 or N-13 labeled amino acids (methionine, alanine, valine, glutamate, glutamine and tryptophan), imaging was restricted mainly to the organ or tissue of interest with little information obtained about the whole-bode distribution of the label. Such data are important for studying interorgan transport of amino acids and for determining accurate dosimetric measurements after intravenous injection of labeled amino acids. The goals of the authors study were to compare the distribution of several N-13 L-amino acids and N-13 ammonia in tumor-bearing mice and to determine the metabolic fate of the label in vivo. The following amino acids were enzymatically labeled using N-13 ammonia: glutamine, glutamate, methionine, α-aminobutyric acid, valine and leucine. 30 references, 2 figures, 14 tables

  11. Oxygen labelled CO2

    International Nuclear Information System (INIS)

    Tests were carried out as to whether additional information concerning pulmonary gas exchange could be obtained from the application of oxygen labelled carbon dioxide. Single breath experiments were performed on two healthy subjects with 0.1 percent C16O18O and 2.8 percent C18O2 in the inspiratory gas. Breath-hold time was varied between 0.5-20s in different experiments. The 18O-concentration of the end-expired gas bi-exponentially decreased with increasing breath-hold time. The high and low rate constants 4s-1 and 0.12s-1 for C18O2 and 2.5s-1 and 0.87s-1 for C16O18O were derived, respectively. These results, together with model calculations, suggest: 1) the rapid disappearance of C18O2 from the alveolar space is primarily limited by diffusion, so that this isotopic species can be applied to quantify pulmonary diffusing conditions; 2) the lower disappearance rate of C16O18O is caused by a lower equilibration kinetics in blood, so that this isotopic species offers a possibility to study carbonic anhydrase activity of the red cells in vivo; 3) the slow phase of label decay is influenced by both alveolar dead space and carbonic anhydrase activity of the pulmonary tissues. Pathological dead spaces are expected to be sensitively detectable by C16O18O as well as by C18O2. (author). 4 refs.; 4 figs

  12. Off-label use of targeted therapies in oncology

    Science.gov (United States)

    Levêque, Dominique

    2016-01-01

    Off-label use is defined by the prescription of a marketed drug outside the conditions described in the summary of product characteristics. In oncology, off-label prescribing of targeted therapies may occur in patients with other tumor types expressing the same target. Agents associated to phenotypic approaches such as therapies against the tumoral vasculature (anti-angiogenic drugs) and new immunotherapies (checkpoint inhibitors) also carry the potential of alternative indications or combinations. Off-label use of targeted therapies is little documented and appears to be in the same range than that regarding older drugs with wide variations among agents. When compared with older agents, off-label use of targeted therapies is probably more rational through tumoral genotyping but is faced with a limited clinical support, reimbursement challenges related to the very high pricing and the cost of genotyping or molecular profiling, when applicable. PMID:27081648

  13. Synthesis of singly 2H-, 3H-, and 14C- and doubly labeled acetaminophen, phenacetin, and p-acetanisidine

    International Nuclear Information System (INIS)

    Several efficient procedures for the synthesis of deuterium, tritium, and 14C-labeled acetaminophen, phenacetin, and p-acetanisidine are described. p-Aminophenol was acylated by the appropriate acetic anhydride under mild conditions yielding labeled acetaminophen. With O-alkylation using NaCH2SOCH3 and appropriate labeled and unlabeled alkyl halides, labeled phenacetin and p-acetanisidine were also obtained. Phenacetin labeled both with 14C on the acyl group and deuterium on the ethoxy group was synthesized in high yield by acylation of p-phenetidine-d5. The last compound was obtained by acid hydrolysis of phenacetin-d5 synthesized previously. (author)

  14. Off-label drug in the newborn

    Directory of Open Access Journals (Sweden)

    Laura Cuzzolin

    2014-06-01

    Full Text Available The lack of specific drugs and labelling recommendations for the neonatal population is a long-standing problem throughout the world. With the introduction of the Paediatric Regulation in 2007, in Europe tangible steps have been made to increase clinical research in children, but only a limited number of clinical trials included neonates that remain therapeutic orphans. This leads to a widespread use of medicines outside the terms indicated in the product license (off-label as regards dose, route of administration, indication, age group or in an unlicensed manner (formulations modified, extemporaneous preparations, imported medicines, chemicals used as drugs. This use, often made on the basis of a consolidated clinical experience in absence of other authorized options, does not imply that a drug is contraindicated or disapproved, but simply means that insufficient data are available to grant approval status and the risks and benefits of using a drug in a particular situation have not been examined. Given the importance that neonatal population not be denied of drugs that are clearly beneficial, an updated overview of the worldwide situation of off-label and unlicensed drug use in the newborn will be presented, by analyzing also the impact of recent legislative initiatives and the well recognized problems (increased risk of ineffective or toxic treatments, adverse drug reactions and medication errors. Proceedings of the 10th International Workshop on Neonatology · Cagliari (Italy · October 22nd-25th, 2014 · The last ten years, the next ten years in Neonatology Guest Editors: Vassilios Fanos, Michele Mussap, Gavino Faa, Apostolos Papageorgiou

  15. Limitations of Label-Free Sensors in Serum Based Molecular Diagnostics

    CERN Document Server

    Varma, Manoj M

    2015-01-01

    Immunoassay formats applicable for clinical or point-of-care diagnostics fall into two broad classes. One which uses labeled secondary antibodies for signal transduction and the other which does not require the use of any labels. Comparison of the limits of detection (LoD) reported by these two sensing approaches over a wide range of detection techniques and target molecules in serum revealed that labeled techniques achieve 2-3 orders of magnitude better LoDs. Further, a vast majority of commercial tests and recent examples of technology translations are based on labeled assay formats. In light of this data, it is argued that extension of traditional labeled approaches and enhancing their functionality may have better clinical impact than the development of newer label-free techniques.

  16. Surface Plasmon Resonance Label-Free Monitoring of Antibody Antigen Interactions in Real Time

    Science.gov (United States)

    Kausaite, Asta; van Dijk, Martijn; Castrop, Jan; Ramanaviciene, Almira; Baltrus, John P.; Acaite, Juzefa; Ramanavicius, Arunas

    2007-01-01

    Detection of biologically active compounds is one of the most important topics in molecular biology and biochemistry. One of the most promising detection methods is based on the application of surface plasmon resonance for label-free detection of biologically active compounds. This method allows one to monitor binding events in real time without…

  17. Accelerated stem cell labeling with ferucarbotran and protamine

    Energy Technology Data Exchange (ETDEWEB)

    Golovko, Daniel M.; Henning, Tobias; Bauer, Jan S. [Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA (United States); Settles, Marcus; Rummeny, Ernst J. [Technical University Munich, Department of Radiology, Munich (Germany); Frenzel, Thomas [Bayer Schering Pharma AG, Berlin (Germany); Mayerhofer, Artur [Ludwig-Maximilians-Universitaet, Institute of Cell Biology, Munich (Germany); Daldrup-Link, Heike E. [Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA (United States); UCSF Medical Center, Contrast Agent Research Group, Department of Radiology, San Francisco, CA (United States)

    2010-03-15

    To develop and characterize a clinically applicable, fast and efficient method for stem cell labeling with ferucarbotran and protamine for depiction with clinical MRI. The hydrodynamic diameter, zeta potential and relaxivities of ferucarbotran and varying concentrations of protamine were measured. Once the optimized ratio was found, human mesenchymal stem cells (MSCs) were labeled at varying incubation times (1-24 h). Viability was assessed via Trypan blue exclusion testing. 150,000 labeled cells in Ficoll solution were imaged with T1-, T2- and T2*-weighted sequences at 3 T, and relaxation rates were calculated. Varying the concentrations of protamine allows for easy modification of the physicochemical properties. Simple incubation with ferucarbotran alone resulted in efficient labeling after 24 h of incubation while assisted labeling with protamine resulted in similar results after only 1 h. Cell viability remained unaffected. R2 and R2* relaxation rates were drastically increased. Electron microscopy confirmed intracellular iron oxide uptake in lysosomes. Relaxation times correlated with results from ICP-AES. Our results show internalization of ferucarbotran can be accelerated in MSCs with protamine, an approved heparin antagonist and potentially clinically applicable uptake-enhancing agent. (orig.)

  18. Accelerated stem cell labeling with ferucarbotran and protamine

    International Nuclear Information System (INIS)

    To develop and characterize a clinically applicable, fast and efficient method for stem cell labeling with ferucarbotran and protamine for depiction with clinical MRI. The hydrodynamic diameter, zeta potential and relaxivities of ferucarbotran and varying concentrations of protamine were measured. Once the optimized ratio was found, human mesenchymal stem cells (MSCs) were labeled at varying incubation times (1-24 h). Viability was assessed via Trypan blue exclusion testing. 150,000 labeled cells in Ficoll solution were imaged with T1-, T2- and T2*-weighted sequences at 3 T, and relaxation rates were calculated. Varying the concentrations of protamine allows for easy modification of the physicochemical properties. Simple incubation with ferucarbotran alone resulted in efficient labeling after 24 h of incubation while assisted labeling with protamine resulted in similar results after only 1 h. Cell viability remained unaffected. R2 and R2* relaxation rates were drastically increased. Electron microscopy confirmed intracellular iron oxide uptake in lysosomes. Relaxation times correlated with results from ICP-AES. Our results show internalization of ferucarbotran can be accelerated in MSCs with protamine, an approved heparin antagonist and potentially clinically applicable uptake-enhancing agent. (orig.)

  19. Fluorine-18 labeled tracers for PET studies in the neurosciences

    Energy Technology Data Exchange (ETDEWEB)

    Ding, Yu-Shin; Fowler, J.S.

    1995-12-31

    This chapter focuses on fluorine-18, the positron emitter with the longest half-life, the lowest positron energy and probably, the most challenging chemistry. The incorporation of F-18 into organic compounds presents many challenges, including: the need to synthesize and purify the compound within a 2--3 hour time frame; the limited number of labeled precursor molecules; the need to work on a microscale; and the need to produce radiotracers which are chemically and radiochemically pure, sterile and pyrogen-free, and suitable for intravenous injection. The PET method and F-18 labeling of organic molecules are described followed by highlights of the applications of F-18 labeled compounds in the neurosciences and neuropharmacology. It is important to emphasize the essential and pivotal role that organic synthesis has played in the progression of the PET field over the past twenty years from one in which only a handful of institutions possessed the instrumentation and staff to carry out research to the present-day situation where there are more than 200 PET centers worldwide. During this period PET has become an important scientific tool in the neurosciences, cardiology and oncology. It is important to point out that PET is by no means a mature field. The fact that a hundreds of different F-18 labeled compounds have been developed but only a few possess the necessary selectivity and sensitivity in vivo to track a specific biochemical process illustrates this and underscores a major difficulty in radiotracer development, namely the selection of priority structures for synthesis and the complexities of the interactions between chemical compounds and living systems. New developments in rapid organic synthesis are needed in order to investigate new molecular targets and to improve the quantitative nature of PET experiments.

  20. Fluorine-18 labeled tracers for PET studies in the neurosciences

    International Nuclear Information System (INIS)

    This chapter focuses on fluorine-18, the positron emitter with the longest half-life, the lowest positron energy and probably, the most challenging chemistry. The incorporation of F-18 into organic compounds presents many challenges, including: the need to synthesize and purify the compound within a 2--3 hour time frame; the limited number of labeled precursor molecules; the need to work on a microscale; and the need to produce radiotracers which are chemically and radiochemically pure, sterile and pyrogen-free, and suitable for intravenous injection. The PET method and F-18 labeling of organic molecules are described followed by highlights of the applications of F-18 labeled compounds in the neurosciences and neuropharmacology. It is important to emphasize the essential and pivotal role that organic synthesis has played in the progression of the PET field over the past twenty years from one in which only a handful of institutions possessed the instrumentation and staff to carry out research to the present-day situation where there are more than 200 PET centers worldwide. During this period PET has become an important scientific tool in the neurosciences, cardiology and oncology. It is important to point out that PET is by no means a mature field. The fact that a hundreds of different F-18 labeled compounds have been developed but only a few possess the necessary selectivity and sensitivity in vivo to track a specific biochemical process illustrates this and underscores a major difficulty in radiotracer development, namely the selection of priority structures for synthesis and the complexities of the interactions between chemical compounds and living systems. New developments in rapid organic synthesis are needed in order to investigate new molecular targets and to improve the quantitative nature of PET experiments

  1. Astatine-211-Labeled Targeted Radiotherapeutics: An Update

    International Nuclear Information System (INIS)

    The heavy halogen 211At was first proposed for use in α-particle targeted radiotherapy more than 30 years ago and continues to be one of the most promising radionuclides for this purpose. Although its 7.2-h half life is not ideal for intravenously administered whole antibodies, it is compatible with the pharmacokinetics of antibody fragments, peptides, aptamers and organic molecules. Its diverse chemistry allows its incorporation into a wide array of targeting vehicles, relying on its chemical similarity to iodine to provide a useful point of departure. On the other hand, the relatively low carbon-astatine bond strength is challenging. In common with the other α-emitters being discussed at this symposium, lack of reliable availability is one of the biggest hurdles in the use of 211At for targeted radiotherapy. However, in the case of 211At, it is not a question of production cost or availability of target material, because 211At can be produced in reasonable yield from natural bismuth targets. Rather, the difficulty is the lack of cyclotrons equipped with the medium energy α-particle beams required for its production. If the infrastructure for producing 211At is to be improved to the stage where 211At-labeled radiopharmaceuticals can have a meaningful impact, several developments must occur. First, the ability to produce clinically relevant levels of 211At that can be shipped to remote locations in chemically tractable form must be demonstrated. Approaches under consideration include compensating for radiolysis-mediated effects and the consideration of alternative chemistries. Second, strategies for compensating for heterogeneities in dose deposition must be developed, hopefully in a way that is compatible with approval for human use. And third, it is essential that more clinical trials be performed with 211At-labeled therapeutics, particularly in settings of minimum residual disease where the radiobiological advantages of α-particles can be best exploited. Our

  2. Aptamer-mediated indirect quantum dot labeling and fluorescent imaging of target proteins in living cells

    International Nuclear Information System (INIS)

    Protein labeling for dynamic living cell imaging plays a significant role in basic biological research, as well as in clinical diagnostics and therapeutics. We have developed a novel strategy in which the dynamic visualization of proteins within living cells is achieved by using aptamers as mediators for indirect protein labeling of quantum dots (QDs). With this strategy, the target protein angiogenin was successfully labeled with fluorescent QDs in a minor intactness model, which was mediated by the aptamer AL6-B. Subsequent living cell imaging analyses indicated that the QDs nanoprobes were selectively bound to human umbilical vein endothelial cells, gradually internalized into the cytoplasm, and mostly localized in the lysosome organelle, indicating that the labeled protein retained high activity. Compared with traditional direct protein labeling methods, the proposed aptamer-mediated strategy is simple, inexpensive, and provides a highly selective, stable, and intact labeling platform that has shown great promise for future biomedical labeling and intracellular protein dynamic analyses. (paper)

  3. Meat and Poultry Labeling Terms

    Science.gov (United States)

    ... Food Standards and Labels: The Facts Labeling and Marketing Information [ Top of Page ] OVEN PREPARED: Product is fully cooked and ready to eat. [ Top of Page ] YOUNG TURKEY: Turkeys of either sex that are less than 8 months of age according to present regulations. [ Top of Page ] Last ...

  4. Nutrition Marketing on Food Labels

    Science.gov (United States)

    Colby, Sarah E.; Johnson, LuAnn; Scheett, Angela; Hoverson, Bonita

    2010-01-01

    Objective: This research sought to determine how often nutrition marketing is used on labels of foods that are high in saturated fat, sodium, and/or sugar. Design and Setting: All items packaged with food labels (N = 56,900) in all 6 grocery stores in Grand Forks, ND were surveyed. Main Outcome Measure(s): Marketing strategy, nutrient label…

  5. Low Literacy Impairs Comprehension of Prescription Drug Warning Labels

    Science.gov (United States)

    Davis, Terry C; Wolf, Michael S; Bass, Pat F; Middlebrooks, Mark; Kennen, Estela; Baker, David W; Bennett, Charles L; Durazo-Arvizu, Ramon; Bocchini, Anna; Savory, Stephanie; Parker, Ruth M

    2006-01-01

    BACKGROUND Adverse events resulting from medication error are a serious concern. Patients' literacy and their ability to understand medication information are increasingly seen as a safety issue. OBJECTIVE To examine whether adult patients receiving primary care services at a public hospital clinic were able to correctly interpret commonly used prescription medication warning labels. DESIGN In-person structured interviews with literacy assessment. SETTING Public hospital, primary care clinic. PARTICIPANTS A total of 251 adult patients waiting for an appointment at the Louisiana State University Health Sciences Center in Shreveport (LSUHSC-S) Primary Care Clinic. MEASUREMENTS Correct interpretation, as determined by expert panel review of patients' verbatim responses, for each of 8 commonly used prescription medication warning labels. RESULTS Approximately one-third of patients (n=74) were reading at or below the 6th-grade level (low literacy). Patient comprehension of warning labels was associated with one's literacy level. Multistep instructions proved difficult for patients across all literacy levels. After controlling for relevant potential confounding variables, patients with low literacy were 3.4 times less likely to interpret prescription medication warning labels correctly (95% confidence interval: 2.3 to 4.9). CONCLUSIONS Patients with low literacy had difficulty understanding prescription medication warning labels. Patients of all literacy levels had better understanding of warning labels that contained single-step versus multiple-step instructions. Warning labels should be developed with consumer participation, especially with lower literate populations, to ensure comprehension of short, concise messages created with familiar words and recognizable icons. PMID:16881945

  6. Intratumoral injection of 188Re labeled cationic polyethylenimine conjugates: a preliminary report.

    Science.gov (United States)

    Kim, Eun-Mi; Jeong, Hwan-Jeong; Heo, Young-Jun; Moon, Hyung-Bae; Bom, Hee-Seung; Kim, Chang-Guhn

    2004-10-01

    188Re (Rhenium) is easily obtained from an in-house 188W/188Re generator that is similar to the current 99Mo/99mTc generator, making it very convenient for clinical use. This characteristic makes this radionuclide a promising candidate as a therapeutic agent. Polyethylenimine (PEI) is a cationic polymer and has been used as a gene delivery vector. Positively charged materials interact with cellular blood components, vascular endothelium, and plasma proteins. In this study, the authors investigated whether intratumoral injection of 188Re labeled transferrin (Tf)-PEI conjugates exert the effect of radionuclide therapy against the tumor cells. When the diameters of the Ramos lymphoma (human Burkitt's lymphoma) xenografted tumors reached approximately 1 cm, 3 kinds of 188Re bound compounds (HYNIC-PEI-Tf, HYNIC-PEI, 188Re perrhenate) were injected directly into the tumors. There were increases in the retention of 188Re inside the tumor when PEI was incorporated with 188Re compared to the use of free 188Re. The 188Re HYNIC-Tf-PEI showed the most retention inside the tumor (retention rate=approximately 97%). H&E stain of isolated tumor tissues showed that 188Re labeled HYNIC-PEI-Tf caused extensive tumor necrosis. These results support 188Re HYNIC-PEI-Tf as being a useful radiopharmaceutical agent to treat tumors when delivered by intratumoral injection. PMID:15483337

  7. A Better Carbon Footprint Label

    DEFF Research Database (Denmark)

    Thøgersen, John; Nielsen, Kristian S.

    2016-01-01

    expected, price and carbon footprint were negatively related to choice. Further, participants preferred organic to non-organic coffee and certification by a public authority. The effect of the carbon label is significantly stronger the more environmentally concerned the consumer is. Using colors to...... indicate relative carbon footprint significantly increases carbon label effectiveness. Hence, a carbon footprint label is more effective if it uses traffic light colors to communicate the product's relative performance.......Based on insights from behavioral economics, it is suggested to extend carbon footprint labeling with information about relative performance, using the well-known “traffic light” color scheme to communicate relative performance. To test this proposition, the impact of a carbon footprint label on...

  8. Sublinear distance labeling for sparse graphs

    DEFF Research Database (Denmark)

    Alstrup, Stephen; Dahlgaard, Søren; Knudsen, Mathias Bæk Tejs; Porat, Ely

    A distance labeling scheme labels the $n$ nodes of a graph with binary strings such that, given the labels of any two nodes, one can determine the distance in the graph between the two nodes by looking only at the labels. A $D$-preserving distance labeling scheme only returns precise distances be...

  9. 21 CFR 201.71 - Magnesium labeling.

    Science.gov (United States)

    2010-04-01

    ... 21 Food and Drugs 4 2010-04-01 2010-04-01 false Magnesium labeling. 201.71 Section 201.71 Food and... LABELING Labeling Requirements for Over-the-Counter Drugs § 201.71 Magnesium labeling. (a) The labeling of over-the-counter (OTC) drug products intended for oral ingestion shall contain the magnesium...

  10. Clinical Effects Observation of Compound Danseng Dripping Pills in Treating Unsteady Angina Pectoris Patients%复方丹参滴丸治疗不稳定性心绞痛疗效观察

    Institute of Scientific and Technical Information of China (English)

    王昕

    2001-01-01

    Aim To observe the clinical effects of treatment for curing the unsteady angina pectoris(belonging to the blood blocked heart vessels symptoms) by taking advantage of the Chinese medicine called compound Danseng dripping pills.Methods By means of randomization control and on the basis of regular treatments,38 cases of the treated group adopt the dripping pills for treatment,meanwhile,35 cases of the control group adopt the Isosorbide dinitrate.Either of the treatments takes four weeks.Observing the changes of the two groups in symptoms,classified angina pectoris,ECG,the blood-flowing power and so on.Results The effect rate of the treated group is 92.1%.Compared with the control group,it has remarkable differences in classified angina pectoris,improving the heart vessels and the character of blood blowing(P<0.05,P<0.001) without any adverse reaction.Conclusion The compound danseng dripping pills have remarkable effects on the unsteady angina pectoris.%目的观察中成药复方丹参滴丸治疗冠心病不稳定性心绞痛(属心血瘀阻证)的临床疗效。方法采用随机对照法,在常规治疗基础上,治疗组38例使用复方丹参滴丸治疗,对照组35例使用硝酸异山梨醇酯片治疗,疗程均为4周。观察两组症状,治疗前后心绞痛分级,心电图,血流动力学等变化。结果治疗组总有效率为92.1%,对心绞痛分级,改善缺血心电图以及改善血液流变性等,与对照组比较,均有显著性差异(P<0.05,P<0.001),无不良反应。结论复方丹参滴丸对不稳定性心绞痛有较显著疗效。

  11. Radiochromatographic Determination of 131I Labeled Eugenol

    Directory of Open Access Journals (Sweden)

    F. Zümrüt Biber Müftüler

    2015-02-01

    Full Text Available Phenolic phytochemicals are a broad class of nutraceuticals found in plants which have been extensively researched by scientists for medicinal potential. Eugenol, a phenolic natural compound available in the essential oils primarily extracted from clove plants, has been exploited for various medicinal applications. It possesses antioxidant, antimutagenic, antigenotoxic, anti-inflammatory and anticancer properties. The goal of current study was to extract Eugenol compound from clove plant and radiolabel the eugenol with 131I which is a well known radioisotope for imaging and therapy in Nuclear Medicine by utilizing iodogen method. The yield of radiolabeling of Eugenol (131I-E was calculated over 80% by Thin Layer Radio Chromatography and High Performance Liquid Radio Chromatograpy methods. Structural analysis of Eugenol was confirmed by Liguid Chromatography Mass Spectroscopy. Lipophilicity and stability studies were performed. Due to the attachment of iodine to Eugenol, radioiodinated Eugenol was more lipophilic. Stability of 131I-E was appropriate for study period. All experimental results suggest that 131I labeled Eugenol compound may be used in the applications of Nuclear Medicine as a radiolabeled agent for imaging and therapy on various cancer types.

  12. Radio-labelled humic materials in migration studies

    International Nuclear Information System (INIS)

    Humic- and fulvic acids are able to complex polyvalent metal ions, e.g. radionuclides, leading to soluble complexes of significant strength, thereby decreasing the sorption of these compounds to soils and sediments. The interaction of humic materials with radionuclides may significantly influence the availability and transport of the latter in the environment. Typically, studies along these lines have focussed almost exclusively on the radionuclides, whereas the actual role of the humic material has been elucidated only indirectly. In order directly to study the behavior of the naturally occurring organic macro-molecules in relation to the environmental fate of radionuclides, radio-labelled humic- and fulvic acids can advantageously be applied. Radio-labels such as 14C and 125I have successfully been covalently incorporated in humic- and fulvic-acids. Labelling of humic substances as well as preliminary migration studies are discussed

  13. Novel Marine Compounds: Anticancer or Genotoxic?

    OpenAIRE

    Arif, Jamal M.; Al-Hazzani, Amal A.; Muhammed Kunhi; Fahad Al-Khodairy

    2004-01-01

    In the past several decades, marine organisms have generously gifted to the pharmaceutical industries numerous naturally bioactive compounds with antiviral, antibacterial, antimalarial, anti-inflammatory, antioxidant, and anticancer potentials. But till date only few anticancer drugs (cytarabine, vidarabine) have been commercially developed from marine compounds while several others are currently in different clinical trials. Majority of these compounds were tested in the tumor xenograft mode...

  14. Imaging in rheumatoid arthritis using liposomes labelled with technetium

    International Nuclear Information System (INIS)

    The results are presented of a preliminary study showing that technetium-labelled liposomes are accumulated in clinically affected joints of patients with rheumatoid arthritis. Typical scintigraph scans are presented. This method offers an opportunity of determining the extent and activity of macrophages within synovial tissue. (UK)

  15. Synthesis of 13C labelled lactose for metabolic studies

    International Nuclear Information System (INIS)

    The most common cause of diarrhoea in Uruguay is lactose intolerance, and to determine the origin of diarrhoea in individual cases a deep and fast clinical method is highly desirable. The present report discusses the synthesis of c-13-labelled lactose and two separation methods for detecting sugars in samples of faeces

  16. Clinical observation of Daphne Huang Tang compound combines with Risperdal in treatment of schizophrenia%复方黄芫花汤联合维思通片治疗精神分裂症临床观察

    Institute of Scientific and Technical Information of China (English)

    张清洁; 张兰华; 谢涛

    2011-01-01

    Objective It is to approach the clinical effect and safety of Daphne Huang Tang compound combines with Risperdal in treatment of schizophrenia. Methods Total 1 000 patients with schizophrenia were randomly divided into treatment group and control group ( each had 500 patients ), all patients were recevied the basic treatment of Risperdal, patients in treatment group were treated with Daphne Huang Tang compound for 3 month. Before and after treatment, Brief Psychiatric Rating Scale ( BPRS ), Wechsler Memory Scale test check ( WMS ) were used to value the effects every week, Treatment Emergent Symptom Scale ( TESS ) was used to observe the adverse reaction every two weeks, ECG, Blood, Urine, Then conventional, biochemical, glucose metabolism, thyroid hormone function were used to value the safety of the drugs. Results After 3 months of treatment, BPRS was decreased, and WMS was elevated in both groups. The scores of TESS in treatment group were significantly lower than that in control group. Conclusion Daphne Huang Tang compound combines with Risperdal in treatment of schizophrenia is a treatment method with good efficacy and less side effects.%目的 探讨复方黄芫花汤联合维思通片治疗精神分裂症的临床疗效及安全性.方法 将1000例精神分裂症患者随机分为2组各500例,2组均给予维思通片治疗,治疗组在维思通药物基础上给予复方黄芫花汤治疗.观察3个月,治疗前及治疗开始后每周应用简明精神病量表及韦氏记忆测查量表评分,每2周应用药物不良反应量表测查评定药物不良反应,每月给予心电图、血尿便常规、生化、糖代谢、甲状腺激素功能检查评价药物安全性.结果 治疗3个月后,2组简明精神病量表评分均较治疗前明显降低,韦氏记忆测查量表评分均较治疗前显著提高,且随时间的延续疗效呈上升趋势;治疗组TESS评分明显低于对照组.结论 复方黄芫花汤联合维思通片治疗精神分裂

  17. An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay-Sachs or Sandhoff variants).

    Science.gov (United States)

    Clarke, Joe T R; Mahuran, Don J; Sathe, Swati; Kolodny, Edwin H; Rigat, Brigitte A; Raiman, Julian A; Tropak, Michael B

    2011-01-01

    Late-onset GM2 gangliosidosis is an autosomal recessive, neurodegenerative, lysosomal storage disease, caused by deficiency of ß-hexosaminidase A (Hex A), resulting from mutations in the HEXA (Tay-Sachs variant) or the HEXB (Sandhoff variant) genes. The enzyme deficiency in many patients with juvenile or adult onset forms of the disease results from the production of an unstable protein, which becomes targeted for premature degradation by the quality control system of the smooth endoplasmic reticulum and is not transported to lysosomes. In vitro studies have shown that many mutations in either the α or β subunit of Hex A can be partially rescued, i.e. enhanced levels of both enzyme protein and activity in lysosomes, following the growth of patient cells in the presence of the drug, pyrimethamine. The objectives of the present clinical trial were to establish the tolerability and efficacy of the treatment of late-onset GM2 gangliosidosis patients with escalating doses of pyrimethamine, to a maximum of 100 mg per day, administered orally in a single daily dose, over a 16-week period . The primary objective, tolerability, was assessed by regular clinical examinations, along with a panel of hematologic and biochemical studies. Although clinical efficacy could not be assessed in this short trial, treatment efficacy was evaluated by repeated measurements of leukocyte Hex A activity, expressed relative to the activity of lysosomal ß-glucuronidase. A total of 11 patients were enrolled, 8 males and 3 females, aged 23 to 50 years. One subject failed the initial screen, another was omitted from analysis because of the large number of protocol violations, and a third was withdrawn very early as a result of adverse events which were not drug-related. For the remaining 8 subjects, up to a 4-fold enhancement of Hex A activity at doses of 50 mg per day or less was observed. Additionally marked individual variations in the pharmacokinetics of the drug among the patients were

  18. How to Read a Nutrition Facts Label

    Medline Plus

    Full Text Available ... Under Control Figuring Out Food Labels Healthy Food Shopping If My Child Has Food Allergies, What Should ... for Parents Figuring Out Food Labels Smart Supermarket Shopping Figuring Out Fat and Calories Food Labels Contact ...

  19. Application of solid-phase heterogeneous catalytic hydrogenation for preparation of ethanolamine labelled by tritium and ethanolamides of aroachidonic, eicosanepentaenic, docosahexaenic acids labelled by tritium partially

    International Nuclear Information System (INIS)

    Ethanolamine labelled with tritium with 35-40 Ci/mmol molar radioactivity is produced from glycolic acid nitrile by means of solid-phase heterogeneous catalytic hydrogenation on 5% Rh/C. Preparational quantities of labelled ethanolamine are produced with 10-20% yield with the use of 5% of pd?C and 70% of glycolic acid aqueous nitrile, the molar activity of the preparation required is 4-6 Ci/mmol. Ethanolamides of arachidonic, eicosapentaenoic, docosahexaenoic acids are synthesized from the labelled ethanolamine. The compound produced are tested by chromatographic and fermentative methods

  20. Characterization of bromine-77-labeled proteins prepared using bromoperoxidase

    International Nuclear Information System (INIS)

    The halogenating enzyme bromoperoxidase, isolated from the red algae Bonnemaisonia hamifera and Penicillus capitatus, was used to catalyze the radiohalogenation of proteins at neutral pH. Human serum albumin and canine fibrinogen were halogenated as model compounds; the proteins were labeled with Br-77, produced by the 75As(α,2n)77Br reaction. For each enzyme, the essential reaction parameters (including the concentrations of hydrogen peroxide or of protein, the amount of enzyme used to catalyze the reaction, the pH of the reaction mixture, and the reaction time) were varied to obtain conditions that resulted in the highest yield of radiolabeled protein. The labeled proteins prepared with bromoperoxidase are stable with respect to loss of the radiolabel by hydrolysis and retain their biologic activity. The extension of this method to radiobromination of other types of compounds for imaging and receptor studies seems promising